{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:06:04Z","timestamp":1791295564864,"version":"4.1.0"},"reference-count":3730,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.pharmthera.2005.11.006","type":"journal-article","created":{"date-parts":[[2006,5,20]],"date-time":"2006-05-20T11:22:17Z","timestamp":1148124137000},"page":"135-370","source":"Crossref","is-referenced-by-count":473,"title":["Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application"],"prefix":"10.1016","volume":"110","author":[{"given":"Mark J.","family":"Millan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2005.11.006_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2265.2001.01320.x","article-title":"Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities","volume":"55","author":"Abdu","year":"2001","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0006-8993(95)01298-2","article-title":"Substance P receptor regulates the photic induction of Fos-like protein in the suprachiasmatic nucleus of Syrian hamsters","volume":"708","author":"Abe","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1254\/jphs.93.95","article-title":"Pharmacological characterization of RS-1259, an orally active dual inhibitor of acetylcholinesterase and serotonin transporter, in rodents: possible treatment of Alzheimer's disease","volume":"93","author":"Abe","year":"2003","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/(SICI)1098-2396(200004)36:1<21::AID-SYN3>3.0.CO;2-D","article-title":"Dual control of dorsal raphe serotonergic neurons by GABAB receptors. Electrophysiological and microdialysis studies","volume":"36","author":"Abellan","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.euroneuro.2003.08.007","article-title":"Dopamine mediation of positive reinforcing effects of amphetamine in stimulant na\u00efve healthy volunteers: results from a large cohort","volume":"13","author":"Abi-Dargham","year":"2003","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00213-002-1057-7","article-title":"Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients: support for serotonin-2 receptor modulation of schizophrenia symptoms","volume":"162","author":"Abi-Saab","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib7","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1021\/jm9806704","article-title":"Synthesis and SAR of adatanserin: novel adamantyl aryl-and heteroarylpiperazines with dual serotonin 5-HT1A and 5-HT2 activity as potential anxiolytic and antidepressant agents","volume":"42","author":"Abou-Gharbia","year":"1999","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.tins.2004.12.003","article-title":"Memory retention\u2014the synaptic stability versus plasticity dilemma","volume":"28","author":"Abraham","year":"2005","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib9","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/jclp.20078","article-title":"Treatment of obsessive\u2013compulsive disorder in patients who have comorbid major depression","volume":"60","author":"Abramowitz","year":"2004","journal-title":"J Clin Psychol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1152\/physrev.00055.2003","article-title":"Adult neurogenesis: from precursors to network and physiology","volume":"85","author":"Abrous","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0014-2999(94)90013-2","article-title":"The potent and selective dopamine D1 receptor agonist A-77636 increases cortical and hippocampal acetylcholine release in the rat","volume":"260","author":"Acquas","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib12","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0022-5347(05)64133-X","article-title":"Direct evidence of facilitative actions of dopamine in the medial preoptic area on reflexive and noncontact erections in male rats","volume":"169","author":"Adachi","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib13","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1111\/j.1460-9568.2005.04100.x","article-title":"Disrupting the melanin-concentrating hormone receptor1 in mice leads to cognitive deficits and alterations of NMDA receptor function","volume":"21","author":"Adamantidis","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/1568007043482516","article-title":"Antidepressant properties of substance P antagonists: relationship to monoaminergic mechanisms?","volume":"3","author":"Adell","year":"2004","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0165-0173(02)00182-0","article-title":"Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei","volume":"39","author":"Adell","year":"2002","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib16","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S1359-6446(05)03398-2","article-title":"Strategies for producing faster acting antidepressants","volume":"10","author":"Adell","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/mds.10390","article-title":"Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease","volume":"18","author":"Adler","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib18","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.eurpsy.2004.09.003","article-title":"Six-month course of mild cognitive impairment and affective symptoms in late-life","volume":"19","author":"Adler","year":"2004","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1087-0792(01)90200-X","article-title":"Neurobiological bases for the relation between sleep and depression","volume":"6","author":"Adrien","year":"2002","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S146114570200322X","article-title":"Algorithm-based treatment of major depression in an outpatient clinic: clinical correlates of response to a specific serotonin reuptake inhibitor and to triiodothyronine augmentation","volume":"6","author":"Agid","year":"2003","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib21","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s002130050203","article-title":"GABAergic drugs and sexual motivation, receptivity and exploratory behaviors in the female rat","volume":"129","author":"Agmo","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib22","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0306-4522(95)00308-6","article-title":"Intercellular communication in the brain: wiring versus volume transmission","volume":"69","author":"Agnati","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1385\/NMM:7:1-2:061","article-title":"Existence and theoretical aspects of homomeric and heteromeric dopamine receptor complexes and their relevance for neurological diseases","volume":"7","author":"Agnati","year":"2005","journal-title":"Neuromol Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.tibs.2005.02.010","article-title":"How receptor mosaics decode transmitter signals. Possible relevance of cooperativity","volume":"30","author":"Agnati","year":"2005","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/sj.npp.1300567","article-title":"Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex","volume":"30","author":"Ago","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib26","doi-asserted-by":"crossref","first-page":"19S","DOI":"10.1111\/j.1469-445X.2000.tb00004.x","article-title":"Regulation of vasopressin V1b receptors in the anterior pituitary gland of the rat","volume":"85","author":"Aguilera","year":"2000","journal-title":"Exp Physiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(99)00483-5","article-title":"Synergistic actions of the 5-HT1A receptor antagonist WAY-100635 and citalopram on male rat ejaculatory behavior","volume":"379","author":"Ahlenius","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s002130050633","article-title":"Evidence for an involvement of 5-HT1B receptors in the inhibition of male rat ejaculatory behavior produced by 5-HTP","volume":"137","author":"Ahlenius","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00210-004-1008-4","article-title":"Effects of combined lamotrigine and valproate on basal and stimulated extracellular amino acids and monoamines in the hippocampus of freely moving rats","volume":"371","author":"Ahmad","year":"2005","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib30","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s002130050791","article-title":"Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat","volume":"140","author":"Ainsworth","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00002826-199706000-00004","article-title":"Mianserin, a 5-HT2A\/2C and \u03b12 antagonist, in the treatment of sexual dysfunction induced by serotonin reuptake inhibitors","volume":"20","author":"Aizenberg","year":"1997","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib32","first-page":"347","article-title":"the serotonin antagonist mianserin for treatment of serotonin reuptake inhibitor-induced sexual dysfunction in women: an open-label add-on study","volume":"22","author":"Aizenberg","year":"1999","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib33","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/00926230390195533","article-title":"Sildenafil for selective serotonin reuptake inhibitor-induced erectile dysfunction in elderly male depressed patients","volume":"29","author":"Aizenberg","year":"2003","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib34","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00002826-199508000-00003","article-title":"Cyproheptadine treatment of sexual dysfunction induced by serotonin reuptake inhibitors","volume":"18","author":"Aizenberg","year":"1995","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1017\/S146114570400478X","article-title":"Signal transduction abnormalities in melancholic depression","volume":"8","author":"Akin","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib36","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/0006-3223(95)00309-6","article-title":"Effects of antidepressants on intracellular Ca2+ mobilization in CHO cells transfected with the human 5-HT2C receptor","volume":"39","author":"Akiyoshi","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0028-3908(01)00049-1","article-title":"Neuropharmacological profile of a selective sigma ligand, igmesine: a potential antidepressant","volume":"41","author":"Akunne","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib38","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1523\/JNEUROSCI.17-12-04895.1997","article-title":"Chronic social stress alters levels of corticotropin-releasing factor and arginine vasopressin mRNA in rat brain","volume":"17","author":"Albeck","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib39","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/35019019","article-title":"Error and attack tolerance of complex networks","volume":"406","author":"Albert","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib40","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1124\/mol.60.6.1349","article-title":"Allosteric modulation of the human 5-HT(7A) receptor by lipidic amphipathic compounds","volume":"60","author":"Alberts","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib41","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0014-2999(94)90119-8","article-title":"Preclinical pharmacology of FG5893: a potential anxiolytic drug with high affinity for both 5-HT1A and 5-HT2A receptors","volume":"261","author":"Albinsson","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0014-2999(94)90396-4","article-title":"Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release","volume":"251","author":"Albinsson","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0167-2789(03)00174-X","article-title":"Boolean dynamics of networks with scale-free topology","volume":"185","author":"Aldana","year":"2003","journal-title":"Physica D"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib44","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/00019442-200211000-00007","article-title":"Frontostriatal and limbic dysfunction in late-life depression","volume":"10","author":"Alexopoulos","year":"2002","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib45","first-page":"2278","article-title":"Executive dysfunction, heart disease burden, and remission of geriatric depression","volume":"29","author":"Alexopoulos","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib46","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.biopsych.2005.04.024","article-title":"Executive dysfunction and the course of geriatric depression","volume":"58","author":"Alexopoulos","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib47","first-page":"306","article-title":"GABA-mediated modification of despair behavior in mice","volume":"339","author":"Aley","year":"1989","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1515\/REVNEURO.2005.16.1.43","article-title":"Chronic stress, depression and antidepressants: effects on gene transcription in the hippocampus","volume":"16","author":"Alfonso","year":"2005","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib49","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1097\/00001756-199812210-00011","article-title":"Melatonin receptor subtype expression in human cerebellum","volume":"9","author":"Al-Ghoul","year":"1998","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib50","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1136\/bmj.320.7245.1287","article-title":"Depression in Parkinson's disease","volume":"320","author":"Allain","year":"2000","journal-title":"Br Med J"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib51","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0959-440X(03)00031-9","article-title":"Biological networks","volume":"13","author":"Alm","year":"2003","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib52","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2174\/0929867043364748","article-title":"Tachykinins and tachykinin receptors: structure and activity relationships","volume":"11","author":"Almeida","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib53","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0306-4522(00)00014-2","article-title":"Immunocytochemical localization of the sigma(1) receptor in the adult rat central nervous system","volume":"97","author":"Alonso","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib54","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1600-0047.2004.00325.x","article-title":"Disability and qualify of life impact of mental disorders in Europe: results from the European study of the epidemiology of mental disorders (ESEMeD) project","volume":"109","author":"Alonso","year":"2004","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib55","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1600-0047.2004.00325.x","article-title":"12-Month comorbidity patterns and associated factors in Europe: results from the European study of the epidemiology of mental disorders (ESEMeD) project","volume":"109","author":"Alonso","year":"2004","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0047.2004.00325.x","article-title":"Prevalence of mental disorders in Europe: results from the European study of the epidemiology of mental disorders (ESEMeD) project","volume":"109","author":"Alonso","year":"2004","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib57","first-page":"55","article-title":"Psychotropic drug utilization in Europe: results from the European study of the epidemiology of mental disorders (ESEMeD) project","volume":"420","author":"Alonso","year":"2004","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib58","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/sj.mp.4001464","article-title":"Blockade of CRF1 or V1b receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression","volume":"9","author":"Alonso","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib59","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1101\/lm.6.3.216","article-title":"Activity-dependent activation of TrkB neurotrophin receptors in the adult CNS","volume":"6","author":"Aloyz","year":"1999","journal-title":"Learn Memory"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib60","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0165-6147(99)01309-7","article-title":"Neurotrophins and depression","volume":"20","author":"Altar","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib61","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0006-3223(03)00073-8","article-title":"Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain","volume":"54","author":"Altar","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib62","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1523\/JNEUROSCI.5377-03.2004","article-title":"Electroconvulsive seizures regulate gene expression of distinct neurotrophic signalling pathways","volume":"24","author":"Altar","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib63","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainres.2003.12.028","article-title":"Expression analysis of brain-derived neurotrophic factor (BDNF) mRNA isoforms after chronic and acute antidepressant treatment","volume":"1000","author":"Altieri","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib64","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1176\/appi.ajp.158.10.1617","article-title":"Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature","volume":"158","author":"Altshuler","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib65","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00008877-200402000-00005","article-title":"Anxiogenic effects in the rat elevated plus-maze of 5-HT2C agonists into ventral but not dorsal hippocampus","volume":"15","author":"Alves","year":"2004","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib66","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0149-7634(94)00068-C","article-title":"Effects of antidepressants on co7gnitive functions: a review","volume":"19","author":"Amado-Boccara","year":"1995","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib67","doi-asserted-by":"crossref","first-page":"15551","DOI":"10.1073\/pnas.0404843101","article-title":"Emergence of complex dynamics in a simple model of signalling networks","volume":"101","author":"Amaral","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib68","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.neuroscience.2004.07.052","article-title":"Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala","volume":"129","author":"Amat","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib69","series-title":"Diagnostic and Statistical Manual of Mental Disorders","first-page":"886","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainres.2003.09.026","article-title":"A serotonergic (5-HT2) receptor mechanism in the laterodorsal tegmental nucleus participates in regulating the pattern of rapid-eye-movement sleep occurrence in the rat","volume":"996","author":"Amici","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib71","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/sj.embor.7400096","article-title":"Convergent evolution of gene networks by single-gene duplications in higher eukaryotes","volume":"5","author":"Amoutzias","year":"2004","journal-title":"EMBO Rep"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib72","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0165-0327(98)00203-1","article-title":"Fluoxetine efficacy in menopausal women with and without estrogen replacement","volume":"55","author":"Amsterdam","year":"1999","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib73","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.brainresbull.2003.11.002","article-title":"Characterization of nicotinic receptors inducing noradrenaline release and absence of nicotinic autoreceptors in human neocortex","volume":"62","author":"Amtage","year":"2004","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib74","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nn992","article-title":"Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice","volume":"6","author":"Anagnostaras","year":"2003","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib75","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0006-3223(98)00293-5","article-title":"Effect of catecholamine depletion on lithium-induced long-term remission of bipolar disorder","volume":"45","author":"Anand","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib76","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/sj.npp.1300725","article-title":"Antidepressant effect on connectivity of the mood-regulating circuit: an fMRI study","volume":"30","author":"Anand","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib77","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0166-4328(01)00318-7","article-title":"Effects of scopolamine and d-cycloserine on non-spatial reference memory in rats","volume":"129","author":"Andersen","year":"2002","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib78","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1520-6394(1998)7:1+<11::AID-DA4>3.0.CO;2-I","article-title":"SSRIs versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability","volume":"7","author":"Anderson","year":"1998","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib79","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-0327(99)00092-0","article-title":"Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability","volume":"58","author":"Anderson","year":"2000","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib80","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1097\/00001756-200208270-00012","article-title":"5-HT2C receptor activation by m-chlorophenylpiperazine detected in humans with fMRI","volume":"13","author":"Anderson","year":"2002","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib81","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0014-2999(94)90091-4","article-title":"Effects of FG 5893, a new compound with 5-HT1A receptor agonistic and 5-HT2 receptor antagonistic properties, on male rat sexual behavior","volume":"255","author":"Andersson","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib82","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0031-6997(24)01503-5","article-title":"Pharmacology of penile erection","volume":"53","author":"Andersson","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib83","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/sj.ijir.3900797","article-title":"New directions for erectile dysfunction therapies","volume":"14","author":"Andersson","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib84","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/PL00007093","article-title":"Oral alpha adrenoceptor blockade as a treatment of erectile dysfunction","volume":"19","author":"Andersson","year":"2001","journal-title":"World J Urol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib85","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1468-1331.2005.01195.x","article-title":"Cost of affective disorders in Europe","volume":"12","author":"Andlin-Sobicki","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib86","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00004714-200208000-00010","article-title":"Reboxetine, a new noradrenaline selective antidepressant, is at least as effective as fluoxetine in the treatment of depression","volume":"22","author":"Andreoli","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib87","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/S0960-894X(03)00525-0","article-title":"Synthesis of 3\u03b1,4-dihydro-3H-[1]benzopyrano[4,3-c)isoxazoles, displaying combined 5-HT uptake inhibiting and alpha2-adrenoceptor antagonistic activities: a novel series of potential antidepressants","volume":"13","author":"Andr\u00e9s","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib88","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1021\/jm049619s","article-title":"Discovery of a new series of centrally active tricyclic isoxazoles combining serotonin (5-HT) reuptake inhibition with \u03b12-adrenoceptor blocking activity","volume":"48","author":"Andr\u00e9s","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib89","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1017\/S0140525X02000092","article-title":"Adaptationism\u2014how to carry out an exaptationist program","volume":"25","author":"Andrews","year":"2002","journal-title":"Behav Brain Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib90","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0014-2999(93)90767-C","article-title":"Litoxetine: a selective 5-HT uptake inhibitor with concomitant 5-HT3 receptor antagonist and antiemetic properties","volume":"232","author":"Angel","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib91","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.mp.4001637","article-title":"BDNF in schizophrenia, depression and corresponding animal models","volume":"10","author":"Angelucci","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib92","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/35082096","article-title":"Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein homer","volume":"411","author":"Ango","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib93","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.ijir.3900950","article-title":"Vardenafil reverses erectile dysfunction induced by paroxetine in rats","volume":"15","author":"Angulo","year":"2003","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib94","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/sj.bjp.0704351","article-title":"Differential effects of serotonin reuptake inhibitors on erectile responses, NO-production, and neuronal NO synthase expression in rat corpus cavernosum tissue","volume":"134","author":"Angulo","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib95","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1124\/jpet.102.047134","article-title":"Calcium-dependent inhibition of synaptosomal serotonin transport by the alpha2-adrenoceptor agonist 5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304)","volume":"305","author":"Ansah","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib96","first-page":"82","article-title":"Antidepressant-induced regulation of 5-HT(1b) mRNA in rat dorsal raphe nucleus reverses rapidly after drug discontinuation","volume":"61","author":"Anthony","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib97","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/0748730403251805","article-title":"Response of the mouse circadian system to serotonin1A\/2\/7 agonists in vivo: surprisingly little","volume":"18","author":"Antle","year":"2003","journal-title":"J Biol Rhythms"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib98","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/1098-2396(20001201)38:3<355::AID-SYN15>3.0.CO;2-E","article-title":"Differential effects of acute and short-term lithium administration on dialysate glutamate and GABA levels in the frontal cortex of the conscious rat","volume":"38","author":"Antonelli","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib99","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0028-3908(00)00057-5","article-title":"Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men","volume":"39","author":"Antonijevic","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","article-title":"A review of the pharmacological and clinical profile of mirtazapine","volume":"7","author":"Anttila","year":"2001","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib101","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-0173(98)00050-2","article-title":"Metabotropic glutamate receptors: electrophysiological properties and role in plasticity","volume":"29","author":"Anwyl","year":"1999","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib102","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pneurobio.2004.02.004","article-title":"Pathophysiology of obsessive\u2013compulsive disorder a necessary link between phenomenology, neuropsychology, imagery and physiology","volume":"72","author":"Aouizerate","year":"2004","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib103","first-page":"811","article-title":"Deep brain stimulation of the ventral striatum in the treatment of obsessive\u2013compulsive disorder and major depression","volume":"21","author":"Aouizerate","year":"2005","journal-title":"Med Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib104","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pain.2003.12.015","article-title":"Chronic pain patients are impaired on an emotional decision-making task","volume":"108","author":"Apkarian","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib105","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4088\/JCP.v62n0608","article-title":"Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomised, double-blind, placebo wash-in study","volume":"62","author":"Appelberg","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib106","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1210\/jc.2004-1147","article-title":"Triiodothyronine addition to paroxetine in the treatment of major depressive disorder","volume":"89","author":"Appelhof","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib107","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.104.077172","article-title":"Memantine blocks \u03b17 nicotinic acetylcholine receptors more potently than NMDA receptors in rat hippocampal neurons","volume":"312","author":"Aracava","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib108","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejpain.2004.03.003","article-title":"Randomized double-blind comparison of serotonergic (citalopram) versus noradrenergic (reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder","volume":"9","author":"Aragona","year":"2005","journal-title":"Eur J Pain"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib109","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3940(95)11817-G","article-title":"L-DOPA is converted to dopamine in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study","volume":"195","author":"Arai","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1254\/jjp.88.133","article-title":"Neuronal nicotinic receptor and psychiatric disorders: functional and behavioral effects of nicotine","volume":"88","author":"Araki","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib111","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0006-8993(95)00826-C","article-title":"Involvement of bulbospinal pathways in the antinociceptive effect of clomipramine in the rat","volume":"695","author":"Ardid","year":"1995","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib112","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0149-7634(99)00068-8","article-title":"Neuropeptides and sexual behaviour","volume":"23","author":"Argiolas","year":"1999","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib113","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.physbeh.2004.08.019","article-title":"The role of oxytocin and the paraventricular nucleus in the sexual behaviour of male mammals","volume":"83","author":"Argiolas","year":"2004","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib114","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.biopsych.2004.07.006","article-title":"Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder","volume":"56","author":"Argyropoulos","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib115","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/0269881105049037","article-title":"Evidence for a combined genetic effect of the 5-HT1A receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram","volume":"19","author":"Arias","year":"2005","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib116","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jnr.20235","article-title":"Neurogenesis in the subventricular zone following transcranial magnetic field stimulation and nigrostriatal lesions","volume":"78","author":"Arias-Carrion","year":"2004","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib117","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1073\/pnas.0306458101","article-title":"The metabolic world of Escherichia coli is not small","volume":"101","author":"Arita","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib118","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0014-2999(00)00798-6","article-title":"Ipsapirone suppresses food intake in food-deprived rats by an action on 5-HT1A receptors","volume":"408","author":"Arkle","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib119","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0091-3057(93)90315-K","article-title":"Successful use of S20098 and melatonin in an animal model of delayed sleep-phase syndrome (DSPS)","volume":"46","author":"Armstrong","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib120","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1192\/bjp.164.6.838","article-title":"Successful treatment of fluvoxamine-induced anorgasmia by cyproheptadine","volume":"164","author":"Arnott","year":"1994","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib121","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/026988119701100208","article-title":"Catecholamine regulation of the prefrontal cortex","volume":"2","author":"Arnsten","year":"1997","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib122","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/archpsyc.1996.01830050084013","article-title":"The contribution of \u03b12 noradrenergic mechanisms to prefrontal cortical cognitive function: potential significance to attention deficit hyperactivity disorder","volume":"53","author":"Arnsten","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib123","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0893-133X(00)00133-0","article-title":"The selective dopamine D4 receptor antagonist, PNU-101387G, prevents stress-induced cognitive deficits in monkeys","volume":"23","author":"Arnsten","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib124","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1176\/ajp.146.6.730","article-title":"Serotonergic measures in the brains of suicide victims. 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects","volume":"146","author":"Arora","year":"1989","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib125","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0165-6147(93)90125-4","article-title":"5-HT and antidepressants: new views from microdialysis studies","volume":"14","author":"Artigas","year":"1993","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib126","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/hup.180","article-title":"Limitations to enhancing the speed of onset of antidepressants- are rapid action antidepressants possible?","volume":"16","author":"Artigas","year":"2001","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib127","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0165-6147(00)01682-5","article-title":"How does pindolol improve antidepressant action?","volume":"22","author":"Artigas","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib128","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0091-3057(94)90459-6","article-title":"Monoamine depletion attenuates the REM sleep deprivation-induced increase in clonidine response in the forced swimming test","volume":"49","author":"Asakura","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib129","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1254\/jjp.75.123","article-title":"Inhibition by nitric oxide of the uptake of [3H]serotonin into rat brain synaptosomes","volume":"75","author":"Asano","year":"1997","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib130","first-page":"395","article-title":"Bupropion: a review of its mechanism of antidepressant activity","volume":"56","author":"Ascher","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib131","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pain.2003.12.012","article-title":"Analgesic effect of amitriptyline in chronic tension-type headache is not directly related to serotonin reuptake inhibition","volume":"108","author":"Ashina","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib132","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4088\/JCP.v59n0304","article-title":"Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction","volume":"59","author":"Ashton","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib133","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/00926239708403922","article-title":"Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: a large-scale retrospective study of 596 psychiatric outpatients","volume":"23","author":"Ashton","year":"1997","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib134","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/sleep\/25.6.666","article-title":"The effects of mirtazapine on sleep: a placebo-controlled, double-blind study in young healthy volunteers","volume":"25","author":"Aslan","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib135","doi-asserted-by":"crossref","first-page":"668","DOI":"10.4088\/JCP.v60n1005","article-title":"Zolpidem for persistent insomnia in SSRI-treated depressed patients","volume":"60","author":"Asnis","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib136","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0028-3908(95)00169-7","article-title":"Pindolol and (\u00b1)-tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT1A but also 5-HT1B receptors","volume":"35","author":"Assie","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib137","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0079-6123(08)63799-1","article-title":"Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology","volume":"88","author":"Aston-Jones","year":"1991","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib138","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/hup.479","article-title":"Switching to tianeptine in patients with antidepressant-induced sexual dysfunction","volume":"18","author":"Atmaca","year":"2003","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib139","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0301-0082(02)00079-5","article-title":"Alzheimer's disease and the basal forebrain cholinergic system: relations to \u03b2-amyloid peptides, cognition, and treatment strategies","volume":"68","author":"Auld","year":"2002","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib140","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1192\/bjp.178.3.200","article-title":"Cognitive deficits in depression, possible implications for functional neuropathology","volume":"170","author":"Austin","year":"2001","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib141","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1176\/appi.ajp.161.11.2066","article-title":"\u03b2-Arrestin-1 levels: reduced in leukocytes of patients with depression and elevated by antidepressants in rat brain","volume":"161","author":"Avissar","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib142","doi-asserted-by":"crossref","first-page":"21522","DOI":"10.1074\/jbc.M200729200","article-title":"Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer","volume":"277","author":"Ayoub","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib143","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1124\/mol.104.000398","article-title":"Preferential formation of MT1\/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared to MT2 homodimers","volume":"66","author":"Ayoub","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib144","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1192\/bjp.179.4.308","article-title":"Depressive disorders in Europe: prevalence figures from the ODIN study","volume":"179","author":"Ayuso-Mateos","year":"2001","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib145","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/cne.10138","article-title":"Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons","volume":"444","author":"Azam","year":"2002","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib146","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0306-4522(03)00220-3","article-title":"Co-expression of \u03b17 and \u03b22 nicotinic acetylcholine receptor subunit mRNAs within rat brain cholinergic neurons","volume":"119","author":"Azam","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib147","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/syn.20108","article-title":"Alpha7 nicotinic receptor subunit is present on serotonin neurons projecting to hippocampus and septum","volume":"55","author":"Aznar","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib148","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/sj.npp.1300158","article-title":"Effect of chronic administration of selective glucocorticoid receptor antagonists on the rat hypothalamic\u2013pituitary\u2013adrenocortical axis","volume":"28","author":"Bachmann","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib149","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000086413","article-title":"The selective glucocorticoid receptor antagonist ORG 34116 decreases immobility time in the forced swim test and affects cAMP-responsive element-binding protein phosphorylation in rat brain","volume":"81","author":"Bachmann","year":"2005","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib150","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0091-3057(94)90093-0","article-title":"Corticosterone influences forced swim-induced immobility","volume":"49","author":"Baez","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib151","first-page":"277","article-title":"Role of the hypothalamic paraventricular nucleus in 5-HT1A and 5-HT2C receptor-mediated oxytocin, prolactin and ACTH\/corticosterone responses","volume":"73","author":"Bagby","year":"1996","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib152","first-page":"399","article-title":"Anxiety-like effects induced by acute fluoxetine, sertraline or mCPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635","volume":"4","author":"Bagby","year":"2001","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib153","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1176\/appi.ajp.161.12.2163","article-title":"The Hamilton depression rating scale: has the gold standard become a lead weight?","volume":"161","author":"Bagby","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib154","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0306-4522(96)00435-6","article-title":"Temporal dynamics of glutamate efflux in the prefrontal cortex and in the hippocampus following repeated stress: effects of pre-treatment with saline or diazepam","volume":"77","author":"Bagley","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib155","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0028-3908(03)00104-7","article-title":"Chronic AMPA receptor potentiator (LY451646) treatment increases cell proliferation in adult rat hippocampus","volume":"44","author":"Bai","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib156","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neuropharm.2003.07.001","article-title":"Lamina-specific differences in GABA(B) autoreceptor-mediated regulation of spontaneous GABA release in rat entorhinal cortex","volume":"46","author":"Bailey","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib157","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1001\/archinte.163.20.2433","article-title":"Depression and pain comorbidity: a literature review","volume":"163","author":"Bair","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib158","first-page":"27","article-title":"Managing mood disorders and co-morbid personality disorders","volume":"18","author":"Bajaj","year":"2005","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib159","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/078538902321117742","article-title":"Stereochemistry and drug efficacy and development: relevance of chirality to antidepressant and antipsychotic drugs","volume":"34","author":"Baker","year":"2002","journal-title":"Ann Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib160","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0306-4522(91)90043-N","article-title":"Distribution, morphology and number of monoamine-synthesizing and substance P-containing neurons in the human dorsal raphe nucleus","volume":"42","author":"Baker","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib161","first-page":"481","article-title":"Neurochemical and metabolic aspects of antidepressants: an overview","volume":"25","author":"Baker","year":"2000","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib162","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1017\/S1461145705005201","article-title":"Evidence-based pharmacotherapy of panic disorder","volume":"8","author":"Bakker","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib163","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.genet.37.040103.103949","article-title":"Pseudogenes: are they \u201cjunk\u201d or functional DNA?","volume":"37","author":"Balakirev","year":"2003","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib164","doi-asserted-by":"crossref","first-page":"18840","DOI":"10.1074\/jbc.M313470200","article-title":"Hetero-oligomerization between GABAA and GABAB receptors regulates GABAB receptor trafficking","volume":"279","author":"Balasubramanian","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib165","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1517\/14740338.3.5.457","article-title":"Sexual dysfunction associated with antidepressant drugs","volume":"3","author":"Baldwin","year":"2004","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib166","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/026988110101500303","article-title":"A randomised, double-blind controlled comparison of nefazodone and paroxetine in the treatment of depression: safety, tolerability and efficacy in continuation phase treatment","volume":"15","author":"Baldwin","year":"2001","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib167","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/sj.npp.1300350","article-title":"Sexual behavior and sex-associated environmental cues activate the mesolimbic system in male rats","volume":"29","author":"Balfour","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib168","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/S0022-5347(01)63299-3","article-title":"Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes","volume":"159","author":"Ballard","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib169","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0165-0327(02)00404-4","article-title":"Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials","volume":"79","author":"Ballesteros","year":"2004","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1901\/jeab.1973.20-119","article-title":"Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration","volume":"20","author":"Balster","year":"1973","journal-title":"J Exp Anal Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib171","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/bja\/79.3.352","article-title":"Actions of tramadol, its enantiomers and principal metabolite, O-desmethyltramadol, on serotonin (5-HT) efflux and uptake in the rat dorsal raphe nucleus","volume":"79","author":"Bamigbade","year":"1997","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib172","first-page":"373","article-title":"Tramadol hydrochloride: an overview of current use","volume":"59","author":"Bamigbade","year":"1998","journal-title":"Hosp Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib173","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1046\/j.0953-816x.2001.01763.x","article-title":"Serotonin mediates oestrogen stimulation of cell proliferation in the adult dentate gyrus","volume":"14","author":"Banasr","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib174","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/sj.npp.1300320","article-title":"Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone","volume":"29","author":"Banasr","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib175","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0306-4522(99)00082-2","article-title":"5-HT2C receptors on spinal neurons controlling penile erection in the rat","volume":"92","author":"Bancila","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib176","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1038\/sj.ijir.3900507","article-title":"Effects of alpha-2 blockade on sexual response: experimental studies with delequamine (RS15385)","volume":"12","author":"Bancroft","year":"2000","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib177","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1016\/S0028-3908(00)00099-X","article-title":"Ventral hippocampal alpha4beta2 nicotinic receptors and chronic nicotine effects on memory","volume":"39","author":"Bancroft","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib178","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0006-8993(00)02285-X","article-title":"Behavioral characterization of neuropeptide Y knockout mice","volume":"868","author":"Bannon","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib179","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/sj.npp.1300390","article-title":"Occupancy of agonist drugs at the 5-HT1A receptor","volume":"29","author":"Bantick","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib180","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/brain\/awh448","article-title":"Colocalization of corticotropin-releasing hormone and oestrogent receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders","volume":"128","author":"Bao","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib181","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1126\/science.286.5439.509","article-title":"Emergence of scaling in random networks","volume":"286","author":"Barabasi","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib182","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nrg1272","article-title":"Network biology: understanding the cell's functional organization","volume":"5","author":"Barabasi","year":"2004","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib183","doi-asserted-by":"crossref","first-page":"15020","DOI":"10.1073\/pnas.95.25.15020","article-title":"Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory","volume":"95","author":"Barad","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib184","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00213-004-1801-2","article-title":"Suicidality and second generation antipsychotics in schizophrenia patients: a case-controlled retrospective study during a 5-year period","volume":"175","author":"Barak","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib185","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/sj.bjp.0704829","article-title":"Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site","volume":"137","author":"Barann","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib186","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4088\/JCP.v63n0813","article-title":"Lamotrigine as an augmentation agent in treatment-resistant depression","volume":"63","author":"Barber","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib187","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4088\/JCP.v64n0407","article-title":"A double-blind, randomised, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes","volume":"64","author":"Barbosa","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib188","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1192\/bjp.178.2.129","article-title":"Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials","volume":"178","author":"Barbui","year":"2001","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib189","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0006-3223(02)01674-8","article-title":"Working memory and prefrontal cortex dysfunction: specificity to schizophrenia compared with major depression","volume":"53","author":"Barch","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib190","first-page":"S64","article-title":"Antidepressant action of S20098 (agomelatine) in a transgenic mouse model","volume":"5","author":"Barden","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib191","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0166-4328(01)00165-6","article-title":"Nitric oxide involvement in the anxiogenic-like effect of substance P","volume":"121","author":"Baretta","year":"2001","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib192","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0306-4522(99)00257-2","article-title":"GABAB receptor activation protects GABAA receptor from cyclic AMP-dependent down-regulation in rat cerebellar granule cells","volume":"93","author":"Barila","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib193","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00001504-200101000-00005","article-title":"Antipsychotic drug treatment: recent advances","volume":"14","author":"Barnes","year":"2001","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib194","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib195","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ddr.430240205","article-title":"Anticonflict and discriminative stimulus effects of the 5-HT1A compounds WY-47,846 and WY-48,324 and the mixed 5-HT1A agonist\/5-HT2 antagonist WY-50,324 in pigeons","volume":"24","author":"Barrett","year":"1991","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib196","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/sj.npp.1300411","article-title":"Mechanisms of action underlying the effect of repetitive transcranial magnetic stimulation on mood: behavioral and brain imaging studies","volume":"29","author":"Barrett","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib197","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2004.10.003","article-title":"Evidence of cost-effective treatments for depression: a systematic review","volume":"84","author":"Barrett","year":"2005","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib198","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00008877-200205000-00004","article-title":"Bupropion and sertraline enhance retrieval of recent and remote long-term memory in rats","volume":"13","author":"Barros","year":"2002","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib199","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.nlm.2004.10.001","article-title":"Modulation of working, short- and long-term memory by nicotinic receptors in the basolateral amygdala in rats","volume":"83","author":"Barros","year":"2005","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib200","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.tpj.6500249","article-title":"Pharmacogenomics in drug development: societal and technical aspects","volume":"4","author":"Bartfai","year":"2004","journal-title":"Pharmacogenet J"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib201","doi-asserted-by":"crossref","first-page":"10470","DOI":"10.1073\/pnas.0403802101","article-title":"Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests","volume":"101","author":"Bartfai","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib202","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/00926239508414646","article-title":"Psychostimulants apparently reverse sexual dysfunction secondary to selective serotonin re-uptake inhibitors","volume":"21","author":"Bartlik","year":"1995","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib203","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000080968","article-title":"Motivational symptoms of depression and preclinical Alzheimer's disease in elderly subjects","volume":"19","author":"Bartolini","year":"2005","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib204","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-2999(96)00999-5","article-title":"EMD 68843, a serotonin reuptake inhibitor with selective presynaptic 5-HT1A receptor agonistic properties","volume":"322","author":"Bartoszyk","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib205","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/10606820490464325","article-title":"Evaluation of pyridine-3-carboxylic acid as a drug carrier by utilizing multivariate methods, structure property correlations, and pattern recognition techniques","volume":"10","author":"Bartzatt","year":"2004","journal-title":"Recept Channels"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib206","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1073\/pnas.0501562102","article-title":"Interaction strength combinations and the overfishing of a marine food web","volume":"102","author":"Bascompte","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib207","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0169-328X(98)00088-6","article-title":"REM sleep deprivation increases the levels of tyrosine hydroxylase and norepinephrine transporter mRNA in the locus coeruleus","volume":"57","author":"Basheer","year":"1998","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib208","first-page":"353","article-title":"Protein kinase C isoforms as therapeutic targets in nervous system disease states","volume":"44","author":"Battaini","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib209","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00004714-199910000-00006","article-title":"Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies","volume":"19","author":"Bauer","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/15622970109027495","article-title":"Thyroid hormone, neural tissue and mood modulation","volume":"2","author":"Bauer","year":"2001","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib211","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0893-133X(97)00181-4","article-title":"Treatment of refractory depression with high-dose thyroxine","volume":"18","author":"Bauer","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib212","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1176\/appi.ajp.157.9.1429","article-title":"Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression","volume":"157","author":"Bauer","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib213","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/sj.mp.4000963","article-title":"Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain","volume":"7","author":"Bauer","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib214","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00004714-199608000-00006","article-title":"A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation","volume":"16","author":"Baumann","year":"1996","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib215","doi-asserted-by":"crossref","first-page":"7571","DOI":"10.1523\/JNEUROSCI.20-20-07571.2000","article-title":"Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase2A","volume":"20","author":"Bauman","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib216","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-3-642-60921-3_2","article-title":"Anatomy of central serotoninergic projection systems","volume":"129","author":"Baumgarten","year":"1997","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib217","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1017\/S1461145700001887","article-title":"Thyroxine and the treatment of affective disorders: an overview of the results of basic and clinical research","volume":"3","author":"Baumgartner","year":"2000","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib218","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.neuroscience.2004.10.032","article-title":"Opposite effects of noradrenaline and acetylcholine upon hypercretin\/orexin versus melanin concentrating hormone neurons in rat hypothalamaic slices","volume":"130","author":"Bayer","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib219","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1017\/S0033291700027008","article-title":"The dissociation of explicit and implicit memory in depressed patients","volume":"24","author":"Bazin","year":"1994","journal-title":"Psychol Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib220","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0920-9964(01)00376-0","article-title":"An investigation of the Wnt-signalling pathway in the prefrontal cortex in schizophrenia, bipolar disorder and major depressive disorder","volume":"58","author":"Beasley","year":"2002","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib221","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0033291700035662","article-title":"Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed","volume":"26","author":"Beats","year":"1996","journal-title":"Psychol Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib222","series-title":"The New Solar System","first-page":"421","year":"1999"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib223","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0091-3057(01)00492-0","article-title":"Extracellular dopamine in the rat prefrontal cortex during reward-, punishment-, and novelty-associated behaviour. Effects of diazepam","volume":"69","author":"Beaufour","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib224","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1093\/emboj\/21.10.2332","article-title":"Synaptic multiprotein complexes associated with 5-HT2C receptors: a proteomic approach","volume":"21","author":"B\u00e9camel","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib225","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1192\/bjp.176.5.421","article-title":"Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression","volume":"176","author":"Bech","year":"2000","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib226","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0031-9384(02)00678-9","article-title":"Effects of D1 receptor agonist SKF 38393 on male rat sexual behavior and postcopulatory departure in the goal compartment-runway paradigm","volume":"76","author":"Beck","year":"2002","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib227","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1523\/JNEUROSCI.21-09-03236.2001","article-title":"The role of dopamine in the nucleus accumbens and striatum during sexual behavior in the female rat","volume":"21","author":"Becker","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib228","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.neuropharm.2004.02.006","article-title":"Melatonin MT (1\/2) receptor stimulation reduces cortical overflow of cholecystokinin-like material in a model of anticipation of social defeat in the rat","volume":"46","author":"Becker","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib229","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s007020200076","article-title":"Multidimensional analysis of the concentrations of 17 substances in the CSF of schizophrenics and controls","volume":"109","author":"Beckmann","year":"2002","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib230","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/ddr.10026","article-title":"Molecular determinants of opioid analgesia: modulation of presynaptic calcium channels","volume":"54","author":"Beedle","year":"2002","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib231","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1192\/bjp.174.4.307","article-title":"Review of community prevalence of depression in later life","volume":"174","author":"Beekman","year":"1999","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib232","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-2999(98)00241-6","article-title":"Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters","volume":"349","author":"Beique","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib233","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00004714-200110000-00009","article-title":"Rapid reversal of psychotic depression using mifepristone","volume":"21","author":"Belanoff","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib234","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1176\/appi.ajp.158.10.1612","article-title":"Cortisol activity and cognitive changes in psychotic major depression","volume":"158","author":"Belanoff","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib235","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0006-3223(02)01432-4","article-title":"An open label trial of C-1073 (Mifepristone) for psychotic major depression","volume":"52","author":"Belanoff","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib236","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrn1703","article-title":"Neurosteroids: endogenous regulators of the GABAA receptor","volume":"6","author":"Belelli","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib237","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/cne.1109","article-title":"Subcellular distribution of 5-HT7 receptors in the mouse suprachiasmatic nucleus","volume":"432","author":"Belenky","year":"2001","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib238","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejca.2004.10.022","article-title":"Intracellular signalling and cancer: complex pathways lead to multiple targets","volume":"41","author":"Bell","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib239","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/cercor\/bhh011","article-title":"Identification and differential vulnerability of a neural network in sleep deprivation","volume":"14","author":"Bell-McGinty","year":"2004","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib240","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1058635","article-title":"Regional-scale assembly rules and biodiversity of coral reefs","volume":"292","author":"Bellwood","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib241","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/archpsyc.1992.01820080059010","article-title":"Sleep and psychiatric disorders. A meta-analysis","volume":"49","author":"Benca","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib242","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1087-0792(97)90005-8","article-title":"Sleep and mood disorders","volume":"1","author":"Benca","year":"1997","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib243","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.neuint.2004.03.015","article-title":"Specific localized expression of cGMP PDEs in Purkinje neurons and macrophages","volume":"45","author":"Bender","year":"2004","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib244","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0031-9384(90)90156-X","article-title":"Effect of clenbuterol on sexual behavior in male rats","volume":"47","author":"Benelli","year":"1990","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib245","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/phrs.1993.1107","article-title":"Male sexual behaviour: further studies on the role of alpha2 receptors","volume":"28","author":"Benelli","year":"1993","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib246","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00213-003-1591-y","article-title":"Influence of mirtazapine on the sexual behavior of male rats","volume":"171","author":"Benelli","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib247","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s002100000294","article-title":"Interaction of the antidepressant mirtazapine with alpha2-adrenoceptors modulating the release of 5-HT in different rat brain regions in vivo","volume":"362","author":"Bengtsson","year":"2000","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib248","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0006-3223(03)00676-0","article-title":"Regulation of the norepinephrine transporter by chronic administration of antidepressants","volume":"55","author":"Benmansour","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib249","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0920-1211(94)00083-9","article-title":"Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures","volume":"20","author":"Ben-Menachem","year":"1995","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib250","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pneurobio.2004.11.002","article-title":"Emotion and cortical\u2013subcortical function: conceptual developments","volume":"75","author":"Bennett","year":"2005","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib251","first-page":"1176","article-title":"Novel 2-substituted cocaine analogs: uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain","volume":"272","author":"Bennett","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib252","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0006-8993(98)01119-6","article-title":"Chronic repetitive transcranial magnetic stimulation alters beta-adrenergic and 5-HT2 receptor characteristics in rat brain","volume":"816","author":"Ben-Shachar","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib253","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF02244313","article-title":"Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants","volume":"105","author":"Berendsen","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib254","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s002130050402","article-title":"Indirect in vivo 5-HT1A agonistic effects of the new antidepressant mirtazapine","volume":"133","author":"Berendsen","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib255","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02253718","article-title":"Involvement of 5-HT1C-receptors in drug-induced penile erections in rats","volume":"101","author":"Berendsen","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib256","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1124\/mol.54.1.94","article-title":"Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus","volume":"54","author":"Berg","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib257","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0924-977X(03)00100-7","article-title":"Glutamate and anxiety","volume":"14","author":"Bergink","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib258","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1021\/jm020986i","article-title":"Absorption classification of oral drugs based on molecular surface properties","volume":"46","author":"Bergstr\u00f6m","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib259","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/hup.697","article-title":"Antidepressants and the placebo response","volume":"20","author":"Berk","year":"2005","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib260","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0361-9230(82)90009-0","article-title":"Efferent connections of the lateral hypothalamic area of the rat: an autoradiographic investigation","volume":"8","author":"Berk","year":"1982","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib261","first-page":"3106","volume":"280","author":"Berkman","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib262","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/18672","article-title":"Strong effects of weak interactions in ecological communities","volume":"398","author":"Berlow","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib263","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1254\/jphs.CRJ04005X","article-title":"The role of sigma receptors in depression","volume":"97","author":"Bermack","year":"2005","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib264","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1124\/jpet.104.066472","article-title":"Effects of the potential antidepressant OPC-14523[1-[3-[4-[3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone monomethanesulfonate] a combined \u03c3 and 5-HT1A ligand: modulation of neuronal activity in the dorsal raphe nucleus","volume":"310","author":"Bermack","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib265","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib266","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0166-4328(02)00371-6","article-title":"Facilitatory effect of the dopamine D4 receptor agonist PD 168,077 on memory consolidation of an inhibitory avoidance learned response in C57BL\/6J mice","volume":"142","author":"Bernaerts","year":"2003","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib267","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/BF03344003","article-title":"Action of thyroid hormone in brain","volume":"25","author":"Bernal","year":"2002","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib268","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0960-894X(01)00572-8","article-title":"Discovery of novel, orally active dual NK1\/NK2 antagonists","volume":"11","author":"Bernstein","year":"2001","journal-title":"Eur Med Chem Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib269","first-page":"185","article-title":"Reduced plasma and CSF gamma-aminobutyric acid in affective illness: effect of lithium carbonate","volume":"18","author":"Berrettini","year":"1983","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib270","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neulet.2004.03.041","article-title":"Non-selective opioid receptor antagonism of the antidepressant-like effect of venlafaxine in the forced swimming test in mice","volume":"363","author":"Berrocoso","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib271","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1471-4159.2004.02501.x","article-title":"Mammalian central nervous system trace amines, pharmacology, amphetamines, physiologic neuromodulators","volume":"90","author":"Berry","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib272","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0149-7634(02)00014-3","article-title":"Multiple neural systems controlling food intake and body weight","volume":"26","author":"Berthoud","year":"2002","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib273","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0924-977X(00)00069-9","article-title":"Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain","volume":"10","author":"Besson","year":"2000","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib274","first-page":"835","article-title":"Molecular structure and physiological functions of GABAB receptors","volume":"84","author":"Bettler","year":"2004","journal-title":"Physiol Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib275","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/35086062","article-title":"Pathophysiology of Levo-Dopa-induced dyskinesia: potential for new therapies","volume":"2","author":"Bezard","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib276","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0169-328X(00)00007-3","article-title":"Singular subsets of locus coeruleus neurons may recover tyrosine hydroxylase phenotype transiently expressed during development","volume":"76","author":"Bezin","year":"2000","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib277","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.mp.4001401","article-title":"Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635","volume":"9","author":"Bhagwagar","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib278","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1176\/appi.ajp.161.2.368","article-title":"Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor","volume":"161","author":"Bhagwagar","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib279","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/bioinformatics\/18.11.1486","article-title":"A duplication growth model of gene expression networks","volume":"18","author":"Bhan","year":"2002","journal-title":"Bioinformatics"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib280","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1021\/jm0342358","article-title":"A bivalent ligand (KDN-21) reveals spinal \u03b4 and \u03ba opioid receptors are organized as heterodimers that give rise to \u03b41 and \u03b42 phenotypes. Selective targeting of \u03b4-\u03ba heterodimers","volume":"47","author":"Bhushan","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib281","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.4088\/JCP.v65n0906","article-title":"A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder","volume":"65","author":"Bielski","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib282","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/sj.npp.1300360","article-title":"Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice","volume":"29","author":"Bielsky","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib283","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1016\/0006-2952(88)90080-9","article-title":"Evidence for the existence of at least two different binding sites for 5HT-reuptake inhibitors within the 5HT-reuptake system from human platelets","volume":"37","author":"Biessen","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib284","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0074-7742(01)46064-8","article-title":"GABAA-receptor plasticity during long-term exposure to and withdrawal from progesterone","volume":"46","author":"Biggio","year":"2001","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib285","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/(SICI)1098-2396(199910)34:1<36::AID-SYN5>3.0.CO;2-G","article-title":"Microdialysis study of the effects of the antiparkinsonian drug budipine on l-dopa-induced release of dopamine and 5-HT by rat substantia nigra and corpus striatum","volume":"34","author":"Biggs","year":"1999","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib286","doi-asserted-by":"crossref","first-page":"10046","DOI":"10.1523\/JNEUROSCI.22-22-10046.2002","article-title":"Diminished anxiety- and depression-related behaviors in mice with selective deletion of the Tac1 gene","volume":"22","author":"Bilkei-Gorzo","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib287","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ng1479","article-title":"Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment","volume":"36","author":"Binder","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib288","doi-asserted-by":"crossref","first-page":"29085","DOI":"10.1074\/jbc.M400930200","article-title":"The heptahelical domain of GABAB2 is activated directly by CGP7930, a positive allosteric modulator of the GABAB receptor","volume":"279","author":"Binet","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib289","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00004850-199510030-00008","article-title":"Benzodiazepines for depression? A review of the literature","volume":"10","author":"Birkenhager","year":"1995","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib290","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1176\/appi.ajp.161.11.2060","article-title":"Comparison of two-phase treatment with imipramine or fluvoxamine, both followed by lithium addition, in inpatients with major depressive disorder","volume":"161","author":"Birkenhager","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib291","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0361-9230(02)00930-9","article-title":"Neurotransmitter release and its presynaptic modulation in the rat hippocampus after selective damage to cholinergic and\/or serotonergic afferents","volume":"59","author":"Birthelmer","year":"2003","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib292","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0006-8993(02)02485-X","article-title":"Alpha-7 nicotinic receptor expression by two distinct cell types in the dorsal raphe nucleus and locus coeruleus of rat","volume":"938","author":"Bitner","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib293","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0149-7634(87)80008-8","article-title":"Pharmacological analysis of male rat sexual behavior","volume":"11","author":"Bitran","year":"1987","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib294","first-page":"171","article-title":"Anxiolytic effect of progesterone is mediated by the neurosteroids allopregnanolone at brain GABAA receptors","volume":"7","author":"Bitran","year":"1995","journal-title":"J Endocrinol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib295","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/cne.903190204","article-title":"The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization","volume":"319","author":"Bittencourt","year":"1992","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib296","doi-asserted-by":"crossref","first-page":"618","DOI":"10.4088\/JCP.v65n0505","article-title":"What characteristics of primary anxiety disorders predict subsequent major depressive disorder?","volume":"65","author":"Bittner","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib297","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1124\/mol.54.3.569","article-title":"\u03b12C-adrenoceptor-over-expressing mice are impaired in executing nonspatial and spatial escape strategies","volume":"54","author":"Bj\u00f6rklund","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib298","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0306-4522(99)00428-5","article-title":"Overexpression of alpha2C-adrenoceptors impairs water maze navigation","volume":"95","author":"Bj\u00f6rklund","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib299","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0278-5846(01)00209-3","article-title":"Spatial working memory improvement by an alpha2-adrenoceptor agonist dexmedetomidine is not mediated through alpha2C-adrenoceptor","volume":"25","author":"Bj\u00f6rklund","year":"2001","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib300","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1467-789x.2001.00027.x","article-title":"Do stress reactions cause abdominal obesity and comorbidities?","volume":"2","author":"Bjorntorp","year":"2001","journal-title":"Obes Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib301","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0306-4522(02)00181-1","article-title":"Effects of sleep deprivation on extracellular serotonin in hippocampus and frontal cortex of the rat","volume":"113","author":"Bjorvatn","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib302","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00213-004-2065-6","article-title":"Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data","volume":"179","author":"Black","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib303","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1192\/bjp.139.3.181","article-title":"The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination","volume":"139","author":"Blackburn","year":"1981","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib304","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0959-4388(00)00088-X","article-title":"Biogenic amine transporters: regulation in flux","volume":"10","author":"Blakely","year":"2000","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib305","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pbb.2004.10.024","article-title":"AVP V1b selective antagonist SSR149415 blocks aggressive behaviors in hamsters","volume":"80","author":"Blanchard","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib306","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1523\/JNEUROSCI.23-02-00700.2003","article-title":"Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning","volume":"23","author":"Blank","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib307","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0166-4328(02)00244-9","article-title":"The corticotropin-releasing factor receptor1 antagonist CP-154,526 reverses stress-induced learning deficits in mice","volume":"138","author":"Blank","year":"2003","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib308","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1523\/JNEUROSCI.10-08-02580.1990","article-title":"Electroconvulsive shock differentially increases binding to \u03b11 adrenergic receptor subtypes in discrete regions of rat brain","volume":"10","author":"Blendy","year":"1990","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib309","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/j.1471-4159.1991.tb06350.x","article-title":"Electroconvulsive shock increases \u03b11b- but not \u03b11a-adrenoceptor binding sites in rat cerebral cortex","volume":"57","author":"Blendy","year":"1991","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib310","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0924-977X(02)00173-6","article-title":"The pharmacology of putative early-onset antidepressant strategies","volume":"13","author":"Blier","year":"2003","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib311","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0165-6147(94)90315-8","article-title":"Current advances and trends in the treatment of depression","volume":"15","author":"Blier","year":"1994","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib312","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0006-3223(98)00114-0","article-title":"Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive\u2013compulsive disorder responses","volume":"44","author":"Blier","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib313","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0006-3223(02)01643-8","article-title":"Is there a role for 5-HT1A agonists in the treatment of depression?","volume":"53","author":"Blier","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib314","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/BF00168834","article-title":"Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain","volume":"337","author":"Blier","year":"1988","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib315","first-page":"208","article-title":"Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant\/anxiolytic response","volume":"29","author":"Blier","year":"2004","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib316","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.biopsych.2004.02.031","article-title":"Postsynaptic signaling networks: cellular cogwheels underlying long-term plasticity","volume":"57","author":"Blitzer","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib317","first-page":"15","article-title":"Is there a role for serotonin (5-HT) in feeding?","volume":"1","author":"Blundell","year":"1977","journal-title":"Int J Obes"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib318","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/cne.10989","article-title":"Anatomical evidence for transsynaptic effects of estrogen on brain-derived neurotrophic factor expression","volume":"468","author":"Blurton-Jones","year":"2004","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib319","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/nlme.1998.3886","article-title":"5-HT antagonists attenuate MK801-impaired radial arm maze performance in rats","volume":"71","author":"Boast","year":"1999","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib320","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/35057480","article-title":"Patents in a genetic age","volume":"409","author":"Bobrow","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib321","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/emboj\/18.7.1723","article-title":"Molecular tinkering of G protein-coupled receptors: an evolutionary success","volume":"18","author":"Bockaert","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib322","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/1568007043482615","article-title":"5-HT4 receptors","volume":"3","author":"Bockaert","year":"2004","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib323","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004714-199502000-00008","article-title":"Buprenorphine treatment of refractory depression","volume":"15","author":"Bodkin","year":"1995","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib324","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4088\/JCP.v58n0401","article-title":"Combining serotonin reuptake inhibitors and bupropion in partial responders to antidrepessant monotherapy","volume":"58","author":"Bodkin","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib325","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00442264","article-title":"A comparison of the effects of diazepam versus typical and atypical antidepressant drugs in an animal model of anxiety","volume":"97","author":"Bodnoff","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib326","first-page":"446","article-title":"Influence of sleep-wake and circadian rhythm disturbance in psychiatric disorders","volume":"25","author":"Boivin","year":"2000","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib327","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00239-004-2629-4","article-title":"Gene network polymorphism is the raw material of natural selection: the selfish gene network hypothesis","volume":"59","author":"Boldogk\u00f6i","year":"2004","journal-title":"J Mol Evol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib328","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/1389557033488169","article-title":"Current strategies for the development of novel antipsychotic drugs","volume":"3","author":"Bolos","year":"2003","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib329","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1017\/S1092852900018964","article-title":"Putative common pathways in therapeutic brain stimulation for affective disorders","volume":"8","author":"Bolwig","year":"2003","journal-title":"CNS Spectr"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib330","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuropharm.2004.09.012","article-title":"Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain","volume":"48","author":"Bomholt","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib331","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1523\/JNEUROSCI.5033-04.2005","article-title":"Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus","volume":"25","author":"Bonanno","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib332","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-2999(03)02010-7","article-title":"Behavioral and biochemical investigations of bupropion metabolites","volume":"474","author":"Bondarev","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib333","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00004714-199812000-00005","article-title":"Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: a review","volume":"18","author":"Bonhomme","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib334","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1185\/030079902125001461","article-title":"The elixir study: evaluation of sexual dysfunction in 4557 depressed patients in France","volume":"19","author":"Bonierbale","year":"2003","journal-title":"Curr Med Opin"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib335","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0091-3057(97)00484-X","article-title":"Pharmacological features of masculine sexual behavior in an animal model of depression","volume":"60","author":"Bonilla-Jaime","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib336","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.neubiorev.2003.12.001","article-title":"Adaptive and maladaptive psychobiological responses to severe psychological stress: implications for the discovery of novel pharmacotherapy","volume":"28","author":"Bonne","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib337","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1527-3458.2002.tb00229.x","article-title":"Moclobemide: evolution, pharmacodynamic and pharmacokinetic properties","volume":"8","author":"Bonnet","year":"2002","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib338","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/sj.npp.1300150","article-title":"Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors","volume":"28","author":"Bontempi","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib339","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/sj.mp.4001423","article-title":"Monoamine depletion in psychiatric and healthy populations: a review","volume":"8","author":"Booij","year":"2003","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib340","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1192\/bjp.187.2.148","article-title":"Acute tryptophan depletion as a model of depressive relapse","volume":"187","author":"Booij","year":"2005","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib341","first-page":"47","article-title":"Sildenafil an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction","volume":"8","author":"Boolell","year":"1996","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib342","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.bjp.0705444","article-title":"Evidence that central 5-HT2A and 5-HT2B\/C receptors regulate 5-HT cell firing in the dorsal raphe nucleus of the anaesthetised rat","volume":"140","author":"Boothman","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib343","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0165-1781(84)90135-5","article-title":"All-night spectral analysis of the sleep EEG in untreated depressive and normal controls","volume":"12","author":"Borb\u00e9ly","year":"1984","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib344","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.1073\/pnas.1337088100","article-title":"Systematic discovery of multicomponent therapeutics","volume":"100","author":"Borisy","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib345","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev.pharmtox.39.1.53","article-title":"The pineal gland and melatonin: molecular and pharmacologic regulation","volume":"39","author":"Borjigin","year":"1999","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib346","doi-asserted-by":"crossref","first-page":"8966","DOI":"10.1073\/pnas.151105198","article-title":"Trace amines: identification of a family of mammalian G protein-coupled receptors","volume":"98","author":"Borowsky","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib347","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nm0902-1039b","article-title":"Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist","volume":"8","author":"Borowsky","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib348","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0091-3057(88)90156-6","article-title":"On the role of endogenous GABA in the forced swimming test in rats","volume":"29","author":"Borsini","year":"1988","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib349","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1527-3458.2002.tb00219.x","article-title":"Pharmacology of flibanserin","volume":"8","author":"Borsini","year":"2002","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib350","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1043-2760(00)00325-8","article-title":"Nongenomic membrane actions of glucocorticoids in vertebrates","volume":"11","author":"Borski","year":"2000","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib351","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00702-004-0168-1","article-title":"Cognitive dysfunction and dementia in Parkinson's disease","volume":"111","author":"Bosboom","year":"2004","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib352","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.brainresbull.2005.01.004","article-title":"Microarray analysis of rat brain gene expression after chronic administration of sodium valproate","volume":"65","author":"Bosetti","year":"2005","journal-title":"Brian Res Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib353","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2165\/00023210-200418110-00002","article-title":"Future antidepressants, what is in the pipeline and what is missing?","volume":"18","author":"Bosker","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib354","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1034\/j.1600-0447.2000.90063.x","article-title":"Prevalence and background factors of depression in first admitted schizophrenic patients","volume":"101","author":"Bottlender","year":"2000","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib355","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1046\/j.1460-9568.2003.02960.x","article-title":"Sex hormone-dependent desensitisation of 5-HT1A autoreceptors in knockout mice deficient in the 5-HT transporter","volume":"18","author":"Bouali","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib356","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/bies.10371","article-title":"Alternative splicing and evolution","volume":"25","author":"Boue","year":"2003","journal-title":"BioEssays"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib357","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0278-5846(91)90076-D","article-title":"Phenylethylaminergic modulation of catecholaminergic neurotransmission","volume":"15","author":"Boulton","year":"1991","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib358","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s002130050560","article-title":"Pindolol does not act only on 5-HT1A receptors in augmenting antidepressant activity in the mouse forced swimming test","volume":"336","author":"Bourin","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib359","first-page":"126","article-title":"Antidepressant-like activity of S20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors","volume":"29","author":"Bourin","year":"2004","journal-title":"Rev Psychiatr Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib360","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1523\/JNEUROSCI.19-08-03204.1999","article-title":"Key role of 5-HT1B receptors in the regulation of paradoxical sleep as evidenced in 5-HT1B knock-out mice","volume":"19","author":"Boutrel","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib361","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1523\/JNEUROSCI.22-11-04686.2002","article-title":"Involvement of 5-HT1A receptors in homeostatic and stress-induced adaptive regulations of paradoxical sleep: studies in 5-HT1A knock-out mice","volume":"22","author":"Boutrel","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib362","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/35067575","article-title":"Oligomerization of G-protein-coupled transmitter receptors","volume":"2","author":"Bouvier","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib363","first-page":"534","article-title":"Buspirone is an effective augmenting agent of serotonin selective re-uptake inhibitors in severe treatment-refractory depression","volume":"87","author":"Bouwer","year":"1997","journal-title":"S Afr Med J"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib364","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1176\/appi.ajp.158.12.2033","article-title":"Cannabis abuse as a risk factor for depressive symptoms","volume":"158","author":"Bovasso","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib365","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/A:1001951104208","article-title":"Mice lacking PKC\u03b3 exhibit decreased anxiety","volume":"30","author":"Bowers","year":"2000","journal-title":"Behav Gen"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib366","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1124\/pr.54.2.247","article-title":"International Union of Pharmacology: XXXIII. Mammalian gamma-aminobutyric acid(B) receptors: structure and function","volume":"54","author":"Bowery","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib367","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/(SICI)1520-6394(1999)9:4<175::AID-DA5>3.0.CO;2-0","article-title":"Sexual functioning in depressed outpatients taking mirtazapine","volume":"9","author":"Boyarsky","year":"1999","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib368","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1358\/dot.1998.34.8.485269","article-title":"Milnacipran, a new specific serotonin and noradrenaline reuptake inhibitor","volume":"34","author":"Boyer","year":"1998","journal-title":"Drugs Today"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib369","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1073\/pnas.0406458102","article-title":"Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior","volume":"102","author":"Boyle","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib370","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0166-4328(86)90006-9","article-title":"Midbrain lesions, dopamine and male sexual behavior","volume":"20","author":"Brackett","year":"1986","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib371","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/713783681","article-title":"Cholecystokinin and panic disorder: past and future clinical research strategies","volume":"234","author":"Bradwejn","year":"2001","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib372","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0898-6568(01)00239-X","article-title":"G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction","volume":"14","author":"Brady","year":"2002","journal-title":"Cell Signalling"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib373","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1176\/appi.ajp.162.8.1483","article-title":"Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress","volume":"162","author":"Brady","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib374","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1172\/JCI115086","article-title":"Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain: therapeutic implications","volume":"87","author":"Brady","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib375","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1172\/JCI117444","article-title":"Repeated electroconvulsive shock produces long-lasting increases in messenger RNA expression of corticotropin-releasing hormone and tyrosine hydroxylase in rat brain. Therapeutic implications","volume":"94","author":"Brady","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib376","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1017\/S1461145701002668","article-title":"Perspectives on the use of anticonvulsants in the treatment of bipolar disorder","volume":"4","author":"Brambilla","year":"2001","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib377","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/sj.mp.4001362","article-title":"GABAergic dysfunction in mood disorders","volume":"8","author":"Brambilla","year":"2003","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib378","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.pharmtox.40.1.319","article-title":"5-HT6 receptors as emerging targets for drug discovery","volume":"40","author":"Branchek","year":"2000","journal-title":"Ann Rev Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib379","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S1471-4892(02)00028-0","article-title":"Trace amine receptors as targets for novel therapeutics: legend, myth and fact","volume":"3","author":"Branchek","year":"2003","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib380","first-page":"130","article-title":"Clinical pharmacology of bupropion and imipramine in elderly depressives","volume":"44","author":"Branconnier","year":"1983","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib381","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.neuron.2005.02.006","article-title":"Regulation of gene expression by lithium and depletion of inositol in slices of adult rat cortex","volume":"45","author":"Brandish","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib382","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0959-4388(97)80069-4","article-title":"PKA isoforms, neural pathways, and behaviour: making the connection","volume":"7","author":"Brandon","year":"1997","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib383","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.gene.2004.11.022","article-title":"Transposable elements as a source of genetic innovation: expression and evolution of a family of retransposon-derived neogenes in mammals","volume":"345","author":"Brandt","year":"2005","journal-title":"Gene"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib384","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jpsychires.2004.05.005","article-title":"Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies","volume":"39","author":"Brannan","year":"2005","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib385","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000080028","article-title":"Late-onset depression with mild cognitive deficits: electrophysiological evidences for a preclinical dementia syndrome","volume":"18","author":"Brassen","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib386","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1021\/jm000007r","article-title":"Ligands for glutamate receptors: design and therapeutic prospects","volume":"43","author":"Br\u00e4uner-Osborne","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib387","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/sj.bjp.0702065","article-title":"Catecholamine transport by the organic cation transporter type 1 (OCT1)","volume":"125","author":"Breidert","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib388","doi-asserted-by":"crossref","first-page":"28756","DOI":"10.1074\/jbc.M313310200","article-title":"Hetero-oligomerization between beta2- and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties","volume":"279","author":"Breit","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib389","doi-asserted-by":"crossref","first-page":"8419","DOI":"10.1021\/bi0106890","article-title":"Inhibition of the serotonin 5-HT3 receptor by nicotine, cocaine and fluoxetine investigated by rapid chemical kinetic techniques","volume":"40","author":"Breitinger","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib390","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archpsyc.55.2.161","article-title":"Major depression and stages of smoking: a longitudinal investigation","volume":"55","author":"Breslau","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib391","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1212\/WNL.54.2.308","article-title":"Headache and major depression: is the association specific to migraine?","volume":"54","author":"Breslau","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib392","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1081\/DMR-200033482","article-title":"The metabolic fate of amitriptyline, nortriptyline and amitriptylinoxide in man","volume":"36","author":"Breyer-Pfaff","year":"2004","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib393","series-title":"Classification and Regression Trees","first-page":"297","author":"Brieman","year":"1984"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib394","first-page":"42","article-title":"New hope in the treatment of painful symptoms in depression","volume":"4","author":"Briley","year":"2003","journal-title":"Curr Opin Invest Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib395","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/hup.621","article-title":"Clinical experience with dual action antidepressants in different chronic pain syndromes","volume":"19","author":"Briley","year":"2004","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib396","series-title":"Antidepressants: New Pharmacological Strategies","first-page":"35","article-title":"Specific serotonin\/noradrenaline reuptake inhibiting antidepressants","author":"Briley","year":"1997"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib397","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2125.2003.02046.x","article-title":"Recent advances in drug action and therapeutics: relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology","volume":"57","author":"Brink","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib398","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1073\/pnas.0308292101","article-title":"Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats","volume":"101","author":"Brioni","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib399","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0028-3908(99)00191-4","article-title":"Evidence for accelerated desensitisation of 5-HT2C receptors following combined treatment with fluoxetine and the 5-HT1A receptor antagonist, WAY100,635, in the rat","volume":"39","author":"Bristow","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib400","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0501008102","article-title":"The majority of human genes have regions repeated in other human genes","volume":"102","author":"Britten","year":"2005","journal-title":"Proc Nat Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib401","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0196-9781(99)00169-2","article-title":"Neuropeptide Y blocks anxiogenic-like behavioural action of corticotrophin-releasing factor in an operant conflict test and elevated plus maze","volume":"21","author":"Britton","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib402","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0091-3057(01)00701-8","article-title":"Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents","volume":"71","author":"Brocco","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib403","first-page":"157.15","article-title":"Induction of contralateral rotation by l-dopa in unilateral, substantia nigra-lesioned rats: a comparison to amphetamine, quinpirole and SKF81297","volume":"29","author":"Brocco","year":"2003","journal-title":"Am Soc Neurosci Abstr"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib404","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0091-3057(02)00828-6","article-title":"Anxiolytic-like activity of the mGluR5 antagonist MPEP. A comparison with diazepam and buspirone","volume":"73","author":"Brodkin","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib405","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0006-3223(97)00388-0","article-title":"The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioural, and physiological responses in young healthy controls","volume":"43","author":"Broocks","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib406","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jjp.90.1","article-title":"Behavioral effects of \u03b4-opioid receptor agonists: potential antidepressants?","volume":"90","author":"Broom","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib407","doi-asserted-by":"crossref","first-page":"10706","DOI":"10.1073\/pnas.89.22.10706","article-title":"On \u201cgenomenclature\u201d: a comprehensive (and respectful) taxonomy for pseudogenes and other \u201cjunk DNA\u201d","volume":"89","author":"Brosius","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib408","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0014-2999(00)00491-X","article-title":"Sex differences in forced swim and open field test behaviours after chronic administration of melatonin","volume":"402","author":"Brotto","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib409","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1212\/WNL.49.2.444","article-title":"Randomized, double-blind, placebo-controlled cross-over trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy","volume":"49","author":"Broughton","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib410","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1530\/eje.1.01828","article-title":"Thyroid and adrenal axis in major depression: a controlled study in outpatients","volume":"152","author":"Brouwer","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib411","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01245227","article-title":"Dopamine and depression","volume":"91","author":"Brown","year":"1993","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib412","first-page":"30","article-title":"Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another?","volume":"56","author":"Brown","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib413","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/S0960-894X(01)00355-9","article-title":"Discovery and SAR of Org 24598\u2014a selective glycine uptake inhibitor","volume":"11","author":"Brown","year":"2001","journal-title":"Biorg Med Chem Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib414","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0301-0082(00)00039-3","article-title":"The physiology of brain histamine","volume":"63","author":"Brown","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib415","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1074\/jbc.275.4.2811","article-title":"Nitric oxide activation of p38 mitogen-activated protein kinase in 293T fibroblasts requires cGMP-dependent protein kinase","volume":"275","author":"Browning","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib416","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.neurobiolaging.2004.07.014","article-title":"Cortical 6-[18F]fluoro-l-dopa uptake and frontal cognitive functions in early Parkinson's disease","volume":"26","author":"Br\u00fcck","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib417","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0165-0327(99)00140-8","article-title":"Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment","volume":"60","author":"Brunello","year":"2000","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib418","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0893-133X(95)00068-O","article-title":"New insights into the biology of schizophrenia through the mechanism of action of clozapine","volume":"13","author":"Brunello","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib419","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0924-977X(02)00057-3","article-title":"The role of noradrenaline and selective noradrenaline reuptake inhibition in depression","volume":"12","author":"Brunello","year":"2002","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib420","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0924-977X(02)00071-8","article-title":"Vasopressin in CSF and plasma in depressed suicide attempters: preliminary results","volume":"12","author":"Brunner","year":"2002","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib421","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.pnpbp.2003.11.013","article-title":"Pindolol does not augment cortical and prolactin responses to paroxetine in healthy subjects","volume":"28","author":"Brunswick","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib422","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.bjp.0705904","article-title":"Nitric oxide donors inhibit 5-HT uptake by the human 5-HT transporter (SERT)","volume":"143","author":"Bryan-Lluka","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib423","first-page":"210","article-title":"Hypothalamic-pituitary-thyroid system activity during lithium augmentation therapy in patients with unipolar major depression","volume":"28","author":"Bschor","year":"2003","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib424","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1055\/s-2003-45135","article-title":"Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms","volume":"36","author":"Bschor","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib425","series-title":"Cognitive Enhancing Drugs","first-page":"1","article-title":"The cholinergic hypothesis\u2014past and present","author":"Buccafusco","year":"2004"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib426","first-page":"438","article-title":"Multiple CNS targets for eliciting beneficial effects on memory and cognition","volume":"295","author":"Buccafusco","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib427","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0306-4522(02)00937-5","article-title":"Potential cognitive actions of (n-propargyl-(3r)-aminoindan-5-yl)-ethyl, methyl carbamate (TV3326), a novel neuroprotective agent, as assessed in old rhesus monkeys in their performance of versions of a delayed matching task","volume":"119","author":"Buccafusco","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib428","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.tips.2005.05.007","article-title":"Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance","volume":"26","author":"Buccafusco","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib429","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0278-5846(88)90003-6","article-title":"The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation","volume":"12","author":"Buckett","year":"1988","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib430","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.pnpbp.2004.05.012","article-title":"Mechanism of action of A-85380 in an animal model of depression","volume":"28","author":"Buckley","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib431","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1176\/appi.ajp.161.11.1967","article-title":"Review of the validity and significance of cannabis withdrawal syndrome","volume":"161","author":"Budney","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib432","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/sj.bjp.0703445","article-title":"Antidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription\u2014a possible mechanism","volume":"130","author":"Budziszewska","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib433","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejphar.2005.04.045","article-title":"Panicolytic-like effect induced by the stimulation of GABAA and GABAB receptors in the dorsal periaqueductal grey of rats","volume":"516","author":"Bueno","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib434","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3109\/07853890008998828","article-title":"Role of serotonin in memory impairment","volume":"32","author":"Buhot","year":"2000","journal-title":"Ann Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib435","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1124\/mol.53.3.555","article-title":"Open-channel blockers at the human \u03b14\u03b22 neuronal nicotinic acetylcholine receptor","volume":"53","author":"Buisson","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib436","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.tips.2005.01.004","article-title":"Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation","volume":"26","author":"Bulenger","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib437","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1469-7793.1999.0005z.x","article-title":"Topical review, G-protein coupled receptor kinases as modulators of G-protein signalling","volume":"517.1","author":"B\u00fcnemann","year":"1999","journal-title":"J Physiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib438","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0166-2236(99)01410-1","article-title":"Paracrine neurotransmission in the CNS: involvement of 5-HT","volume":"22","author":"Bunin","year":"1999","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib439","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0893-133X(99)00145-1","article-title":"Molecular clock genes in man and lower animals: possible implications for circadian abnormalities in depression","volume":"22","author":"Bunney","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib440","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1037\/0735-7044.109.5.903","article-title":"Specific effects of idazoxan in a distraction task: evidence that endogenous norepinephrine plays a role in selective attention in rats","volume":"109","author":"Bunsey","year":"1995","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib441","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1124\/mol.60.6.1181","article-title":"Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor","volume":"60","author":"Bunzow","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib442","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF02071318","article-title":"Molecular neurobiology and pharmacology of the vasopressin\/oxytocin receptor family","volume":"15","author":"Burbach","year":"1995","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib443","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1081\/CBI-200025979","article-title":"Bright light therapy for winter depression\u2014is phase advancing beneficial?","volume":"21","author":"Burgess","year":"2004","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib444","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4088\/JCP.v63n0410","article-title":"Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients","volume":"63","author":"Burke","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib445","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0006-8993(02)04269-5","article-title":"GABAB receptor subunits, R1 and R2, in brainstem catecholamine and serotonin neurons","volume":"970","author":"Burman","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib446","first-page":"78","article-title":"Expression of 5-HT receptors and the 5-HT transporter in rat brain after electroconvulsive shock","volume":"277","author":"Burnett","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib447","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-2999(01)00777-4","article-title":"Electroconvulsive shock increases tachykinin NK1 receptors, but not the encoding mRNA, in rat cortex","volume":"413","author":"Burnett","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib448","first-page":"20","article-title":"Plotting the course to remission: the search for better outcomes in the treatment of depression","volume":"65","author":"Burt","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib449","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S1461145702002791","article-title":"Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis","volume":"5","author":"Burt","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib450","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/mol.54.2.342","article-title":"Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine","volume":"54","author":"Busch","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib451","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/sj.npp.1300540","article-title":"The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety","volume":"29","author":"Busse","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib452","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1471-4159.1993.tb13618.x","article-title":"Chronic electroconvulsive seizures increase the expression of serotonin2 receptor mRNA in rat frontal cortex","volume":"61","author":"Butler","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib453","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2165\/00023210-200317090-00004","article-title":"The glutamatergic system and Alzheimer's disease: therapeutic implication","volume":"17","author":"Butterfield","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib454","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/depr.3050020207","article-title":"Do electroencephalographic sleep studies predict recurrence in depressed patients successfully treated with psychotherapy?","volume":"2","author":"Buysse","year":"1994","journal-title":"Depression"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib455","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0022-3956(95)00021-V","article-title":"Circadian patterns of unintended sleep episodes during a constant routine in remitted depressed patients","volume":"29","author":"Buysse","year":"1995","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib456","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0893-133X(01)00298-6","article-title":"Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors","volume":"25","author":"Bymaster","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib457","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00213-001-0986-x","article-title":"Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex","volume":"160","author":"Bymaster","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib458","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/1568007024606249","article-title":"Muscarinic receptors as a target for drugs treating schizophrenia","volume":"1","author":"Bymaster","year":"2003","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib459","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1517\/13543784.12.4.531","article-title":"New approaches to developing antidepressants by enhancing monoaminergic neurotransmission","volume":"12","author":"Bymaster","year":"2003","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib460","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0169-328X(98)00137-5","article-title":"Alterations in neuropeptide Y and Y1 receptor mRNA expression in brains from an animal model of depression: region-specific adaptation after fluoxetine treatment","volume":"59","author":"Caberlotto","year":"1998","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib461","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(99)00234-7","article-title":"Alterations in neuropeptide Y levels and Y1 binding sites in the Flinders Sensitive Line rats, a genetic animal model of depression","volume":"265","author":"Caberlotto","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib462","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1046\/j.1460-9568.2003.02600.x","article-title":"Neurokinin1 receptor and relative abundance of the short and long isoform in the human brain","volume":"17","author":"Caberlotto","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib463","first-page":"R1189","article-title":"Melatonin and S-20098 increase REM sleep and wake-up propensity without modifying NREM sleep homeostasis","volume":"272","author":"Cajochen","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib464","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1365-2826.2003.00989.x","article-title":"Role of melatonin in the regulation of human circadian rhythms and sleep","volume":"15","author":"Cajochen","year":"2003","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib465","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4088\/JCP.v60n0203","article-title":"A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression","volume":"60","author":"Calabrese","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib466","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4088\/JCP.v64n0511","article-title":"Citalopram treatment of fluoxetine-intolerant depressed patients","volume":"64","author":"Calabrese","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib467","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.biopsych.2004.08.010","article-title":"High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation","volume":"56","author":"Caldarone","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib468","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/syn.890080306","article-title":"Clinical and biochemical aspects of depressive disorders: I. Introduction, classification, and research techniques","volume":"8","author":"Caldecott-Hazard","year":"1991","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib469","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/syn.890090404","article-title":"Clinical and biochemical aspects of depressive disorders: II. Transmitter\/receptor theories","volume":"9","author":"Caldecott-Hazard","year":"1991","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib470","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-0327(99)00068-3","article-title":"Motor and cognitive aspects of motor retardation in depression","volume":"57","author":"Caligiuri","year":"2000","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib471","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1579\/0044-7447-33.7.404","article-title":"Biodiversity, distributions and adaptations of Arctic species in the context of environmental change","volume":"33","author":"Callaghan","year":"2004","journal-title":"Ambio"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib472","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/sj.bjp.0703219","article-title":"Pharmacology of nociceptin and its receptor: a novel therapeutic target","volume":"129","author":"Calo","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib473","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0006-8993(88)90523-9","article-title":"Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro","volume":"463","author":"Calogero","year":"1988","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib474","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000068257","article-title":"GABAB receptors: from monogamy to promiscuity","volume":"11","author":"Calver","year":"2002","journal-title":"NeuroSignals"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib475","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pnpbp.2004.10.002","article-title":"Escitalopram\/reboxetine combination in depressed patients with substance use disorder","volume":"29","author":"Camarasa","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib476","doi-asserted-by":"crossref","first-page":"12224","DOI":"10.1073\/pnas.0503880102","article-title":"Beyond affect: a role for genetic variation of the serotonin transporter in neural activation during a cognitive attention task","volume":"102","author":"Canli","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib477","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2004.09.005","article-title":"Differential nicotinic acetylcholine receptor subtypes mediating striatal and prefrontal cortical [3H]dopamine release","volume":"48","author":"Cao","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib478","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1124\/jpet.104.076794","article-title":"Nicotinic acetylcholine receptor-mediated [3H] dopamine release from hippocampus","volume":"312","author":"Cao","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib479","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrd839","article-title":"Glivec (STI1571, IMATINIB), a rationally developed, targeted anticancer drug","volume":"1","author":"Capdeville","year":"2002","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib480","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1021\/jm0493461","article-title":"Further studies on the interaction of the 5-HT3 receptor with arylpiperazine ligands. Development of a new 5-HT3 receptor ligand showing potent acetylcholinesterase inhibitory properties","volume":"48","author":"Cappelli","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib481","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0006-3223(95)00367-3","article-title":"Yohimbine augmentation of fluvoxamine in refractory depression: a single-blind study","volume":"38","author":"Cappiello","year":"1995","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib482","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00004850-199809000-00001","article-title":"Lithium and desipramine versus desipramine alone in the treatment of severe major depression: a preliminary study","volume":"13","author":"Cappiello","year":"1998","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib483","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.biopsych.2004.02.009","article-title":"Cytokines and psychopathology: lessons from interferon-\u03b1","volume":"56","author":"Capuron","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib484","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.euroneuro.2004.02.001","article-title":"Effect of chronic lithium treatment on the turnover of \u03b12-adrenoceptors after chemical inactivation in rats","volume":"14","author":"Carbonell","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib485","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1615\/CritRevNeurobiol.v16.i12.130","article-title":"Dopamine reuptake by norepinephrine neurons: exception or rule?","volume":"16","author":"Carboni","year":"2004","journal-title":"Crit Rev Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib486","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1471-4159.1990.tb04599.x","article-title":"Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals","volume":"55","author":"Carboni","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib487","first-page":"9","article-title":"The human body circadian: how the biologic clock influences sleep and emotion","volume":"21","author":"Cardinali","year":"2000","journal-title":"Neuroendocrinol Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib488","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.biopsych.2004.12.011","article-title":"Antidepressant-like effect of cranial stimulation within a low-energy magnetic field in rats","volume":"57","author":"Carlezon","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib489","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/1801200a0","article-title":"Dihydroxyphenylalamine and 5-hydroxytryptophan as reserpine antagonists","volume":"180","author":"Carlsson","year":"1957","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib490","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.pharmtox.41.1.237","article-title":"Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence","volume":"41","author":"Carlsson","year":"2001","journal-title":"Ann Rev Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib491","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0006-3223(98)00049-3","article-title":"Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease","volume":"45","author":"Carney","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib492","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0893-133X(97)00198-X","article-title":"Tryptophan depletion during continuous CSF sampling in healthy human subjects","volume":"19","author":"Carpenter","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib493","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4088\/JCP.v60n0110","article-title":"Mirtazapine augmentation in the treatment of refractory depression","volume":"60","author":"Carpenter","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib494","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0006-3223(01)01262-8","article-title":"A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine","volume":"51","author":"Carpenter","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib495","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1042-3680(02)00121-3","article-title":"Cervical vagus nerve stimulation for treatment-resistant depression","volume":"14","author":"Carpenter","year":"2003","journal-title":"Neurosurg Clin N Am"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib496","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.biopsych.2004.06.025","article-title":"Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentration in depressed patients","volume":"56","author":"Carpenter","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib497","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.npp.1300375","article-title":"Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects","volume":"29","author":"Carpenter","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib498","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.2174\/1381612043383421","article-title":"Recent approaches to novel anti-Alzheimer therapy","volume":"10","author":"Carreiras","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib499","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1471-4159.2000.0750889.x","article-title":"Regulation of neurotransmitter release by metabotropic glutamate receptors","volume":"75","author":"Cartmell","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib500","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.bbr.2004.01.004","article-title":"Aged neuropeptide Y transgenic rats are resistant to acute stress but maintain spatial and non-spatial learning","volume":"153","author":"Carvajal","year":"2004","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib501","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1353-8020(00)00061-4","article-title":"Neuroprotective effects of D3 dopamine receptor agonists","volume":"7","author":"Carvey","year":"2001","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib502","first-page":"4","article-title":"The pharmacology of weight gain with antipsychotics","volume":"62","author":"Casey","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib503","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.1083968","article-title":"Influence of life stress on depression: moderation by a polymorphism in the 5-HT gene","volume":"301","author":"Caspi","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib504","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0924-9338(96)82332-7","article-title":"A double-blind comparison of tianeptine, imipramine and placebo in the treatment of major depressive episodes","volume":"11","author":"Cassano","year":"1996","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib505","doi-asserted-by":"crossref","first-page":"396","DOI":"10.4088\/JCP.v63n0504","article-title":"Paroxetine and fluoxetine effects on mood and cognitive functions in depressed nondemented elderly patients","volume":"63","author":"Cassano","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib506","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/da.20038","article-title":"Pramipexole in treatment-resistant depression: an extended follow-up","volume":"20","author":"Cassano","year":"2004","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib507","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(95)00241-A","article-title":"Serotonergic modulation of cholinergic function in the central nervous system. Cognitive implications","volume":"69","author":"Cassel","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib508","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s002130000595","article-title":"Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1beta in the rat","volume":"154","author":"Castanon","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib509","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0889-1591(02)00008-9","article-title":"Effects of antidepressants on cytokine production and actions","volume":"16","author":"Castanon","year":"2002","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib510","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0306-4530(02)00005-7","article-title":"Chronic treatment with the antidepressant tianeptine attenuates lipopolysaccharide-induced Fos expression in the rat paraventricular nucleus and HPA axis activation","volume":"28","author":"Castanon","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib511","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0306-4530(03)00142-2","article-title":"Chronic administration of tianeptine balances lipopolysaccharide-induced expression of cytokines in the spleen and hypothalamus of rats","volume":"29","author":"Castanon","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib512","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1126\/science.287.5460.2020","article-title":"Reversal of antipsychotic induced working memory deficits by short-term dopamine D1 receptor stimulation","volume":"287","author":"Castner","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib513","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrn1629","article-title":"Is mood chemistry?","volume":"6","author":"Castren","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib514","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1038\/sj.ijo.0801284","article-title":"Glucocorticoids and neuroendocrine function","volume":"24","author":"Cavagnini","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib515","first-page":"252","article-title":"The therapeutic role of 5-HT1A and 5-HT2A receptors in depression","volume":"29","author":"Celada","year":"2004","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib516","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0006-3223(02)01491-9","article-title":"Selective regulation of presynaptic calcium\/calmodulin-dependent protein kinase II by psychotropic drugs","volume":"53","author":"Celano","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib517","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00213-005-0016-5","article-title":"Acute administration of the novel serotonin and noradrenaline reuptake inhibitor, S33005, markedly modifies sleep-wake cycle architecture in rats","volume":"181","author":"Cespuglio","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib518","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00213-003-1465-3","article-title":"Agomelatin (S20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats","volume":"170","author":"Chagraoui","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib519","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1358\/dof.2004.029.10.840349","article-title":"The MC4 receptor as a therapeutic target","volume":"29","author":"Chaki","year":"2004","journal-title":"Drugs Future"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib520","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1124\/jpet.102.044826","article-title":"Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor","volume":"304","author":"Chaki","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib521","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2003.11.032","article-title":"Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995\/CRA0450","volume":"485","author":"Chaki","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib522","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.neuropharm.2003.10.009","article-title":"MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity","volume":"46","author":"Chaki","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib523","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1124\/jpet.104.081711","article-title":"Anxiolytic- and antidepressant-like profile of ATC0065 and ATC0175: nonpeptidic and orally active melanin-concentrating hormone receptor1 antagonists","volume":"313","author":"Chaki","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib524","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0006-8993(98)00491-0","article-title":"An NK1 receptor antagonist affects the circadian regulation of locomotor activity in golden hamsters","volume":"800","author":"Challet","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib525","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0028-3908(00)00165-9","article-title":"The selective neurokinin1 receptor antagonist R116301 modulates photic responses of the hamster circadian system","volume":"40","author":"Challet","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib526","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/sj.npp.1300209","article-title":"Duloxetine increases serotonin and norepinephrine availability in healthy subjects: a double-blind, controlled study","volume":"28","author":"Chalon","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib527","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.103.049718","article-title":"Brain stimulation for neurological and psychiatric disorders, current status and future direction","volume":"309","author":"Chang","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib529","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0005-2736(98)00255-7","article-title":"Nongenomic steroidal modulation of high-affinity serotonin transport","volume":"1417","author":"Chang","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib530","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0149-7634(01)00024-0","article-title":"Corticotropin-releasing hormone (CRH) as a regulator of waking","volume":"25","author":"Chang","year":"2001","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib531","first-page":"R400","article-title":"Role of corticotropin-releasing hormone in stressor-induced alterations of sleep in rat","volume":"283","author":"Chang","year":"2002","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib532","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/sj.bjp.0703478","article-title":"Hippocampal noradrenergic neurotransmission in concurrent EEG desynchronization and inhibition of penile erection induced by cocaine in the rat","volume":"130","author":"Chang","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib533","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/hipo.1094","article-title":"Involvement of noradrenergic innervation from locus coeruleus to hippocampal formation in negative feedback regulation of penile erection in the rat","volume":"11","author":"Chang","year":"2001","journal-title":"Hippocampus"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib534","doi-asserted-by":"crossref","first-page":"28S","DOI":"10.1016\/S0893-133X(99)00008-1","article-title":"Serotonin and stress","volume":"21","author":"Chaouloff","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib535","first-page":"608","article-title":"A morphometric study of the cranium of the pachycephalosaurid dinosaur Stegoceras","volume":"55","author":"Chapman","year":"1981","journal-title":"J Paleontol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib536","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S1044-7431(03)00162-3","article-title":"GABAB receptor subunit expression in glia","volume":"24","author":"Charles","year":"2003","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib537","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1212\/WNL.50.5_Suppl_5.S17","article-title":"Levodopa therapy: consequences of the nonphysiologic replacement of dopamine","volume":"50","author":"Chase","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib538","first-page":"1218","article-title":"Melatonin: therapeutic use in sleep disorders","volume":"31","author":"Chase","year":"1997","journal-title":"Am Pharm"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib539","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0143-4179(90)90042-W","article-title":"Proopiomelanocortin (POMC)-derived peptides and sleep in the rat: Part 1. Hypnogenic properties of ACTH derivatives","volume":"15","author":"Chastrette","year":"1990","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib540","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S1367-5931(00)00228-3","article-title":"Prediction of pharmacokinetic properties using experimental approaches during early drug discovery","volume":"5","author":"Chaturvedi","year":"2001","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib541","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0306-4522(01)00133-6","article-title":"Nucleus accumbens muscarinic receptors in the control of behavioral depression: antidepressant-like effects of local M1 antagonist in the Porsolt swim test","volume":"104","author":"Chau","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib542","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1162\/089976699300016089","article-title":"Neuronal regulation: a mechanism for synaptic pruning during brain maturation","volume":"11","author":"Chechik","year":"1999","journal-title":"Neural Comput"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib543","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1523\/JNEUROSCI.0007-04.2004","article-title":"Functional imaging of working memory after 24 hr of total sleep deprivation","volume":"24","author":"Chee","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib544","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1124\/jpet.104.068692","article-title":"Chronic antidepressant treatment causes a selective reduction of \u03bc-opioid receptor binding and functional coupling to G proteins in the amygdala of fawn-hooded rats","volume":"310","author":"Chen","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib545","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0006-8993(02)04123-9","article-title":"Spinal, GABAB, receptors mediate antinociceptive actions of cholinergic agents in normal and diabetic rats","volume":"965","author":"Chen","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib546","first-page":"292","article-title":"Possible genomic consequence of nongenomic action of glucocorticoids in neural cells","volume":"16","author":"Chen","year":"2001","journal-title":"News Physiol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib547","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1046\/j.1471-4159.1995.64041585.x","article-title":"Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (1\/-)-8-hydroxy-2-(di-n-propylamino)tetralin","volume":"64","author":"Chen","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib548","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0361-9230(95)00082-P","article-title":"Further evidence that fluoxetine interacts with a 5-HT2C receptor in glial cells","volume":"38","author":"Chen","year":"1995","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib549","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1523\/JNEUROSCI.21-16-06348.2001","article-title":"Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: abnormal intestinal motility and the expression of cation transporters","volume":"21","author":"Chen","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib550","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1460-9568.2004.03548.x","article-title":"Central blockade of muscarinic cholinergic receptors disrupts affective and attentional set-shifting","volume":"20","author":"Chen","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib551","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00424-003-1064-5","article-title":"Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6","volume":"447","author":"Chen","year":"2004","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib552","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1471-4159.2004.02835.x","article-title":"Characterization of an allosteric citalopram-binding site at the serotonin transporter","volume":"92","author":"Chen","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib553","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.euroneuro.2004.08.008","article-title":"The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors","volume":"15","author":"Chen","year":"2005","journal-title":"Eur Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib554","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/sj.bjp.0706100","article-title":"GABAB receptor modulators potentiate baclofen-induced depression of dopamine neuron activity in the rat ventral tegmental area","volume":"144","author":"Chen","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib555","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ng1518","article-title":"Complex trait analysis gene expression uncovers polygenic and pleiotropic networks that modulate nervous system function","volume":"37","author":"Chesler","year":"2005","journal-title":"Nat Gen"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib556","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00001756-199803090-00002","article-title":"Nitric oxide synthase activity in the dorsal periaqueductal gray of rats expressing innate fear responses","volume":"9","author":"Chiavegatto","year":"1998","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib557","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1358\/dof.2003.028.01.716379","article-title":"Agomelatine","volume":"28","author":"Chilman-Blair","year":"2003","journal-title":"Drugs Future"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib558","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1525-142X.2001.01033.x","article-title":"Developmental exaptation and evolutionary change","volume":"3","author":"Chipman","year":"2001","journal-title":"Evol Dev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib559","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1017\/S1461145704004912","article-title":"Antidepressant effects of different schedules of repetitive transcranial magnetic stimulation vs clomipramine in patients with major depression: relationship to changes in cortical excitability","volume":"8","author":"Chistyakov","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib560","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1097\/00001756-200312190-00032","article-title":"Fluoxetine blocks cloned neuronal A-type K+ channels Kvl.4","volume":"14","author":"Choi","year":"2003","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib561","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.bcp.2003.08.012","article-title":"Mechanism of block by fluoxetine of 5-HT3 mediated currents in NCB-20 neuroblastoma cells","volume":"66","author":"Choi","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib562","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1124\/jpet.301.1.187","article-title":"Effects of acute and subchronic administration of dexefaroxan, an \u03b12-adrenoceptor antagonist, on memory performance in young adult and aged rodents","volume":"301","author":"Chopin","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib563","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nn1240","article-title":"Proteomics in postgenomic neuroscience: the end of the beginning","volume":"7","author":"Choudhary","year":"2004","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib564","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.biopsych.2004.03.003","article-title":"Decreased plasma nitric oxide metabolites and platelet nitric oxide synthase activity in patients with major depression","volume":"56","author":"Chrapko","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib565","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1017\/S1355617797006310","article-title":"A quantitative review of cognitive deficits in depression and Alzheimer-type dementia","volume":"3","author":"Christensen","year":"1997","journal-title":"J Int Neuropsychol Soc"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib566","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0024-3205(98)00348-8","article-title":"The generation of nitric oxide by G protein-coupled receptors","volume":"64","author":"Christopoulos","year":"1999","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib567","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/pr.54.2.323","article-title":"G protein-coupled receptor allosterism and complexing","volume":"54","author":"Christopoulos","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib568","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/jama.1992.03480090092034","article-title":"The concepts of stress and stress system disorders. Overview of physical and behavioural homeostasis","volume":"267","author":"Chrousos","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib569","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1542\/peds.102.SE1.1225","article-title":"Biological basis of emotions: brain systems and brain development","volume":"102","author":"Chugani","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib570","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1353-8020(03)00108-1","article-title":"Systematic review of antidepressant therapies in Parkinson's disease","volume":"10","author":"Chung","year":"2003","journal-title":"Parkinsonian Relat Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib571","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00424-004-1355-5","article-title":"Regulation of organic cation transport","volume":"449","author":"Ciarimboli","year":"2005","journal-title":"Pflugers Arch Eur J Physiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib572","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1101\/gr.3266405","article-title":"Complex genomic rearrangements lead to novel primate gene function","volume":"15","author":"Ciccarelli","year":"2005","journal-title":"Genome Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib573","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1177\/0269881104047284","article-title":"Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspects","volume":"18","author":"Ciusani","year":"2004","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib574","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1043-2760(01)00407-6","article-title":"Depression: a major, unrecognised risk factor for osteoporosis?","volume":"12","author":"Cizza","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib575","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/neu.10129","article-title":"Patterns and processes in the early evolution of the tetrapod ear","volume":"53","author":"Clack","year":"2002","journal-title":"J Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib576","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/js9804011","article-title":"Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena: I. Prediction of intestinal absorption","volume":"88","author":"Clark","year":"1999","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib577","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000124151","article-title":"Evidence for the modulation of sexual behavior by \u03b1-adrenoceptors in male rats","volume":"41","author":"Clark","year":"1985","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib578","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/4600","article-title":"Enhanced recognition memory following vagus nerve stimulation in human subjects","volume":"2","author":"Clark","year":"1999","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib579","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0006-8993(00)01958-2","article-title":"Distribution of the GABA(B) receptor subunit gb2 in rat CNS","volume":"860","author":"Clark","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib580","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/35075564","article-title":"Scalable architecture in mammalian brains","volume":"411","author":"Clark","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib581","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.biopsych.2005.01.013","article-title":"Differential hormonal regulation of tryptophan hydroxylase-2 mRNA in the murine dorsal raphe nucleus","volume":"57","author":"Clark","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib582","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(02)11668-0","article-title":"Dopamine agonist monotherapy in Parkinson's disease","volume":"360","author":"Clarke","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib583","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1116800","article-title":"Fewer genes, more noncoding RNA","volume":"309","author":"Claverie","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib584","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4088\/JCP.v62n0309","article-title":"Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction","volume":"62","author":"Clayton","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib585","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4088\/JCP.v63n0414","article-title":"Prevalence of sexual dysfunction among newer antidepressants","volume":"63","author":"Clayton","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib586","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0028-3908(99)00086-6","article-title":"Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS","volume":"39","author":"Clemett","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib587","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0361-9230(01)00637-2","article-title":"Genetic basis of anxiety-like behaviour: a critical review","volume":"57","author":"Clement","year":"2002","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib588","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cbpa.2004.04.002","article-title":"Complex phenotypic assays in high-throughput screening","volume":"8","author":"Clemons","year":"2004","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib589","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0924-977X(01)00078-5","article-title":"Involvement of 5-HT2C receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice","volume":"11","author":"Clenet","year":"2001","journal-title":"Eur Neuropharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib590","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s002130000504","article-title":"Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist, and d-fenfluramine on feeding patterns in the rat","volume":"152","author":"Clifton","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib591","doi-asserted-by":"crossref","first-page":"13365","DOI":"10.1073\/pnas.222532599","article-title":"The discovery of susceptibility genes for mental disorders","volume":"99","author":"Cloninger","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib592","first-page":"1263","article-title":"Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception","volume":"274","author":"Codd","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib593","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrd1415","article-title":"GSK3 inhibitors: development and therapeutic potential","volume":"3","author":"Cohen","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib594","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-2999(82)90614-8","article-title":"Functional subsensitivity of alpha2-adrenoceptors accompanies reductions in yohimbine binding clorgyline treatment","volume":"81","author":"Cohen","year":"1982","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib595","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.1982.04290050061012","article-title":"Effort and cognition in depression","volume":"39","author":"Cohen","year":"1982","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib596","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1523\/JNEUROSCI.22-13-05572.2002","article-title":"Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha5 subunit of the GABAA receptor","volume":"22","author":"Collinson","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib597","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/074873049200700204","article-title":"NMDA as well as non-NMDA receptor antagonists can prevent the phase-shifting effects of light on the circadian system of the golden hamster","volume":"7","author":"Colwell","year":"1992","journal-title":"J Biol Rhythms"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib598","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/ng1181","article-title":"Convergent evolution of gene circuits","volume":"34","author":"Conant","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib599","doi-asserted-by":"crossref","first-page":"7730","DOI":"10.1523\/JNEUROSCI.22-17-07730.2002","article-title":"Substance P (neurokinin1) receptor antagonists enhance dorsal raphe neuronal activity","volume":"22","author":"Conley","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib600","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0024-3205(97)00990-9","article-title":"Depression, stress and immunological activation: the role of cytokines in depressive disorders","volume":"62","author":"Connor","year":"1998","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib601","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/da.20060","article-title":"Effects of sertraline on depressive symptoms and attentional and executive functions in major depression","volume":"21","author":"Constant","year":"2005","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib602","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(98)01158-5","article-title":"Reduced anxiety-like and cognitive performance in mice lacking the corticotrophin-releasing factor receptor 1","volume":"835","author":"Contarino","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib603","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0014-2999(02)01812-5","article-title":"Lack of reward and locomotor stimulation induced by heroin in \u03bc-opioid receptor-deficient mice","volume":"446","author":"Contarino","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib604","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1385\/MN:30:2:143","article-title":"Regulation of antidepressant activity by cAMP response element binding proteins","volume":"30","author":"Conti","year":"2004","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib605","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1523\/JNEUROSCI.22-08-03262.2002","article-title":"cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs","volume":"22","author":"Conti","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib606","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000081785","article-title":"Nonpeptide corticotropin-releasing hormone receptor type 1 antagonists and their applications in psychosomatic disorders","volume":"80","author":"Contoreggi","year":"2004","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib607","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1021\/jm001088u","article-title":"Design, synthesis and structure\u2013activity relationships of a series of 3-[2-(1-benzylpiperidin-4-yl)ethylamino]pyridazine derivatives as acetylcholinesterase inhibitors","volume":"44","author":"Contreras","year":"2001","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib608","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/npp.1994.43","article-title":"Evidence that the acute behavioural and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism","volume":"11","author":"Cooper","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib609","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/sj.ijir.3901205","article-title":"Mechanisms of action of PDE5 inhibition in erectile dysfunction","volume":"16","author":"Corbin","year":"2004","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib610","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000057321","article-title":"Mechanisms of cross-talk between G-protein-coupled receptors","volume":"11","author":"Cordeaux","year":"2002","journal-title":"NeuroSignals"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib611","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1021\/jm001040g","article-title":"Potential antidepressants display combined alpha(2)-adrenoceptor antagonist and monoamine uptake inhibitor properties","volume":"44","author":"Cordi","year":"2001","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib612","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1742-1241.2003.tb10467.x","article-title":"Galantamine: a review of its use in Alzheimer's disease and vascular dementia","volume":"57","author":"Corey-Bloom","year":"2003","journal-title":"Int J Clin Practice"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib613","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1471-4159.2004.02823.x","article-title":"Dopamine D3 receptor stimulation promotes the proliferation of cells derived from the post-natal subventricular zone","volume":"91","author":"Coronas","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib614","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00213-004-1949-9","article-title":"Pharmacogenetics of antipsychotic-induced weight gain","volume":"174","author":"Correll","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib615","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/(SICI)1520-6394(2000)11:2<58::AID-DA2>3.0.CO;2-H","article-title":"Comparison of pramipexole, fluoxetine, and placebo in patients with major depression","volume":"11","author":"Corrigan","year":"2000","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib616","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.biopsych.2003.10.004","article-title":"Effectiveness of the selective D4 antagonist sonepiprazole in schizophrenia: a placebo-controlled trial","volume":"55","author":"Corrigan","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib617","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.4088\/JCP.v64n1111","article-title":"Long-term antidepressant efficacy and safety of olanzapine\/fluoxetine combination: a 76-week open-label study","volume":"64","author":"Corya","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib618","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1021\/jm025570j","article-title":"3-[2-methyl-1,3-thiazol-1-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity","volume":"46","author":"Cosford","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib619","first-page":"27","article-title":"5-HT3 receptors","volume":"3","author":"Costall","year":"2004","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib620","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neubiorev.2004.09.016","article-title":"Behavioural, neural and cardiovascular adaptations in mice lacking the NPY Y1 receptor","volume":"29","author":"Costoli","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib621","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archpsyc.58.6.545","article-title":"Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder","volume":"58","author":"Cotter","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib622","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2165\/00002512-199405020-00005","article-title":"Pharmacological manipulations of the \u03b12-noradrenergic system: effects on cognition","volume":"5","author":"Coull","year":"1994","journal-title":"Drugs Ageing"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib623","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF02246578","article-title":"The \u03b12 antagonist idazoxan remediates certain attentional and executive dysfunctions in patients with dementia of frontal type","volume":"123","author":"Coull","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib624","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/cercor\/11.1.73","article-title":"The noradrenergic alpha2 agonist clonidine modulates behavioural and neuroanatomical correlates of human attentional orienting and alerting","volume":"11","author":"Coull","year":"2001","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib625","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1300\/J069v17n01_04","article-title":"Cigarette smoking and major depression","volume":"17","author":"Covey","year":"1998","journal-title":"J Addict Dis"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib626","series-title":"Methods in Neuroendocrinology","first-page":"205","article-title":"Neuroendocrine challenge tests: what can we learn from them?","author":"Cowen","year":"1998"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib627","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00001504-200405000-00010","article-title":"Oestrogen, brain function and neuropsychiatric disorders","volume":"17","author":"Craig","year":"2004","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib628","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.291.5505.864","article-title":"Scale dependence in plant biodiversity","volume":"291","author":"Crawley","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib629","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nrd1089","article-title":"Is there a future for \u201cspeculative\u201d gene patents in Europe?","volume":"2","author":"Crease","year":"2003","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib630","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0006-3223(00)01093-3","article-title":"Is the beneficial antidepressant effect of coadministation of pindolol really due to somatodendritic autoreceptor antagonism?","volume":"50","author":"Cremers","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib631","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/sj.npp.1300474","article-title":"Inactivation of 5-HT2C receptors potentiates consequences of serotonin reuptake blockade","volume":"29","author":"Cremers","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib632","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/0028-3908(83)90082-5","article-title":"Rapid down-regulation of serotonin2 receptor binding during combined administration of tricyclic antidepressant drugs and alpha2 antagonists","volume":"22","author":"Crews","year":"1983","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib633","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/jpet.102.034686","article-title":"Effects of antidepressants in rats trained to discriminate centrally-administered isoproterenol","volume":"302","author":"Crissman","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib634","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1460-9568.2005.03932.x","article-title":"Modulation of synaptic transmission in neocortex by network activities","volume":"21","author":"Crochet","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib635","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0149-2918(00)88317-4","article-title":"A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline","volume":"21","author":"Croft","year":"1999","journal-title":"Clin Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib636","doi-asserted-by":"crossref","first-page":"963","DOI":"10.4088\/JCP.v63n1102","article-title":"The impact of treatment-resistant depression on health care utilization and costs","volume":"63","author":"Crown","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib637","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.biopsych.2003.12.026","article-title":"Flanking gene and genetic background problems in genetically manipulated mice","volume":"56","author":"Crusio","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib638","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nn1181","article-title":"Bi-directional effects of GABAB receptor agonists on the mesolimbic dopamine system","volume":"7","author":"Cruz","year":"2004","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib639","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tips.2004.11.004","article-title":"Don't worry \u201cB\u201d happy!: a role for GABAB receptors in anxiety and depression","volume":"26","author":"Cryan","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib640","first-page":"1120","article-title":"Antidepressant-like behavioral effects mediated by 5-HT2C receptors","volume":"295","author":"Cryan","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib641","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0014-2999(00)00858-X","article-title":"5-HT4 receptors do not mediate the antidepressant-like behavioral effects of fluoxetine in a modified forced swim test","volume":"409","author":"Cryan","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib642","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/sj.mp.4001457","article-title":"In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice","volume":"9","author":"Cryan","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib643","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(98)00402-6","article-title":"Combining pindolol and paroxetine in an animal model of chronic antidepressant action\u2014can early onset of action be detected?","volume":"352","author":"Cryan","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib644","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib645","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)01628-4","article-title":"Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test","volume":"436","author":"Cryan","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib646","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00213-003-1445-7","article-title":"Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat","volume":"168","author":"Cryan","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib647","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1046\/j.1460-9568.2003.02667.x","article-title":"Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7","volume":"17","author":"Cryan","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib648","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1124\/jpet.104.066753","article-title":"Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N\u2032-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines","volume":"310","author":"Cryan","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib649","doi-asserted-by":"crossref","first-page":"8186","DOI":"10.1073\/pnas.0401080101","article-title":"Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors","volume":"101","author":"Cryan","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib650","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","article-title":"Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib651","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tibs.2004.05.004","article-title":"Strong links are important, but weak links stabilize them","volume":"29","author":"Csermely","year":"2004","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib652","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.tips.2005.02.007","article-title":"The efficiency of multi-target drugs: the network approach might help drug design","volume":"26","author":"Csermely","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib653","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1126\/science.1069981","article-title":"Reverse engineering of biological complexity","volume":"295","author":"Csete","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib654","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.brainres.2003.09.019","article-title":"Effect of \u03b12-adrenoceptor blockade on lithium action in the rat brain","volume":"994","author":"Culli","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib655","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/BF00172967","article-title":"Antidepressants and human memory: an investigation of four drugs with different sedative and anticholinergic profiles","volume":"95","author":"Curran","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib656","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1192\/S0007125000296682","article-title":"The effects of tianeptine and other antidepressants on a rat model of depression","volume":"15","author":"Curzon","year":"1992","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib657","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0165-6147(97)90621-0","article-title":"Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability","volume":"18","author":"Curzon","year":"1997","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib658","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1093\/molbev\/msi218","article-title":"Changes in alternative splicing of human and mouse genes are accompanied by faster evolution of constitutive exons","volume":"22","author":"Cusack","year":"2005","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib659","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1124\/mol.56.5.1025","article-title":"Human dopamine D3 receptors mediate mitogen-activated protein kinase activation via a phosphatidylinositol 3-kinase and an atypical protein kinase C-dependent mechanism","volume":"56","author":"Cussac","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib660","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00213-002-1043-0","article-title":"Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h) serotonin (5-HT)1A receptors","volume":"162","author":"Cussac","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib661","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00210-001-0505-y","article-title":"Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols","volume":"365","author":"Cussac","year":"2002","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib662","doi-asserted-by":"crossref","first-page":"12796","DOI":"10.1073\/pnas.211427898","article-title":"Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine","volume":"98","author":"Cz\u00e9h","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib663","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/sj.npp.1300581","article-title":"Chronic stress decreases the number of parvalbumin-immunoreactive interneurons in the hippocampus: prevention by treatment with a substance P receptor (NK1) antagonist","volume":"30","author":"Cz\u00e9h","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib664","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0006-8993(03)03352-3","article-title":"Serotonin 5-HT1A receptors might control the output of cortical glutamatergic neurons in rat cingulate cortex","volume":"989","author":"Czyrak","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib665","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejphar.2004.11.024","article-title":"Antidepressant-like effects of neurokinin receptor antagonists in the forced swim test in the rat","volume":"507","author":"Dableh","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib666","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1528-1157.1998.tb01290.x","article-title":"Carbamazepine-induced release of serotonin from rat hippocampus in vitro","volume":"39","author":"Dailey","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib667","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0165-0327(92)90015-X","article-title":"Circadian rhythm abnormalities of deep body temperature in depressive disorders","volume":"26","author":"Daimon","year":"1992","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib668","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1177\/070674379003500709","article-title":"Lithium carbonate augmentation of desipramine in refractory depression","volume":"35","author":"Dallal","year":"1990","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib669","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.neubiorev.2004.09.006","article-title":"Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates","volume":"28","author":"Dalley","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib670","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/s-2007-979298","article-title":"Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression","volume":"31","author":"Dam","year":"1998","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib671","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1124\/mol.104.001313","article-title":"Enantioselective effects of hydroxymetabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors","volume":"66","author":"Damaj","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib672","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1196\/annals.1279.014","article-title":"Feelings of emotion and the self","volume":"1001","author":"Damasio","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib673","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.4088\/JCP.v65n0806","article-title":"\u201cDopamine-dependent\u201d side effects of selective serotonin reuptake inhibitors: a clinical review","volume":"65","author":"Damsa","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib674","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0304-3940(02)01368-X","article-title":"Hypothalamic co-localization of substance P receptor and transneuronal tracer from the lordosis-relevant lumbar epaxial muscles in the female rat","volume":"338","author":"Daniels","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib675","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1021\/jm034234f","article-title":"A bivalent ligand (KDAN-18) containing \u03b4-antagonist and \u03ba-agonist pharmacophores bridges \u03b42 and \u03ba1 opioid receptor phenotypes","volume":"48","author":"Daniels","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib676","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuroscience.2005.01.002","article-title":"Role of hippocampal M2 muscarinic receptors in the estrogen-induced enhancement of working memory","volume":"132","author":"Daniels","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib677","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF00518192","article-title":"Modulation of social memory in the male rat by neurohypophyseal peptides","volume":"91","author":"Dantzer","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib678","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/sj.mp.4000572","article-title":"Cytokines and depression: fortuitous or causative association?","volume":"4","author":"Dantzer","year":"1999","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib679","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0031-6997(24)01382-6","article-title":"Glycine and N-methyl-d-aspartate receptors: physiological significance and possible therapeutic applications","volume":"50","author":"Danysz","year":"1998","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib680","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(94)90033-7","article-title":"Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression","volume":"262","author":"D'Aquila","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib681","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0014-2999(00)00566-5","article-title":"The role of dopamine in the mechanism of action of antidepressant drugs","volume":"405","author":"D'Aquila","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib682","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-2999(02)02881-9","article-title":"Dopamine D1 receptor agonists induce penile erections in rats","volume":"460","author":"D'Aquila","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib683","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1212\/WNL.59.4.563","article-title":"Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months","volume":"59","author":"Darreh-Shori","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib684","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1023\/A:1010947205224","article-title":"Butyrylcholinesterase-mediated enhancement of the enzymatic activity of trypsin","volume":"21","author":"Darvesh","year":"2001","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib685","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/0028-3908(93)90138-S","article-title":"Behavioural and neurochemical evidence for the decrease of brain extracellular 5-HT by the antidepressant drug tianeptine","volume":"32","author":"Datla","year":"1993","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib686","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0022-3565(24)37535-4","article-title":"Long-acting blockade of biogenic amine transporters in rat brain by administration of the potent novel tropane 2\u03b2-propranoyl-3\u03b2-(2-naphthyl)-tropane","volume":"285","author":"Daunais","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib687","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0165-6147(02)01946-6","article-title":"The CRF peptide family and their receptors: yet more partners discovered","volume":"23","author":"Dautzenberg","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib688","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1523\/JNEUROSCI.3769-04.2005","article-title":"A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans","volume":"25","author":"David","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib689","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1517\/13543784.12.6.993","article-title":"Current and potential pharmacological treatments for obsessive\u2013compulsive disorder","volume":"12","author":"Davidson","year":"2003","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib690","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1073\/pnas.0502024102","article-title":"Gene regulatory networks","volume":"102","author":"Davidson","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib691","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0304-3940(95)11390-I","article-title":"The effect of paroxetine on 5-HT efflux in the rat dorsal raphe nucleus is potentiated by both 5-HT1A and 5-HT1B\/D receptor antagonists","volume":"188","author":"Davidson","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib692","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0165-0327(85)90050-3","article-title":"Neurovegetative symptoms in chronic pain and depression","volume":"9","author":"Davidson","year":"1985","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib693","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4088\/JCP.v60n0805","article-title":"Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder","volume":"60","author":"Davidson","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib694","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1176\/appi.ajp.160.1.64","article-title":"The neural substrates of affective processing in depressed patients treated with venlafaxine","volume":"160","author":"Davidson","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib695","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00213-004-2017-1","article-title":"The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical and atypical antipsychotic drugs: is M(1) agonism a pre-requisite for mimicking clozapine's actions?","volume":"178","author":"Davies","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib696","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1358\/dof.2005.030.03.889852","article-title":"SGS-742","volume":"30","author":"Davies","year":"2005","journal-title":"Drugs Future"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib697","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0278-5846(94)90022-1","article-title":"The trace amines and their acidic metabolites in depression\u2014an overview","volume":"18","author":"Davis","year":"1994","journal-title":"Prog Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib698","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2165\/00003495-199652050-00007","article-title":"Dexfenfluramine. An updated review of its therapeutic use in the management of obesity","volume":"52","author":"Davis","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib699","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.292.5517.673","article-title":"Range shifts and adaptive responses to Quaternary climate change","volume":"292","author":"Davis","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib700","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/00023210-199605050-00007","article-title":"Mirtazapine: a review of its pharmacology and therapeutic potential in the management of major depression","volume":"5","author":"Davis","year":"1996","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib701","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2165\/00003495-199753040-00006","article-title":"Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression","volume":"53","author":"Davis","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib702","series-title":"Neuropsychopharmacology: The Fifth Generation of Progress","first-page":"2080","year":"2002"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib703","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0006-8993(03)02508-3","article-title":"REM sleep deprivation-induced deficits in the latency-to-peak induction and maintenance of long-term potentiation within the CA1 region of hippocampus","volume":"973","author":"Davis","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib704","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0304-3940(99)00277-3","article-title":"5-HT1B antagonists modulate clearance of extracellular serotonin in rat hippocampus","volume":"266","author":"Daws","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib705","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1046\/j.1471-4159.2000.0752113.x","article-title":"5-HT(1B) receptor-mediated regulation of serotonin clearance in rat hippocampus in vivo","volume":"75","author":"Daws","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib706","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jneumeth.2004.09.011","article-title":"Transport mechanisms governing serotonin clearance in vivo revealed by high-speed chronoamperometry","volume":"143","author":"Daws","year":"2005","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib707","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/sj.bjp.0703288","article-title":"In vivo effects of the 5-HT6 receptor antagonist SB-270146 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate","volume":"130","author":"Dawson","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib708","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0028-3908(03)00190-4","article-title":"l-Dopa increases noradrenaline turnover in central and peripheral nervous systems","volume":"45","author":"Dayan","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib709","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0028-3908(99)00206-3","article-title":"Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells","volume":"39","author":"Deak","year":"2000","journal-title":"Neuropharmacology"},{"issue":"Suppl. 3","key":"10.1016\/j.pharmthera.2005.11.006_bib710","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00004850-199112003-00002","article-title":"Depression and 5-HT","volume":"6","author":"Deakin","year":"1991","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib711","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/00004850-200206001-00003","article-title":"Optimizing antidepressant treatment: efficacy and tolerability","volume":"17","author":"Deakin","year":"2002","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib712","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s00213-003-1686-5","article-title":"Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomised controlled trial","volume":"172","author":"Deakin","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib713","first-page":"217","article-title":"Antipsychotic drugs: evolving mechanisms of action with improved therapeutic benefits","volume":"3","author":"Dean","year":"2004","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib714","first-page":"106","article-title":"5-HT2A antagonists in psychiatric disorders","volume":"3","author":"De Angelis","year":"2002","journal-title":"Curr Opin Invest Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib715","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0006-3223(98)00161-9","article-title":"Serotonergic synergism: the risks and benefits of combining the selective serotonin reuptake inhibitors with other serotonergic drugs","volume":"44","author":"DeBattista","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib716","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1176\/appi.ajp.157.8.1334","article-title":"Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: a double-blind, placebo-controlled study","volume":"157","author":"DeBattista","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib717","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00004714-200004000-00029","article-title":"Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression","volume":"20","author":"DeBattista","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib718","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4088\/JCP.v64n0911","article-title":"Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study","volume":"64","author":"DeBattista","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib719","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00004714-200302000-00005","article-title":"A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants","volume":"23","author":"DeBattista","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib720","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/01.jcp.0000104910.75206.b9","article-title":"A prospective trial of modafinil as an adjunctive treatment of major depression","volume":"24","author":"DeBattista","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib721","doi-asserted-by":"crossref","first-page":"844","DOI":"10.4088\/JCP.v66n0706","article-title":"A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction","volume":"66","author":"DeBattista","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib722","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0165-6147(00)01635-7","article-title":"Molecular determinants of metabotropic glutamate receptor signaling","volume":"22","author":"De Blasi","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib723","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1046\/j.1460-9568.2003.02544.x","article-title":"\u03b12-adrenoceptor activations inhibits LTP and LTD in the basolateral amygdala: involvement of Gi\/Go-protein-mediated modulation of Ca2+-channels and inwardly rectifying K+-channels in LTD","volume":"17","author":"DeBoek","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib724","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00004850-199512004-00004","article-title":"The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission","volume":"10","author":"De Boer","year":"1996","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib725","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1523\/JNEUROSCI.0112-04.2004","article-title":"Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens","volume":"24","author":"De Deurwaerd\u00e8re","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib726","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/32904","article-title":"Altered nociception, analgesia and aggression in mice lacking the receptor for substance P","volume":"392","author":"De Felipe","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib727","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.neuroscience.2004.06.054","article-title":"Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment","volume":"128","author":"De Foubert","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib728","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-2999(02)01417-6","article-title":"The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice","volume":"439","author":"De Groote","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib729","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00213-005-2186-6","article-title":"Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine","volume":"179","author":"De Jong","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib730","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1192\/bjp.185.1.37","article-title":"Psychotherapy alone and combined with pharmacotherapy in the treatment of depression","volume":"185","author":"De Jonghe","year":"2004","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib731","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0166-2236(00)01933-0","article-title":"Picking on transporters","volume":"24","author":"Deken","year":"2001","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib732","first-page":"391","article-title":"Discriminative stimulus properties of antidepressant agents: a review","volume":"14","author":"Dekeyne","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib733","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0028-3908(99)00268-3","article-title":"Citalopram reduces social interaction in rats by activation of serotonin (5-HT)2C receptors","volume":"39","author":"Dekeyne","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib734","first-page":"269","article-title":"Brain corticosteroid receptor balance in health and disease","volume":"19","author":"De Kloet","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib735","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0006-3223(92)90041-W","article-title":"Carbamazepine addition in tricyclic antidepressant-resistant unipolar depression","volume":"32","author":"De la Fuente","year":"1992","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib736","first-page":"7","article-title":"Depression: the case for a monoamine deficiency","volume":"61","author":"Delgago","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib737","first-page":"389","article-title":"Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants","volume":"29","author":"Delgado","year":"1993","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib738","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0006-3223(99)00014-1","article-title":"Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action","volume":"46","author":"Delgado","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib739","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S1461145702002778","article-title":"Sequential catecholamine and serotonin depletion in mirtazapine-treated depressed patients","volume":"5","author":"Delgado","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib740","doi-asserted-by":"crossref","first-page":"686","DOI":"10.4088\/JCP.v66n0603","article-title":"Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder","volume":"66","author":"Delgado","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib741","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0278-5846(99)00039-1","article-title":"Sleep deprivation therapy in depressive illness and Parkinson's disease","volume":"23","author":"Demet","year":"1999","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib742","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/sj.ijir.3901293","article-title":"Peripheral relaxant activity of apomorphine and of a D1 selective receptor agonist on human corpus cavernosum strips","volume":"17","author":"D'Emmanuele di Villa Bianca","year":"2004","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib743","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00004850-199406002-00006","article-title":"Lithium addition in treatment-resistant depression","volume":"9","author":"De Montigny","year":"1994","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib744","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1017\/S1461145704004729","article-title":"The many faces of fatigue in major depressive disorder","volume":"8","author":"Demyttenaere","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib745","doi-asserted-by":"crossref","first-page":"700","DOI":"10.4088\/JCP.v63n0807","article-title":"Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive\u2013compulsive disorder: an open-label study","volume":"63","author":"Denys","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib746","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/01.jcp.0000095342.32154.54","article-title":"A double blind comparison of venlafaxine and paroxetine in obsessive\u2013compulsive disorder","volume":"23","author":"Denys","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib747","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00213-004-1880-0","article-title":"Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine","volume":"176","author":"Denys","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib748","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2165\/00003495-200161030-00001","article-title":"Irritable bowel syndrome, new agents targeting serotonin receptor subtypes","volume":"61","author":"De Ponti","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib749","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/73873","article-title":"Acute cortisone administration impairs retrieval of long-term declarative memory in humans","volume":"3","author":"De Quervain","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib750","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1097\/00001756-200111160-00032","article-title":"Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats","volume":"12","author":"De Saint Hilaire","year":"2001","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib751","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0306-4530(95)00011-9","article-title":"Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders","volume":"20","author":"De Souza","year":"1995","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib752","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s002130050895","article-title":"Differential EEG effects of the anxiolytic drugs, deramciclane (EGIS-3886), ritanserin and chlordiazepoxide in rats","volume":"142","author":"Detari","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib753","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.euroneuro.2004.01.002","article-title":"Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial","volume":"14","author":"Detke","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib754","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nrd1578","article-title":"Making protein interactions druggable: targeting PDZ domains","volume":"3","author":"Dev","year":"2004","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib755","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0006-3223(98)00086-9","article-title":"Effects of electroconvulsive therapy on plasma vasopressin and oxytocin","volume":"44","author":"Devanand","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib756","first-page":"S7","article-title":"Pharmacology of antidepressants: focus on nefazodone","volume":"63","author":"DeVane","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib757","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2165\/00003088-200241150-00002","article-title":"Clinical pharmacokinetics of sertraline","volume":"41","author":"DeVane","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib758","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0166-4328(05)80056-7","article-title":"Memory retrieval enhancement by locus coeruleus stimulation: evidence for mediation by beta-receptors","volume":"43","author":"Devauges","year":"1991","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib759","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1046\/j.0022-3042.2002.00797.x","article-title":"Modulation of cannabinoid agonist binding by 5-HT in the rat cerebellum","volume":"80","author":"Devlin","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib760","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1046\/j.1471-4159.2003.02239.x","article-title":"Alpha2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex","volume":"88","author":"Devoto","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib761","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejphar.2004.01.018","article-title":"Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex","volume":"487","author":"Devoto","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib762","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1471-4159.2004.02866.x","article-title":"Stimulaton of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex","volume":"92","author":"Devoto","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib763","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02245588","article-title":"5-HT1A receptor agonists: recent developments and controversial issues","volume":"121","author":"De Vry","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib764","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0149-7634(99)00083-4","article-title":"Effects of selected serotonin 5-HT1 and 5-HT2 receptor agonists on feeding behavior: possible mechanisms of action","volume":"24","author":"De Vry","year":"2000","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib765","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.euroneuro.2004.01.004","article-title":"5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat","volume":"14","author":"De Vry","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib766","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/35055547","article-title":"Evolutionary radiations and convergences in the structural organization of mammalian brains","volume":"409","author":"De Winter","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib767","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1017\/S0033291704001965","article-title":"The risk factors for depression in first myocardial infarction patients","volume":"34","author":"Dickens","year":"2004","journal-title":"Psychol Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib768","first-page":"197","article-title":"Alpha2-adrenoceptor antagonism and depression","volume":"4","author":"Dickinson","year":"1991","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib769","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2165\/00003495-200060030-00002","article-title":"Potential of substance P antagonists as antiemetics","volume":"60","author":"Diemunsch","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib770","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0306-4522(98)00655-1","article-title":"Selective blockade of serotonin2C\/2B receptors enhances mesolimbic and mesocortical dopaminergic function: a combined in vivo electrophysiological and microdialysis study","volume":"91","author":"Di Giovanni","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib771","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0165-0173(86)90016-0","article-title":"Cholinergic mechanisms in depression","volume":"396","author":"Dilsaver","year":"1986","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib772","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/1570159033477189","article-title":"Serotonin control of dopaminergic neurotransmission: focus on 5-HT2 receptors","volume":"1","author":"Di Matteo","year":"2003","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib773","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0091-3057(01)00705-5","article-title":"Role of serotonin(2C) receptors in the control of brain dopaminergic function","volume":"71","author":"Di Matteo","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib774","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00004714-199812000-00009","article-title":"Buspirone augmentation of antidepressant therapy","volume":"18","author":"Dimitriou","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib775","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0031-6997(24)01394-2","article-title":"The glutamate receptor ion channels","volume":"51","author":"Dingledine","year":"1999","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib776","series-title":"Dinosaurs, The Mistaken Extinction","first-page":"332","author":"Dingus","year":"1998"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib777","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1046\/j.1460-9568.2002.02245.x","article-title":"Overexpression of corticotropin-releasing hormone in transgenic mice and chronic stress-like autonomic and physiological alterations","volume":"16","author":"Dirks","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib778","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1471-4159.2004.02729.x","article-title":"Functional importance of the C-terminus of the human norepinephrine transporter","volume":"91","author":"Distelmaier","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib779","doi-asserted-by":"crossref","first-page":"8363","DOI":"10.1073\/pnas.95.14.8363","article-title":"Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex","volume":"95","author":"Dixon","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib780","doi-asserted-by":"crossref","first-page":"12516","DOI":"10.1073\/pnas.1534702100","article-title":"Information exchange and the robustness of organizational networks","volume":"100","author":"Dodds","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib781","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1517\/13543784.12.10.1633","article-title":"Treatment of dementia with neurotransmission modulation","volume":"12","author":"Doggrell","year":"2003","journal-title":"Expert Opin Investig Drug"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib782","first-page":"24","article-title":"Treatment strategies for sleep disturbance in patients with depression","volume":"64","author":"Doghramji","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib783","first-page":"17","article-title":"Assessment of excessive sleepiness and insomnia as they relate to circadian rhythm sleep disorders","volume":"16","author":"Doghramji","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib784","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0024-3205(03)00249-2","article-title":"G protein signalling and the molecular basis of antidepressant action","volume":"73","author":"Donati","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib785","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1476-5381.1992.tb14493.x","article-title":"Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo","volume":"107","author":"Done","year":"1992","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib786","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0028-3908(94)90071-X","article-title":"Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors microdialysis studies in the awake and anaesthetized rat","volume":"33","author":"Done","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib787","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/10401230209147450","article-title":"The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists","volume":"14","author":"Dording","year":"2002","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib788","first-page":"912","article-title":"The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism","volume":"82","author":"Dorn","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib789","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0149-7634(89)80046-6","article-title":"Neuropeptides and male sexual behavior","volume":"13","author":"Dornan","year":"1989","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib790","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0031-9384(89)90034-6","article-title":"Peptidergic control of male rat sexual behavior: the effects of intracerebral injections of substance P and cholecystokinin","volume":"46","author":"Dornan","year":"1989","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib791","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1159\/000124781","article-title":"Facilitation of lordosis by injection of substance P into the midbrain central gray","volume":"45","author":"Dornan","year":"1987","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib792","doi-asserted-by":"crossref","first-page":"449S","DOI":"10.1002\/j.1550-8528.1995.tb00212.x","article-title":"Multiple serotonin receptors: opportunities for new treatments for obesity?","volume":"4","author":"Dourish","year":"1995","journal-title":"Obes Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib793","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00702-003-0001-2","article-title":"l-Dopa biotransformation: correlations of dosage, erythrocyte catechol O-methyltransferase and platelet SULT1A3 activities with metabolic pathways in Parkinsonian patients","volume":"110","author":"Dousa","year":"2003","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib794","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0006-8993(00)02715-3","article-title":"Acute low doses of melatonin restore full sexual activity in impotent male rats","volume":"878","author":"Drago","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib795","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pnpbp.2003.09.030","article-title":"The serotonin-dopamine interaction is critical for fast-onset action of antidepressant treatment: in vivo studies in an animal model of depression","volume":"28","author":"Dremencov","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib796","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuropharm.2004.09.013","article-title":"Hyperfunctionality of serotonin2C receptor-mediated inhibition of accumbal dopamine release in an animal model of depression is reversed by antidepressant treatment","volume":"48","author":"Dremencov","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib797","first-page":"S51","article-title":"Electrophysiological effects of tianeptine on rat locus coeruleus, raphe dorsalis, and hippocampus activity","volume":"11","author":"Dresse","year":"1988","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib798","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0006-3223(00)01020-9","article-title":"Neuroimaging studies of mood disorders","volume":"48","author":"Drevets","year":"2000","journal-title":"Biol Psychol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib799","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0959-4388(00)00203-8","article-title":"Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders","volume":"11","author":"Drevets","year":"2001","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib800","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/026999398379646","article-title":"Reciprocal suppression of regional cerebral blood flow during emotional versus higher cognitive processes: implications for interactions between emotion and cognition","volume":"12","author":"Drevets","year":"1998","journal-title":"Cogn Emot"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib801","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/5405","article-title":"Biotechnology's metamorphosis into a drug discovery industry","volume":"16","author":"Drews","year":"1998","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib802","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.287.5460.1960","article-title":"Drug discovery: a historical perspective","volume":"287","author":"Drews","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib803","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0166-4328(00)00261-8","article-title":"Alzheimer's disease: more than a \u201ccholinergic disorder\u201d\u2014evidence that cholinergic\u2013monoaminergic interactions contribute to EEG slowing and dementia","volume":"115","author":"Dringenberg","year":"2000","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib804","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/S0893-133X(01)00325-6","article-title":"The effects of total sleep deprivation on cerebral responses to cognitive performance","volume":"26","author":"Drummond","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib805","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1034\/j.1399-5618.2002.01203.x","article-title":"Antidepressants and neuroplasticity","volume":"4","author":"D'sa","year":"2002","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib806","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis","volume":"29","author":"D'souza","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib807","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0306-4522(03)00009-5","article-title":"NMDA-induced excitation and sensitization of normal and inflamed nociceptors","volume":"118","author":"Du","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib808","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1017\/S1461145704004432","article-title":"Focus on CaMKII: a molecular switch in the pathophysiology and treatment of mood and anxiety disorders","volume":"7","author":"Du","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib809","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s00239-003-2519-1","article-title":"Mammalian mutation pressure, synonymous codon choice, and mRNA degradation","volume":"57","author":"Duan","year":"2003","journal-title":"J Mol Evol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib810","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2741\/1089","article-title":"Molecular pharmacology, regulation and function of mammalian melatonin receptors","volume":"8","author":"Dubocovich","year":"2003","journal-title":"Front Biosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib811","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pnpbp.2004.11.001","article-title":"Steroids, neuroactive steroids and neurosteroids in psychopathology","volume":"29","author":"Dubrovsky","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib812","first-page":"547","article-title":"Issues in polypharmacotherapy: focus on major depression","volume":"32","author":"Dufresne","year":"1996","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib813","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0304-3940(89)90596-X","article-title":"Melatonin modulation of the sensitivity of 5-HT2 receptor mediated sleep-wakefulness regulation in the rat","volume":"104","author":"Dugovic","year":"1989","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib814","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/BF00439544","article-title":"Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat","volume":"97","author":"Dugovic","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib815","first-page":"CD003726","article-title":"Tramadol for neuropathic pain","volume":"2","author":"Dulmke","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib816","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.biopsych.2004.02.033","article-title":"Depression: a case of neuronal life and death?","volume":"56","author":"Duman","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib817","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00124509-199809000-00004","article-title":"Molecular and cellular actions of chronic electroconvulsive seizures","volume":"14","author":"Duman","year":"1998","journal-title":"J ECT"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib818","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0006-3223(99)00177-8","article-title":"Neural plasticity to stress and antidepressant treatment","volume":"46","author":"Duman","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib819","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0163-7258(96)00092-7","article-title":"Circadian rhythms and the pharmacology of affective illness","volume":"71","author":"Duncan","year":"1996","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib820","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mam.2004.09.004","article-title":"Nitric oxide and neurological disorders","volume":"26","author":"Duncan","year":"2005","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib821","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/074873098129000165","article-title":"Decreased sensitivity to light of the photic entrainment pathway during chronic clorgyline and lithium treatments","volume":"13","author":"Duncan","year":"1998","journal-title":"J Biol Rhythms"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib822","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0006-8993(00)02383-0","article-title":"Localization of serotonin5A receptors in the discrete regions of the circadian timing system in the Syrian hamster","volume":"869","author":"Duncan","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib823","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.brainres.2004.02.025","article-title":"Aging and SB-269970-A, a selective 5-HT7 receptor antagonist, attenuates circadian phase advances induced by microinjections of serotonergic drugs in the hamster dorsal raphe nucleus","volume":"1008","author":"Duncan","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib824","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1471-4159.2004.02797.x","article-title":"Tyrosine hydroxylase phosphorylation: regulation and consequences","volume":"91","author":"Dunkley","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib825","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/da.10122","article-title":"Duloxetine in treatment of anxiety symptoms associated with depression","volume":"18","author":"Dunner","year":"2003","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib826","first-page":"32","article-title":"Six-year perspectives on the safety tolerability of nefazodone","volume":"63","author":"Dunner","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib827","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0169-328X(99)00052-2","article-title":"Magnitude of 5-HT1B and 5-HT1A receptor activation in guinea-pig and rat brain: evidence from sumatriptan dimer-mediated [35S]GTP(S binding responses","volume":"67","author":"Dupuis","year":"1999","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib828","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1111\/j.1471-4159.1980.tb11267.x","article-title":"Kinetic measurements of the turnover rates of phenylethylamine and tryptamine in vivo in the rat brain","volume":"34","author":"Durden","year":"1980","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib829","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0169-328X(99)00182-5","article-title":"An in situ hybridization study of the distribution of the GABAB2 protein mRNA in the rat CNS","volume":"71","author":"Durkin","year":"1999","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib830","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0014-2999(92)90505-X","article-title":"Dopamine and melatonin in the nucleus accumbens may be implicated in the mode of action of antidepressant drugs","volume":"217","author":"Durlach-Misteli","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib831","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s002130000579","article-title":"Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms","volume":"153","author":"Dursun","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib832","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0014-2999(90)90591-S","article-title":"Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals","volume":"180","author":"Duteil","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib833","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1074\/jbc.M108900200","article-title":"A single subunit (GB2) is required for G-protein activation by the heterodimeric GABAB receptor","volume":"277","author":"Duthey","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib834","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neuropharm.2004.10.004","article-title":"Differential regulation of serotonin (5-HT)2A receptor mRNA and protein levels after single and repeated stress in rat brain: role in learned helplessness behavior","volume":"48","author":"Dwivedi","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib835","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF01281156","article-title":"The effect of prolonged treatment with imipramine and electroconvulsive shock on the levels of endogenous enkephalins in the nucleus accumbens and the ventral tegmentum of the rat","volume":"102","author":"Dziedzicka-Wasylewska","year":"1995","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib836","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00008877-200203000-00004","article-title":"Effect of repeated treatment with tianeptine and fluoxetine on central dopamine D2\/D3 receptors","volume":"13","author":"Dziedzicka-Wasylewska","year":"2002","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib837","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00008877-200403000-00008","article-title":"The effect of combined treatment with imipramine and amantadine on the behavioral reactivity of central apha1-adrenergic system in rats","volume":"15","author":"Dziedzicka-Wasylewska","year":"2004","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib838","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00001756-199801050-00001","article-title":"Opposite roles of D1 and D5 dopamine receptors in locomotion revealed by selective antisense oligonucleotides","volume":"9","author":"Dziewczapolski","year":"1998","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib839","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00008571-200301000-00006","article-title":"Role of CYP2D6 in the stereoselective disposition of venlafaxine in humans","volume":"13","author":"Eap","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib840","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00007691-200404000-00011","article-title":"Therapeutic monitoring of antidepressants in the era of pharmacogenetical studies","volume":"26","author":"Eap","year":"2004","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib841","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0091-3057(91)90418-2","article-title":"D2 receptors in the paraventricular nucleus regulate genital responses and copulations in male rats","volume":"39","author":"Eaton","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib842","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1086\/340787","article-title":"Genomewide comparison of DNA sequences between humans and chimpanzees","volume":"70","author":"Ebersberger","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib843","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050732","article-title":"Neurobiological similarities in antidepressant sleep deprivation and psychostimulant use: a psychostimulant theory of antidepressant sleep deprivation","volume":"140","author":"Ebert","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib844","first-page":"75","article-title":"On the dual nature of chance in evolutionary biology and paleobiology","volume":"25","author":"Eble","year":"1999","journal-title":"Paleobiology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib845","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0301-0082(96)00032-9","article-title":"The role of glutamate in the photic regulation of the suprachiasmatic nucleus","volume":"50","author":"Ebling","year":"1996","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib846","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1046\/j.0953-816x.2001.01869.x","article-title":"Forced swimming triggers vasopressin release within the amygdala to modulate stress-coping strategies in rats","volume":"15","author":"Ebner","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib847","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/10606820213678","article-title":"Pharmacology and biology of corticotropin-releasing factor (CRF) receptors","volume":"8","author":"Eckart","year":"2002","journal-title":"Recept Channels"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib848","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2165\/00003495-199957040-00005","article-title":"Systematic review and guide to selection of selective serotonin reuptake inhibitors","volume":"57","author":"Edwards","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib849","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1043-2760(02)00633-1","article-title":"Estrogen action and cytoplasmic signalling cascades: Part I. Membrane-associated signalling complexes","volume":"13","author":"Egars","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib850","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neulet.2003.11.050","article-title":"V1a receptor knockout mice exhibit impairment of spatial memory in an eight-arm radial maze","volume":"356","author":"Egashira","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib851","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1254\/jjp.75.275","article-title":"Rolipram and its optical isomers, phosphodiesterase 4 inhibitors, attenuated the scopolamine-induced impairments of learning and memory in rats","volume":"75","author":"Egawa","year":"1997","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib852","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0306-4522(94)90177-5","article-title":"The distribution of nitric oxide synthase immunoreactivity in the human brain","volume":"59","author":"Egberongbe","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib853","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2337\/diacare.27.2.421","article-title":"Diabetes, major depression, and functional disability among U.S. adults","volume":"27","author":"Egede","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib854","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1034\/j.1600-0447.2003.00146.x","article-title":"Attention profile in schizophrenia compared with depression: differential effects of processing speed, selective attention and vigilance","volume":"108","author":"Egeland","year":"2003","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib855","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/archpsyc.1988.01800340076012","article-title":"Social zeitgebers and biological rhythms. A unified approach to understanding the etiology of depression","volume":"45","author":"Ehlers","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib856","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00007691-200404000-00017","article-title":"Clinical aspects of the MDR1 (ABCB1) gene polymorphism","volume":"26","author":"Eichelbaum","year":"2004","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib857","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0024-3205(02)01479-0","article-title":"Sleep deprivation in depression: stabilizing antidepressant effects by repetitive transcranial magnetic stimulation","volume":"70","author":"Eichhammer","year":"2002","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib858","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.tig.2004.12.005","article-title":"Is abundant A-to-I RNA editing primate-specific?","volume":"21","author":"Eisenberg","year":"2005","journal-title":"Trends Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib859","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0163-7258(01)00144-9","article-title":"The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines","volume":"91","author":"Eisenhofer","year":"2001","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib860","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00171059","article-title":"Disprocynium24, a novel inhibitor of the extraneuronal monoamine transporter, has potent effects on the inactivation of circulating noradrenaline and adrenaline in conscious rat","volume":"354","author":"Eisenhofer","year":"1996","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib861","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/pr.56.3.1","article-title":"Catecholamine metabolism: a contemporary view with implications for physiology and medicine","volume":"56","author":"Eisenhofer","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib862","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.mp.4001314","article-title":"Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor","volume":"8","author":"Eisensamer","year":"2003","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib863","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1471-4914(01)02266-3","article-title":"Glycogen synthase kinase 3: an emerging therapeutic target","volume":"8","author":"Eldar-Finkelman","year":"2002","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib864","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0887-6177(03)00022-2","article-title":"Neuropsychological deficits among patients with late-onset minor and major depression","volume":"18","author":"Elderkin-Thompson","year":"2003","journal-title":"Arch Clin Neuropsychol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib865","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1046\/j.1460-9568.2003.02496.x","article-title":"Attenuation of sucrose reinforcement in dopamine D1 receptor deficient mice","volume":"17","author":"El-Ghundi","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib866","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pnpbp.2003.11.018","article-title":"Central monoamines and their role in major depression","volume":"28","author":"Elhwuegi","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib867","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1365-2869.1999.00142.x","article-title":"Functional magnetic resonance imaging neuroactivation studies in normal subjects and subjects with the narcoleptic syndrome. Actions of modafinil","volume":"8","author":"Ellis","year":"1999","journal-title":"J Sleep Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib868","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1461145705005407","article-title":"Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans","volume":"9","author":"Ellis","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib869","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.1073\/pnas.1034823100","article-title":"Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression","volume":"100","author":"El Yacoubi","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib870","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nature03450","article-title":"Species diversity can drive speciation","volume":"434","author":"Emerson","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib871","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-8993(74)91052-X","article-title":"The effect of ovarian steroids on the accumulation of 3H-labelled monoamiens by hypothalamic tissue in vitro","volume":"73","author":"Endersby","year":"1974","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib872","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0304-3940(97)00962-2","article-title":"Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil","volume":"241","author":"Engber","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib873","doi-asserted-by":"crossref","first-page":"50042","DOI":"10.1074\/jbc.M407913200","article-title":"Identification and characterization of a novel monoamine transporter in the human brain","volume":"279","author":"Engel","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib874","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/35079573","article-title":"Effects of macrophyte species richness on wetland ecosystem functioning and services","volume":"411","author":"Engelhardt","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib875","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1523\/JNEUROSCI.3895-04.2005","article-title":"How stress and fluoxetine modulate serotonin2C receptor pre-mRNA editing","volume":"25","author":"Englander","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib876","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1034\/j.1600-0447.2002.01250.x","article-title":"An association between depression, anxiety and thyroid function\u2014a clinical fact or an artefact?","volume":"106","author":"Engum","year":"2002","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib877","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.bcp.2004.06.037","article-title":"GABAB receptor alterations as indicators of physiological and pharmacological functions","volume":"68","author":"Enna","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib878","doi-asserted-by":"crossref","first-page":"869","DOI":"10.4088\/JCP.v62n1106","article-title":"Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo","volume":"62","author":"Entsuah","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib879","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1038\/sj.npp.1300493","article-title":"Repetitive transcranial magnetic stimulation increases the release of dopamine in the nucleus accumbens shell of morphine-sensitized rats during abstinence","volume":"29","author":"Erhardt","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib880","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0149-7634(03)00033-2","article-title":"Glucocorticoid regulation of diverse cognitive functions in normal and pathological emotional states","volume":"27","author":"Erickson","year":"2003","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib881","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1034\/j.1600-0447.2000.00003.x","article-title":"Antidepressant drugs: does it matter if they inhibit the reuptake of noradrenaline or serotonin?","volume":"101","author":"Eriksson","year":"2000","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib882","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/1522-2675(20010228)84:2<360::AID-HLCA360>3.0.CO;2-S","article-title":"Molecular-dynamics and NMR investigation of the property space of the zwitterionic antihistamine cetirizine","volume":"84","author":"Ermondi","year":"2001","journal-title":"Helv Chim Acta"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib883","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/sj.npp.1300459","article-title":"Increased mRNA expression of \u03b12A-adrenoceptors, serotonin receptors and \u03bc-opioid receptors in the brains of suicide victims","volume":"29","author":"Escriba","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib884","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0022-3565(24)38214-X","article-title":"Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type","volume":"289","author":"Eshleman","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib885","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s002109900045","article-title":"Activation and desensitisation by cyclic antidepressant drugs of \u03b12-autoreceptors, \u03b12-heteroceptors and 5-HT1A-autoreceptors regulating monoamine synthesis in the rat brain in vivo","volume":"360","author":"Esteban","year":"1999","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib886","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/sj.npp.1300097","article-title":"Antidepressant-like effect of different estrogenic compounds in the forced swimming test","volume":"28","author":"Estrada-Camarena","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib887","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00213-003-1707-4","article-title":"Interaction between estrogens and antidepressants in the forced swimming test in rats","volume":"173","author":"Estrada-Camarena","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib888","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/00912700122009809","article-title":"The process of knowledge discovery from large pharmacokinetic data sets","volume":"41","author":"Ette","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib889","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0006-3223(03)00639-5","article-title":"Mood disorders and medical illness: a major public health problem","volume":"54","author":"Evans","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib890","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0149-7634(05)80222-2","article-title":"Sexual motivation: a neural and behavioural analysis of the mechanisms underlying appetitive and copulatory responses of male rats","volume":"14","author":"Everitt","year":"1990","journal-title":"Neurosci Biobehav Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib891","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.psych.48.1.649","article-title":"Central cholinergic systems and cognition","volume":"48","author":"Everitt","year":"1997","journal-title":"Ann Rev Psychol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib892","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0306-4522(89)90353-9","article-title":"Interactions between the amygdala and ventral striatum in stimulus-reward associations: studies using a second-order schedule of sexual reinforcement","volume":"30","author":"Everitt","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib893","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1046\/j.1460-9568.2002.01917.x","article-title":"Altered regulation of the 5-HT system in the brain of MAO-A knock-out mice","volume":"15","author":"Evrard","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib894","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0028-3908(02)00410-0","article-title":"Biphasic role of dopamine on female sexual behaviour via D2 receptors in the mediobasal hypothalamus","volume":"44","author":"Fabre-Nys","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib895","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00213-004-1984-6","article-title":"Mirtazapine acutely inhibits basal and K+-stimulated release of corticotropin-releasing hormone from the rat hypothalamus via a non-genomic mechanism","volume":"178","author":"Fabricio","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib896","doi-asserted-by":"crossref","first-page":"12565","DOI":"10.1074\/jbc.M311389200","article-title":"Phosphorylation and chronic agonist treatment atypically modulate GABAB receptor cell surface stability","volume":"279","author":"Fairfax","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib897","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2125.1995.tb05767.x","article-title":"The psychomotor and cognitive effects of litoxetine in young and middle aged volunteers","volume":"40","author":"Fairweather","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib898","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0022-3999(02)00308-2","article-title":"Obesity\u2013depression association in the population","volume":"53","author":"Faith","year":"2002","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib899","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00001504-200401000-00003","article-title":"Mood disorders and obesity","volume":"17","author":"Faith","year":"2004","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib900","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1476-5381.1994.tb13140.x","article-title":"Effects of antidepressants on the inward current mediated by 5-HT3 receptors in rat nodose ganglion neurones","volume":"112","author":"Fan","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib901","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4088\/JCP.v60n0412a","article-title":"Relief of SSRI-induced sexual dysfunction with mirtazapine treatment","volume":"60","author":"Farah","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib902","first-page":"22","article-title":"NMDA receptor antagonists: a new therapeutic approach for Alzheimer's disease","volume":"59","author":"Farlow","year":"2004","journal-title":"Geriatrics"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib903","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.brainres.2004.05.026","article-title":"Effects of tramadol on \u03b11-adrenergic receptors in the rat brain","volume":"1016","author":"Faron-Gorecka","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib904","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2004.08.011","article-title":"Long-term exposure of rats to tramadol alters brain dopamine and \u03b11-adrenoceptor function that may be related to antidepressant potency","volume":"501","author":"Faron-Gorecka","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib905","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1517\/13543784.12.1.65","article-title":"Recent developments in the psychobiology and pharmacotherapy of depression: optimising existing treatments and novel approaches for the future","volume":"12","author":"Farvolden","year":"2003","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib906","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0028-3908(90)90076-4","article-title":"Tianeptine stimulates uptake of 5-hydroxytryptamine in vivo in the rat brain","volume":"29","author":"Fattaccini","year":"1990","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib913","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0006-3223(03)00231-2","article-title":"Diagnosis and definition of treatment-resistant depression","volume":"53","author":"Fava","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib908","first-page":"27","article-title":"Daytime sleepiness and insomnia as correlates of depression","volume":"65","author":"Fava","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib909","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/10401239809147030","article-title":"A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression","volume":"10","author":"Fava","year":"1998","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib910","doi-asserted-by":"crossref","first-page":"863","DOI":"10.4088\/JCP.v61n1109","article-title":"Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment","volume":"61","author":"Fava","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib911","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0278-5846(02)00226-9","article-title":"Residual symptoms in depression: an emerging therapeutic target","volume":"26","author":"Fava","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib912","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00004714-200208000-00008","article-title":"Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine","volume":"22","author":"Fava","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib907","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2165\/00023210-200317150-00005","article-title":"Treatment of recurrent depression: a sequential psychotherapeutic and psychopharmacological approach","volume":"17","author":"Fava","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib914","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4088\/JCP.v66n0112","article-title":"A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness","volume":"66","author":"Fava","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib915","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1124\/mol.59.1.30","article-title":"SCH-202676: an allosteric modulator of both agonist and antagonist binding to G protein-coupled receptors","volume":"59","author":"Fawzi","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib916","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1124\/mol.104.007427","article-title":"Trace amines depress GABAB response in dopaminergic neurons by inhibiting G-\u03b2\u03b3-gated inwardly rectifying potassium channels","volume":"67","author":"Federici","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib917","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1358\/dof.2001.026.02.608830","article-title":"SLV 308","volume":"26","author":"Feenstra","year":"2001","journal-title":"Drugs Future"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib918","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0893-133X(01)00314-1","article-title":"Fluoxetine and sleep EEG: effects of a single dose, subchronic treatment, and discontinuation in healthy subjects","volume":"2","author":"Feige","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib919","first-page":"53","article-title":"Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction","volume":"57","author":"Feiger","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib920","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00004850-199901000-00002","article-title":"Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression","volume":"14","author":"Feiger","year":"1999","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib921","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1515\/REVNEURO.2005.16.1.23","article-title":"Function of cGMP-dependent protein kinases in the nervous system","volume":"16","author":"Feil","year":"2005","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib922","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4088\/JCP.v58n0806b","article-title":"Antiepileptic drug augmentation for treatment-resistant depression","volume":"58","author":"Feiner","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib923","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00210-002-0688-x","article-title":"Effects of selective serotonin and serotonin\/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex","volume":"367","author":"Felton","year":"2003","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib924","doi-asserted-by":"crossref","first-page":"6502","DOI":"10.1523\/JNEUROSCI.21-17-06502.2001","article-title":"Serotonin receptors modulate GABAA receptor channels through activation of anchored protein kinase C in prefrontal cortical neurons","volume":"21","author":"Feng","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib925","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s002130000531","article-title":"Antidepressant-like effects of the subtype-selective nicotinic acetylcholine receptor agonist, SIB-1508Y, in the learned helplessness rat model of depression","volume":"152","author":"Ferguson","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib926","doi-asserted-by":"crossref","first-page":"9697","DOI":"10.1523\/JNEUROSCI.23-30-09697.2003","article-title":"Vesicular localization and activity-dependent trafficking of presynaptic choline transporters","volume":"23","author":"Ferguson","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib927","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/026988110401800313","article-title":"Effects of reboxetine on sleep and nocturnal cardiac autonomic activity in patients with dysthymia","volume":"18","author":"Ferini-Strambi","year":"2004","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib928","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF01244702","article-title":"Role of presynaptic serotonergic receptors on the mechanism of action of 5-HT1A and 5-HT1B agonists on masculine sexual behaviour: physiological and pharmacological implications","volume":"85","author":"Fernandez-Guasti","year":"1991","journal-title":"J Neural Transm Gen Sect"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib929","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0091-3057(89)90279-7","article-title":"Inhibitory action of various 5-HT1B receptor agonists on rat masculine sexual behaviour","volume":"34","author":"Fernandez-Guasti","year":"1989","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib930","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0014-2999(92)90662-N","article-title":"Stimulation of 5-HT1A and 5-HT1B receptors in brain regions and its effects on male rat sexual behaviour","volume":"210","author":"Fernandez-Guasti","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib931","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/S0024-3205(01)01515-6","article-title":"Influence of sildenafil on central dopamine-mediated behaviour in male rats","volume":"70","author":"Ferrari","year":"2002","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib932","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(96)13212-2","article-title":"The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor","volume":"220","author":"Ferraro","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib933","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0006-3223(97)00353-3","article-title":"Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers","volume":"42","author":"Ferraro","year":"1997","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib934","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1097\/00001756-199709080-00016","article-title":"The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus","volume":"8","author":"Ferraro","year":"1997","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib935","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0893-133X(98)00085-2","article-title":"The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade","volume":"20","author":"Ferraro","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib936","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/S0028-3908(00)00019-8","article-title":"Amplification of cortical serotonin release: a further neurochemical action of the vigilance-promoting drug modafinil","volume":"39","author":"Ferraro","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib937","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/jnr.10196","article-title":"Differential enhancement of dialysate serotonin levels in distinct brain regions of the awake rat by modafinil: possible relevance for wakefulness and depression","volume":"68","author":"Ferraro","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib938","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/syn.20111","article-title":"Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: a dual probe microdialysis study in awake rat","volume":"55","author":"Ferraro","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib939","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0091-3057(02)01007-9","article-title":"Role of hippocampal M1 and M4 muscarinic receptor subtypes in memory consolidation in the rat","volume":"74","author":"Ferreira","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib940","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1034\/j.1600-0447.2001.00148.x","article-title":"Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone","volume":"103","author":"Ferreri","year":"2001","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib941","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1055\/s-2007-979220","article-title":"Amantadine revisited: an open trial of amantadinesulfate treatment in chronically depressed patients with Borna disease virus infection","volume":"32","author":"Ferszt","year":"1999","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib942","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejphar.2004.07.090","article-title":"Opioid and monoamine systems mediate the discriminative stimulus of tramadol in rats","volume":"498","author":"Filip","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib943","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/76061","article-title":"Mice deficient for \u03b4- and \u03bc-opioid receptors exhibit opposing alterations of emotional responses","volume":"25","author":"Filliol","year":"2000","journal-title":"Nat Gen"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib944","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1017\/S1461145704004675","article-title":"Evidence-based pharmacotherapy of obsessive\u2013compulsive disorder","volume":"8","author":"Fineberg","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib945","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/BF00172776","article-title":"Stimulation of serotonin release in the rat brain cortex by activation of ionotropic glutamate receptors and its modulation via alpha2-heteroceptors","volume":"352","author":"Fink","year":"1995","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib946","first-page":"653","article-title":"Paroxetine is a novel nitric oxide synthase inhibitor","volume":"32","author":"Finkel","year":"1996","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib947","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/BF00171093","article-title":"Repression by neuropeptide Y of noradrenergic inhibitory postsynaptic potentials of locus coeruleus neurons","volume":"346","author":"Finta","year":"1992","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib948","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1570159033477206","article-title":"Nerve growth factor and brain-derived neurotrophic factor in schizophrenia and depression: findings in humans, and animal models","volume":"1","author":"Fiore","year":"2003","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib949","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1523\/JNEUROSCI.19-01-00456.1999","article-title":"Facilitation of sexual behavior and enhanced dopamine efflux in the nucleus accumbens of male rats after D-amphetamine-induced behavioral sensitization","volume":"19","author":"Fiorino","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib950","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000064927","article-title":"A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease","volume":"14","author":"Firbank","year":"2002","journal-title":"Dementia Geriatr Cogn Dis"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib951","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00004850-199803000-00005","article-title":"Weak antidepressant response after buspirone augmentation of serotonin reuptake inhibitors in refractory severe depression","volume":"13","author":"Fischer","year":"1998","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib952","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1385\/JMN:20:3:349","article-title":"M1 muscarinic agonists can modulate some of the hallmarks of Alzheimer's disease: implications for future therapy","volume":"20","author":"Fisher","year":"2003","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib953","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0065-7743(04)39003-2","article-title":"Melatonin agonists for the treatment of sleep disorders and major depression","volume":"39","author":"Fitzgerald","year":"2004","journal-title":"Annu Rep Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib954","doi-asserted-by":"crossref","first-page":"82S","DOI":"10.1038\/sj.npp.1395328","article-title":"Messenger RNA editing of the human serotonin 5-HT2C receptor","volume":"21","author":"Fitzgerald","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib955","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1001\/archpsyc.60.9.1002","article-title":"Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial","volume":"60","author":"Fitzgerald","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib956","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.biochem.68.1.355","article-title":"Tetrahydropterin-dependent amino acid hydroxylases","volume":"68","author":"Fitzpatrick","year":"1999","journal-title":"Ann Rev Biochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib957","doi-asserted-by":"crossref","first-page":"24431","DOI":"10.1074\/jbc.M400738200","article-title":"Mepyramine, a histamine H1 receptor inverse agonist, binds preferentially to a G protein-coupled form of the receptor and sequesters G protein","volume":"279","author":"Fitzsimons","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib958","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1046\/j.1460-9568.2003.02510.x","article-title":"\u03b12A and \u03b12C-adrenoceptor regulation in the brain: \u03b12A changes persist after chronic stress","volume":"17","author":"Fl\u00fcgge","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib959","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ddr.10089","article-title":"Cholinergic abnormalities in Alzheimer's disease: are there new targets for drug development?","volume":"56","author":"Fodero","year":"2002","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib960","first-page":"109","article-title":"Plasma levels of citalopram enantiomers and metabolites in elderly patients","volume":"33","author":"Foglia","year":"1997","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib961","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00702-003-0059-x","article-title":"Dopamine receptor agonists in the therapy of Parkinson's disease","volume":"111","author":"Foley","year":"2004","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib962","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF02246645","article-title":"Increased 5-HT2C receptor responsiveness occurs on rearing rats in social isolation","volume":"123","author":"Fone","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib963","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/BF02245812","article-title":"Ondansetron improves cognitive performance in the Morris water maze spatial navigation task","volume":"120","author":"Fontana","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib964","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/jama.1989.03430110069030","article-title":"Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention","volume":"262","author":"Ford","year":"1989","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib965","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0024-3205(89)90128-8","article-title":"The role of the 5-HT2 receptor in the regulation of sexual performance of male rats","volume":"45","author":"Foreman","year":"1989","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib966","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1471-4892(02)00013-9","article-title":"The MCH receptor family: feeding brain disorders?","volume":"3","author":"Forray","year":"2003","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib967","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1192\/bjp.167.1.61","article-title":"Prevalence and correlates of depression in a population of nonagenarians","volume":"167","author":"Forsell","year":"1995","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib968","first-page":"9","article-title":"Repeated administration of a selective 5-HT uptake inhibitor downregulates 5-HT2C but not 5-HT1A receptor-mediated behaviour in the rat","volume":"116","author":"Forster","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib969","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0165-1781(01)00307-9","article-title":"Problem-solving abilities in unipolar depressed patients: comparison of performance on the modified version of the Wisconsin and the California sorting tests","volume":"104","author":"Fossati","year":"2001","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib970","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2165\/00003495-200363140-00002","article-title":"Female sexual dysfunction","volume":"63","author":"Fourcroy","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib971","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuroscience.2003.10.021","article-title":"Cortical acetylcholine release and electroencephalogram activation evoked by ionotropic glutamate receptor agonists in the rat basal forebrain","volume":"123","author":"Fournier","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib972","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1124\/jpet.104.078402","volume":"313","author":"Fox","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib973","doi-asserted-by":"crossref","first-page":"9673","DOI":"10.1073\/pnas.0504136102","article-title":"The human brain is intrinsically organized into dynamic, anticorrelated functional networks","volume":"102","author":"Fox","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib974","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00001756-200504040-00001","article-title":"The case for feedforward multisensory convergence during early cortical processing","volume":"16","author":"Foxe","year":"2005","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib975","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1152\/jn.1999.81.2.925","article-title":"17 beta-estradiol enhances NMDA receptor-mediated EPSPs and long-term potentiation","volume":"81","author":"Foy","year":"1999","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib976","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","article-title":"The cholinergic hypothesis of Alzheimer's disease: a review of progress","volume":"66","author":"Francis","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib977","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tips.2004.12.010","article-title":"A preclinical review of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease?","volume":"28","author":"Francis","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib978","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1126\/science.1113075","article-title":"Trophic cascades in a formerly cod-dominated ecosystem","volume":"308","author":"Frank","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib979","doi-asserted-by":"crossref","first-page":"8771","DOI":"10.1523\/JNEUROSCI.22-19-08771.2002","article-title":"Mutation of the \u03b12A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine","volume":"22","author":"Franowicz","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib980","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1038\/sj.mp.4001015","article-title":"Delayed pharmacological effects of antidepressants","volume":"7","author":"Fraser","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib981","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1068696","article-title":"Evolutionary rate in the protein interaction network","volume":"296","author":"Fraser","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib982","doi-asserted-by":"crossref","first-page":"9033","DOI":"10.1073\/pnas.0402591101","article-title":"Coevolution of gene expression among interacting proteins","volume":"101","author":"Fraser","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib983","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s007020050158","article-title":"Tolerance to a suprathreshold dose of l-dopa in MPTP mice: effects of glutamate antagonists","volume":"106","author":"Fredriksson","year":"1999","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib984","first-page":"301","article-title":"Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison","volume":"55","author":"Freeman","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib985","doi-asserted-by":"crossref","first-page":"14488","DOI":"10.1073\/pnas.222546799","article-title":"The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate","volume":"99","author":"Fremeau","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib986","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/00129785-200202040-00007","article-title":"Emerging ethical issues in pharmacogenomics from research to clinical practice","volume":"2","author":"Freund","year":"2002","journal-title":"Am J Pharmacogen"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib987","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00213-004-1794-x","article-title":"Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists","volume":"174","author":"Friedman","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib988","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.parkreldis.2003.11.006","article-title":"Sleep and fatigue in Parkinson's disease","volume":"10","author":"Friedman","year":"2004","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib989","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1523\/JNEUROSCI.20-17-06694.2000","article-title":"Superior water maze performance and increase in fear-related behavior in the endothelial nitric oxide synthase-deficient mouse together with monoamine changes in cerebellum and ventral striatum","volume":"20","author":"Frisch","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib990","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cne.903590111","article-title":"GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits","volume":"359","author":"Fritschy","year":"1995","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib991","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.bcp.2004.07.030","article-title":"SGS742: the first GABAB receptor antagonist in clinical trials","volume":"68","author":"Froestl","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib992","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1523\/JNEUROSCI.21-20-08188.2001","article-title":"5-HT1A autoreceptor adaptive changes in substance P (neurokinin1) receptor knock-out mice mimic antidepressant-induced desensitisation","volume":"21","author":"Froger","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib993","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0031-9384(00)00344-9","article-title":"Evidence that serotonin affects female sexual functioning via peripheral mechanisms","volume":"71","author":"Frohlich","year":"2000","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib994","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4088\/JCP.v61n0104","article-title":"The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study","volume":"61","author":"Frye","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib995","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2004.01.020","article-title":"Progesterone enhances motor, anxiolytic, analgesic and antidepressive behavior of wild-type mice, but not those deficient in type1 5\u03b1-reductase","volume":"1004","author":"Frye","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib996","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1046\/j.1471-4159.1999.0721117.x","article-title":"Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function","volume":"72","author":"Fryer","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib997","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0022-3565(24)37928-5","article-title":"Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor by bupropion, phencyclidine and iboguine","volume":"288","author":"Fryer","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib998","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/archpsyc.61.9.877","article-title":"Attenuation of the neural response to sad faces in major depression by antidepressant treatment","volume":"61","author":"Fu","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib999","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00008877-200409000-00003","article-title":"Examining novel concepts of the pathophysiology of depression in the chronic psychosocial stress paradigm in tree shrews","volume":"15","author":"Fuchs","year":"2004","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1000","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1385\/JMN:21:3:223","article-title":"Short-term sleep disturbance enhances brain derived neurotrophic factor gene expression in rat hippocampus by acting as internal stressor","volume":"21","author":"Fujihara","year":"2003","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1001","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.molbrainres.2003.09.005","article-title":"Six-hour selective REM sleep deprivation increases the expression of the galanin gene in the hypothalamus of rats","volume":"119","author":"Fujihara","year":"2003","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1002","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1523\/JNEUROSCI.1065.03.2004","article-title":"Activation of cAMP signaling facilitates the morphological maturation of newborn neurons in adult hippocampus","volume":"24","author":"Fujioka","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1003","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/gut.42.6.845","article-title":"Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome","volume":"42","author":"Fukudo","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1004","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0165-0327(00)00254-8","article-title":"Is antidepressant-benzodiazepine combination therapy clinically more useful? A meta-analytic study","volume":"65","author":"Furukawa","year":"2001","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1005","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1176\/appi.ajp.157.12.1960","article-title":"Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients","volume":"157","author":"Gagn\u00e9","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1006","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev.pharmtox.43.050802.112309","article-title":"Monoamine transporters: from genes to behavior","volume":"43","author":"Gainetdinov","year":"2003","journal-title":"Annu Rev Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1007","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1146\/annurev.neuro.27.070203.144206","article-title":"Desensitization of G protein-coupled receptors and neuronal functions","volume":"27","author":"Gainetdinov","year":"2004","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1008","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbr.2003.12.016","article-title":"Alpha2-agonist-induced memory impairment is mediated by the alpha2A-adrenoceptor subtype","volume":"153","author":"Galeotti","year":"2004","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1009","first-page":"19","article-title":"Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study","volume":"27","author":"Gallopin","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1010","doi-asserted-by":"crossref","first-page":"41166","DOI":"10.1074\/jbc.M007848200","article-title":"Mapping the agonist-binding site of GABAB type 1 subunit sheds light on the activation process of GABAB receptors","volume":"275","author":"Galvez","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1011","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/ndt\/17.7.1159","article-title":"Strategies to safely interfere with prostanoid activity while avoiding adverse renal effects: could COX-2 and COX-LOX dual inhibition be the answer?","volume":"17","author":"Gambaro","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1012","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.neuroscience.2004.04.018","article-title":"Neuropeptide Y and NMDA acid interact within the suprachiasmatic nuclei to alter circadian phase","volume":"126","author":"Gamble","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1013","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.brainresbull.2005.03.004","article-title":"Circadian control during the day and night: role of neuropeptide Y Y5 receptors in the suprachiasmatic nucleus","volume":"65","author":"Gamble","year":"2005","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1014","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.4088\/JCP.v65n1013","article-title":"Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000","volume":"65","author":"Ganguly","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/074873040101600103","article-title":"5-HT7 receptors in the rodent suprachiasmatic nucleus","volume":"16","author":"Gannon","year":"2001","journal-title":"J Biol Rhythms"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1016","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0306-4522(03)00161-1","article-title":"Serotonergic serotonin(1A) mixed agonists\/antagonists elicit large-magnitude phase shifts in hamster circadian wheel-running rhythms","volume":"119","author":"Gannon","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1018","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejphar.2005.10.012","article-title":"The selective neurokinin1 (NK1) receptor antagonist, GR205,171, stereospecifically inhibits light-induced phase shifts of hamster circadian activity rhythms","volume":"527","author":"Gannon","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1017","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuroscience.2005.04.059","article-title":"5-HT1A autoreceptor activation by S15535 advances circadian activity rhythms in hamsters: evaluation of potential interactions with 5HT2A and 5-HT2C receptors","volume":"137","author":"Gannon","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1019","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2174\/1566524023362023","article-title":"Stress, metaplasticity, and antidepressants","volume":"2","author":"Garcia","year":"2002","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1020","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1471-4159.2004.02748.x","article-title":"Autoreceptor-mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment","volume":"91","author":"Garcia","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1021","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.94.5.2041","article-title":"Blockade of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac)","volume":"94","author":"Garcia-Colunga","year":"1997","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1022","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0301-0082(00)00025-3","article-title":"Neuroprotection by estradiol","volume":"63","author":"Garcia-Segura","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1023","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0167-0115(96)00071-7","article-title":"GR205171: a novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity","volume":"65","author":"Gardner","year":"1996","journal-title":"Regul Pept"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1024","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/nrd1550","article-title":"Drugs as materials: valuing physical form in drug discovery","volume":"3","author":"Gardner","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1525-8610(04)70063-8","article-title":"Mirtazapine is associated with less anxiolytic use among elderly depressed patients in long-term care facilities","volume":"5","author":"Gardner","year":"2004","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1026","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-2999(92)90768-Y","article-title":"Selective 5-HT1A and 5-HT2 receptor-mediated adrenocorticotropin release in the rat: effect of repeated antidepressant treatments","volume":"221","author":"Gartside","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1027","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.bjp.0702546","article-title":"Effects of (\u2212)-tertatolol, (\u2212)-penbutolol and (\u00b1)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study","volume":"127","author":"Gartside","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1028","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0006-8993(93)90750-H","article-title":"Interaction of cholinergic\u2013dopaminergic systems in the regulation of memory storage in aversively motivated learning tasks","volume":"627","author":"Gasbarri","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1029","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1523\/JNEUROSCI.5635-03.2004","article-title":"Redistribution of GABAB(1) protein and atypical GABAB responses in GABAB(2)-deficient mice","volume":"24","author":"Gassmann","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1030","first-page":"434","article-title":"Comparison of oral and intravenous treatment of depressive states: preliminary results of a WHO collaborative study","volume":"9","author":"Gastpar","year":"1986","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1031","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0024-3205(03)00422-3","article-title":"Discriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety","volume":"73","author":"Gatch","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1032","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2337\/diacare.16.8.1167","article-title":"Prevalence of depression in adults with diabetes: an epidemiological evaluation","volume":"16","author":"Gavard","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1033","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0166-4328(02)00054-2","article-title":"The role of lateral septal NK1 receptors in mediating anxiogenic effects induced by intracerebrocentricular injection of substance P","volume":"134","author":"Gavioli","year":"2002","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1034","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0006-291X(03)01094-5","article-title":"Constitutive precoupling to G(i) and increased agonist potency in the alpha(2B)-adrenoceptor","volume":"306","author":"Ge","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1035","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0140-6736(03)12599-8","article-title":"Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review","volume":"361","author":"Geddes","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1036","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.npep.2004.07.002","article-title":"Introduction to the reviews on neuropeptide Y","volume":"38","author":"Gehlert","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1037","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2004.12.030","article-title":"Stress and central urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor","volume":"509","author":"Gehlert","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1038","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00002508-200006000-00004","article-title":"Negative affect, self-report of depressive symptoms, and clinical depression: relation to the experience of chronic pain","volume":"16","author":"Geisser","year":"2000","journal-title":"Clin J Pain"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1039","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1001\/jama.283.23.3082","article-title":"Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: a 6-month randomized controlled trial","volume":"283","author":"Gelenberg","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1040","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4088\/JCP.v61n0506","article-title":"Mirtazapine substitution in SSRI-induced sexual dysfunction","volume":"61","author":"Gelenberg","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1041","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/0269881103174001","article-title":"Thyroid indices and response to fluoxetine and nortriptyline in major depression","volume":"17","author":"Gendall","year":"2003","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1042","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/1568007023339184","article-title":"Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure","volume":"1","author":"Gentry","year":"2002","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1043","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tips.2003.11.003","article-title":"Current pharmacological treatments for nicotine dependence","volume":"25","author":"George","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1044","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/depr.3050020202","article-title":"Prefrontal cortex dysfunction in clinical depression","volume":"2","author":"George","year":"1994","journal-title":"Depression"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1045","doi-asserted-by":"crossref","first-page":"26128","DOI":"10.1074\/jbc.M000345200","article-title":"Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties","volume":"275","author":"George","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1046","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/scnp.2002.35229","article-title":"Novel treatments of mood disorders based on brain circuitry (ECT, MST, TMS, VNS, DBS)","volume":"7","author":"George","year":"2002","journal-title":"Semin Clin Neuropsychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1047","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nrd913","article-title":"G-protein-coupled receptor oligomerization and its potential for drug discovery","volume":"1","author":"George","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1048","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S1461145703003250","article-title":"Vagus nerve stimulation (VNS): utility in neuropsychiatric disorders","volume":"6","author":"George","year":"2003","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1049","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1523\/JNEUROSCI.1714-04.2005","article-title":"The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance","volume":"25","author":"Georgescu","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1050","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.neuropharm.2003.11.031","article-title":"Inhibitory effects of trace amines on rat midbrain dopaminergic neurons","volume":"46","author":"Geracitano","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1051","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/BF01291788","article-title":"Animal models of Parkinson's disease: an empirical comparison with the phenomenology of disease in man","volume":"103","author":"Gerlach","year":"1996","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1052","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2036.2004.02180.x","article-title":"Review article: serotonin receptors and transporters\u2014roles in normal and abnormal gastrointestinal motility","volume":"20","author":"Gershon","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1053","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1176\/appi.ajp.160.5.835","article-title":"Transcranial magnetic stimulation in the treatment of depression","volume":"160","author":"Gershon","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1054","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/362345a0","article-title":"Different binding epitopes on the NK1 receptor for substance P and non-peptide antagonist","volume":"362","author":"Gether","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1055","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1073\/pnas.90.13.6194","article-title":"Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors","volume":"90","author":"Gether","year":"1993","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1056","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1358\/dot.2004.40.8.850473","article-title":"Butyrylcholinesterase, cholinergic neurotransmission and the pathology of Alzheimer's disease","volume":"40","author":"Geula","year":"2004","journal-title":"Drugs Today"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1057","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00228-003-0710-3","article-title":"Time course of clinical response to venlafaxine: relevance of plasma level and chirality","volume":"59","author":"Gex-Fabry","year":"2004","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1058","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0197-0186(02)00129-8","article-title":"Pharmacological heterogeneity of release-regulating presynaptic AMPA\/kainate receptors in the rat brain: study with receptor antagonists","volume":"42","author":"Ghersi","year":"2003","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1059","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1023\/A:1022869222652","article-title":"Cholinesterases: new roles in brain function and in Alzheimer's disease","volume":"28","author":"Giacobini","year":"2003","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1060","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s007020200089","article-title":"Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit","volume":"109","author":"Giacobini","year":"2002","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1061","first-page":"42","article-title":"Adherence with antidepressant medication","volume":"13","author":"Giannetti","year":"2004","journal-title":"Manag Care"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1062","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/ddr.430350406","article-title":"A-80426, a potent and selective \u03b12-adrenoceptor antagonist with serotonin uptake-blocking activity and putative antidepressant-like effects: II. Pharmacological profile","volume":"35","author":"Giardina","year":"1995","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1063","first-page":"758","article-title":"Antagonists at the neurokinin receptors\u2014recent patent literature","volume":"6","author":"Giardina","year":"2003","journal-title":"IDrugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1064","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-0327(02)00071-X","article-title":"Direct comparison of total sleep deprivation and late partial sleep deprivation in the treatment of major depression","volume":"76","author":"Giedke","year":"2003","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1065","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1037\/0735-7044.116.5.785","article-title":"Ventral tegmental area dopamine neurons mediate the shock sensitization of acoustic startle: a potential site of action for benzodiazepine anxiolytics","volume":"116","author":"Gifkins","year":"2002","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1066","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1087-0792(02)90235-2","article-title":"Therapeutic use of sleep deprivation in depression","volume":"6","author":"Giedke","year":"2002","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1067","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1016\/j.bmcl.2004.08.030","article-title":"Novel aryloxy-8-azabicyclo{3.2.1]oct-3-enes with 5-HT transporter and 5-HT1A affinity","volume":"14","author":"Gilbert","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1068","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1523\/JNEUROSCI.20-12-04745.2000","article-title":"Sustained visual attention performance-associated prefrontal neurons activity: evidence for cholinergic mechanisms","volume":"20","author":"Gill","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1069","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S0033291704002727","article-title":"The relationship between stressful life events, the serotonin transporter (5-HTTLPR) genotype and major depression","volume":"35","author":"Gillespie","year":"2005","journal-title":"Psychological Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1070","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1124\/jpet.102.045419","article-title":"The effects of chronic treatment with the mood stabilizers valproic acid and lithium on corticotropin-releasing factor neuronal systems","volume":"305","author":"Gilmor","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1071","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0006-8993(96)00074-1","article-title":"Tyrosine hydroxylase expression within Balb\/C and C57black\/6 mouse locus coeruleus:I. Topological organization and phenotypic plasticity of the enzyme-containing cell population","volume":"721","author":"Ginovart","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1072","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2004.01.036","article-title":"Contributions of 5-HT2C receptors to multiple actions of central serotonin systems","volume":"488","author":"Giorgetti","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1073","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1046\/j.1460-9568.2000.00079.x","article-title":"Local GABAergic modulation of acetylcholine release from the cortex of freely moving rats","volume":"12","author":"Giorgetti","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1074","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1126\/science.1090289","article-title":"A protein interaction map of Drosophila melanogaster","volume":"302","author":"Giot","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1075","doi-asserted-by":"crossref","first-page":"7821","DOI":"10.1073\/pnas.122653799","article-title":"Community structure in social and biological networks","volume":"99","author":"Girvan","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1076","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/00926230252851870","article-title":"Bupropion-sustained release as a treatment for SSRI-induced sexual side effects","volume":"28","author":"Gitlin","year":"2002","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1077","first-page":"383","article-title":"Peripheral thyroid hormones and response to selective serotonin reuptake inhibitors","volume":"29","author":"Gitlin","year":"2004","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1078","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0149-7634(00)00020-8","article-title":"Central neural regulation of penile erection","volume":"24","author":"Giuliano","year":"2000","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1079","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/sj.ijir.3900509","article-title":"Central noradrenergic control of penile erection","volume":"12","author":"Giuliano","year":"2000","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1080","doi-asserted-by":"crossref","first-page":"7451","DOI":"10.1523\/JNEUROSCI.23-20-07451.2003","article-title":"Midbrain raphe modulation of nonphotic circadian clock resetting and 5-HT release in the mammalian suprachiasmatic nucleus","volume":"23","author":"Glass","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1081","first-page":"13","article-title":"Cardiovascular effects of antidepressant drugs: updated","volume":"59","author":"Glassman","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1082","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.gene.2004.11.003","article-title":"Eighty percent of proteins are different between humans and chimpanzees","volume":"346","author":"Glazko","year":"2005","journal-title":"Gene"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1083","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00008877-200112000-00005","article-title":"m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT2C receptors but not 5-HT2A or 5-HT2B receptors","volume":"12","author":"Gleason","year":"2001","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1084","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-2999(00)00216-8","article-title":"Enantioselective behavioural effects of sibutramine metabolites","volume":"397","author":"Glick","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1085","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/cercor\/bhh202","article-title":"Mice lacking dopamine D2 and D3 receptors exhibit differential activation of prefrontal cortical neurons during tasks requiring attention","volume":"15","author":"Glickstein","year":"2004","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1086","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/BF02245791","article-title":"Regional neurotransmitter responses alter acute and chronic electroconvulsive shock","volume":"100","author":"Glue","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1087","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.peptides.2005.03.032","article-title":"Effect of neurokinin-1 receptor antagonists on serotoninergic, noradrenergic and hippocampal neurons: comparison with antidepressant drugs","volume":"26","author":"Gobbi","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1088","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.jcp.0000084023.22282.03","article-title":"Neurochemical and psychotropic effects of bupropion in healthy male subjects","volume":"23","author":"Gobbi","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1089","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0893-133X(99)00035-4","volume":"21","author":"Gobert","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1090","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0028-3908(98)00188-9","article-title":"Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats","volume":"38","author":"Gobert","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1091","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1046\/j.1471-4159.1997.69062616.x","article-title":"Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats","volume":"69","author":"Gobert","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1092","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1046\/j.1471-4159.1997.68031326.x","article-title":"Buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate levels of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely moving rats","volume":"68","author":"Gobert","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1093","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0306-4522(99)00211-0","article-title":"Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions","volume":"93","author":"Gobert","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1094","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0028-3908(99)00229-4","article-title":"The ability of WAY100,635 to potentiate the neurochemical and functional actions of fluoxetine is enhanced by co-administration of SB224,289, but not BRL15572","volume":"39","author":"Gobert","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1098-2396(20000601)36:3<205::AID-SYN5>3.0.CO;2-D","article-title":"Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat","volume":"36","author":"Gobert","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1096","first-page":"S248","article-title":"The novel antidepressant, S35966, is a mixed serotonin and noradrenaline reuptake inhibitor and an antagonist at \u03b12-adrenoceptors","volume":"12","author":"Gobert","year":"2002","journal-title":"Eur Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1097","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1124\/jpet.102.046383","article-title":"Piribedil enhances frontocortical and hippocampal release of acetylcholine in freely moving rats by blockade of \u03b12A-adrenoceptors: a dialysis comparison to talipexole and quinelorane in the absence of acetylcholinesterase inhibitors","volume":"305","author":"Gobert","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1098","first-page":"247.8","article-title":"The melatonin concentrating hormone (MCH)1 antagonist, SNAP7941, enhances cholinergic but not monoaminergic transmission in frontal cortex (FCX) of freely-moving rats","volume":"29","author":"Gobert","year":"2003","journal-title":"Am Soc Neurosci Abstr"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1099","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jneumeth.2004.04.040","article-title":"Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by \u03b12-autoreceptors","volume":"140","author":"Gobert","year":"2004","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000118414","article-title":"Circadian rhythm of free urinary cortisol, temperature and heart rate in endogenous depressives and under antidepressant therapy","volume":"18","author":"Goetze","year":"1987","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1101","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1017\/S1461145704004183","article-title":"Focus on polypharmacy in schizophrenia: does anyone truly benefit?","volume":"7","author":"Goff","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1102","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-2836(02)01038-0","article-title":"Co-evolutionary analysis reveals insights into protein\u2013protein interactions","volume":"324","author":"Goh","year":"2002","journal-title":"J Mol Biol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1103","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nlm.2003.07.003","article-title":"Acetylcholine modulation of neural systems involved in learning and memory","volume":"80","author":"Gold","year":"2003","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1104","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1525-1381.1999.09423.x","article-title":"The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences","volume":"111","author":"Gold","year":"1998","journal-title":"Proc Assoc Am Physicians"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1105","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/sj.mp.4001032","article-title":"Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH\/NE states","volume":"7","author":"Gold","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1106","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0889-8529(01)00022-6","article-title":"Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications","volume":"31","author":"Gold","year":"2002","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1107","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/archpsyc.61.1.34","article-title":"Modulation of cortical-limbic pathways in major depression","volume":"61","author":"Goldapple","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1108","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1176\/ajp.156.5.798","article-title":"Pramipexole in refractory bipolar depression","volume":"156","author":"Goldberg","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1109","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/archpsyc.1988.01800260060008","article-title":"Antidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymetlatonin output","volume":"45","author":"Golden","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1110","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1176\/appi.ajp.162.4.656","article-title":"The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence","volume":"162","author":"Golden","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1111","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1525-1497.1999.03478.x","article-title":"Awareness, diagnostic, and treatment of depression","volume":"14","author":"Goldman","year":"1999","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1112","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1177\/0269881198012003041","article-title":"Selective serotonin reuptake inhibitors in the treatment of affective disorders: III. Tolerability, safety and pharmacoeconomics","volume":"12","author":"Goldstein","year":"1998","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1113","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4088\/JCP.v63n0309","article-title":"Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial","volume":"63","author":"Goldstein","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1114","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1176\/appi.psy.45.1.17","article-title":"Effects of duloxetine on painful physical symptoms associated with depression","volume":"45","author":"Goldstein","year":"2004","journal-title":"Psychosomatics"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1115","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.jcp.0000132448.65972.d9","article-title":"Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine","volume":"24","author":"Goldstein","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1116","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pain.2005.03.029","article-title":"Duloxetine vs. placebo in patients with painful diabetic neuropathy","volume":"116","author":"Goldstein","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1117","first-page":"625","article-title":"Inhibition of amino acid release by 5-HT1B receptor agonist in the rat prefrontal cortex","volume":"54","author":"Golembiowska","year":"2002","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1118","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1367-5931(03)00059-0","article-title":"Lead compounds discovered from libraries: part 2","volume":"7","author":"Golebiowski","year":"2003","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1119","doi-asserted-by":"crossref","first-page":"RC110","DOI":"10.1523\/JNEUROSCI.20-22-j0007.2000","article-title":"Heterodimerization or \u03bc and \u03b4 opioid receptors: a role in opiate synergy","volume":"20","author":"Gomes","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1120","first-page":"285","article-title":"Combined treatment with venlafaxine and tricyclic antidepressants in depressed patients who had partial response to clomipramine or imipramine: initial findings","volume":"61","author":"Gomez","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1121","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/hup.583","article-title":"Decrease of the platelet 5-HT2A receptor function by long-term imipramine treatment in endogenous depression","volume":"19","author":"Gomez-Gil","year":"2004","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1122","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s002130050622","article-title":"Discriminative stimulus properties of mCPP: evidence for a 5-HT2C receptor mode of action","volume":"137","author":"Gommans","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1123","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jad.2005.05.007","article-title":"Subthreshold depression is linked to the functional polymorphism in the 5-HT transporter gene","volume":"87","author":"Gonda","year":"2005","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1124","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0091-3057(94)90164-3","article-title":"Interactions between 5HT and testosterone in the control of sexual and nonsexual behaviour in male and female rats","volume":"47","author":"Gonzalez","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0196-9781(95)02092-6","article-title":"Behavioral effects of alpha-MSH and MCH after central administration in the female rat","volume":"17","author":"Gonzalez","year":"1996","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1126","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000127246","article-title":"Stimulatory effect of melanin-concentrating hormone on luteinising hormone release","volume":"66","author":"Gonzalez","year":"1997","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1127","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1096\/fj.03-0189fje","article-title":"The neuropeptide Y Y1 receptor mediates NPY-induced inhibition of the gonadotrope axis under poor metabolic conditions","volume":"18","author":"Gonzales","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1128","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000074445","article-title":"Neuroendocrinology of neurodegenerative diseases","volume":"78","author":"Gonzalez de Aguilar","year":"2003","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1129","first-page":"8","article-title":"Selecting pharmacotherapy for generalized anxiety disorder","volume":"65","author":"Goodman","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1130","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1177\/0269881198012003021","article-title":"Selective serotonin reuptake inhibitors in affective disorders-I. Basic pharmacology","volume":"12","author":"Goodnick","year":"1998","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1131","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jad.2004.11.011","article-title":"Treatment of generalized anxiety disorder with escitalopram: pooled results from double-blind, placebo-controlled trials","volume":"87","author":"Goodman","year":"2005","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1132","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/026988119701100204","article-title":"Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression","volume":"11","author":"Goodwin","year":"1997","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1133","first-page":"1","article-title":"Evidence that the pathophysiology of depression and the mechanism of action of antidepressant drugs both involve alterations in circadian rhythms","volume":"32","author":"Goodwin","year":"1982","journal-title":"Adv Biochem Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1134","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1053\/comp.2002.33500","article-title":"The relationship between anxiety and substance use disorders among individuals with servere affective disorders","volume":"43","author":"Goodwin","year":"2002","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1135","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1192\/bjp.176.2.142","article-title":"First-episode major depression in adolescents. Affective, cognitive and endocrine characteristics of risk status and predictors of onset","volume":"176","author":"Goodyer","year":"2000","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1136","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1089\/dna.1997.16.871","article-title":"Cloning and characterization of two human polyspecific organic cation transporters","volume":"16","author":"Gorboulev","year":"1997","journal-title":"DNA Cell biol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1137","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2307\/2981629","article-title":"A review of hierarchical classification","volume":"150","author":"Gordon","year":"1987","journal-title":"J R Statistical Soc, A"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1138","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0306-4522(99)00146-3","article-title":"Evidence that 3,3\u2032,5-triiodothyronine is concentrated in and delivered from the locus coeruleus to its noradrenergic targets via anterograde axonal transport","volume":"93","author":"Gordon","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1139","first-page":"24","article-title":"Treating generalized anxiety disorder","volume":"64","author":"Gorman","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1140","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1017\/S1092852900028595","article-title":"Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo controlled trials","volume":"7","author":"Gorman","year":"2002","journal-title":"CNS Spectrums"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1141","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0091-3057(98)00106-3","article-title":"Chronic stress effects on sexual behavior in male and female rats: mediation by 5-HT2A receptors","volume":"61","author":"Gorzalka","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1142","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1254\/jjp.53.47","article-title":"l-Dopa facilitates the release of endogenous norepinephrine and dopamine via presynaptic \u03b21- and \u03b22-adrenoceptors under essentially complete inhibition of L-aromatic amino acid decarboxylase in rat hypothalamic slices","volume":"53","author":"Goshima","year":"1990","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1143","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1176\/appi.ajp.160.4.636","article-title":"The endophenotype concept in psychiatry: etymology and strategic intentions","volume":"160","author":"Gottesman","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1144","doi-asserted-by":"crossref","first-page":"46S","DOI":"10.1016\/S0893-133X(99)00045-7","article-title":"Serotonin and hippocampal neurogenesis","volume":"21","author":"Gould","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1145","series-title":"The Structure of Evolutionary Theory","first-page":"1464","author":"Gould","year":"2002"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1146","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/sj.npp.1300731","article-title":"Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs","volume":"30","author":"Gould","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1147","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1017\/S0094837300004310","article-title":"Exaptation\u2014a missing term in the science of form","volume":"8","author":"Gould","year":"1982","journal-title":"Paleobiology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1148","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0006-3223(00)01021-0","article-title":"Regulation of hippocampal neurogenesis in adulthood","volume":"48","author":"Gould","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1149","first-page":"1","article-title":"AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test","volume":"26","author":"Gould","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1150","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.mp.4001518","article-title":"Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers","volume":"9","author":"Gould","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1151","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1124\/jpet.104.067264","article-title":"Isobolographic analysis for combinations of a full and partial agonist: curved isoboles","volume":"310","author":"Grabovsky","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1152","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0896-6273(00)80712-6","article-title":"Increased exploratory activity and altered response to LSD in mice lacking the 5-HT(5A) receptor","volume":"22","author":"Grailhe","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1153","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1471-4159.2001.00067.x","article-title":"Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple G-proteins","volume":"76","author":"Grammatopoulos","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1154","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejphar.2005.05.033","article-title":"\u03b12-adrenoceptor involvement in the in vitro inhibitory effect of eitalopram on a subpopulation of rat locus coeruleus neurons","volume":"517","author":"Grandoso","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1155","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1523\/JNEUROSCI.20-03-01208.2000","article-title":"Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex","volume":"20","author":"Granon","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1156","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0899-3289(95)90017-9","article-title":"Co-morbidity between DSM-IV drug use disorders and major depression: results of a national survey of adults","volume":"7","author":"Grant","year":"1995","journal-title":"J Subst Abuse"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1157","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.conb.2003.09.016","article-title":"Systems biology in neuroscience: bridging genes to cognition","volume":"13","author":"Grant","year":"2003","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1162","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S0167-7799(01)01799-1","article-title":"Proteomics of multiprotein complexes: answering fundamental questions in neuroscience","volume":"19","author":"Grant","year":"2001","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1158","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0006-3223(00)00936-7","article-title":"Effects of chronic antidepressant drug administration and electroconvulsive shock on locus coeruleus electrophysiologic activity","volume":"49","author":"Grant","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1159","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0006-3223(00)01072-6","article-title":"Cognitive disturbance in outpatient depressed younger adults: evidence of modest impairment","volume":"50","author":"Grant","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1160","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/archpsyc.61.11.1107","article-title":"Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiology survey on alcohol and related conditions","volume":"61","author":"Grant","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1161","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archpsyc.61.8.807","article-title":"Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders","volume":"61","author":"Grant","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1163","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1523\/JNEUROSCI.22-13-05442.2002","article-title":"A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons","volume":"22","author":"Gras","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1164","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0361-9230(95)02032-2","article-title":"Melatonin and its new agonist S-20098 restore synchronized sleep fragmented by experimental trypanosome infection in the rat","volume":"39","author":"Grassi-Zucconi","year":"1996","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1165","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0168-9525(00)02176-4","article-title":"Alternative splicing: increasing diversity in the proteomic world","volume":"17","author":"Graveley","year":"2001","journal-title":"Trends Gen"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1166","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1476-5381.1987.tb11331.x","article-title":"Increased GABAB receptor function in mouse frontal cortex after repeated administration of antidepressant drugs or electroconvulsive shocks","volume":"92","author":"Gray","year":"1987","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1167","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0361-9230(01)00623-2","article-title":"Paradoxical trafficking and regulation of 5-HT2A receptors by agonists and antagonists","volume":"56","author":"Gray","year":"2001","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1168","first-page":"5","article-title":"Physical symptoms of depression: unmet needs","volume":"64","author":"Greden","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1169","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/089198879901200205","article-title":"Accelerating antidepressant response in geriatric depression: a post hoc comparison of combined sleep deprivation and paroxetine versus monotherapy with paroxetine, nortriptyline, or placebo","volume":"12","author":"Green","year":"1999","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1170","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.biopsych.2004.06.023","article-title":"Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria","volume":"56","author":"Green","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1171","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.4088\/JCP.v64n1211","article-title":"The economic burden of depression in the United States: how did it change between 1990 and 2000?","volume":"64","author":"Greenberg","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1172","first-page":"17","article-title":"The economic burden of depression with painful symptoms","volume":"64","author":"Greenberg","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1173","doi-asserted-by":"crossref","first-page":"23S","DOI":"10.1097\/00004714-199910001-00003","article-title":"Human cytochromes and some newer antidepressants: kinetics, metabolism, and drug interactions","volume":"19","author":"Greenblatt","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1174","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2165\/00003495-199753010-00003","article-title":"The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications","volume":"53","author":"Greenshaw","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1175","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1196\/annals.1300.037","article-title":"Prefrontal group II metabotropic glutamate receptor activation decreases performance on a working memory task","volume":"1003","author":"Gregory","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1176","first-page":"8","article-title":"Factors contributing to failed trials of new agents: can technology prevent some problems?","volume":"63","author":"Greist","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1177","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1359-6446(04)03275-1","article-title":"High-throughput drug discovery: what can we expect from HTS?","volume":"10","author":"Gribbon","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(98)00041-2","article-title":"Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders?","volume":"82","author":"Griebel","year":"1999","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1179","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s002130100830","article-title":"Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents","volume":"15","author":"Griebel","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1180","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1073\/pnas.092012099","article-title":"Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders","volume":"99","author":"Griebel","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1181","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/1568007033482850","article-title":"The vasopressin V1b receptor as a therapeutic target in stress-related disorders","volume":"2","author":"Griebel","year":"2003","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1182","doi-asserted-by":"crossref","first-page":"13512","DOI":"10.1073\/pnas.96.23.13512","article-title":"Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes","volume":"96","author":"Griffin","year":"1999","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1183","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0074-7696(02)13016-6","article-title":"Cell and molecular biology of melanin-concentrating hormone","volume":"213","author":"Griffond","year":"2002","journal-title":"Int Rev Cytol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1184","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1038\/sj.bjp.0702028","article-title":"Citalopram-induced hypophagia is enhanced by blockade of 5-HT1A receptors: role of 5-HT2C receptors","volume":"124","author":"Grignaschi","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1185","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1471-4159.2005.03126.x","article-title":"Chronic nicotine differentially affects the function of nicotinic receptor subtypes regulating neurotransmitter release","volume":"93","author":"Grilli","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1186","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/ng1097-206","article-title":"Increased stress response and beta-phenylethylamine in MAOB-deficient mice","volume":"17","author":"Grimsby","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1187","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0014-2999(03)01281-0","article-title":"5-HT1A receptor knockout mice and mice overexpressing corticotropin-releasing hormone in models of anxiety","volume":"463","author":"Groenink","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1188","first-page":"369","article-title":"5-HT1A receptor and 5-HT1B receptor knockout mice in stress and anxiety","volume":"14","author":"Groenink","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1189","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1097\/00001756-200006260-00024","article-title":"Sleep deprivation stimulates serotonin release in the suprachiasmatic nucleus","volume":"11","author":"Grossman","year":"2000","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1190","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1517\/13543776.10.10.1539","article-title":"Positive modulators of the AMPA receptor","volume":"10","author":"Grove","year":"2000","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1191","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.neubiorev.2005.01.004","article-title":"Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects","volume":"29","author":"Groves","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1192","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neulet.2004.12.055","article-title":"Recordings from the rat locus coeruleus during acute vagal nerve stimulation in the anaesthetised rat","volume":"379","author":"Groves","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1193","doi-asserted-by":"crossref","first-page":"30915","DOI":"10.1074\/jbc.273.47.30915","article-title":"Transport of monoamine transmitters by the organic cation transporter type 2, OCT2","volume":"273","author":"Gr\u00fcndemann","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1194","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/1557","article-title":"Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter","volume":"1","author":"Gr\u00fcndemann","year":"1998","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/mol.56.1.1","article-title":"Selective substrates for non-neuronal monoamine transporters","volume":"56","author":"Gr\u00fcndemann","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1196","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1124\/jpet.102.044404","article-title":"Agmatine is efficiently transported by non-neuronal monoamine transporters, extraneuronal monoamine transporter (EMT) and organic cation transporter 2 (OCT2)","volume":"304","author":"Gr\u00fcndemann","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1197","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF02257418","article-title":"Roxindole, a dopamine autoreceptor agonist, in the treatment of major depression","volume":"111","author":"Gr\u00fcnder","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1198","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.4088\/JCP.v65n1103","article-title":"Antidepressants and suicide risk in the United States, 1985-1999","volume":"65","author":"Grunebaum","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1199","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0006-3223(02)01499-3","article-title":"A randomised controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression","volume":"53","author":"Grunhaus","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1200","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nature01198","article-title":"Role of duplicate genes in genetic robustness against null mutations","volume":"421","author":"Gu","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1201","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.mp.4001196","article-title":"Lack of thyroid hormone receptor alpha1 is associated with selective alterations in behavior and hippocampal circuits","volume":"8","author":"Guadano-Ferraz","year":"2003","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1202","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0091-3057(92)90118-Y","article-title":"Combined effects of diazepam and melatonin in two tests for anxiolytic activity in the mouse","volume":"41","author":"Guardiola-Lemaitre","year":"1992","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1203","first-page":"450","article-title":"Effectiveness of venlafaxine in patients hospitalised for major depression and melancholia","volume":"56","author":"Guelfi","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1204","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1081\/DMR-120033996","article-title":"Cytochrome P450: what have we learned and what are the future issues?","volume":"36","author":"Guengerich","year":"2004","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2003.11.064","article-title":"Mechanisms of action of the antidepressants fluoxetine and the substance P antagonist L-00760735 are associated with altered neurofilaments and synaptic remodeling","volume":"1002","author":"Guest","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1206","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1471-4159.2003.02304.x","article-title":"Blockade of substance P (neurokinin1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice","volume":"89","author":"Guiard","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1207","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/ana.410420613","article-title":"Butyrylcholinesterase in the life cycle of amyloid plaques","volume":"42","author":"Guillozet","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1208","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00213-004-1920-9","article-title":"Sigma receptors: biology and therapeutic potential","volume":"174","author":"Guitart","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1209","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/22409","article-title":"Ethics of population genomics research","volume":"400","author":"Gulcher","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1210","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0091-3057(02)00771-2","article-title":"Role of the lateral septal noradrenergic system in the elaboration of male sexual behavior in rats","volume":"72","author":"Gulia","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1211","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0028-3908(02)00171-5","article-title":"Progesterone withdrawal increases the alpha4 subunit of the GABAA receptor in male rats in association with anxiety and altered pharmacology\u2014a comparison with female rats","volume":"43","author":"Gulinello","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1212","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0022-3565(24)38751-8","article-title":"Dinapsoline: characterization of a D1 dopamine receptor agonist in a rat model of Parkinson's disease","volume":"296","author":"Gulwadi","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1213","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.mcn.2004.01.017","article-title":"GABAergic synapses in hippocampus exocytose aspartate on to NMDA receptors: quantitative immunogold evidence for co-transmission","volume":"26","author":"Gundersen","year":"2004","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1214","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-2999(02)02642-0","article-title":"Effects of triiodothyronine and imipramine on basal 5-HT levels and 5-HT1 autoreceptor activity in rat cortex","volume":"457","author":"Gur","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1215","doi-asserted-by":"crossref","first-page":"10529","DOI":"10.1523\/JNEUROSCI.22-24-10529.2002","article-title":"Modulation of serotonin2C receptor editing by sustained changes in serotonergic neurotransmission","volume":"22","author":"Gurevich","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1216","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0896-6273(02)00660-8","article-title":"Altered editing of serotonin2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims","volume":"34","author":"Gurevich","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1217","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2174\/0929867013371798","article-title":"Peptide-binding G protein-coupled receptors: new opportunities for drug design","volume":"8","author":"Gurrath","year":"2001","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1218","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.neuropharm.2004.11.015","article-title":"Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression","volume":"48","author":"Guscott","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1219","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1056\/NEJMra012240","article-title":"Genomic medicine\u2014a primer","volume":"347","author":"Guttmacher","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1220","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1523\/JNEUROSCI.21-14-05089.2001","article-title":"Experience-dependent gene expression in the rat hippocampus after spatial learning: a comparison of the immediate-early genes Arc, c-fos, and zif268","volume":"21","author":"Guzowski","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1222","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1471-4159.2004.02180.x","article-title":"The localisation of the extraneuronal monoamine transporter (EMT) in rat brain","volume":"88","author":"Haag","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1223","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0014-2999(98)00077-6","article-title":"Facilitation of cognitive functions by a specific \u03b12-adrenoceptor antagonist, atipamezole","volume":"347","author":"Haapalinna","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1221","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/PL00005342","article-title":"Comparison of the effects of acute and subchronic administration of atipamezole on reaction to novelty and active avoidance learning in rats","volume":"359","author":"Haapalinna","year":"1999","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1224","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1042\/bst0290722","article-title":"Regulation of the serotonin transporter by interacting proteins","volume":"29","author":"Haase","year":"2001","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1225","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.1073\/pnas.97.11.6079","article-title":"Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioural, neuroendocrine, and autonomic responses to stress in primates","volume":"97","author":"Habib","year":"2000","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1226","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/026988119801200311","article-title":"The SSRI discontinuation syndrome","volume":"12","author":"Haddad","year":"1998","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1227","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00004850-199512004-00003","article-title":"Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapine","volume":"10","author":"Haddjeri","year":"1995","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1228","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0165-0327(98)00223-7","article-title":"Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission","volume":"51","author":"Haddjeri","year":"1998","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1229","doi-asserted-by":"crossref","first-page":"10150","DOI":"10.1523\/JNEUROSCI.18-23-10150.1998","article-title":"Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors","volume":"18","author":"Haddjeri","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1230","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.schres.2005.01.004","article-title":"Schizophrenia and depression: challenging the paradigm of two separate diseases\u2014a controlled study of schizophrenia, depression and healthy controls","volume":"77","author":"H\u00e4fner","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1231","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev.med.46.1.37","article-title":"Borderline hypothyroidism and depression","volume":"46","author":"Haggerty","year":"1995","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1232","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00213-003-1438-6","article-title":"Involvement of the prefrontal cortex but not the dorsal hippocampus in the attention-enhancing effects of nicotine in rats","volume":"168","author":"Hahn","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1233","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00239-003-2544-0","article-title":"Molecular evolution in large genetic networks: does connectivity equal constraint?","volume":"58","author":"Hahn","year":"2004","journal-title":"J Mol Evol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1234","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1124\/mol.105.011270","article-title":"Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulation","volume":"68","author":"Hahn","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1235","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1527-3458.2004.tb00002.x","article-title":"The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile","volume":"10","author":"Hajos","year":"2004","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1236","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1460-9568.2005.03968.x","article-title":"Short-term treatment with the antidepressant fluoxetine triggers pyramidal dendritic spine synapse formation in rat hippocampus","volume":"21","author":"Hajszan","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1237","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1021\/jm960552l","article-title":"Serotonin dimers: application of the bivalent ligand approach to the design of new potent and selective 5-HT(1B\/1D) agonists","volume":"39","author":"Halazy","year":"1996","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1238","first-page":"281","article-title":"Hormonal intervention with psychopharmacological potential: an overview","volume":"33","author":"Halbreich","year":"1997","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1239","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2165\/00023210-200115100-00005","article-title":"Role of estrogen in the aetiology and treatment of mood disorders","volume":"15","author":"Halbreich","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1240","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3109\/07853890008998829","article-title":"Separate systems for serotonin and leptin in appetite control","volume":"32","author":"Halford","year":"2000","journal-title":"Ann Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1241","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/bja\/83.6.909","article-title":"Effects of tramodol stereoisomers on norepinephrine efflux and uptake in the rat locus coeruleus measured by real time voltammetry","volume":"83","author":"Halfpenny","year":"1999","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1242","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1096-9861(19990823)411:2<181::AID-CNE2>3.0.CO;2-1","article-title":"Distribution of preprovasopressin mRNA in the rat central nervous system","volume":"411","author":"Hallbeck","year":"1999","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1243","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/070674378603100315","article-title":"Affective disorders and circadian rhythms","volume":"31","author":"Hallonquist","year":"1986","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1244","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1467-789X.2003.00083.x","article-title":"Treatment of obesity: an update on anti-obesity medications","volume":"4","author":"Halpern","year":"2003","journal-title":"Obes Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1245","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0006-3223(90)90627-E","article-title":"Analysis of tandospirone (SM-3997) interactions with neurotransmitter receptor binding sites","volume":"28","author":"Hamik","year":"1990","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1246","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1523\/JNEUROSCI.23-03-01019.2003","article-title":"Corticotropin releasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioural consequences of uncontrollable stress","volume":"23","author":"Hammack","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1247","series-title":"The Pharmacology of Pain","first-page":"361","article-title":"Inhibitory neurotransmitters and nociception: role of GABA and glycine","author":"Hammond","year":"1997"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1248","series-title":"Novel Aspects of Pain Management: Opioids and Beyond","first-page":"203","article-title":"Serotonin and its receptors in pain control","author":"Hamon","year":"1999"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1249","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1523\/JNEUROSCI.18-07-02748.1998","article-title":"Facilitatory effects of the ampakine CX516 on short-term memory in rats: correlations with hippocampal neuronal activity","volume":"18","author":"Hampson","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1250","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1517\/13543784.13.10.1237","article-title":"Perspectives on cognitive domains, H3 receptor ligands and neurological disease","volume":"13","author":"Hancock","year":"2004","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1251","first-page":"1160","volume":"272","author":"Hancock","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1253","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cbpa.2004.04.003","article-title":"Pursuing the leadlikeness concept in pharmaceutical research","volume":"8","author":"Hann","year":"2004","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1254","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.neuropharm.2004.06.003","article-title":"Differential effects of the novel antidepressant agomelatine (S 20098) versus fluoxetine on 5-HT1A receptors in the rat brain","volume":"47","author":"Hanoun","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1255","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0014-2999(99)00191-0","article-title":"Nitric oxide synthase inhibitors have antidepressant-like properties in mice: I. Acute treatments are active in the forced swim test","volume":"372","author":"Harkin","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1256","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0028-3908(03)00030-3","article-title":"Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors","volume":"44","author":"Harkin","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1257","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.euroneuro.2003.08.010","article-title":"Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test","volume":"14","author":"Harkin","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1258","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s002130000654","article-title":"Administration of the beta-adrenoceptor blocker propranolol impairs the processing of facial expressions of sadness","volume":"154","author":"Harmer","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1259","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archpsyc.58.4.353","article-title":"Differential circadian rhythm disturbance in men with Alzheimer disease and frontotemporal degeneration","volume":"58","author":"Harper","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1260","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/nar\/30.5.1083","article-title":"A question of size: the eukaryotic proteome and the problems in defining it","volume":"30","author":"Harrison","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1261","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/syn.20081","article-title":"Alteration of hippocampal cell proliferation in mice lacking the beta2 subunit of the neuronal nicotinic acetylcholine receptor","volume":"54","author":"Harrist","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1262","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2174\/1570159043359567","article-title":"The clinical neuroscience of post stroke depression","volume":"2","author":"Harro","year":"2004","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1263","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0091-3057(03)00221-1","article-title":"Serotonergic and histaminergic mechanisms involved in intralipid drinking?","volume":"76","author":"Hartfield","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1264","doi-asserted-by":"crossref","first-page":"C47","DOI":"10.1038\/35011540","article-title":"From molecular to modular cell biology","volume":"402","author":"Hartwell","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1265","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00002826-200003000-00006","article-title":"Neuropharmacology of paradoxic weight gain with selective serotonin reuptake inhibitors","volume":"23","author":"Harvey","year":"2000","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1266","first-page":"494","article-title":"Stress\u2013restress evokes sustained iNOS activity and altered GABA levels and NMDA receptors in rat hippocampus","volume":"175","author":"Harvey","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1267","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00213-004-1872-0","article-title":"Possible role for the 5-HT1A receptor in the behavioral effects of REM sleep deprivation on free-operant avoidance responding in rat","volume":"176","author":"Harvey","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1268","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0006-2952(03)00187-4","article-title":"Search for a common mechanism of mood stabilizers","volume":"66","author":"Harwood","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1269","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0304-3940(97)00451-5","article-title":"Serotonin and human information processing; fluvoxamine can improve reaction time performance","volume":"229","author":"Hasbroucq","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1270","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1054\/npep.2000.0824","article-title":"Substance P and its role in neural mechanisms governing learning, anxiety and functional recovery","volume":"34","author":"Hasenohrl","year":"2000","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1271","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.brainresrev.2004.02.003","article-title":"Critical role of brain-derived neurotrophic factor in mood disorders","volume":"45","author":"Hashimoto","year":"2004","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1272","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/sj.npp.1300506","article-title":"Discovering endophenotypes for major depression","volume":"29","author":"Hasler","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1273","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/sj.npp.1300371","article-title":"Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression","volume":"29","author":"Hastings","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1274","doi-asserted-by":"crossref","first-page":"45045","DOI":"10.1074\/jbc.C300349200","article-title":"The human dopamine transporter forms a tetramer in the plasma membrane","volume":"278","author":"Hastrup","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1275","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0028-3908(96)00079-2","article-title":"Biochemical profile of YM992, a novel selective serotonin reuptake inhibitor with 5-HT2A receptor antagonistic activity","volume":"35","author":"Hatanaka","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1276","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(00)00173-4","article-title":"Effect of acute treatment with YM992 on extracellular norepinephrine levels in the rat frontal cortex","volume":"395","author":"Hatanaka","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1277","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1210\/endo.141.12.7833","article-title":"The melanin-concentrating hormone receptor couples to multiple G proteins to activate diverse intracellular signalling pathways","volume":"141","author":"Hawes","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1278","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00004850-200015040-00002","article-title":"Efficacy, safety and tolerability of combined administration of lithium and selective serotonin reuptake inhibitors: a review of the current evidence","volume":"15","author":"Hawley","year":"2000","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1279","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0028-3908(92)90136-D","article-title":"The effects of electroconvulsive shock or imipramine on subtypes of \u03b11-adrenoceptors in the frontal cortex of the rat","volume":"31","author":"Hayakawa","year":"1992","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1280","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1124\/jpet.103.051284","article-title":"Sigma1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export","volume":"306","author":"Hayashi","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1281","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2165\/00023210-200418050-00001","article-title":"Sigma1 receptor ligands: potential in the treatment of neuropsychiatric disorders","volume":"18","author":"Hayashi","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1282","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.bjp.0704785","article-title":"Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3","volume":"136","author":"Hayer-Zillgen","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1283","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1534\/genetics.104.037051","article-title":"Rapid subfunctionalization accompanied by prolonged and substantial neofunctionalization in duplicate gene evolution","volume":"169","author":"He","year":"2005","journal-title":"Genetics"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1284","first-page":"S18","article-title":"Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine","volume":"1","author":"Heal","year":"1998","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1285","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0163-7258(94)00077-G","article-title":"The circadian system and the therapeutics of the affective disorders","volume":"65","author":"Healy","year":"1995","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1286","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s002130051062","article-title":"Metyrapone displays antidepressant-like properties in preclinical paradigms","volume":"145","author":"Healy","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1287","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0149-7634(00)00023-3","article-title":"Central neuropharmacological agents and mechanisms in erectile dysfunction: the role of dopamine","volume":"24","author":"Heaton","year":"2000","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1288","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1055\/s-2007-1014599","article-title":"Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine","volume":"22","author":"Hebenstreit","year":"1989","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1289","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.tips.2004.07.002","article-title":"Functional, molecular and pharmacological advances in 5-HT7 receptor research","volume":"25","author":"Hedlund","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1290","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.biopsych.2005.05.012","article-title":"5-HT7 receptor inhibition and inactivation induce antidepressant like behavior and sleep pattern","volume":"58","author":"Hedlund","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1291","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0028-3908(99)00166-5","article-title":"GABAB receptor antagonists elevate both mRNA and protein levels of the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) but not neurotrophin-3 (NT-3) in brain and spinal cord of rats","volume":"39","author":"Heese","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1292","first-page":"356.16","article-title":"Evidence for the mechanism of action of melanin concentrating hormone- 1 (MCH-1) receptor antagonists in rodent models of anxiety and depression","volume":"30","author":"Hegde","year":"2004","journal-title":"Am Soc Neurosci Abstr"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1293","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00213-004-1983-7","article-title":"Differential effects of reboxetine and citalopram on hand-motor function in patients suffering from major depression","volume":"178","author":"Hegerl","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1294","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1523\/JNEUROSCI.22-13-05452.2002","article-title":"Metabotropic glutamate receptor1-induced upregulation of NMDA receptor current: mediation through the Pyk2\/Src-family kinase pathway in cortical neurons","volume":"22","author":"Heidinger","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1295","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s10571-004-6921-z","article-title":"The alpha-2B adrenoceptor in the paraventricular thalamic nucleus is persistently upregulated by chronic psychosocial stress","volume":"24","author":"Heilbronner","year":"2004","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1296","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.npep.2004.05.002","article-title":"The NPY system in stress, anxiety and depression","volume":"38","author":"Heilig","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1297","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0014-2999(88)90182-3","article-title":"Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain","volume":"147","author":"Heilig","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1298","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0022-3956(03)00101-8","article-title":"Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment-refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism","volume":"38","author":"Heilig","year":"2004","journal-title":"J Psychiatric Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1299","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1016\/j.bmc.2004.07.014","article-title":"Dual 5-HT1A agonists and 5-HT re-uptake inhibitors by combination of indole-butyl-amine and chromenonyl-piperazine structural elements in a single molecular entity","volume":"12","author":"Heinrich","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1300","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1124\/jpet.103.052092","article-title":"Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation","volume":"311","author":"Heinrichs","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1301","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1054\/npep.1999.0047","article-title":"The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behavior","volume":"33","author":"Heinrichs","year":"1999","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1302","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0306-4522(96)00140-6","article-title":"Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor","volume":"74","author":"Heinrichs","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1303","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0306-4530(97)00030-9","article-title":"Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated","volume":"22","author":"Heinrichs","year":"1997","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1304","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-7091-0579-5_4","article-title":"Depletion and restoration of endogenous monoamines affects beta-CIT binding to serotonin but not dopamine transporters in non-human primates","volume":"68","author":"Heinz","year":"2004","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1305","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nn1366","article-title":"Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter","volume":"8","author":"Heinz","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1306","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.neuropharm.2005.01.019","article-title":"GABAB receptor antagonist SGS742 improves spatial memory and reduces protein binding to the camp response element (CRE) in the hippocampus","volume":"48","author":"Helm","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1307","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1254\/jjp.77.107","article-title":"The role of calcium in the etiology of the affective disorders","volume":"77","author":"Helmeste","year":"1998","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1308","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1016\/S1359-6446(02)02390-5","article-title":"Novel detection strategies for drug discovery","volume":"7","author":"Hemmila","year":"2002","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1309","series-title":"Organization of Neuropeptide Y Neurons in the Mammalian Central Nervous System","first-page":"192","author":"Hendry","year":"1993"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1310","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.biopsych.2004.04.011","article-title":"Neurogenesis and depression: etiology or epiphenomenon?","volume":"56","author":"Henn","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1311","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0006-8993(97)00343-0","article-title":"Nicotinic acetylcholine receptor antagonist effect of fluoxetine in rat hippocampal slices","volume":"759","author":"Hennings","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1312","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1046\/j.1471-4159.1999.0731043.x","article-title":"Nicotinic acetylcholine receptor antagonistic activity of monoamine uptake blockers in rat hippocampal slices","volume":"73","author":"Hennings","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1313","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1528-1157.1998.tb01448.x","article-title":"Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: I. Acute effects at high and low levels of stimulation","volume":"39","author":"Henry","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1314","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0024-3205(02)02482-7","article-title":"Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration","volume":"72","author":"Hensler","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/da.20022","article-title":"Long-term effectiveness of cognitive therapy in major depressive disorder","volume":"20","author":"Hensley","year":"2004","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1316","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1152\/jn.2000.84.6.2799","article-title":"Dopamine increases excitability of pyramidal neurons in primate prefrontal cortex","volume":"84","author":"Henze","year":"2000","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1317","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0006-8993(89)90641-0","article-title":"Chronic electroconvulsive shock treatment elicits up-regulation of CRF and AVP mRNA in select populations of neuroendocrine neurons","volume":"501","author":"Herman","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1318","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0091-3057(01)00681-5","article-title":"Paraventricular hypothalamic stress integration: limbic connections with local circuit neurons","volume":"71","author":"Herman","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1319","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neulet.2004.10.080","article-title":"Coexpression of the cannabinoid receptor type 1 with the corticotropin-releasing hormone receptor type 1 in distinct regions of the adult mouse forebrain","volume":"375","author":"Hermann","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1320","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1210\/endo.142.4.8067","article-title":"Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin","volume":"142","author":"Hernando","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1321","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2165\/00023210-200519040-00001","article-title":"Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential","volume":"19","author":"Herpfer","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1322","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.neuropharm.2004.12.016","article-title":"A comparison of neurokinin1 receptor knock-out (NK1-\/-) and wildtype mice: exploratory behaviour and extracellular noradrenaline concentration in the cerebral cortex of anaesthetised subjects","volume":"48","author":"Herpfer","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1323","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1046\/j.1471-4159.1999.731711.x","article-title":"Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction","volume":"73","author":"Herrick-Davis","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1324","doi-asserted-by":"crossref","first-page":"13963","DOI":"10.1021\/bi048398p","article-title":"Biochemical and biophysical characterization of serotonin 5-HT2C receptor homodimers on the plasma membrane of living cells","volume":"43","author":"Herrick-Davis","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1325","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuropharm.2004.09.015","article-title":"PKC modulation of GABAA receptor endocytosis and function is inhibited by mutation of a dileucine motif within the receptor \u03b22 subunit","volume":"48","author":"Herring","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1326","doi-asserted-by":"crossref","first-page":"7150","DOI":"10.1523\/JNEUROSCI.15-11-07150.1995","article-title":"Local modulation of hippocampal acetylcholine release by dopamine D1 receptors: a combined receptor autoradiography and in vivo dialysis study","volume":"15","author":"Hersi","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1327","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0169-328X(00)00015-2","article-title":"Dopamine D5 receptor modulates hippocampal acetylcholine release","volume":"76","author":"Hersi","year":"2000","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1328","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0028-3908(99)00045-3","article-title":"The antipsychotic drug risperidone interacts with auto- and hetero-receptors regulating serotonin output in the rat frontal cortex","volume":"38","author":"Hertel","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1329","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/sj.bjp.0703297","article-title":"Role of uptake inhibition and autoreceptor activation in the control of 5-HT release in the frontal cortex and dorsal hippocampus of the rat","volume":"130","author":"Hervas","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1330","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1046\/j.1460-9568.2000.00008.x","article-title":"The distribution of the mRNA and protein products of the melanin-concentrating hormone (MCH) receptor gene, slc-1, in the central nervous system of the rat","volume":"12","author":"Hervieu","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1331","first-page":"841","volume":"vol. 104","year":"1993"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1332","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.neuroscience.2003.10.039","article-title":"Localization of VGLUT3, the vesicular glutamate transporter type 3, in the rat brain","volume":"123","author":"Herzog","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1333","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0950-351X(98)80018-9","article-title":"Growth hormone deficiency and cardiovascular risk","volume":"12","author":"Hew","year":"1998","journal-title":"Bailliere's Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1334","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1017\/S0033291701004731","article-title":"Late-onset depression: genetic, vascular and clinical contributions","volume":"31","author":"Hickie","year":"2001","journal-title":"Psychol Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1335","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1440-1614.2003.01105.x","article-title":"Vascular risk to late-life depression: evidence from a longitudinal community study","volume":"3","author":"Hickie","year":"2003","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1336","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1192\/bjp.186.3.197","article-title":"Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression","volume":"186","author":"Hickie","year":"2005","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1337","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1192\/bjp.180.6.528","article-title":"Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression","volume":"180","author":"Hicks","year":"2002","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1338","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejphar.2003.08.102","article-title":"Serotonin and drug reward: focus on 5-HT2C receptors","volume":"480","author":"Higgins","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1339","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.neuropharm.2004.01.018","article-title":"Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent","volume":"46","author":"Higgins","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1340","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0165-6147(00)01502-9","article-title":"NK1 (substance P) receptor antagonists\u2014why are they not analgesic in humans?","volume":"21","author":"Hill","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1341","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0278-5846(03)00149-0","article-title":"Corticosterone attenuates the antidepressant-like effects elicited by melatonin in the forced swim test in both male and female rats","volume":"27","author":"Hill","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1342","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/sj.bjp.0702239","article-title":"Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181","volume":"125","author":"Hillegaart","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1343","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0924-977X(97)00416-1","article-title":"The effects of antidepressants on psychomotor function with particular reference to reboxetine","volume":"7","author":"Hindmarch","year":"1997","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1344","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1046\/j.1365-2125.1999.00993.x","article-title":"A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function","volume":"48","author":"Hindmarch","year":"1999","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1345","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.pnpbp.2004.11.015","article-title":"Distinct effects of sleep deprivation on binding to norepinephrine and serotonin transporters in rat brain","volume":"29","author":"Hipolide","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1346","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0028-3908(02)00330-1","article-title":"Behavioral action of ethanol in Porsolt's forced swim test: modulation by 3\u03b1-hydroxy-5\u03b1-pregnan-20-one","volume":"43","author":"Hirani","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1347","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/nn764","article-title":"GABAB receptor activation enhances mGluR-mediated responses at cerebellar excitatory synapses","volume":"4","author":"Hirono","year":"2001","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1348","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4088\/JCP.v60n0511","article-title":"Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs","volume":"60","author":"Hirschfeld","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1349","first-page":"32","article-title":"Care of the sexually active depressed patients","volume":"60","author":"Hirschfeld","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1350","first-page":"20","article-title":"Long-term side effects of SSRIs: sexual dysfunction and weight gain","volume":"64","author":"Hirschfeld","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1351","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jama.1997.03540280071036","article-title":"The national depressive and manic-depressive association consensus statement on the undertreatment of depression","volume":"277","author":"Hirschfeld","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1352","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/da.20071","article-title":"Time course of depression-symptom improvement during treatment with duloxetine","volume":"21","author":"Hirschfeld","year":"2005","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1353","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00125817-200203000-00002","article-title":"A comprehensive review of genetic association studies","volume":"4","author":"Hirschhorn","year":"2002","journal-title":"Genet Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1354","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/026988110001400208","article-title":"Serotonin autoreceptor function and antidepressant drug action","volume":"14","author":"Hjorth","year":"2000","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1355","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1124\/mol.63.3.751","article-title":"Mechanism of corticotropin-releasing factor type I receptor regulation by nonpeptide antagonists","volume":"63","author":"Hoare","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1356","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1021\/bi036110a","article-title":"Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists","volume":"43","author":"Hoare","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1357","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1172\/JCI200215903","article-title":"Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase C\u03b5","volume":"110","author":"Hodge","year":"2002","journal-title":"J Clin Investig"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1358","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.biopsych.2004.11.027","article-title":"The power of sample size and homogenous sampling: association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder","volume":"57","author":"Hoefgen","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1359","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/00004714-200010000-00008","article-title":"Lithium augmentation of venlafaxine: an open-label trial","volume":"20","author":"Hoencamp","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1360","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1527-3458.2002.tb00220.x","article-title":"Ensaculin (KA-672. HCI): a multitransmitter approach to dementia treatment","volume":"8","author":"Hoerr","year":"2002","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1361","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1017\/S1461145703003456","article-title":"The safety of clozapine in the treatment of first- and multiple-episode patients with treatment-resistant schizophrenia","volume":"6","author":"Hofer","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1362","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/frne.1998.0168","article-title":"Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system","volume":"19","author":"Hoffman","year":"1998","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1363","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00213-004-2028-y","article-title":"Effects of CRF(1) receptor antagonists and benzodiazepines in the Morris water maze and delayed non-matching to position tests","volume":"178","author":"Hogan","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1364","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1073\/pnas.2630225100","article-title":"Adult male rat hippocampus synthesizes estradiol from pregnenolone by cytochromes P45017\u03b1 and P450 aromatas localized in neurons","volume":"101","author":"Hojo","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1365","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0028-3908(00)00010-1","article-title":"Neuropeptides\u2014an overview","volume":"39","author":"H\u00f6kfelt","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1366","first-page":"207","article-title":"Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers","volume":"53","author":"Hollander","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1367","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1017\/S1092852900007148","article-title":"Uncomplicated and co-morbid obsessive\u2013compulsive disorder in an epidemiological sample","volume":"3","author":"Hollander","year":"1998","journal-title":"CNS Spectrum"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1368","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2165\/00003495-199549020-00010","article-title":"Venlafaxine, a review of its pharmacology and therapeutic potential in depression","volume":"49","author":"Holliday","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1369","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/archpsyc.62.4.417","article-title":"Prevention of relapse following cognitive therapy vs medications in moderate to severe depression","volume":"62","author":"Hollon","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1370","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tips.2003.09.011","article-title":"Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders","volume":"24","author":"Holmes","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1371","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1601-1848.2003.00050.x","article-title":"Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background","volume":"2","author":"Holmes","year":"2003","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1372","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0893-133X(00)00159-7","article-title":"The corticosteroid receptor hypothesis of depression","volume":"23","author":"Holsboer","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1373","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/15622970109026805","article-title":"Antidepressant drug discovery in the postgenomic era","volume":"2","author":"Holsboer","year":"2001","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1374","first-page":"46","article-title":"Corticotrophin-releasing hormone modulators and depression","volume":"4","author":"Holsboer","year":"2003","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1375","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0165-1781(91)90041-M","article-title":"Repeated administration of the combined dexamethasone\/hCRH stimulation test during treatment of depression","volume":"38","author":"Holsboer-Trachsler","year":"1991","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1376","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0361-9230(01)00613-X","article-title":"Biochemical, behavioral, physiologic, and neurodevelopmental changes in mice deficient in monoamine oxidase A or B","volume":"56","author":"Holschneider","year":"2001","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1377","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0167-0115(95)00019-8","article-title":"Tachykinin receptors in gastrointestinal motility","volume":"57","author":"Holzer-Petsche","year":"1995","journal-title":"Regul Pept"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1378","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/sj.npp.1300417","article-title":"Functional interaction between NMDA and mGlu5 receptors: effects of working memory, instrumental learning, motor behaviors, and dopamine release","volume":"29","author":"Homayoun","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1379","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/da.20024","article-title":"Clinical correlates of recurrent major depression in obsessive\u2013compulsive disorder","volume":"20","author":"Hong","year":"2004","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1380","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/nbt1004-1215","article-title":"The impact of systems approaches on biological problems in drug discovery","volume":"22","author":"Hood","year":"2004","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1381","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1126\/science.1086763","article-title":"Central nervous system targets of RNA editing identified by comparative genomics","volume":"301","author":"Hoopengardner","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1382","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1073\/pnas.79.8.2554","article-title":"Neural networks and physical systems with emergent collective computational abilities","volume":"79","author":"Hopfield","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1383","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1126\/science.3755256","article-title":"Computing with neural circuits: a model","volume":"233","author":"Hopfield","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1384","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd892","article-title":"The druggable genome","volume":"1","author":"Hopkins","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1385","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0028-3908(00)00192-1","article-title":"Multiple 5-HT1 autoreceptor subtypes govern serotonin release in dorsal and median raphe nuclei","volume":"40","author":"Hopwood","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1386","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nature03073","article-title":"A taxa\u2013area relationship for bacteria","volume":"432","author":"Horner-Devine","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1387","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1046\/j.1471-4159.2003.01899.x","article-title":"Functional coupling of serotonin and noradrenaline transporters","volume":"86","author":"Horschitz","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1388","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1471-4159.2003.01895.x","article-title":"Neuropeptide Y is neuroproliferative for post-natal hippocampal precursor cells","volume":"86","author":"Howell","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1389","first-page":"S148","article-title":"ORG 34517, a selective glucocorticoid receptor antagonist with potent antidepressant activity: first clinical results","volume":"5","author":"Hoyberg","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1390","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1124\/jpet.103.057455","article-title":"Central mechanisms regulating penile erection in conscious rats: the dopaminergic systems related to the proerectile effect of apomorphine","volume":"308","author":"Hsieh","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1391","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature03553","article-title":"Distinguishing random environmental fluctuations from ecological catastrophes for the North Pacific Ocean","volume":"435","author":"Hsieh","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1392","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00213-003-1413-2","article-title":"Effects of a single dose of cortisol on the neural correlates of episodic memory and error processing in healthy volunteers","volume":"167","author":"Hsu","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1393","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nn1218","article-title":"Neural activity and the dynamics of central nervous systems development","volume":"7","author":"Hua","year":"2004","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1394","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1517\/14622416.2.3.203","article-title":"Genomics, complexity and drug discovery: insights from Boolean network models of cellular regulation","volume":"2","author":"Huang","year":"2001","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1395","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1016\/S1359-6446(02)02463-7","article-title":"Rational drug discovery: what can we learn from regulatory networks?","volume":"7","author":"Huang","year":"2002","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1396","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.npp.1300609","article-title":"Serotonin modulates the suppressive effects of corticosterone on proliferating progenitor cells in the dentate gyrus of the hippocampus in the adult rat","volume":"30","author":"Huang","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1397","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/excr.2000.5044","article-title":"Shape-dependent control of cell growth, differentiation, and apoptosis: switching between attractors in cell regulatory networks","volume":"261","author":"Huang","year":"2000","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1398","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","article-title":"Neurotrophins: roles in neuronal development and function","volume":"24","author":"Huang","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1399","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/hup.696","article-title":"Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials","volume":"20","author":"Hudson","year":"2005","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1400","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0168-9525(02)02755-5","article-title":"Adaptive evolution after gene duplication","volume":"18","author":"Hughes","year":"1994","journal-title":"Trends Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1401","doi-asserted-by":"crossref","first-page":"8791","DOI":"10.1073\/pnas.0503922102","article-title":"Gene duplication and the origin of novel proteins","volume":"102","author":"Hughes","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1402","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00239-004-2616-9","article-title":"Recent mammalian gene duplications: robust search for functionally divergent gene pairs","volume":"59","author":"Hughes","year":"2004","journal-title":"J Mol Evol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1403","doi-asserted-by":"crossref","first-page":"8998","DOI":"10.1073\/pnas.0402642101","article-title":"Genetic diversity enhances the resistance of a seagrass ecosystem to disturbance","volume":"101","author":"Hughes","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1404","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-2999(96)00715-7","article-title":"Increased noradrenaline efflux induced by local infusion of fluoxetine in the rat frontal cortex","volume":"317","author":"Hughes","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1405","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1017\/S1461145703003845","article-title":"Selective effects of simultaneous monoamine depletion on mood and emotional responsiveness","volume":"7","author":"Hughes","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1406","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.tree.2005.03.022","article-title":"New paradigms for supporting the resilience of marine ecosystems","volume":"20","author":"Hughes","year":"2005","journal-title":"Trends Ecol Evol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1407","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2005.01.018","article-title":"Neurochemical evaluation of the novel 5-HT1A receptor partial agonist\/serotonin reuptake inhibitor, vilazodone","volume":"510","author":"Hughes","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1408","series-title":"Neurobiological Effects of Sex Steroid Hormones","first-page":"234","article-title":"Dopaminergic influences on male rat sexual behavior","author":"Hull","year":"1995"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1409","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.physbeh.2004.08.018","article-title":"Dopamine and serotonin: influences on male sexual behavior","volume":"83","author":"Hull","year":"2004","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1410","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2036.1999.00003.x-i2","article-title":"Review article: the therapeutic potential of 5-HT3 receptor antagonists in the treatment of irritable bowel syndrome","volume":"13","author":"Humphrey","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1411","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00001504-200203000-00006","article-title":"The current status of the diagnostic validity and treatment of generalized anxiety disorder","volume":"15","author":"Hunt","year":"2002","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1412","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0924-977X(01)00126-2","article-title":"Genetics and genomics in neuropsychopharmacology: the impact on drug discovery and development","volume":"11","author":"Hurko","year":"2001","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1413","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jad.2004.05.006","article-title":"Electroconvulsive therapy in depressive illness that has not responded to drug treatment","volume":"83","author":"Husain","year":"2004","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1414","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0028-3908(00)00009-5","article-title":"Involvement of hippocampal neuropeptide Y in mediating the chronic actions of lithium, electroconvulsive stimulation and citalopram","volume":"39","author":"Husum","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1415","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0143-4179(02)00086-0","article-title":"Extracellular levels of NPY in the dorsal hippocampus of freely moving rats are markedly elevated following a single electroconvulsive stimulation, irrespective of anticonvulsive Y1 receptor blockade","volume":"36","author":"Husum","year":"2002","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1416","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00004850-199403001-00004","article-title":"Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)","volume":"9","author":"Hyttel","year":"1994","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1417","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF01244820","article-title":"The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer","volume":"88","author":"Hyttel","year":"1992","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1418","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0006-8993(99)01876-4","article-title":"The effect of ipsapirone and S-pindolol on dopamine release in rat striatum and nucleus accumbens","volume":"842","author":"Ichikawa","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1419","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.brainres.2005.05.005","article-title":"Lithium differs from anticonvulsant mood stabilizers in prefrontal cortical and accumbal dopamine release: role of 5-HT1A receptor agonism","volume":"1049","author":"Ichikawa","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1420","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1471-4159.2004.02691.x","article-title":"In vivo regulation of dopamine and noradrenaline release by alpha2A-adrenoceptors in the mouse nucleus accumbens","volume":"91","author":"Ihalainen","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1421","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/BF00173217","article-title":"Neuropeptide Y potentiates via Y2-receptors the inhibitory effect of noradrenaline in rat locus coeruleus neurones","volume":"348","author":"Illes","year":"1993","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1422","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0006-291X(02)00636-8","article-title":"Inhibition of glycogen synthase kinase-3\u03b2 by bivalent zinc ions: insight into the insulin-mimetic action of zinc","volume":"295","author":"Ilouz","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1423","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1124\/mol.64.1.78","article-title":"Positive allosteric modulator of the human 5-HT2C receptor","volume":"64","author":"Im","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1424","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S1359-6446(05)03565-8","article-title":"\u201cThe 39 steps\u201d in gene expression profiling: critical issues and proposed best practices for microarray experiments","volume":"10","author":"Imbeaud","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1425","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.pbb.2003.12.024","article-title":"Dual effects of nitric oxide in the mouse forced swimming test: possible contribution of nitric oxide-mediated serotonin release and potassium channel modulation","volume":"77","author":"Inan","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1426","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1471-4159.2003.01566.x","article-title":"Expression and functional characterization of the extraneuronal monoamine transporter in normal human astrocytes","volume":"84","author":"Inazu","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1427","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tips.2004.02.007","article-title":"Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future","volume":"25","author":"Ingelman-Sundberg","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1428","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0165-6147(99)01363-2","article-title":"Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment","volume":"20","author":"Ingelman-Sundberg","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1429","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0006-3223(95)00666-4","article-title":"Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression","volume":"40","author":"Inoue","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1430","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature03001","article-title":"Finishing the euchromatic sequence of the human genome","volume":"431","author":"International Human Genome Sequencing Consortium","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1431","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.pnpbp.2004.05.026","article-title":"Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies","volume":"28","author":"Invernizzi","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1432","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0028-3908(92)90171-K","article-title":"Tianeptine increases the extracellular concentrations of dopamine in the nucleus accumbens by a serotonin-independent mechanism","volume":"31","author":"Invernizzi","year":"1992","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1433","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1176\/appi.ajp.160.12.2122","article-title":"The impact of medical comorbidity on acute treatment in major depressive disorder","volume":"160","author":"Iosifescu","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1434","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.4088\/JCP.v66n0812","article-title":"An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder","volume":"66","author":"Iosifescu","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1435","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1124\/jpet.105.084764","article-title":"Effects of \u03b2-phenylethylamine on dopaminergic neurons of the ventral tegmental area in the rat: a combined electrophysiological and microdialysis study","volume":"314","author":"Ishida","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1436","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/cbic.200400068","article-title":"Ligand-binding modes in cationic biogenic amine receptors","volume":"5","author":"Ishiguro","year":"2004","journal-title":"ChemBioChem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1437","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0304-3940(01)02112-7","article-title":"Potentiation of 5-HT3 receptor functions in the hippocampal CA1 region of rats following repeated electroconvulsive shock treatments","volume":"320","author":"Ishihara","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1438","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-3940(03)00006-5","article-title":"Modafinil increases histamine release in the anterior hypothalamus of rats","volume":"339","author":"Ishizuka","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1439","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0165-1781(02)00141-5","article-title":"A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine","volume":"111","author":"Itoh","year":"2002","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1440","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2004.07.084","article-title":"Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats","volume":"498","author":"Itoh","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1441","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3940(03)00608-6","article-title":"RNA editing of serotonin2C receptor in human postmortem brains of major mental disorders","volume":"346","author":"Iwamoto","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1442","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1124\/jpet.104.070656","article-title":"Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats","volume":"311","author":"Iyengar","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1443","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0165-0327(99)00199-8","article-title":"Open pergolide treatment of tricyclic and heterocyclic antidepressant-resistant depression","volume":"61","author":"Izumi","year":"2000","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1444","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/sj.bjp.0701311","article-title":"Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat","volume":"121","author":"Jackson","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1445","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/sj.bjp.0701312","article-title":"Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat","volume":"121","author":"Jackson","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1446","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/sj.mp.4000712","article-title":"Adult brain neurogenesis and psychiatry: a novel theory of depression","volume":"5","author":"Jacobs","year":"2000","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1447","first-page":"119","article-title":"Fluoxetine-induced sexual dysfunction and an open trial of yohimbine","volume":"53","author":"Jacobsen","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1448","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.brainres.2004.07.065","article-title":"The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HTAA levels","volume":"1024","author":"Jacobsen","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1449","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1001\/archpsyc.61.12.1235","article-title":"Metyrapone as additive treatment in major depression","volume":"61","author":"Jahn","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1450","first-page":"67","article-title":"Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton rating scale for depression","volume":"37","author":"Jamerson","year":"2003","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1451","doi-asserted-by":"crossref","first-page":"752","DOI":"10.4088\/JCP.v65n0605","article-title":"The use of trazodone as a hypnotic: a critical review","volume":"65","author":"James","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1452","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S1359-6446(04)03244-1","article-title":"Pharmaceutical approaches to the treatment of obesity","volume":"9","author":"Jandacek","year":"2004","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1453","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pain.2004.06.007","article-title":"Depression increases onset of tension-type headache following laboratory stress","volume":"111","author":"Janke","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1454","series-title":"Psychopharmacology: The Fourth Generation of Progress","first-page":"945","article-title":"The role of acetylcholine mechanisms in mood disorders","author":"Janowsky","year":"1995"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1455","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.biopsych.2004.09.011","article-title":"Hippocampal changes and white matter lesions in early-onset depression","volume":"56","author":"Janssen","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1456","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0165-0327(02)00086-1","article-title":"Multicenter double-blind randomized parallel-group clinical trial of efficacy of the combination clomipramine (150 mg\/day) plus lithium carbonate (750 mg\/day) versus clomipramine (150 mg\/day) plus placebo in the treatment of unipolar major depression","volume":"76","author":"Januel","year":"2003","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1457","doi-asserted-by":"crossref","first-page":"P.1.062","DOI":"10.1016\/S0924-977X(04)80151-2","article-title":"Reboxetine added to SSRI accelerates the improvement in depressed patients who failed to respond to SSRI alone","volume":"14","author":"Jaracz","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1458","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1017\/S1461145704004742","article-title":"The combination of nicotine with the D2 antagonist raclopride or the weak D4 antagonist L-745,870 generates a clozapine-like facilitation of NMDA receptor-mediated neurotransmission in pyramidal cells of the rat medial prefrontal cortex","volume":"8","author":"Jardemark","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1459","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/0006-3223(87)90029-1","article-title":"Prolactin secretion during sleep: a comparison between depressed patients and normal control subjects","volume":"22","author":"Jarrett","year":"1987","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1460","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archpsyc.1990.01810140013002","article-title":"Recurrent depression is associated with a persistent and not sharp reduction in sleep related hormone secretion","volume":"47","author":"Jarrett","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1461","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/026988110001400107","article-title":"An evaluation of the abuse potential of modafinil using methylphenidate as a reference","volume":"14","author":"Jasinski","year":"2000","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1462","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature01808","article-title":"Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex","volume":"424","author":"Jasmin","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1463","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pain.2003.08.010","article-title":"Is noradrenaline a significant factor in the analgesic effect of antidepressants?","volume":"106","author":"Jasmin","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1464","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/sj.mp.4001551","article-title":"Glutamate as a therapeutic target in psychiatric disorders","volume":"9","author":"Javitt","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1465","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0301-0082(03)00085-6","article-title":"Dopamine: a potential substrate for synaptic plasticity and memory mechanisms","volume":"69","author":"Jay","year":"2003","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1466","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF03033225","article-title":"Plasticity at hippocampal to prefrontal cortex synapses is impaired by loss of dopamine and stress: importance for psychiatric diseases","volume":"6","author":"Jay","year":"2004","journal-title":"Neurotox Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1467","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1124\/mol.104.009555","article-title":"Evidence for biphasic effects of protein kinase C on serotonin transporter function, endocytosis, and phosphorylation","volume":"67","author":"Jayanthi","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1468","doi-asserted-by":"crossref","first-page":"9703","DOI":"10.1523\/JNEUROSCI.2830-04.2004","article-title":"Corticotropin-releasing hormone directly activates noradrenergic neurons of the locus caeruleus recorded in vitro","volume":"24","author":"Jedema","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1469","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1017\/S1092852900010063","article-title":"Lamotrigine in psychiatry: pharmacology and therapeutics","volume":"10","author":"Jefferson","year":"2005","journal-title":"CNS Spectr"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1470","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0968-0004(98)01335-8","article-title":"Moonlighting proteins","volume":"24","author":"Jeffery","year":"1999","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1471","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1176\/ajp.154.2.156","article-title":"Modifiable neuronal connections: an overview for psychiatrists","volume":"154","author":"Jeffery","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1472","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0014-2999(93)90453-O","article-title":"Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs","volume":"231","author":"Jenck","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1473","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1517\/13543784.7.10.1587","article-title":"The role of 5-HT2C receptors in affective disorders","volume":"7","author":"Jenck","year":"1998","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1474","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0006-3223(01)01354-3","article-title":"Repetitive transcranial magnetic stimulation vs electroconvulsive therapy for major depression: preliminary results of a randomised trial","volume":"51","author":"Jenicak","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1475","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1212\/WNL.45.3_Suppl_3.S6","article-title":"The rationale for the use of dopamine agonists in Parkinson's disease","volume":"45","author":"Jenner","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1476","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00019052-200312001-00002","article-title":"Dopamine agonists, receptor selectivity and dyskinesia induction in Parkinson's disease","volume":"1","author":"Jenner","year":"2003","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1477","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.mi.30.100176.002205","article-title":"Enzyme recruitment in evolution of new function","volume":"30","author":"Jensen","year":"1976","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1478","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s002130050865","article-title":"Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval\/detour deficits in monkeys","volume":"142","author":"Jentsch","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1479","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/35036627","article-title":"The large-scale organization of metabolic networks","volume":"407","author":"Jeong","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1480","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1161\/01.CIR.0000148138.25157.F9","article-title":"Prognostic value of anxiety and depression in patients with chronic heart failure","volume":"110","author":"Jiang","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1481","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0022-3956(00)00036-4","article-title":"Neuropeptide Y in male and female brains of flinders sensitive line, a rat model of depression. Effects of electroconvulsive stimuli","volume":"34","author":"Jimenez-Vasquez","year":"2000","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1482","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1227\/01.NEU.0000170434.44335.19","article-title":"A patient with a resistant major depression disorder treated with deep brain stimulation in the inferior thalamic peduncle","volume":"57","author":"Jimenez","year":"2005","journal-title":"Neurosurgery"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1483","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.neuropharm.2004.11.010","article-title":"Opposite effects of lithium and valproic acid on trophic factor deprivation-induced glycogen synthase kinase-3 activation, c-Jun expression and neuronal cell death","volume":"48","author":"Jin","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1484","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/neu.10147","article-title":"Nicotinic receptor-mediated effects on appetite and food intake","volume":"53","author":"Jo","year":"2002","journal-title":"J Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1485","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1615\/CritRevNeurobiol.v13.i4.10","article-title":"A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders","volume":"13","author":"Jobe","year":"1999","journal-title":"Crit Rev Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1486","first-page":"327","article-title":"Refractory depression: treatment strategies, with particular reference to the thyroid axis","volume":"22","author":"Joffe","year":"1997","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1487","first-page":"26","article-title":"The use of thyroid supplements to augment antidepressant medication","volume":"59","author":"Joffe","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1488","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1176\/appi.ajp.157.10.1689","article-title":"Thyroid hormone levels and recurrence of major depression","volume":"157","author":"Joffe","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1489","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.cellsig.2004.05.001","article-title":"What turns CREB on?","volume":"16","author":"Johannessen","year":"2004","journal-title":"Cell Signalling"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1490","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2982.2004.00550.x","article-title":"Options for patients with irritable bowel syndrome: contrasting traditional and novel serotonergic therapies","volume":"16","author":"Johanson","year":"2004","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1491","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0898-6568(03)00013-5","article-title":"Functional interactions between native Gs-coupled 5-HT receptors in HEK-293 cells and the heterologously expressed serotonin transporter","volume":"15","author":"Johnson","year":"2003","journal-title":"Cell Signalling"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1492","first-page":"466","article-title":"Autoradiographic evaluation of electromagnetic field effects on serotonin (5-HT1A) receptors in rat brain","volume":"39","author":"Johnson","year":"2003","journal-title":"Biomed Sci Instrum"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1493","series-title":"Principles and Practice of Sleep Medicine","first-page":"134","article-title":"Basic mechanisms of sleep\u2013wake states","author":"Jones","year":"2000"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1494","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1139\/y80-038","article-title":"Interactions between p-tyramine, m-tyramine, or beta-phenylethylamine and dopamine on single neurones in the cortex and caudate nucleus of the rat","volume":"58","author":"Jones","year":"1980","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1495","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2165\/00019053-200017060-00003","article-title":"A critical review of published economic modelling studies in depression","volume":"17","author":"Jones","year":"2000","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1496","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/25348","article-title":"GABAB receptors function as a heteromeric assembly of the subunits GABABR1 and GABABR2","volume":"396","author":"Jones","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1497","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/jpet.104.075960","article-title":"Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents","volume":"312","author":"Jones","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1498","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.103.053298","article-title":"Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3)","volume":"308","author":"Jonker","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1499","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2004.10.014","article-title":"Towards a mechanism-based analysis of pharmacodynamic drug\u2013drug interactions in vivo","volume":"106","author":"Jonker","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1500","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0014-2999(00)00753-6","article-title":"MK801 influences l-dopa-induced dopamine release in intact and hemi-parkinson rats","volume":"407","author":"Jonkers","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1501","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0165-6147(03)00206-2","article-title":"Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes","volume":"24","author":"Jope","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1502","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/21441","article-title":"G-protein-coupled receptor heterodimerization modulates receptor function","volume":"399","author":"Jordan","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1503","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0092-8674(00)00112-4","article-title":"Signaling networks: the origins of cellular multitasking","volume":"103","author":"Jordan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1504","first-page":"343","article-title":"Oligomerization of opioid receptors with beta2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation","volume":"98","author":"Jordan","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1505","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/molbev\/msh222","article-title":"Conservation and coevolution in the scale-free human gene coexpression network","volume":"21","author":"Jordan","year":"2004","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1506","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejphar.2005.05.035","article-title":"In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors","volume":"517","author":"Jordan","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1507","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.biopsych.2003.08.017","article-title":"Repetitive transcranial magnetic stimulation as treatment of poststroke depression: a preliminary study","volume":"55","author":"Jorge","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1508","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000126385","article-title":"Effect of selective serotonin receptor agonists on prolactin secretion in male rats","volume":"57","author":"Jorgensen","year":"1993","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1509","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0165-0327(83)90006-X","article-title":"Antiparkinsonian and antidepressant effects of high doses of bromocriptine","volume":"5","author":"Jouvent","year":"1983","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1510","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0163-7258(01)00139-5","article-title":"Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs","volume":"90","author":"Joyce","year":"2001","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1511","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S1359-6446(05)03491-4","article-title":"Dopamine D3 receptor antagonists as therapeutic agents","volume":"10","author":"Joyce","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1512","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0014-4886(03)00353-4","article-title":"Neuroprotective effects of the novel D3\/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole","volume":"184","author":"Joyce","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1513","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1017\/S1461145703003663","article-title":"Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein \u03b23 subunit as predictors of response to fluoxetine and nortriptyline","volume":"6","author":"Joyce","year":"2003","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1514","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0006-3223(03)00568-7","article-title":"Depression and cardiovascular disease: mechanisms of interaction","volume":"54","author":"Joynt","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1515","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0893-133X(98)00097-9","article-title":"Electrical stimulation of rat medial prefrontal cortex enhances forebrain serotonin output: implications for electroconvulsive therapy and transcranial magnetic stimulation in depression","volume":"21","author":"Juckel","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1516","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0165-0327(98)00138-4","article-title":"Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse","volume":"50","author":"Judd","year":"1998","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1517","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1176\/appi.ajp.157.9.1501","article-title":"Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?","volume":"157","author":"Judd","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1518","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/35093019","article-title":"Molecular mechanisms of nociception","volume":"413","author":"Julius","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1519","doi-asserted-by":"crossref","first-page":"6650","DOI":"10.1074\/jbc.M306092200","article-title":"Identification of an additional interaction domain in transmembrane domains 11 and 12 that supports oligomer formation in the human serotonin transporter","volume":"279","author":"Just","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1520","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00008877-200311000-00003","article-title":"Effects of the delta-opioid receptor agonist SNC80 on learning relative to its antidepressant-like effects in rats","volume":"14","author":"Jutkiewicz","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1521","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(24)39196-7","article-title":"In vivo gene modification elucidates subtype-specific functions of \u03b12-adrenergic receptors","volume":"293","author":"Kable","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1522","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.gde.2004.07.001","article-title":"Applying proteomics to signaling networks","volume":"14","author":"Kabuyama","year":"2004","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1523","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0006-8993(99)01599-1","article-title":"Nitric oxide modulates the release of serotonin in the rat hypothalamus","volume":"835","author":"Kaehler","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1524","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1073\/pnas.0409554102","article-title":"Genotype\u2013environment interactions in mouse behavior: a way out of the problem","volume":"102","author":"Kafkafi","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1525","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/0269881104042631","article-title":"Transcranial magnetic stimulation: applications for neuropsychopharmacology","volume":"18","author":"K\u00e4hk\u00f6nen","year":"2004","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1526","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00213-005-2197-3","article-title":"Prefrontal, T.MS., produces smaller EEG responses than motor-cortex TMS: implications for rTMS treatment in depression","volume":"181","author":"K\u00e4hk\u00f6nen","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1527","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/0006-3223(91)90184-N","article-title":"m-Chlorophenylpiperazine as a probe of serotonin function","volume":"30","author":"Kahn","year":"1991","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1528","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0165-1781(90)90073-E","article-title":"Effects of serotonin antagonists on m-chlorophenylpiperazine-mediated responses in normal subjects","volume":"33","author":"Kahn","year":"1990","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1529","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.biopsych.2004.01.008","article-title":"Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on \u03b2-catenin in mouse hippocampus","volume":"55","author":"Kaidanovich-Beilin","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1530","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.pnpbp.2004.05.027","article-title":"Adverse effects of cannabis on health: an update of the literature since 1996","volume":"28","author":"Kalant","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1531","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-2999(03)01308-6","article-title":"\u03b12C-Adrenoceptor blockade by clozapine and other antipsychotic drugs","volume":"462","author":"Kalkman","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1532","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.peptides.2004.03.001","article-title":"NPY-an endearing journey in search of a neurochemical on\/off switch for appetite, sex and reproduction","volume":"25","author":"Kalra","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1533","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0006-8993(91)91397-J","article-title":"Clonidine inhibition of potassium-evoked release of glutamate and aspartate from rat cortical synaptosomes","volume":"568","author":"Kamisaki","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1534","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0022-3565(24)29307-1","article-title":"Combinations of neurokinin receptor antagonists reduce visceral hyperalgesia","volume":"299","author":"Kamp","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1535","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0149-2918(04)90024-0","article-title":"A systematic review and meta-analysis of the efficacy and safety of a fixed, low-dose perindopril\u2013indapamide combination as first-line treatment of hypertension","volume":"26","author":"Kang","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1536","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0278-5846(03)00173-8","article-title":"Activation of protein kinaseB (Akt) signalling after electroconvulsive shock in the rat hippocampus","volume":"28","author":"Kang","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1537","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1046\/j.1471-4159.2001.00184.x","article-title":"Activation of 5-HT(1A) but not 5-HT(1B) receptors attenuated an increase in extracellular dopamine derived from exogenously administered l-dopa in the striatum with nigrostriatal denervation","volume":"76","author":"Kannari","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1538","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1460-9568.2004.03540.x","article-title":"Decreased histamine H1 receptor binding in the brain of depressed patients","volume":"20","author":"Kano","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1539","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jns.2003.08.013","article-title":"Effects of acute repetitive transcranial magnetic stimulation on dopamine release in the rat dorsolateral striatum","volume":"217","author":"Kanno","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1540","first-page":"66","article-title":"The role of 5-HT2A, 5-HT2C and 5-HT3 serotonin receptors in the regulation of sleep","volume":"526","author":"Kantor","year":"2000","journal-title":"J Physiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1541","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/sj.bjp.0705887","article-title":"Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505","volume":"142","author":"Kantor","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1542","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1023\/A:1021489323828","article-title":"Multivariate statistics of disposition pharmacokinetic parameters for structurally unrelated drugs used in therapeutics","volume":"19","author":"Karalis","year":"2002","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1543","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainres.2005.02.032","article-title":"AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist","volume":"1042","author":"Karasawa","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1544","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/jnr.490390604","article-title":"Role of GABAB receptors in intracellular Ca2+ homeostasis and possible interaction between GABAA and GABAB receptors in regulation of transmitter release in cerebellar granule neurons","volume":"39","author":"Kardos","year":"1994","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1545","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1460-9568.2002.02099.x","article-title":"Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression","volume":"16","author":"Karishma","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1546","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0306-4522(97)00359-X","article-title":"Estradiol reduction of \u03b12-adrenoceptor binding in female rat cortex is correlated with decreases in \u03b12A\/D-adrenoceptor messenger RNA","volume":"81","author":"Karkarnias","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1547","doi-asserted-by":"crossref","first-page":"12742","DOI":"10.1073\/pnas.0404085101","article-title":"Y1 receptors regulate aggressive behavior by modulating serotonin pathways","volume":"101","author":"Karl","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1548","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0014-2999(99)00192-2","article-title":"Nitric oxide synthase inhibitors have antidepressant-like properties in mice: 2. Chronic treatment results in downregulation of cortical \u03b2-adrenoceptors","volume":"372","author":"Karolewicz","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1549","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1124\/mol.58.4.677","article-title":"The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3\u2013D3nf interaction causes mislocalization of D3 receptors","volume":"58","author":"Karpa","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1550","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1176\/jnp.5.3.322","article-title":"Human brain fluoxetine concentrations","volume":"5","author":"Karson","year":"1993","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1551","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.peptides.2004.07.003","article-title":"Neurokinin-1 receptor antagonism by SR140333: enhanced in vivo ACh in the hippocampus and promnestic post-trial effects","volume":"25","author":"Kart","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1552","doi-asserted-by":"crossref","first-page":"031909","DOI":"10.1103\/PhysRevE.70.031909","article-title":"Topological generalization of network motifs","volume":"70","author":"Kashtan","year":"2004","journal-title":"Phys Rev E"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1553","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0149-7634(01)00066-5","article-title":"The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y","volume":"26","author":"Kask","year":"2002","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1554","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0924-9338(02)00651-X","article-title":"A meta-analysis of randomised controlled trials of tianeptine versus SSRI in the short-term treatment of depression","volume":"3","author":"Kasper","year":"2002","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1555","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1471-4159.1993.tb03616.x","article-title":"Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease","volume":"61","author":"Kastner","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1556","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2133\/dmpk.18.1","article-title":"Intestinal absorption of drugs mediated by drug transporters: mechanisms and regulation","volume":"18","author":"Katsura","year":"2003","journal-title":"Drug Metab Pharmacokineti"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1557","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0893-133X(02)00329-9","article-title":"Enhancing the technology of clinical trials and the trials model to evaluate newly-developed, targeted antidepressants","volume":"27","author":"Katz","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1558","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1017\/S1461145704004407","article-title":"A multivantaged behavioural method for measuring onset and sequence of the clinical actions of antidepressants","volume":"7","author":"Katz","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1559","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/sj.npp.1300341","article-title":"Onset and early behavioural effects of pharmacologically-different antidepressants and placebo in depression","volume":"29","author":"Katz","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1560","series-title":"The Origins of Order: Self-Organization and Selection in Evolution","first-page":"292","author":"Kauffman","year":"1993"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1561","doi-asserted-by":"crossref","first-page":"17102","DOI":"10.1073\/pnas.0407783101","article-title":"Genetic networks with canalyzing Boolean rules are always stable","volume":"101","author":"Kauffman","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1562","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/386239a0","article-title":"Expression cloning of GABAB receptors uncovers similarity to metabotropic glutamate receptors","volume":"386","author":"Kaupmann","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1563","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/25360","article-title":"GABAB-receptor subtypes assemble into functional heteromeric complexes","volume":"396","author":"Kaupmann","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1564","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0006-8993(98)01043-9","article-title":"Intrahippocampal d-cycloserine improves MK-801-induced memory deficits: radial-arm maze performance in rats","volume":"814","author":"Kawabe","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1565","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0006-8993(99)01062-8","article-title":"Tonic regulation of the activity of noradrenergic neurons in the locus coeruleus of the conscious rat studied by dual-probe microdialysis","volume":"823","author":"Kawahara","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1566","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neulet.2004.12.021","article-title":"Neuropharmacological profiles of antagonists of group II metabotropic glutamate receptors","volume":"378","author":"Kawashima","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1567","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0306-3356(21)00626-9","article-title":"The Royal College of General Practitioners Oral Contraception Study: some recent observations","volume":"11","author":"Kay","year":"1984","journal-title":"Clin Obstet Gynaecol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1568","first-page":"H875","article-title":"S-nitrosothiols inhibit neuronal norepinephrine transport","volume":"272","author":"Kaye","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1569","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/sj.bjp.0703416","article-title":"Nitric oxide mediated modulation of norepinephrine transport: identification of a potential target for S-nitrosylation","volume":"130","author":"Kaye","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1570","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.sleep.2003.06.006","article-title":"The effects of trazodone on sleep in patients treated with stimulant antidepressants","volume":"5","author":"Kaynak","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1571","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1126\/science.1089670","article-title":"Mobile elements: drivers of genome evolution","volume":"303","author":"Kazazian","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1572","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0196-9781(01)00398-9","article-title":"Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders","volume":"22","author":"Keck","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1573","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1046\/j.1460-9568.2000.00243.x","article-title":"Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amino acids in the rat brain","volume":"12","author":"Keck","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1574","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0028-3908(02)00069-2","article-title":"Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system","volume":"43","author":"Keck","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1575","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0893-133X(01)00351-7","article-title":"Vasopressin mediates the response of the combined dexamethasone\/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders","volume":"26","author":"Keck","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1576","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.npp.1300040","article-title":"Reduction of hypothalamic vasopressinergic hyperdrive contribution to clinically relevant behavioural and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model","volume":"28","author":"Keck","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1577","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0065-7743(03)38003-0","article-title":"Neuropeptide receptor antagonists for CNS disorders","volume":"38","author":"Kehne","year":"2003","journal-title":"Annu Rep Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1578","first-page":"19","article-title":"Multi-target lead discovery for networked systems","author":"Keith","year":"2004","journal-title":"Curr Drug Discov"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1579","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrd1609","article-title":"Multicomponent therapeutics for networked systems","volume":"4","author":"Keith","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1580","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0167-0115(03)00114-9","article-title":"Behavioural analysis of melanin-concentrating hormone in rats: evidence for orexigenic and anxiolytic properties","volume":"114","author":"Kela","year":"2003","journal-title":"Regul Pept"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1581","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0361-9230(01)00638-4","article-title":"Corticosteroid receptors in the brain: gene targeting studies","volume":"57","author":"Kellendonk","year":"2002","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1582","first-page":"241","article-title":"Neuropsychiatric manifestations of cardiovascular drug therapy","volume":"1","author":"Keller","year":"1999","journal-title":"Heart Dis"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1583","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJM200005183422001","article-title":"A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy and their combination for the treatment of chronic depression","volume":"342","author":"Keller","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1584","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/00926239708403922","article-title":"Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: a large-scale retrospective study of 596 psychiatric outpatients","volume":"23","author":"Keller-Ashton","year":"1997","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1585","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0014-2999(02)02960-6","article-title":"Targeted gene deletion of the 5-HT3A receptor subunit produces an anxiolytic phenotype in mice","volume":"461","author":"Kelley","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1586","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1176\/appi.ajp.162.5.977","article-title":"Relief of expressed suicidal intent by ECT: a consortium for research in ECT study","volume":"162","author":"Kellner","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1587","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/0028-3908(94)90160-0","article-title":"The effect of tianeptine and sertraline in three animal models of depression","volume":"33","author":"Kelly","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1588","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-0447.106.s415.4.x","article-title":"Treatment strategies in achieving remission in major depressive disorder","volume":"106","author":"Kelsey","year":"2002","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1589","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.conb.2004.03.001","article-title":"Functional significance of adult neurogenesis","volume":"14","author":"Kempermann","year":"2004","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1590","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0165-6147(00)89020-3","article-title":"Agonist-receptor efficacy: I. Mechanisms of efficacy and receptor promiscuity","volume":"16","author":"Kenakin","year":"1995","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1591","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0165-6147(00)89032-X","article-title":"Agonist-receptor efficacy: II. Agonist trafficking of receptor signals","volume":"16","author":"Kenakin","year":"1995","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1592","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1096\/fj.00-0438rev","article-title":"Inverse, protean, and ligand-selective agonism: matters of receptor conformation","volume":"15","author":"Kenakin","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1593","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev.pharmtox.42.091401.113012","article-title":"Drug efficacy at G protein-coupled receptors","volume":"42","author":"Kenakin","year":"2002","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1594","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tips.2004.02.012","article-title":"Principles: receptor theory in pharmacology","volume":"25","author":"Kenakin","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1595","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0165-6147(02)02036-9","article-title":"The ligand paradox between affinity and efficacy: can you be there and not make a difference?","volume":"23","author":"Kenakin","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1596","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(98)00746-X","article-title":"Serotonin 5-HT2C agonists mimic the effect of light pulses on circadian rhythms","volume":"806","author":"Kennaway","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1597","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0006-8993(01)02091-1","article-title":"Serotonin, excitatory amino acids and the photic control of melatonin rhythms and SNC c-fos in the rat","volume":"897","author":"Kennaway","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1598","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0165-0327(99)00050-6","article-title":"Sexual dysfunction before antidepressant therapy in major depression","volume":"56","author":"Kennedy","year":"1999","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1599","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4088\/JCP.v63n0302","article-title":"Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects","volume":"63","author":"Kennedy","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1600","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/0028-3908(94)90133-3","article-title":"Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5-HT2C\/2B receptor function","volume":"33","author":"Kennett","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1601","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0028-3908(97)00038-5","article-title":"SB242084, a selective and brain penetrant 5-HT2C receptor antagonist","volume":"36","author":"Kennett","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1602","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1046\/j.1471-4159.2000.0752409.x","article-title":"Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release","volume":"75","author":"Kenny","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1603","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(99)11381-3","article-title":"SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression","volume":"355","author":"Kent","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1604","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey","volume":"51","author":"Kessler","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1605","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1192\/S0007125000298371","article-title":"Comorbidity of DSM-III-R major depressive disorder in the general population. Results from the US National Comorbidity Survey","volume":"168","author":"Kessler","year":"1996","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1606","first-page":"232","article-title":"Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the national comorbidity survey","volume":"53","author":"Kessler","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1607","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder","volume":"289","author":"Kessler","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1608","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1609","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00213-005-2200-z","article-title":"Ionotropic and metabotropic glutamate receptor structure and pharmacology","volume":"179","author":"Kew","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1610","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/0006-3223(91)90184-N","article-title":"m-Chlorophenylpiperazine as a probe of serotonin function","volume":"30","author":"Khan","year":"1991","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1611","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4088\/JCP.v61n0712a","article-title":"Lack of sertraline efficacy probably due to an interaction with carbamazepine","volume":"61","author":"Khan","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1612","first-page":"193","article-title":"Are placebo controls necessary to test new antidepressants and anxiolytics?","volume":"5","author":"Khan","year":"2002","journal-title":"Int J Neuropsychol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1613","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/sj.npp.1300059","article-title":"Frequency of positive studies among fixed and flexible dose antidepressant clinical trials: an analysis of the food and drug administration summary basis of approval reports","volume":"28","author":"Khan","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1614","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0006-8993(00)02373-8","article-title":"Serotonergic agents modulate antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice","volume":"865","author":"Khisti","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1615","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0091-3057(00)00300-2","article-title":"Antidepressant-like effect of the neurosteroids 3\u03b1-hydroxy-5\u03b1-pregnan-20-one in mice forced swim test","volume":"67","author":"Khisti","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1616","doi-asserted-by":"crossref","first-page":"12841","DOI":"10.1073\/pnas.192442699","article-title":"Untangling the wires: a strategy to trace functional interactions in signalling and gene networks","volume":"99","author":"Kholodenko","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1617","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0301-0082(02)00008-4","article-title":"Exploring the opioid system by gene knockout","volume":"66","author":"Kieffer","year":"2002","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1618","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1210\/en.2004-0650","article-title":"Chronic treatment with the monoamine oxidase inhibitor phenelzine increases hypothalamic\u2013pituitary\u2013adrenocortical activity in male C57BL\/6 mice: relevance to atypical depression","volume":"146","author":"Kier","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1619","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0065-7743(00)35030-8","article-title":"Principles for multivalent ligand design","volume":"38","author":"Kiessling","year":"2000","journal-title":"Annual Reports Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1620","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1073\/pnas.97.7.3106","article-title":"Oligomerization of sertonin transporter and its functional consequences","volume":"97","author":"Kilic","year":"2000","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1621","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1176\/appi.ajp.160.7.1272","article-title":"Burdens and benefits of placebos in antidepressant clinical trials: a decision and cost-effectiveness analysis","volume":"160","author":"Kim","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1622","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0091-3057(02)00833-X","article-title":"Activation of brainstem metabotropic glutamate receptors inhibits spinal nociception in adult rats","volume":"73","author":"Kim","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1623","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0924-977X(02)00054-8","article-title":"Modulation of tianeptine on ion currents induced by inhibitory neurotransmitters in acutely dissociated dorsal raphe neurons of Sprague\u2013Dawley rats","volume":"12","author":"Kim","year":"2002","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1624","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/ng0904-915","article-title":"Estimating rates of alternative splicing in mammals and invertebrates","volume":"36","author":"Kim","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1625","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neuropharm.2005.03.007","article-title":"Fluoxetine inhibits ATP-induced [Ca2+]i increase in PC12 cells by inhibiting both extracellular Ca2+influx and Ca2+ release from intracellular stores","volume":"49","author":"Kim","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1626","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1139\/g89-009","article-title":"The neutral theory of molecular evolution and the world view of the neutralists","volume":"31","author":"Kimura","year":"1989","journal-title":"Genome"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1627","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuropharm.2004.03.012","article-title":"5HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation\u2014an effect sensitive to NMDA receptor antagonism","volume":"47","author":"King","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1628","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1385\/MN:21:3:137","article-title":"The augmentation hypothesis for improvement of antidepressant therapy: is pindolol a suitable candidate for testing the ability of 5-HT1A receptor antagonists to enhance SSRI efficacy and onset latency?","volume":"21","author":"Kinney","year":"2000","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1629","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0169-328X(01)00034-1","article-title":"Distribution of 5-HT5A, 5-HT5B, 5-HT6 and 5-HT7 receptor mRNAs in the rat brain","volume":"88","author":"Kinsey","year":"2001","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1630","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1055\/s-2003-45136","article-title":"Individualized medicine\u2014implementation of pharmacogenetic diagnostics in antidepressant drug treatment of major depressive disorders","volume":"36","author":"Kirchheiner","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1631","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/sj.mp.4001494","article-title":"Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response","volume":"9","author":"Kirchheiner","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1632","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.cell.2005.05.005","article-title":"The meaning of systems biology","volume":"121","author":"Kirschner","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1633","doi-asserted-by":"crossref","first-page":"8420","DOI":"10.1073\/pnas.95.15.8420","article-title":"Evolvability","volume":"95","author":"Kirschner","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1634","first-page":"39","article-title":"Biochemistry of Parkinson's disease: is a brain serotonergic deficiency characteristic of idiopathic Parkinson's disease?","volume":"91","author":"Kish","year":"2003","journal-title":"Adv Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1635","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/sj.mp.4001638","article-title":"Body weight is regulated by the brain: a link between feeding and emotion","volume":"10","author":"Kishi","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1636","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0361-9230(00)00282-3","article-title":"Role of nitric oxide in the regulation of monoaminergic neurotransmission","volume":"52","author":"Kiss","year":"2000","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1637","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neuint.2003.11.004","article-title":"Inhibitory effect of nitric oxide on dopamine transporters: interneuronal communication without receptors","volume":"45","author":"Kiss","year":"2004","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1638","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejphar.2004.02.039","article-title":"Effect of co-administration of lithium and reboxetine on extracellular monoamine concentrations in rats","volume":"489","author":"Kitaichi","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1639","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejphar.2005.04.038","article-title":"Effect of milnacipran on extracellular monoamine concentrations in the medial prefrontal cortex of rats pre-treated with lithium","volume":"516","author":"Kitaichi","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1640","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ng945","article-title":"Biochemical networking contributes more to genetic buffering in human and mouse metabolic pathways than does gene duplication","volume":"32","author":"Kitami","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1641","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00294-002-0285-z","article-title":"Looking beyond the details: a rise in system-oriented approaches in genetics and molecular biology","volume":"41","author":"Kitano","year":"2002","journal-title":"Curr Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1642","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1126\/science.1069492","article-title":"Systems biology: a brief overview","volume":"295","author":"Kitano","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1643","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2003.08.057","article-title":"Norepinephrine transporter splice variants and their interaction with substrates and blockers","volume":"479","author":"Kitayama","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1644","doi-asserted-by":"crossref","first-page":"10731","DOI":"10.1074\/jbc.274.16.10731","article-title":"Dominant negative isoform of rat norepinephrine transporter produced by alternative RNA splicing","volume":"274","author":"Kitayama","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1645","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0165-1781(94)90108-2","article-title":"Antidepressant and depressogenic drugs lack consistent effects on hamster circadian rhythms","volume":"53","author":"Klemfuss","year":"1994","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1646","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-0327(99)00020-8","article-title":"Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response","volume":"55","author":"Klein","year":"1999","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1647","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1017\/S1092852900002248","article-title":"Therapy of treatment resistant depression: focus on the management of TRD with atypical antipsychotics","volume":"9","author":"Klein","year":"2004","journal-title":"CNS Spectr"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1648","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0925-4927(99)00009-8","article-title":"Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT","volume":"90","author":"Klimke","year":"1999","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1649","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1523\/JNEUROSCI.21-05-01452.2001","article-title":"Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei","volume":"21","author":"Klink","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1650","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF02246293","article-title":"Clozapine acts as a 5-HT2 antagonist by attenuating DOI-induced inhibition of male rat sexual behaviour","volume":"119","author":"Klint","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1651","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0028-3908(99)00066-0","article-title":"Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptor agonist in animal models","volume":"38","author":"Klodzinska","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1652","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0361-9230(01)00521-4","article-title":"0 Multivariate analysis of prefrontal cortical data from the Stanley foundation neuropathology consortium","volume":"55","author":"Knable","year":"2001","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1653","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0014-2999(02)01338-9","article-title":"Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model","volume":"440","author":"Knapp","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1654","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1043-6618(02)00311-0","article-title":"Anseculin improves passive avoidance learning of aged mice","volume":"47","author":"Knauber","year":"2003","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1655","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0022-3565(24)29478-7","article-title":"Regional patterns of compensation following genetic deletion of either 5-HT1A or 5-HT1B receptor in the mouse","volume":"298","author":"Knobelman","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1656","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0022-3565(24)29477-5","article-title":"Genetic regulation of extracellular serotonin by 5-HT1A and 5-HT1B autoreceptors in different brain regions of the mouse","volume":"298","author":"Knobelman","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1657","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1126\/science.1061690","article-title":"Coral reef biodiversity\u2014habitat size matters","volume":"292","author":"Knowlton","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1658","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/sj.bjp.0705172","article-title":"Inhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac)","volume":"138","author":"Kobayashi","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1659","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1038\/sj.npp.1300484","article-title":"Inhibition of G protein-activated inwardly rectifying K+ channels by various antidepressant drugs","volume":"29","author":"Kobayashi","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1660","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1046\/j.1471-4159.2003.01793.x","article-title":"Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters","volume":"85","author":"Kocabas","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1661","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1126\/science.284.5411.96","article-title":"Complexity and the nervous system","volume":"284","author":"Koch","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1662","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0893-133X(02)00377-9","article-title":"R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study","volume":"27","author":"Koch","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1663","first-page":"935","article-title":"Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats","volume":"45","author":"Koch","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1664","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neuropharm.2003.09.001","article-title":"Brain region and dose effects of an olanzapine\/fluoxetine combination on extracellular monoamine concentrations in the rat","volume":"46","author":"Koch","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1665","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.biopsych.2004.07.008","article-title":"Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat","volume":"56","author":"Kodama","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1666","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/sj.npp.1300588","article-title":"Electroconvulsive seizures increase the expression of MAP kinase phosphatases in limbic regions of rat brain","volume":"30","author":"Kodama","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1667","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.tips.2004.05.005","article-title":"Polyspecific organic cation transporters: their functions and interactions with drugs","volume":"25","author":"Koepsell","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1668","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s10254-003-0017-x","article-title":"Organic cation transporters","volume":"150","author":"Koepsell","year":"2003","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1669","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.4088\/JCP.v65n1005","article-title":"A 3-month, follow-up, randomised, placebo-controlled study of repetitive transcranial magnetic stimulation in depression","volume":"65","author":"Koerselman","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1670","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1021\/ol026418e","article-title":"Design and synthesis of dual inhibitors of acetylcholinesterase and serotonin transporter: targeting potential agents for Alzheimer's disease","volume":"4","author":"Kogen","year":"2002","journal-title":"Organic Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1671","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.npep.2004.04.002","article-title":"Novel modified and radiolabelled neuropeptide Y analogues to study Y-receptor subtypes","volume":"38","author":"Koglin","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1672","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0006-3223(97)00033-4","article-title":"Depression in schizophrenia: I. Association with neuropsychological deficits","volume":"43","author":"Kohler","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1673","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.0953-816x.2001.01829.x","article-title":"Substance P in the descending cholinergic projection to REM sleep-induction regions of the rat pontine reticular formation: anatomical and electrophysiological analyses","volume":"15","author":"Kohlmeier","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1674","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.brainres.2005.02.038","article-title":"Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats","volume":"1043","author":"Kokare","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1675","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0006-8993(99)01257-3","article-title":"Changes in 5-HT1A and NMDA binding sites by a single rapid transcranial magnetic stimulation procedure in rats","volume":"826","author":"Kole","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1676","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1046\/j.1460-9568.2002.02136.x","article-title":"The antidepressant tianeptine persistently modulates glutamate receptor currents of the hippocampal CA3 commissural associational synapse in chronically stressed rats","volume":"16","author":"Kole","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1677","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/mrm.1910310214","article-title":"In vivo 19F spin relaxation and localized spectroscopy of fluoxetine in human brain","volume":"31","author":"Komoroski","year":"1994","journal-title":"Magnetic Resonance Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1678","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1093\/hmg\/10.23.2661","article-title":"Origin of alternative splicing by tandem exon duplication","volume":"10","author":"Kondrashov","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1679","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0168-9525(02)00029-X","article-title":"Evolution of alternative splicing deletions, insertions and origin of functional parts of proteins from intron sequences","volume":"19","author":"Kondrashov","year":"2003","journal-title":"Trends Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1680","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/383535a0","article-title":"Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin","volume":"383","author":"Konig","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1681","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0166-2236(00)02088-9","article-title":"Cytokine-induced sickness behaviour: mechanisms and implications","volume":"25","author":"Konsman","year":"2002","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1682","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1749-6632.1999.tb07876.x","article-title":"Stress, corticotropin-releasing factor, and drug addiction","volume":"897","author":"Koob","year":"1999","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1683","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1126\/science.2903550","article-title":"Cellular molecular mechanisms of drug dependence","volume":"242","author":"Koob","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1684","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/026988119801200106","article-title":"Substance dependence as a compulsive behavior","volume":"12","author":"Koob","year":"1998","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1685","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0165-1781(02)00305-0","article-title":"Mood regulation in seasonal affective disorder patients and healthy controls studied in forced desynchrony","volume":"117","author":"Koorengevel","year":"2003","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1686","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0028-3908(94)90081-7","article-title":"Interaction between enantiomers of mianserin and ORG3770 at 5-HT3 receptors in cultured mouse neuroblastoma cells","volume":"33","author":"Kooyman","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1687","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00008877-199902000-00007","article-title":"The effects of melatonin on the behavioural disturbances induced by chronic mild stress in C3H\/He mice","volume":"10","author":"Kopp","year":"1999","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1688","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0091-3057(99)00071-4","article-title":"Antagonistic effects of S22153, a new MT1 and MT2 receptor ligand, on the neophobia-reducing properties of melatonin in BALB\/c mice","volume":"64","author":"Kopp","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1689","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/S0028-3908(99)00263-4","article-title":"Anxiolytic-like properties of melatonin receptor agonists in mice: involvement of MT1 and\/or MT2 receptors in the regulation of emotional responsiveness","volume":"39","author":"Kopp","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1690","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0304-3940(95)11785-U","article-title":"Cerebrospinal fluid and serum concentrations of the NMDA receptor antagonist memantine in man","volume":"195","author":"Kornhuber","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1691","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0028-3908(95)00056-C","article-title":"Therapeutic brain concentration of the NMDA receptor antagonist amantadine","volume":"34","author":"Kornhuber","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1692","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0149-7634(01)00002-1","article-title":"Corticosteroids in relation to fear, anxiety and psychopathology","volume":"25","author":"Korte","year":"2001","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1693","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0014-2999(96)00064-7","article-title":"Antisense to the glucocorticoid receptor in hippocampal dentate gyrus reduces immobility in forced swim test","volume":"301","author":"Korte","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1694","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00008877-200505000-00004","article-title":"A comparison of the predictive therapeutic and undesired side-effects of the NMDA receptor antagonist, memantine, in mice","volume":"16","author":"Kos","year":"2005","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1695","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1017\/S1092852900018988","article-title":"Beyond the treatment of epilepsy: new applications of vagal nerve stimulation in psychiatry","volume":"8","author":"Kosel","year":"2003","journal-title":"CNS Spectr"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1696","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1038\/sj.npp.1300293","article-title":"Magnetic seizure therapy improves mood in refractory major depression","volume":"28","author":"Kosel","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1697","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1177\/002215540004800512","article-title":"Immunohistochemical localization of cGMP-binding cGMP-specific phosphodiesterase (PDES) in rat tissues","volume":"48","author":"Kotera","year":"2000","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1698","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0006-8993(79)91009-6","article-title":"Effects of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures","volume":"175","author":"Kovacs","year":"1979","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1699","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1517\/13543784.13.9.1113","article-title":"Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity","volume":"13","author":"Kowalski","year":"2004","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1700","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1528-1157.1998.tb01155.x","article-title":"Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation","volume":"39","author":"Krahl","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1701","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpsychires.2003.11.005","article-title":"Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action","volume":"38","author":"Krahl","year":"2004","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1702","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1126\/science.281.5383.1640","article-title":"Distinct mechanism for antidepressant activity by blockade of central substance P receptors","volume":"281","author":"Kramer","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1703","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.npp.1300260","article-title":"Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression","volume":"29","author":"Kramer","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1704","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1046\/j.0953-816x.2001.01735.x","article-title":"The nitric oxide system modulates the in vivo release of acetylcholine in the nucleus accumbens induced by stimulation of the hippocampal fornix\/fimbria-projection","volume":"14","author":"Kraus","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1705","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0306-4522(02)00079-9","article-title":"Involvement of nitric oxide, cyclic GMP and phosphodiesterase 5 in excitatory amino acid and GABA release in the nucleus accumbens evoked by activation of the hippocampal fimbria","volume":"112","author":"Kraus","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1706","doi-asserted-by":"crossref","first-page":"15148","DOI":"10.1073\/pnas.0404315101","article-title":"Molecular triangulation: bridging linkage and molecular-network information for identifying candidate genes in Alzheimer's disease","volume":"101","author":"Krauthammer","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1707","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tig.2003.11.001","article-title":"The origins and implications of Aluternative splicing","volume":"20","author":"Kreahling","year":"2004","journal-title":"Trends Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1708","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/(SICI)1098-2396(199702)25:2<107::AID-SYN1>3.0.CO;2-G","article-title":"Chronic administration of the 5-HT1A receptor agonist 8-OH-DPAT differentially desensitises 5-HT1A autoreceptors of the dorsal and median raphe nuclei","volume":"25","author":"Kreiss","year":"1995","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1709","first-page":"866","article-title":"Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo","volume":"274","author":"Kreiss","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1710","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.schres.2004.02.022","article-title":"Heterogeneity of schizophrenia: a study of individual neuropsychological profiles","volume":"71","author":"Kremen","year":"2004","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1711","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1113\/jphysiol.2002.021170","article-title":"Organic cation transporter mRNA and function in the rat superior cervical ganglion","volume":"543.1","author":"Kristufek","year":"2002","journal-title":"J Physiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1712","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/sj.bjp.0704588","article-title":"The human 5-HT7 serotonin receptor: splice variants, constitutive activity and inverse agonist effects","volume":"135","author":"Krobert","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1713","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0361-9230(01)00473-7","article-title":"Antidepressant-like properties of zinc in rodent forced swim test","volume":"55","author":"Kroczka","year":"2001","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1714","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.npp.1300027","article-title":"H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs","volume":"28","author":"Kroeze","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1715","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/archpsyc.56.10.921","article-title":"The structure of common mental disorders","volume":"56","author":"Krueger","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1716","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/(SICI)1096-9861(19970127)377:4<509::AID-CNE3>3.0.CO;2-6","article-title":"Stress-induced activation of nitric oxide-producing neurons in the rat brain","volume":"377","author":"Krukoff","year":"1997","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1717","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1101\/gr.1589103","article-title":"Gene loss, protein sequence divergence, gene dispensability, expression level, and interactivity are correlated in eukaryotic evolution","volume":"13","author":"Krylov","year":"2003","journal-title":"Genome Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1718","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/sj.mp.4001021","article-title":"Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments","volume":"7","author":"Krystal","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1719","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00213-004-1982-8","article-title":"Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects","volume":"179","author":"Krystal","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1720","first-page":"586","volume":"vol. 22","author":"Krzanowski","year":"2000"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1721","series-title":"Multivariate Statistics","first-page":"364","author":"Krzanowski","year":"1994"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1722","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrd1156","article-title":"Drug research: myths, hype and reality","volume":"2","author":"Kubinyi","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1723","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1113\/jphysiol.2005.089987","article-title":"Acetylcholine modulates cortical synaptic transmission via different muscarinic receptors, as studied with receptor knockout mice","volume":"566.3","author":"Kuczewski","year":"2005","journal-title":"J Physiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1724","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1016\/j.lfs.2004.10.046","article-title":"Repetitive transcranial magnetic stimulation induces kf-1 expression in the rat brain","volume":"76","author":"Kudo","year":"2005","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1725","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00000539-200207000-00020","article-title":"Small-dose ketamine improves the postoperative state of depressed patients","volume":"95","author":"Kudoh","year":"2002","journal-title":"Anesth Analg"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1726","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s00213-005-2150-5","article-title":"Dopamine D5 receptor modulates male and female sexual behavior in mice","volume":"180","author":"Kudwa","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1727","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.biopsych.2004.07.001","article-title":"Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors","volume":"56","author":"Kugaya","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1728","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.bjp.0703964","article-title":"Agonist trafficking of G(i\/o)-mediated alpha2A-adrenoceptor responses in HEL 92.1.7 cells","volume":"132","author":"Kukkonen","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1729","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0165-6147(00)01864-2","article-title":"Modelling of promiscuous receptor-Gi\/Gs-protein coupling and effector response","volume":"22","author":"Kukkonen","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1730","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1358\/mf.2004.26.10.872561","article-title":"Phosphodiesterase 5 enzyme and its inhibitors: update on pharmacological and therapeutical aspects","volume":"26","author":"Kulkarni","year":"2004","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1731","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0891-0618(03)00003-6","article-title":"Role of noradrenergic fibers of the preoptic area in regulating sleep","volume":"26","author":"Kumar","year":"2003","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1732","first-page":"431","article-title":"Influence of antidepressant drugs on learning and memory paradigms in mice","volume":"34","author":"Kumar","year":"1996","journal-title":"Indian J Exp Biol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1733","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0960-894X(03)00303-2","article-title":"Advances towards new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism\/SSRI activities","volume":"13","author":"Kumiko","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1734","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/35039564","article-title":"Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor","volume":"407","author":"Kunishima","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1735","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1517\/13543784.11.10.1335","article-title":"Developments in the pharmacological treatment of schizophrenia","volume":"11","author":"Kuperberg","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1736","first-page":"159","article-title":"REM latency: a psychobiologic marker for primary depressive disease","volume":"11","author":"Kupfer","year":"1976","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1737","first-page":"353","article-title":"Effect of sildenafil on anxiety in the plus-maze test in mice","volume":"56","author":"Kurt","year":"2004","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1738","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1037\/0735-7044.100.5.664","article-title":"Differential interactions of \u201cprosexual\u201d drugs with 5-HT1A and alpha2-adrenergic receptors","volume":"100","author":"Kwong","year":"1986","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1739","first-page":"11","article-title":"Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation","volume":"64","author":"Labbate","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1740","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1192\/S0007125000296694","article-title":"Neurochemical and pharmacological properties of tianeptine, a novel antidepressant","volume":"15","author":"Labrid","year":"1992","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1741","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/sj.npp.1300114","article-title":"Selective antagonism at dopamine D3 receptors enhances monoaminergic and cholinergic neurotransmitters in the rat anterior cingulate cortex","volume":"28","author":"Lacroix","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1742","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0306-4522(02)00185-9","article-title":"Behavioral and neurochemical characterization of alpha2A-adrenergic receptor knockout mice","volume":"113","author":"Lahdesmaki","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1743","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0278-5846(84)90040-X","article-title":"Effect of apomorphine, a dopamine receptor agonist, on penile tumescence in normal subjects","volume":"8","author":"Lal","year":"1984","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1744","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0306-4522(02)00811-4","article-title":"Attenuation of circadian light induced phase advances and delays by neuropeptide Y and a neuropeptide Y Y1\/Y5 receptor agonist","volume":"119","author":"Lall","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1745","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0306-4522(03)00396-8","article-title":"Neuropeptide Y GABA and circadian phase shifts to photic stimuli","volume":"120","author":"Lall","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1746","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4088\/JCP.v63n0805","article-title":"Combining antidepressants for treatment-resistant depression: a review","volume":"63","author":"Lam","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1747","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/archpsyc.57.8.787","article-title":"Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness","volume":"57","author":"Lambert","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1748","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0278-5846(02)00351-2","article-title":"Combined treatment with galanthaminium bromide, a new cholinesterase inhibitor, and RS 67333, a partial agonist of 5-HT4 receptors, enhances place and object recognition in young adult and old rats","volume":"27","author":"Lamirault","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1749","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/sj.mp.4000754","article-title":"Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments","volume":"5","author":"Lammers","year":"2000","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1750","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0006-8993(00)03287-X","article-title":"Repeated electroconvulsive stimulation, but not antidepressant drugs, induces mossy fibre sprouting in the rat hippocampus","volume":"893","author":"Lamont","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1751","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1523\/JNEUROSCI.21-16-06058.2001","article-title":"Activation of metabotropic glutamate receptor1 accelerates NMDA receptor trafficking","volume":"21","author":"Lan","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1752","doi-asserted-by":"crossref","first-page":"664","DOI":"10.4088\/JCP.v59n1204","article-title":"A randomised, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression","volume":"59","author":"Landen","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1753","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00004714-199906000-00012","article-title":"Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors","volume":"19","author":"Landen","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1754","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4088\/JCP.v66n0114","article-title":"Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine","volume":"66","author":"Landen","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1755","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1523\/JNEUROSCI.15-06-04250.1995","article-title":"V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats","volume":"15","author":"Landgraf","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1756","first-page":"233","article-title":"Neuropsychological function in nonpsychotic unipolar major depression","volume":"14","author":"Landro","year":"2001","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1757","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/026988119801200212","article-title":"SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment","volume":"12","author":"Lane","year":"1998","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1758","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00702-003-0100-0","article-title":"State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations","volume":"111","author":"Lang","year":"2004","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1759","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00004714-199808000-00002","article-title":"A Canadian multicenter study of three fixed doses of controlled-release ipsapirone in outpatients with moderate to severe major depression","volume":"18","author":"Lapierre","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1760","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1124\/mol.61.6.1465","article-title":"Proteochemometrics modelling of the interaction of amine G-protein coupled receptors with a diverse set of ligands","volume":"61","author":"Lapinsh","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1761","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/sj.npp.1300467","article-title":"Reduction in acetylcholine release in the hippocampus of dopamine D5 receptor-deficient mice","volume":"29","author":"Laplante","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1762","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/01.jcp.0000085416.08426.1d","article-title":"Paroxetine-induced increase in metabolic end products of nitric oxide","volume":"23","author":"Lara","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1763","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/nimg.1997.0267","article-title":"In vivo evidence for the involvement of dopamien D2 receptors in striatum and anterior cingulate gyrus in major depression","volume":"5","author":"Larisch","year":"1997","journal-title":"Neuroimage"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1764","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0022-3565(24)29558-6","article-title":"Transgenic studies of pain and analgesia: mutation or background genotype?","volume":"297","author":"Larivi\u00e8re","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1765","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ejmech.2004.03.005","article-title":"Preparation of 4-azaindole and 7-azaindole dimers with a bisalkoxyalkyl spacer in order to preferentially target melatonin MT1 receptors over melatonin MT2 receptors","volume":"39","author":"Larraya","year":"2004","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1766","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ajmg.b.30104","article-title":"Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders","volume":"133","author":"Lasky-Su","year":"2005","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1767","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00213-004-2096-z","article-title":"Dopamine D3 receptor antagonists improve the learning performance in memory-impaired rats","volume":"179","author":"Laszy","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1768","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1073\/pnas.97.1.28","article-title":"The theory of everything","volume":"97","author":"Laughlin","year":"2000","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1769","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0006-3223(03)00529-8","article-title":"Co-morbid mood disorders and medical illness: a food and drug administration perspective","volume":"54","author":"Laughren","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1770","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-2007-1014403","article-title":"Combined treatment with imipramine and mianserin, a controlled pilot study","volume":"25","author":"Lauritzen","year":"1992","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1771","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1523\/JNEUROSCI.20-01-00008.2000","article-title":"Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons","volume":"20","author":"Lauterborn","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1772","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1124\/jpet.103.053694","article-title":"Chronic elevation of brain-derived neurotorophic factor by ampakines","volume":"307","author":"Lauterborn","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1773","first-page":"298","volume":"vol. 4","author":"Laux","year":"1997"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1774","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.4088\/JCP.v64n1202","article-title":"Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: an open trial","volume":"64","author":"Lavretsky","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1775","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev.pharmtox.40.1.389","article-title":"Molecular mechanisms and regulation of opioid receptor signalling","volume":"40","author":"Law","year":"2000","journal-title":"Annu Rev Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1776","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1358\/dnp.2003.16.8.829350","article-title":"Modulation of metabotropic glutamate receptors as potential treatment for acute and chronic neurodegenerative disorders","volume":"16","author":"Lea","year":"2003","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1777","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev.neuro.23.1.155","article-title":"Emotion circuits in the brain","volume":"23","author":"LeDoux","year":"2000","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1778","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0006-3223(03)00375-5","article-title":"Alternative splicing in the nervous system: an emerging source of diversity and regulation","volume":"54","author":"Lee","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1779","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0893-133X(00)00155-X","article-title":"Oligomerization of dopamine and serotonin receptors","volume":"23","author":"Lee","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1780","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00213-002-1162-7","article-title":"5-HT1B receptors modulate components of satiety in the rat: behavioural and pharmacological analyses of the selective serotonin1B agonist CP-94,253","volume":"164","author":"Lee","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1781","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1126\/science.1075090","article-title":"Transcriptional regulatory networks in Saccharomyces cerevisiae","volume":"298","author":"Lee","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1782","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.lfs.2003.09.028","article-title":"Homo- and hetero-oligomerization of G protein-coupled receptors","volume":"74","author":"Lee","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1783","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1023\/B:NERE.0000026404.08779.43","article-title":"Syntaxin1A and receptor for activated C kinase interact with the N-terminal region of human dopamine transporter","volume":"29","author":"Lee","year":"2004","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1784","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00213-004-1864-0","article-title":"Reduced hypophagic effects of d-fenfluramine and the 5-HT(2C) receptor agonist mCPP in 5-HT(1B) receptor knockout mice","volume":"176","author":"Lee","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1785","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1111\/j.0953-816X.2004.03406.x","article-title":"Tonic regulation of satiety by 5-HT receptors in the mouse: converging evidence from behavioural and c-fos immunoreactivity studies?","volume":"19","author":"Lee","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1786","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0165-6147(00)88989-0","article-title":"The two-state model of receptor activation","volume":"16","author":"Leff","year":"1995","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1787","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0304-3940(01)02543-5","article-title":"Neurokinin NK1- and NK3-immunoreactive neurons in serotonergic cell groups in the rat brain","volume":"323","author":"L\u00e9ger","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1788","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00213-002-1199-7","article-title":"Potential antidepressant properties of pramipexole detected in locomotor and operant behavioural investigation in mice","volume":"163","author":"Lehr","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1789","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1113\/jphysiol.2002.034017","article-title":"GABAB receptor modulation of excitatory and inhibitory synaptic transmission onto rat CA3 hippocampal interneurons","volume":"546","author":"Lei","year":"2003","journal-title":"J Physiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1790","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0006-3223(98)00186-3","article-title":"Hypothalamic serotonin in control of eating behavior, meal size, and body weight","volume":"44","author":"Leibowitz","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1791","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1046\/j.1460-9568.2000.00222.x","article-title":"Pindolol excites dopaminergic and adrenergic neurons, and inhibits serotonergic neurons, by activation of 5-HT1A receptors","volume":"12","author":"Lejeune","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1792","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-2999(03)01383-9","article-title":"The CRF1 receptor antagonist, DMP695, abolishes activation of locus coeruleus noradrenergic neurones by CRF in anesthetized rats","volume":"464","author":"Lejeune","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1793","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-2999(94)90012-4","article-title":"Clozapine inhibits serotonergic transmission by an action at \u03b11-adrenoceptors not at 5-HT1A receptors","volume":"260","author":"Lejeune","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1794","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0006-8993(94)91490-7","article-title":"Blockade of transmission at NMDA receptors falicitates the electrical and synthetic activity of ascending serotoninergic neurones","volume":"656","author":"Lejeune","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1795","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0006-8993(02)02476-9","article-title":"The selective NK1 antagonist, GR205,171, stereospecifically enhances mesocortical dopaminergic transmission in the rat: a combined dialysis and electrophysiological study","volume":"935","author":"Lejeune","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1796","first-page":"889.22","article-title":"The NK1 antagonist, GR205,171, alters the influence of serotonin (5-HT) reuptake inhibitors (SSRIs) on serotonergic neurones: a dual electrophysiological and microdialysis analysis","volume":"29","author":"Lejeune","year":"2003","journal-title":"Am Soc Neurosci Abstr"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1797","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1124\/jpet.103.058784","volume":"309","author":"Lelas","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1798","first-page":"414","article-title":"Nitric oxide: a key player in the relation between cardiovascular disease and major depressive disorder?","volume":"29","author":"Le Mell\u00e9do","year":"2004","journal-title":"Rev Psychiatr Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1799","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00210-003-0743-2","article-title":"BIMU 1 and RS 67333, two 5-HT4 receptor agonists, modulate spontaneous alternation deficits induced by scopolamine in the mouse","volume":"367","author":"Lelong","year":"2003","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1800","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-0447.1999.tb07221.x","article-title":"Psychomotor retardation and anhedonia in depression","volume":"99","author":"Lemke","year":"1999","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1801","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1152\/physrev.1991.71.1.155","article-title":"Mesocorticolimbic dopaminergic network: functional and regulatory roles","volume":"71","author":"Le Moal","year":"1991","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1802","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1345\/aph.1A040","article-title":"Treatment of insomnia in hospitalised patients","volume":"35","author":"Lenhart","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1803","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/sj.mp.4001306","article-title":"Molecular basis of lithium action: integration of lithium-responsive signalling and gene expression networks","volume":"8","author":"Lenox","year":"2003","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1804","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1176\/appi.ajp.157.5.722","article-title":"Comorbid anxiety disorders in depressed elderly patients","volume":"157","author":"Lenze","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1805","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hup.289","article-title":"Tianepine and paroxetine in major depressive disorder, with a special focus on the anxious component in depression: an international, 6-week double-blind study","volume":"16","author":"Lepine","year":"2001","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1806","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00176767","article-title":"Early desentization of somato-denditric 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine","volume":"352","author":"Le Poul","year":"1995","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1807","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2265.2005.02341.x","article-title":"Phase-shifts of 24-h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men","volume":"63","author":"Leproult","year":"2005","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1808","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1017\/S1461145702002936","article-title":"Pharmacogenetics of antidepressant and mood-stabilizing drugs: a review of candidate-gene studies and future research directions","volume":"5","author":"Lerer","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1809","first-page":"110","article-title":"Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene","volume":"30","author":"Le Saux","year":"2005","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1810","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/107385849800400110","article-title":"Serotonin transporter and psychiatric disorders: listening to the gene","volume":"4","author":"Lesch","year":"1998","journal-title":"Neuroscientist"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1811","first-page":"174","article-title":"Gene\u2013environment interaction and the genetics of depression","volume":"29","author":"Lesch","year":"2004","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1812","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF01276434","article-title":"Organization of the human serotonin transporter gene","volume":"95","author":"Lesch","year":"1994","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1813","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1176\/appi.ajp.160.7.1209","article-title":"Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomised, controlled trials","volume":"160","author":"Leucht","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1814","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1176\/appi.ajp.159.1.122","article-title":"Changes in brain function of depressed subjects during treatment with placebo","volume":"159","author":"Leuchter","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1815","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1471-4892(02)00124-8","article-title":"Oligomerization of opioid receptors: generation of novel signalling units","volume":"2","author":"Levac","year":"2002","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1816","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/neu.10151","article-title":"Nicotinic receptor subtypes and cognitive function","volume":"53","author":"Levin","year":"2002","journal-title":"J Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1817","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s002130050667","article-title":"Nicotinic acetylcholine involvement in cognitive function in animals","volume":"138","author":"Levin","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1818","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0163-1047(90)90639-N","article-title":"Cholinergic\u2013dopaminergic interactions in cognitive performance","volume":"54","author":"Levin","year":"1990","journal-title":"Behav Neural Biol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1819","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1300\/J069v21n02_01","article-title":"Bupropion treatment for cocaine abuse and adult attention-deficit\/hyperactivity disorder","volume":"21","author":"Levin","year":"2002","journal-title":"J Addict Dis"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1820","first-page":"337","article-title":"Preliminary randomised double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects","volume":"25","author":"Levitan","year":"2000","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1821","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4088\/JCP.v60n0908","article-title":"Do depressed subjects who have failed both fluoxetine and a tricyclic antidepressant respond to the combination?","volume":"60","author":"Levitt","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1822","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00004583-199901000-00020","article-title":"Natural course of adolescent major depressive disorder: I. Continuity into young adulthood","volume":"38","author":"Lewinsohn","year":"1999","journal-title":"J Am Acad Child Adolesc Psych"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1823","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0196-9781(85)90010-5","article-title":"Combined autoradiographic-immunocytochemical analysis of opioid receptors and opioid peptide neuronal systems in brain","volume":"6","author":"Lewis","year":"1985","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1824","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.1523\/JNEUROSCI.23-15-06351.2003","article-title":"Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry","volume":"23","author":"Lewis","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1825","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/074873048800300203","article-title":"Winter depression and the phase-shift hypothesis mental evidence","volume":"3","author":"Lewy","year":"1988","journal-title":"J Biol Rhythms"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1826","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/archpsyc.55.10.890","article-title":"Morning versus evening light treatment of patients with winter depression","volume":"55","author":"Lewy","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1827","first-page":"11","article-title":"5-HT2 receptors","volume":"3","author":"Leysen","year":"2004","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1828","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0893-133X(99)00070-6","article-title":"Alpha-2 adrenergic modulation of prefrontal cortical neuronal activity related to spatial working memory in monkeys","volume":"21","author":"Li","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1829","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0028-3908(00)00194-5","article-title":"Antidepressant-like actions of an AMPA receptor potentiator (LY392098)","volume":"40","author":"Li","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1830","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00210-001-0526-6","article-title":"Is Na+ required for the binding of dopamine, amphetamine, tyramine, and octopamine to the human dopamine transporter?","volume":"365","author":"Li","year":"2002","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1831","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1046\/j.1471-4159.2003.01607.x","article-title":"Brain region-specific alterations of 5-HT2A and 5-HT2C receptors in serotonin transporter knockout mice","volume":"84","author":"Li","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1832","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1016-8478(23)13763-0","article-title":"Differential distribution of GABAB1 and GABAB2 receptor mRNAs in the rat brain","volume":"16","author":"Li","year":"2003","journal-title":"Molecules Cells"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1833","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/A:1023648923447","article-title":"Enhancement of antidepressant potency by a potentiator of AMPA receptors","volume":"23","author":"Li","year":"2003","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1834","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0014-2999(03)01735-7","article-title":"Antidepressant-like effect of agmatine and its possible mechanism","volume":"469","author":"Li","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1835","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.pain.2004.02.021","article-title":"Electrophysiological characterization of NMDA receptors in rat dorsal root ganglia neurons","volume":"109","author":"Li","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1836","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.biopsych.2004.01.017","article-title":"Acute left prefrontal transcranial magnetic stimulation in depressed patients is associated with immediately increased activity in prefrontal cortical as well as subcortical regions","volume":"55","author":"Li","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1837","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/sj.npp.1300439","article-title":"In vivo regulation of glycogen synthase kinase-3\u03b2 (GSK-3\u03b2) by serotonergic activity in mouse brain","volume":"29","author":"Li","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1838","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1093\/molbev\/msh220","article-title":"Recent origin of a hominoid-specific splice form of neuropsin, a gene involved in learning and memory","volume":"21","author":"Li","year":"2004","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1839","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1073\/pnas.102174799","article-title":"\u03bc-Opioid receptors and limbic responses to aversive emotional stimuli","volume":"99","author":"Liberzon","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1840","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00213-002-0999-0","article-title":"Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation","volume":"161","author":"Licht","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1841","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jad.2004.06.007","article-title":"Depression in older persons with versus without vascular disease in the open population: similar depressive symptom patterns, more disability","volume":"83","author":"Licht-Strunk","year":"2004","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1842","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0893-133X(02)00369-X","article-title":"Effects of the neuropeptide substance P on sleep, mood and neuroendocrine measures in healthy young men","volume":"27","author":"Lieb","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1843","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1471-4159.2003.01802.x","article-title":"Valproic acid inhibits substance P-induced activation of protein kinase C epsilon and expression of the substance P receptor","volume":"86","author":"Lieb","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1844","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.npp.1300571","article-title":"Comparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacy","volume":"30","author":"Lieberman","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1845","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4088\/JCP.v63n0113","article-title":"A randomised, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder","volume":"63","author":"Liebowitz","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1846","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archpsyc.62.2.190","article-title":"Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder","volume":"62","author":"Liebowitz","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1847","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4088\/JCP.v66n0213","article-title":"A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder","volume":"66","author":"Liebowitz","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1848","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-8993(02)02620-3","article-title":"5-HT2A receptor antagonism potentiates haloperodil-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accubens in a dose-dependent manner","volume":"947","author":"Liegeois","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1849","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1073\/pnas.90.8.3665","article-title":"Structural basis for receptor subtype-specific regulation revealed by a chimeric beta3\/beta2-adrenergic receptor","volume":"90","author":"Liggett","year":"1993","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1850","first-page":"CD2950","article-title":"Antidepressants for cocaine dependence","volume":"2","author":"Lima","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1851","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1124\/mi.4.6.6","article-title":"The receptor concept: a continuing evolution","volume":"4","author":"Limbird","year":"2004","journal-title":"Mol Interv"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1852","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00003088-200342010-00003","article-title":"Role of p-glycoprotein in pharmacokinetics: clinical implications","volume":"42","author":"Lin","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1853","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.tips.2005.03.007","article-title":"A renaissance in trace amines inspired by a novel GPCR family","volume":"26","author":"Lindemann","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1854","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ygeno.2004.11.010","article-title":"Trace amine-associated receptors from structurally and functionally distinct subfamilies of novel G protein-coupled receptors","volume":"85","author":"Lindemann","year":"2005","journal-title":"Genomics"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1855","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00004714-199904000-00007","article-title":"The prescribing of psychotropic drugs by primary care physicians: an international collaborative study","volume":"19","author":"Linden","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1856","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/sj.npp.1300321","article-title":"Anxiolytic activity of the MGLU2\/3 receptor agonist LY354740 on the elevated plus maze is associated with the suppression of stress-induced c-Fos in the hippocampus and increases in c-Fos induction in several other stress-sensitive brain regions","volume":"29","author":"Linden","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1857","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1124\/jpet.103.056002","article-title":"An assessment of the effects of serotonin6 (5-HT6) receptor antagonists in rodent models of learning","volume":"307","author":"Lindner","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1858","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1176\/ajp.146.6.803b","article-title":"Treatment of a refractory depression with a combination of fluoxetine and d-amphetamine","volume":"146","author":"Linet","year":"1989","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1859","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1017\/S1461145703003407","article-title":"Neuroendocrine profiles in mood disorders","volume":"6","author":"Linkowski","year":"2003","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1860","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1210\/jcem-61-3-429","article-title":"The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness","volume":"61","author":"Linkowski","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1861","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0006-3223(99)00126-2","article-title":"Locus coeruleus neuronal activity and noradrenaline availability in the frontal cortex of rats chronically treated with imipramine: effect of \u03b12-adrenoceptor blockade","volume":"46","author":"Linner","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1862","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00213-005-2210-x","article-title":"Modulators of the glycine site on NMDA receptors, d-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia","volume":"179","author":"Lipina","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1863","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","article-title":"Drug-like properties and the causes of poor solubility and poor permeability","volume":"44","author":"Lipinski","year":"2000","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1864","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv Drug Delivery Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1865","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.3233\/JAD-2004-6S610","article-title":"Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders","volume":"6","author":"Lipton","year":"2004","journal-title":"J Alzheimer's Dis"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1866","first-page":"CD003382","article-title":"Strategies for managing sexual dysfunction induced by antidepressant medication","volume":"18","author":"Lisa","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1867","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/1520-6394(2000)12:3<178::AID-DA10>3.0.CO;2-N","article-title":"Animal models of the mechanisms of action of repetitive transcranial magnetic stimulation (RTMS): comparisons with electroconvulsive shock (ECS)","volume":"12","author":"Lisanby","year":"2000","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1868","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0306-4530(87)90055-2","article-title":"Nocturnal prolactin and cortisol secretion and recovery from melancholia","volume":"12","author":"Lisansky","year":"1987","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1869","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrn753","article-title":"The molecular basis of CaMKII function in synaptic and behavioural memory","volume":"3","author":"Lisman","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1870","doi-asserted-by":"crossref","first-page":"C11","DOI":"10.1038\/35011503","article-title":"How common are habitable planets?","volume":"402","author":"Lissauer","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1871","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejphar.2003.11.080","article-title":"Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease","volume":"486","author":"Liston","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1872","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1527-3458.2002.tb00230.x","article-title":"Selective estrogen receptor modulators: tissue actions and potential for CNS protections","volume":"8","author":"Littleton-Kearney","year":"2002","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1873","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0006-8993(98)00729-X","article-title":"Excitatory effects of muscarine on septohippocampal neurons: involvement of M3 receptors","volume":"805","author":"Liu","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1874","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0091-3057(98)00022-7","article-title":"Sexual behavior in male rats after radiofrequency or dopamine-depleting lesions in nucleus accumbens","volume":"60","author":"Liu","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1875","doi-asserted-by":"crossref","first-page":"18351","DOI":"10.1074\/jbc.274.26.18351","article-title":"Serotonin2C receptor pre-mRNA editing in rat brain and in vitro by splice site variants of the interferon-inducible double-stranded RNA-specific adonosine deaminase ADAR1","volume":"274","author":"Liu","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1876","first-page":"85","article-title":"Stereoselectivity in trans-tramadol metabolism and trans-o-demethyltramadol formation in rat liver microsomes","volume":"24","author":"Liu","year":"2003","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1877","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00129785-200404040-00006","article-title":"Technological advances in high-throughput screening","volume":"4","author":"Liu","year":"2004","journal-title":"Am J Pharmacogenomics"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1878","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.4088\/JCP.v63n1112","article-title":"Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study","volume":"63","author":"Llorca","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1879","first-page":"159","article-title":"GABA and affective disorders","volume":"65","author":"Lloyd","year":"1987","journal-title":"Med Biol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1880","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0278-5846(89)90123-1","article-title":"The GABAergic hypothesis of depression","volume":"13","author":"Lloyd","year":"1989","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1881","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0091-3057(01)00555-X","article-title":"Antidepressant effects of thyrotropin-releasing hormone analogues using a rodent model of depression","volume":"70","author":"Lloyd","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1882","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0531-5565(02)00163-8","article-title":"Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders: why? When? Which?","volume":"38","author":"Lockhart","year":"2003","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1883","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1176\/appi.ajp.159.7.1119","article-title":"Executive dysfunction in geriatric depression","volume":"159","author":"Lockwood","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1884","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.1073\/pnas.0408424102","article-title":"Evolutionary emergence of size-structured food webs","volume":"102","author":"Loeuille","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1885","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0079-6123(08)63055-1","article-title":"Forebrain nuclei involved in autonomic control","volume":"87","author":"Loewy","year":"1991","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1886","first-page":"447","article-title":"Distinct effects of diazepam and NK1 receptor antagonists in two conflict procedures in rats","volume":"14","author":"Loiseau","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1887","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0022-3956(02)00013-4","article-title":"Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency\/dose dependent effects","volume":"36","author":"Lomarev","year":"2002","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1888","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-0327(99)00195-0","article-title":"Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression","volume":"61","author":"Londborg","year":"2000","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1889","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1024153609285","article-title":"Origin of new genes: evidence from experimental and computational analyses","volume":"118","author":"Long","year":"2003","journal-title":"Genetica"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1890","first-page":"3.E.031","article-title":"A double-blind study of S20098 in patients with major depressive or bipolar II disorders: effect on anxiety","volume":"5","author":"L\u00f4o","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1891","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00004850-200209000-00004","article-title":"Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT2C antagonist, in the treatment of major depressive disorder. A placebo-controlled dose range study","volume":"17","author":"L\u00f4o","year":"2002","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1892","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0006-3223(97)00484-8","article-title":"A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression","volume":"43","author":"Lopez","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1893","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pain.2004.06.010","article-title":"Dopamine and NMDA systems modulate long-term nociception in the rat anterior cingulate cortex","volume":"111","author":"Lopez-Avila","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1894","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1185\/030079904125003719","article-title":"Spanish milnacipran\/imipramine study","volume":"20","author":"Lopez-Ibor","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1895","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0306-4522(03)00335-X","article-title":"Total sleep deprivation increases extracellular serotonin in the rat hippocampus","volume":"121","author":"Lopez-Rodriguez","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1896","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/sj.npp.1300406","article-title":"Total sleep deprivation decreases immobility in the forced-swim test","volume":"29","author":"Lopez-Rodriguez","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1897","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1016\/j.bmc.2004.07.023","article-title":"Benzimidazole derivatives: Part 5. Design and synthesis of new benzimidazole-arylpiperazine derivatives acting as mixed 5-HT1A\/5-HT3 ligands","volume":"12","author":"Lopez-Rodriguez","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1898","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.mp.4000885","article-title":"Antagonism of nicotinic acetylcholine receptors by inhibitors of monoamine uptake","volume":"6","author":"Lopez-Valdes","year":"2001","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1899","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1126\/science.1064088","article-title":"Biodiversity and ecosystem functioning: current knowledge and future challenges","volume":"294","author":"Loreau","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1900","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00001756-199310000-00024","article-title":"Nitric oxide increases dopamine and serotonin release in the medial preoptic area","volume":"5","author":"Lorrain","year":"1993","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1901","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1523\/JNEUROSCI.17-23-09361.1997","article-title":"Extracellular serotonin in the lateral hypothalamic area is increased during the postejaculatory interval and impairs copulation in male rats","volume":"17","author":"Lorrain","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1902","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0006-8993(98)00065-1","article-title":"8-OH-DPAT influences extracellular levels of serotonin and dopamine in the medial preoptic area of male rats","volume":"790","author":"Lorrain","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1903","doi-asserted-by":"crossref","first-page":"7648","DOI":"10.1523\/JNEUROSCI.19-17-07648.1999","article-title":"Lateral hypothalamic serotonin inhibits nucleus accumbens dopamine: implications for sexual satiety","volume":"19","author":"Lorrain","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1904","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.neuropharm.2004.12.022","article-title":"Comparison of the effects of diazepam, the CRF1 antagonist CP-154,526 and the group II mGlu receptor agonist LY379268 on stress-evoked extracellular norepinephrine levels","volume":"48","author":"Lorrain","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1905","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/35048558","article-title":"Analysis of an evolutionary species\u2013area relationship","volume":"408","author":"Losos","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1906","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00041444-200409000-00001","article-title":"Meta-analysis of serotonin transporter polymorphisms and affective disorders","volume":"14","author":"Lotrich","year":"2004","journal-title":"Psychiatr Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1907","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/nedt.1.1.17.52301","article-title":"Candidate genes for antidepressant response to selective serotonin reuptake inhibitors","volume":"1","author":"Lotrich","year":"2005","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1908","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0896-6273(93)90149-L","article-title":"A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms","volume":"11","author":"Lovenberg","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1909","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1046\/j.1471-4159.1995.65010268.x","article-title":"Effect of acute stress on hippocampal glutamate levels and spectrin proteolysis in young and aged rats","volume":"65","author":"Lowy","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1910","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bbr.2005.03.023","article-title":"Assessing combination treatments in acute stroke: preclinical experiences","volume":"162","author":"Lu","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1911","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1073\/pnas.0408891102","article-title":"A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus","volume":"102","author":"Lu","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1912","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.biopsych.2004.12.023","article-title":"Frontocortical 5-HT4 receptors exert positive feedback on serotonergic activity: viral transfections, subacute and chronic treatments with 5-HT4 agonists","volume":"57","author":"Lucas","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1913","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.biopsych.2003.12.014","article-title":"Antidepressant treatment with tianeptine reduces apoptosis in the hippocampal dentate gyrus and temporal cortex","volume":"55","author":"Lucassen","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1914","first-page":"24","article-title":"Behavioral studies of serotonin receptor agonists as antidepressant drugs","volume":"52","author":"Lucki","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1915","first-page":"11","article-title":"Distinguishing roles for norepinephrine and serotonin in the behavioral effects of antidepressant drugs","volume":"4","author":"Lucki","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1916","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0149-7634(94)90039-6","article-title":"Antidepressant-like behavioral effects of serotonin receptor agonists","volume":"18","author":"Lucki","year":"1994","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1917","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130100694","article-title":"Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice","volume":"155","author":"Lucki","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1918","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/074873002129002320","article-title":"The suprachiasmatic nucleus exhibits diurnal variations in spontaneous excitatory postsynaptic activity","volume":"17","author":"Lundkvist","year":"2002","journal-title":"J Biol Rhythms"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1919","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1037\/0735-7044.113.3.420","article-title":"Working memory is more sensitive than declarative memory to the acute effects of corticosteroids: a dose\u2013response study in humans","volume":"113","author":"Lupien","year":"1999","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1920","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/cne.903630410","article-title":"Cellular expression of mRNAs encoding monoamine oxidases A and B in the rat central nervous system","volume":"363","author":"Luque","year":"1995","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1921","first-page":"637","article-title":"A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression","volume":"32","author":"Luthringer","year":"1996","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1922","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.neuropharm.2005.01.007","article-title":"Analysis of the role of 5-HT1A receptors in spatial and aversive learning in the rat","volume":"48","author":"L\u00fcttgen","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1923","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jchemneu.2004.09.001","article-title":"5-HT1A receptor mRNA and immunoreactivity in the rat medial septum\/diagonal band of Broca-relationships to GABAergic and cholinergic neurons","volume":"29","author":"L\u00fcttgen","year":"2005","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1924","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000074277","article-title":"Diagnosis and treatment of depression in Alzheimer's disease","volume":"17","author":"Lyketsos","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1925","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.coph.2003.09.009","article-title":"AMPA receptor modulators as cognitive enhancers","volume":"4","author":"Lynch","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1926","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/genetics\/154.1.459","article-title":"The probability of duplicate gene preservation by subfunctionalization","volume":"154","author":"Lynch","year":"2000","journal-title":"Genetics"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1927","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.tig.2004.09.001","article-title":"The altered evolutionary trajectories of gene duplicates","volume":"20","author":"Lynch","year":"2004","journal-title":"Trends Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1928","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1074\/jbc.R200025200","article-title":"A-to-I RNA editing: recent news and residual mysteries","volume":"278","author":"Maas","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1929","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.1108876","article-title":"Formation of regulatory patterns during signal propagation in a mammalian cellular network","volume":"309","author":"Ma'ayan","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1930","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.neuro.22.1.443","article-title":"Presynaptic ionotropic receptors and the control of transmitter release","volume":"22","author":"MacDermott","year":"2000","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1931","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0028-3908(02)00066-7","article-title":"An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study","volume":"43","author":"Mackowiak","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1932","first-page":"27S","article-title":"Special issues in the management of depression in women","volume":"49","author":"MacQueen","year":"2004","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1933","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1073\/pnas.0337481100","article-title":"Course of illness, hippocampal function, and hippocampal volume in major depression","volume":"100","author":"MacQueen","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1934","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrn725","article-title":"The structure and function of glutamate receptor ion channels","volume":"3","author":"Madden","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1935","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/0269881104040230","article-title":"Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms","volume":"18","author":"Maddock","year":"2004","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1936","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0306-4522(00)00083-X","article-title":"Repeated electroconvulsive shock promotes the sprouting of serotonergic axons in the lesioned rat hippocampus","volume":"97","author":"Madhav","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1937","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0006-3223(00)00228-6","article-title":"Increased neurogenesis in a model of electroconvulsive therapy","volume":"47","author":"Madsen","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1938","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.npp.1300565","article-title":"Electroconvulsive seizure treatment increases cell proliferation in rat frontal cortex","volume":"30","author":"Madsen","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1939","series-title":"Psychopharmacology: The Fourth Generation in Progress","first-page":"933","article-title":"The serotonin hypothesis of major depression","author":"Maes","year":"1995"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1940","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00004714-199710000-00004","article-title":"Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic, pharmacokinetic and pharmacodynamic interactions through formation of meta-chlorophenylpiperazine","volume":"17","author":"Maes","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1941","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00004714-199904000-00014","article-title":"Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalised major depressed patients, including those with treatment resistance","volume":"19","author":"Maes","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1942","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0306-4522(95)00259-L","article-title":"Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors","volume":"69","author":"Magarinos","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1943","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0014-2999(99)00163-6","article-title":"Effects of antidepressants and benzodiazepine treatment on the dendritic structure of CA3 pyramidal neurons after chronic stress","volume":"371","author":"Magarinos","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1944","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0306-3623(94)00292-U","article-title":"The mammalian tachykinin receptors","volume":"26","author":"Maggi","year":"1995","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1945","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/sj.mp.4000392","article-title":"Effects of fluoxetine on wild and mutant neuronal alpha7 nicotinic receptors","volume":"3","author":"Maggi","year":"1998","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1946","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1073\/pnas.90.7.3103","article-title":"Coexpression studies with mutant muscarinic\/adrenergic receptors provide evidence for intermolecular \u201ccross-talk\u201d between G-protein-linked receptors","volume":"90","author":"Maggio","year":"1993","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1947","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1471-4159.2003.02038.x","article-title":"Potent activation of dopamine D3\/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole","volume":"87","author":"Maggio","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1948","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1081\/CBI-120019310","article-title":"Seasonal affective disorder: an overview","volume":"20","author":"Magnusson","year":"2003","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1949","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1017\/S1092852900019593","article-title":"The diagnosis, symptomatology, and epidemiology of seasonal affective disorder","volume":"10","author":"Magnusson","year":"2005","journal-title":"CNS Spectr"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1950","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pbb.2004.07.004","article-title":"Histaminergic H1 and H2 receptors located within the ventromedial hypothalamus regulate food and water intake in rats","volume":"79","author":"Magrani","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1951","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.102.046433","article-title":"Antidepressant-like effects of \u03ba-opioid receptor antagonists in the forced swim test in rats","volume":"305","author":"Mague","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1952","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/eje.0.1510325","article-title":"Atypical depression in growth hormone deficient adults, and the beneficial effects of growth hormone treatment on depression and quality of life","volume":"151","author":"Mahajan","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1953","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1471-4159.2002.00939.x","article-title":"BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents","volume":"82","author":"Mai","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1954","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF02245573","article-title":"Treatment of chronic depression with sulpiride: evidence of efficacy in placebo-controlled single case studies","volume":"115","author":"Maier","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1955","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(98)00297-0","article-title":"Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain","volume":"351","author":"Maj","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1956","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0301-0082(01)00012-0","article-title":"Non-genomic effects of glucocorticoids in the neural system evidence, mechanisms and implications","volume":"65","author":"Makara","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1957","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000076045","article-title":"Modulation of neuroendocrine response and non-verbal behavior during psychosocial stress in healthy volunteers by the glutamate release-inhibiting drug lamotrigine","volume":"79","author":"Makatsori","year":"2004","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1958","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0091-3057(02)00791-8","article-title":"Multiple feedback mechanisms activating corticotropin-releasing hormone system in the brain during stress","volume":"73","author":"Makino","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1959","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2005.03.019","article-title":"Allosteric modulation of 5-HT3 serotonin receptors","volume":"514","author":"Maksay","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1960","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(00)00486-6","article-title":"Effects of acute and chronic tianeptine administration on serotonin outflow in rats: comparison with paroxetine by using in vivo microdialysis","volume":"403","author":"Malagi\u00e9","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1961","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.1471-4159.2001.00083.x","article-title":"5-HT1B autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex","volume":"76","author":"Malagi\u00e9","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1962","first-page":"196","article-title":"Implications of adult hippocampal neurogenesis in antidepressant action","volume":"29","author":"Malberg","year":"2004","journal-title":"Rev Psychiatr Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1963","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/sj.npp.1300234","article-title":"Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment","volume":"28","author":"Malberg","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1964","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","article-title":"Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus","volume":"20","author":"Malberg","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1965","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1600-0447.2004.00475.x","article-title":"Structural and functional models of depression: from sub-types to substrates","volume":"111","author":"Malhi","year":"2005","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1966","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1176\/appi.ajp.161.5.780","article-title":"Pharmacogenetics of psychotropic drug response","volume":"161","author":"Malhotra","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1967","doi-asserted-by":"crossref","first-page":"6157","DOI":"10.1523\/JNEUROSCI.19-14-06157.1999","article-title":"5-HT1B receptor knock-out mice exhibit increased exploratory activity and enhanced spatial memory performance in the Morris water maze","volume":"19","author":"Malleret","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1968","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0166-4328(95)00168-9","article-title":"Beta-adrenergic modulation of male sexual behavior elicited from the medial preoptic area in rats","volume":"74","author":"Mallick","year":"1996","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1969","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0306-4522(01)00062-8","article-title":"Interactions between cholinergic and GABAergic neurotransmitters in and around the locus coeruleus for the induction and maintenance of rapid eye movement sleep in rats","volume":"104","author":"Mallick","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1970","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbr.2004.08.004","article-title":"Role of alpha and beta adrenoceptors in locus coeruleus stimulation-induced reduction in rapid eye movement sleep in freely moving rats","volume":"158","author":"Mallick","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1971","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4088\/PCC.v05n0105","article-title":"Duloxetine: a new treatment for the emotional and physical symptoms of depression","volume":"5","author":"Mallinckrodt","year":"2003","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1972","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-244X-4-26","article-title":"The efficacy of duloxetine: a comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials","volume":"4","author":"Mallinckrodt","year":"2004","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1973","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0028-3908(03)00227-2","article-title":"Pharmacology and expression analysis of glycine transporter GlyT-1 with [3H]-(N-[3-(4\u2032-fluorophenyl)-3-(4\u2032phenylphenoxy)propyl)sarcosine","volume":"45","author":"Mallorga","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1974","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/cercor\/bhi047","article-title":"The metabotropic glutamate receptor, mGluR5, is a key determinant of good and bad spatial learning performance and hippocampal synaptic plasticity","volume":"15","author":"Manahan-Vaughan","year":"2005","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1975","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/sleep\/26.2.130","article-title":"The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression","volume":"26","author":"Manber","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1976","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jmb.2003.09.049","article-title":"The coherent feedforward loop serves as a sign-sensitive delay element in transcription networks","volume":"334","author":"Mangan","year":"2003","journal-title":"J Mol Biol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1977","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/hbeh.2001.1687","article-title":"Ligand-independent activation of progestin receptors in sexual receptivity","volume":"40","author":"Mani","year":"2001","journal-title":"Horm Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1978","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1038\/sj.mp.4001018","article-title":"PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers","volume":"7","author":"Manji","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1979","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/archpsyc.1991.01810300017003","article-title":"The mechanisms of action of lithium: I. Effects on serotoninergic and noradrenergic systems in normal subjects","volume":"48","author":"Manji","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1980","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0006-3223(03)00117-3","article-title":"Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression","volume":"53","author":"Manji","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1981","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1471-4159.2004.02367.x","article-title":"GABAB receptors in 5-HT transporter- and 5-HT1A receptor-knock-out mice: further evidence of a transduction pathway shared with 5-HT1A receptors","volume":"89","author":"Mannoury la Cour","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1982","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0166-2236(88)90093-8","article-title":"Anatomy of CNS opioid receptors","volume":"11","author":"Mansour","year":"1988","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1983","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0166-2236(95)93946-U","article-title":"Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications","volume":"18","author":"Mansour","year":"1995","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1984","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(03)00306-9","article-title":"Melatonin exerts an antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-d-aspartate receptors and the l-arginine-nitric oxide pathway","volume":"343","author":"Mantovani","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1985","first-page":"6","article-title":"Neurobiology of substance P and the NK1 receptor","volume":"63","author":"Mantyh","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1986","doi-asserted-by":"crossref","first-page":"A25","DOI":"10.1016\/S0149-2918(00)80071-5","article-title":"Augmentation of standard depression therapy","volume":"22","author":"Marangell","year":"2000","journal-title":"Clin Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1987","first-page":"12","article-title":"Switching antidepressants for treatment-resistant major depression","volume":"62","author":"Marangell","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1988","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0006-3223(01)01343-9","article-title":"Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes","volume":"51","author":"Marangell","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1989","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0304-3959(03)00168-4","article-title":"Evidence for a monoamine mediated, opioid-independent, antihyperalgesic effect of venlafaxine, a non-tricyclic antidepressant, in a neurogenic pain model in rats","volume":"103","author":"Marchand","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1990","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0006-8993(03)02946-9","article-title":"Evidence for an antihyperalgesic effect of venlafaxine in vincristine-induced neuropathy in rat","volume":"980","author":"Marchand","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1991","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.brainres.2004.02.041","article-title":"Blockade of supraspinal 5-HT1A receptors potentiates the inhibitory effect of venlafaxine on wind-up activity in mononeuropathic rats","volume":"1008","author":"Marchand","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1992","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.neuropharm.2004.06.033","article-title":"Modulation of memory processes and cellular excitability in the dentate gyrus of freely moving rats by a 5-HT4 receptor partial agonist, and an antagonist","volume":"47","author":"Marchetti","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1993","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.schres.2004.09.010","article-title":"Measurement and treatment research to improve cognition in schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia","volume":"72","author":"Marder","year":"2004","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1994","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1468-1331.9.s3.2.x","article-title":"Do dopamine agonists or levodopa modify Parkinson's disease progression?","volume":"9","author":"Marek","year":"2002","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1995","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/sj.npp.1300057","article-title":"Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders","volume":"28","author":"Marek","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1996","doi-asserted-by":"crossref","first-page":"14643","DOI":"10.1073\/pnas.251554798","article-title":"Ligand-induced signal transduction within heterodimeric GABAB receptor","volume":"98","author":"Margeta-Mitrovic","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1997","doi-asserted-by":"crossref","first-page":"9981","DOI":"10.1523\/JNEUROSCI.23-31-09981.2003","article-title":"Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons","volume":"23","author":"Margolis","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1998","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1460-9568.2002.02089.x","article-title":"Interaction between glucocorticoid hormones, stress and psychostimulant drugs","volume":"16","author":"Marinelli","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib1999","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0006-8993(96)00681-6","article-title":"Effects of tianeptine, sertraline and clomipramine on brain serotonin metabolism: a voltammetric approach in the rat","volume":"736","author":"Marinesco","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2000","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0165-6147(00)01678-3","article-title":"G-protein-coupled receptors and signalling networks: emerging paradigms","volume":"22","author":"Marinissen","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2001","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1074\/jbc.M308742200","article-title":"RNA editing induces variation in desensitisation and trafficking of 5HT2C receptor isoforms","volume":"279","author":"Marion","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2002","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0893-133X(97)00113-9","article-title":"Neurobiological similarities in depression and drug dependence: a self-medication hypothesis","volume":"18","author":"Markou","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2003","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1385\/JMN:26:2-3:169","article-title":"Is the GABAB heterodimer a good drug target?","volume":"26","author":"Marshall","year":"2005","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2004","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1046\/j.1471-4159.1997.68041511.x","article-title":"Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of na\u00efve and chronic nicotine-treated rats","volume":"68","author":"Marshall","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2005","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/1389200033489433","article-title":"An update on the extraneuronal monoamine transporter (EMT): characteristics, distribution and regulation","volume":"4","author":"Martel","year":"2003","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2006","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/PL00005356","article-title":"Comparison between uptake2 and rOCT1: effects of catecholamines, metanephrines and corticosterone","volume":"359","author":"Martel","year":"1999","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2007","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00213-003-1754-x","article-title":"[N-methyl-11C]mirtazapine for positron emission tomography neuroimaging of antidepressant actions in humans","volume":"174","author":"Marthi","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2008","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000118620","article-title":"Decreased G.ABAB receptors in helpless rats: reversal by tricyclic antidepressants","volume":"22","author":"Martin","year":"1989","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2009","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1055\/s-2007-1014505","article-title":"Antidepressant profile of bupropion and three metabolite in mice","volume":"23","author":"Martin","year":"1990","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2010","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0022-3565(24)37669-4","article-title":"5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential","volume":"286","author":"Martin","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2011","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0091-3057(01)00713-4","article-title":"Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety","volume":"71","author":"Martin","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2012","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0893-133X(00)00187-1","article-title":"Differential occupancy of somatodendritic and postsynaptic 5-HT1A receptors by pindolol: a dose-occupancy study with [11C]WAY 100,635 and positron emission tomography in humans","volume":"24","author":"Martinez","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2013","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0223-5234(00)01198-3","article-title":"New 3-[4-(aryl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)propane derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporters as a new class of antidepressants","volume":"36","author":"Martinez","year":"2001","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2014","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/1355621031000069837","article-title":"Treatment of nicotine dependence with bupropion SR: review of its efficacy, safety and pharmacological profile","volume":"8","author":"Martinez-Raga","year":"2003","journal-title":"Addict Biol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2015","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0028-3908(02)00299-X","article-title":"Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus","volume":"43","author":"Martinez-Turrillan","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2016","doi-asserted-by":"crossref","first-page":"9856","DOI":"10.1523\/JNEUROSCI.21-24-09856.2001","article-title":"Control of serotonergic function in medial prefrontal cortex by serotonin2A receptors through a glutamate-dependent mechanism","volume":"21","author":"Martin-Ruiz","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2017","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/(SICI)1096-9861(19990322)405:4<450::AID-CNE2>3.0.CO;2-#","article-title":"Differential distribution of endomorphin1- and endomorphin2-like immunoreactivities in the CNS of the rodent","volume":"405","author":"Martin-Schild","year":"1999","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2018","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0304-3940(03)00211-8","article-title":"Anti-apoptotic action of anti-Alzheimer drug, TV3326{(N-propargyl)-(3R)-aminoindan-5-yl]-ethyl methyl carbamate, a novel cholinesterase-monoamine oxidase inhibitor","volume":"341","author":"Maruyama","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2019","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2337\/diabetes.50.2.376","article-title":"Central infusion of histamine reduces fat accumulation and upregulates UCP family in Leptin-resistant obese mice","volume":"50","author":"Masaki","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2020","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2337\/diabetes.50.2.385","article-title":"Targeted disruption of histamine H1-receptor attenuates regulatory effects of leptin on feeding, adiposity, and UCP family in mice","volume":"50","author":"Masaki","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2021","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1176\/appi.ajp.158.5.805","article-title":"Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel group study","volume":"158","author":"Masand","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2022","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1210\/en.2004-1150","article-title":"Anti-obesity effect of an MCH1R antagonist in diet-induced obese mice, anti-obesity effect of MCH1R antagonist","volume":"146","author":"Mashiko","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2023","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/sj.bjp.0705559","article-title":"Inhibition of human \u03b17 nicotinic acetylcholine receptors by open channel blockers of NMDA receptors","volume":"140","author":"Maskell","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2024","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0014-2999(02)02688-2","article-title":"Modulation of stress-induced neurobehavioral changes by nitric oxide in rats","volume":"458","author":"Masood","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2025","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/sj.mp.4001615","article-title":"Association between COMT (Val(158)Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study","volume":"10","author":"Massat","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2026","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/hup.393","article-title":"Effect of serotonin1A agonist tandospirone on depression symptoms in senile patients with dementia","volume":"17","author":"Masuda","year":"2002","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2027","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.0953-816x.2001.01619.x","article-title":"Inhibition of synaptically evoked cortical acetylcholine release by intracortical glutamate: involvement of GABAergic neurons","volume":"14","author":"Materi","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2028","first-page":"60","article-title":"Neuropeptide and electroconvulsive treatment","volume":"15","author":"Mathe","year":"1999","journal-title":"J ECT"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2029","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0278-5846(98)00023-2","article-title":"Neuropeptide Y, Neurokinin A and neurotensin in brain regions of Fawn-Hooded depressed, Wistar and Sprague Dawley rats. Effects of electroconvulsive stimuli","volume":"22","author":"Mathe","year":"1998","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2030","first-page":"53","article-title":"Tricyclic side effects without tricyclics in depression","volume":"16","author":"Mathew","year":"1980","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2031","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/0269881104040215","article-title":"Simultaneous depletion of serotonin and catecholamines impairs sustained attention in healthy female subjects without affecting learning and memory","volume":"18","author":"Matrenza","year":"2004","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2032","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1471-4159.2005.03141.x","article-title":"Metabotropic glutamate receptors and neuroadaptation to antidepressants: imipramine-induced down-regulation of \u03b2-adrenergic receptors in mice treated with metabotropic glutamate 2\/3 receptor ligands","volume":"93","author":"Matrisciano","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2033","first-page":"149","article-title":"Electrophysiologic analysis of antidepressant drug effects on the GABAA receptor complex based upon antagonist-induced encephalographic power spectrum changes","volume":"42","author":"Matsubara","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2034","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0022-3565(24)38802-0","article-title":"Evidence for involvement of central 5-HT(4) receptors in cholinergic function associated with cognitive processes: behavioral, electrophysiological, and neurochemical studies","volume":"296","author":"Matsumoto","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0014-2999(96)00497-9","article-title":"Sigma1 receptor subtype is involved in the relief of behavioural despair in the mouse forced swimming test","volume":"312","author":"Matsuno","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2036","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.conb.2004.03.014","article-title":"Imaging genetic influences in human brain function","volume":"14","author":"Mattay","year":"2004","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2037","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.tins.2004.08.001","article-title":"BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders","volume":"27","author":"Mattson","year":"2004","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2038","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0893-133X(98)00040-2","article-title":"Subchronic administration of fluoxetine impairs estrous behavior in intact female rats","volume":"19","author":"Matuszczyk","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2039","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0006-8993(98)01331-6","article-title":"Partial antagonism of 8-OH-DPAT's effects on male rat sexual behavior with a D2, but not a 5-HT1A, antagonist","volume":"820","author":"Matuszewich","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2040","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1021\/jm9811054","article-title":"5-HT reuptake inhibitors with 5-HT1B\/1D antagonistic activity: a new approach toward efficient antidepressants","volume":"43","author":"Matzen","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2041","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1367-5931(99)80070-2","article-title":"Novel strategies for pharmacotherapy of depression","volume":"3","author":"Maubach","year":"1999","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2042","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0306-4522(01)00467-5","article-title":"Chronic substance P (NK1) receptor antagonist and conventional antidepressant treatment increases burst firing of monoamine neurones in the locus coeruleus","volume":"109","author":"Maubach","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2043","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1358\/dnp.2002.15.10.740241","article-title":"Improving Alzheimer's disease-related cognitive deficits with \u03c31 receptor agonists","volume":"15","author":"Maurice","year":"2002","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2044","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0165-0173(01)00112-6","article-title":"The interaction between neuroactive steroids and the sigma1 receptor function: behavioral consequences and therapeutic opportunities","volume":"37","author":"Maurice","year":"2001","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2045","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-2999(02)02553-0","article-title":"Sleep\u2013wake effects of meta-chlorophenyl piperazine and mianserin in the behaviorally depressed rat","volume":"455","author":"Mavanji","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2046","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1052-5149(03)00104-7","article-title":"Positron emission tomography imaging in depression: a neural systems perspectives","volume":"13","author":"Mayberg","year":"2003","journal-title":"Neuroimaging Clin N Am"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2047","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/00001756-199703030-00048","article-title":"Cingulate function in depression: a potential predictor of treatment response","volume":"8","author":"Mayberg","year":"1997","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2048","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1176\/ajp.156.5.675","article-title":"Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness","volume":"156","author":"Mayberg","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2049","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.neuron.2005.02.014","article-title":"Deep brain stimulation for treatment-resistant depression","volume":"45","author":"Mayberg","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2050","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1212\/WNL.34.5.642","article-title":"Altered serotonin metabolism in depressed patients with Parkinson's disease","volume":"39","author":"Mayeux","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2051","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0022-3565(24)29479-9","article-title":"Antidepressant-like behavioral effects in 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor mutant mice","volume":"298","author":"Mayorga","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2052","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0169-328X(96)00017-4","article-title":"The melatonin receptor in the human brain: cloning experiments and distribution studies","volume":"39","author":"Mazzucchelli","year":"1996","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2053","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-2999(98)00405-1","article-title":"GR205171 blocks apomorphine and amphetamine-induced conditioned taste aversions","volume":"353","author":"McAllister","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2054","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00213-002-1339-0","article-title":"EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans","volume":"166","author":"McAllister-Williams","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2055","first-page":"74","article-title":"Effects of repeated cortisol administration on brain potential correlates of episodic memory retrieval","volume":"60","author":"McAllister-Williams","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2056","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1192\/bjp.173.3.203","article-title":"Pindolol augmentation of antidepressant therapy","volume":"173","author":"McAskill","year":"1998","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2057","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1017\/S1461145701002437","article-title":"Electroconvulsive therapy in the era of modern psychopharmacology","volume":"4","author":"McCall","year":"2001","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2058","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.psychres.2003.09.003","article-title":"Cognitive deficits are associated with functional impairment in severely depressed patients","volume":"121","author":"McCall","year":"2003","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2059","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1192\/bjp.185.5.405","article-title":"Quality of life and function after electroconvulsive therapy","volume":"185","author":"McCall","year":"2004","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2060","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/35012234","article-title":"The diversity-stability debate","volume":"405","author":"McCann","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2061","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2165\/00003495-200363110-00007","article-title":"Tramadol\/paracetamol","volume":"63","author":"McClellan","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2062","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1192\/bjp.185.1.55","article-title":"Cost-effectiveness of computerised cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial","volume":"185","author":"McCrone","year":"2004","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2063","doi-asserted-by":"crossref","first-page":"9687","DOI":"10.1523\/JNEUROSCI.23-29-09687.2003","article-title":"Sleep deprivation causes behavioural, synaptic, and membrane excitability alterations in hippocampal neurons","volume":"23","author":"McDermott","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2064","series-title":"Neuropsychopharmacology: The Fifth Generation of Progress","first-page":"1097","article-title":"Electroconvulsive therapy: sixty years of progress and a comparison with transcranial magnetic stimulation and vagal nerve stimulation","author":"McDonald","year":"2002"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2065","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00213-002-1239-3","article-title":"The CRF1 receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in rats","volume":"165","author":"McElroy","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2066","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4088\/JCP.v65n0507","article-title":"Are mood disorders and obesity related? A review for the mental health professional","volume":"65","author":"McElroy","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2067","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1152\/jappl.2001.91.6.2785","article-title":"Estrogen effects on the brain: multiple sites and molecular mechanisms","volume":"91","author":"McEwen","year":"2001","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2068","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/sj.mp.4001648","article-title":"Neurobiology of mood, anxiety, and emotions as revealed by studies of a unique antidepressant: tianeptine","volume":"10","author":"McEwen","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2069","doi-asserted-by":"crossref","first-page":"S323","DOI":"10.1016\/S0924-977X(97)00064-3","article-title":"Prevention of stress-induced morphological and cognitive consequences","volume":"7","author":"McEwen","year":"1997","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2070","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.1073\/pnas.121146898","article-title":"Tracking the estrogen receptor in neurons: implications for estrogen-induced synapse formation","volume":"98","author":"McEwen","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2071","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0924-9338(02)00650-8","article-title":"Structural plasticity and tianeptine: cellular and molecular targets","volume":"17","author":"McEwen","year":"2002","journal-title":"Eur Psychiatr"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2072","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/415068a","article-title":"Resource-based niches provide a basis for plant species diversity and dominance in arctic tundra","volume":"415","author":"McKane","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2073","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0149-7634(00)00021-X","article-title":"Some proposals regarding the organization of the central nervous system control of penile erection","volume":"24","author":"McKenna","year":"2000","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2074","first-page":"3216","article-title":"Novel tacrine analogues for potential use against Alzheimer's disease: potent and selective acetylcholinesterase inhibitors and 5-HT uptake inhibitors","volume":"40","author":"McKenna","year":"1997","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2075","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1471-4159.2004.02850.x","article-title":"Different properties of the central and peripheral forms of human tryptophan hydroxylase","volume":"92","author":"McKinney","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2076","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1523\/JNEUROSCI.23-13-05674.2003","article-title":"Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioural responses","volume":"23","author":"McLaughlin","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2077","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1365-2265.2003.01870.x","article-title":"Psychological effects of withdrawal of growth hormone therapy from adults with growth hormone deficiency","volume":"59","author":"McMillan","year":"2003","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2078","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2165\/00003495-199856060-00019","article-title":"Sibutramine: a review of its contribution to the management of obesity","volume":"56","author":"McNeely","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2079","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1600-0447.2004.00498.x","article-title":"The effectiveness of psychological treatments for treatment-resistant depression: a systematic review","volume":"111","author":"McPherson","year":"2005","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2080","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1192\/bjp.177.5.390","article-title":"Future therapeutic targets in mood disorders: the glucocorticoid receptor","volume":"177","author":"McQuade","year":"2000","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2082","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/0269881104047276","article-title":"Effect of chronic lithium treatment on glucocorticoid and 5-HT1A receptor messenger RNA in hippocampal and dorsal raphe nucleus regions of the rat brain","volume":"18","author":"McQuade","year":"2004","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2083","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s00213-004-1945-0","article-title":"Tyrosine depletion does not cause depressive relapse in antidepressant-treated patients","volume":"175","author":"McTavish","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2084","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0304-3959(03)00301-4","article-title":"Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample","volume":"106","author":"McWilliams","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2085","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pain.2004.06.002","article-title":"Depression and anxiety associated with three pain conditions: results from a nationally representative sample","volume":"111","author":"McWilliams","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2086","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0960-894X(01)00334-1","article-title":"Studies towards the next generation of antidepressants. Part 1: indolylcyclohexylamines as potent serotonin reuptake inhibitors","volume":"11","author":"Meagher","year":"2001","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2087","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0278-5846(01)00172-5","article-title":"Similarities in the pattern of regional brain dysfunction in negative schizophrenia and unipolar depression: a single photon emission-compared tomography and auditory evoked potentials study","volume":"25","author":"Medved","year":"2001","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2088","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0031-9384(95)02271-6","article-title":"Long-term changes in open field behaviour following a single social defeat in rats can be reversed by sleep deprivation","volume":"60","author":"Meerlo","year":"1996","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2089","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.tips.2004.07.006","article-title":"Pharmacological inhibitors of glycogen synthase kinase 3","volume":"25","author":"Meijer","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(96)00266-X","article-title":"Dopamine\u2013N-methyl-d-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice","volume":"308","author":"Mele","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2091","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0149-7634(94)00020-2","article-title":"Dopamine and sexual behaviour","volume":"19","author":"Melis","year":"1995","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2092","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0006-8993(87)90272-1","article-title":"Apomorphine-induced penile erection and yawning: site of action in brain","volume":"415","author":"Melis","year":"1987","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2093","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1046\/j.1460-9568.2003.02558.x","article-title":"Extra-cellular dopamine increases in the paraventricular nucleus of male rats during sexual activity","volume":"17","author":"Melis","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2094","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neulet.2004.12.053","article-title":"PD-168077, a selective dopamine D4 receptor agonist, induces penile erection when injected into the paraventricular nucleus of male rats","volume":"379","author":"Melis","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2095","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2165\/00003495-200464070-00003","article-title":"Adverse metabolic effects associated with atypical antipsychotics","volume":"64","author":"Melkersson","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2096","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11920-996-0047-6","article-title":"Suicidality in schizophrenia: a review of the evidence for risk factors and treatment options","volume":"4","author":"Meltzer","year":"2002","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2097","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF01292618","article-title":"Effect of pindolol on hormone secretion and body temperature, partial agonist effects","volume":"103","author":"Meltzer","year":"1996","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2098","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archpsyc.60.1.82","article-title":"Clozapine treatment for suicidality in schizophrenia: international suicide prevention trial (InterSePT)","volume":"60","author":"Meltzer","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2099","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.pnpbp.2003.09.010","article-title":"Serotonin receptors: their key role in drugs to treat schizophrenia","volume":"27","author":"Meltzer","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2100","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1038\/sj.npp.1300556","article-title":"Serotonin1A receptor binding and treatment response in late-life depression","volume":"29","author":"Meltzer","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2101","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/0028-3908(90)90133-C","article-title":"Sex differences in the effects of 1-(m-trifluoromethylphenyl) piperazine and 1(m-chlorophenyl) piperazine on copulatory behavior in the rat","volume":"29","author":"Mendelson","year":"1990","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2102","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1087-0792(03)00042-X","article-title":"The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit Meeting symposium","volume":"8","author":"Mendelson","year":"2004","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2103","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0149-7634(99)00067-6","article-title":"5-HT system and cognition","volume":"23","author":"Meneses","year":"1999","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2104","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0149-7634(01)00007-0","article-title":"Could the 5-HT1B receptor inverse agonism affect learning consolidation?","volume":"25","author":"Meneses","year":"2001","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2105","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1023\/A:1021800822997","article-title":"Involvement of 5-HT(2A\/2B\/2C) receptors on memory formation: simple agonism, antagonism, or inverse agonism?","volume":"22","author":"Meneses","year":"2002","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2106","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4088\/JCP.v61n0510","article-title":"Modafinil augmentation of antidepressant treatment in depression","volume":"61","author":"Menza","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2107","doi-asserted-by":"crossref","first-page":"516","DOI":"10.4088\/JCP.v64n0504","article-title":"Residual symptoms in depression: can treatment be symptom-specific?","volume":"64","author":"Menza","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2108","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1523\/JNEUROSCI.4734-03.2004","article-title":"Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain","volume":"24","author":"Merali","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2109","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1523\/JNEUROSCI.17-07-02267.1997","article-title":"Monoamine oxidase inhibition causes a long-term prolongation of the dopamine-induced responses in rat midbrain dopaminergic cells","volume":"17","author":"Mercuri","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0301-0082(01)00031-4","article-title":"Costorage and coexistence of neuropeptides in the mammalian CNS","volume":"66","author":"Merighi","year":"2002","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2111","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1176\/ajp.156.5.780","article-title":"Prefrontal cortical dysfunction in depression determined by Wisconsin card sorting test performance","volume":"156","author":"Merriam","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2112","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archpsyc.57.11.1012","article-title":"The neurobiology of sexual function","volume":"57","author":"Meston","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2113","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00006842-199707000-00010","article-title":"Inhibition of subjective and physiological sexual arousal in women by clonidine","volume":"59","author":"Meston","year":"1997","journal-title":"Psychosom Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2114","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1101\/lm.69204","article-title":"The cholinergic lesion of Alzheimer's disease: pivotal factor or side show?","volume":"11","author":"Mesulam","year":"2004","journal-title":"Learn Mem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2115","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1021\/jm0304010","article-title":"Studies toward the discovery of the next generation of antidepressants: 3. Dual 5-HT1A and serotonin transporter affinity within a class of N-aryloxyethylindolylalkylamines","volume":"47","author":"Mewshaw","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2116","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1097\/00001756-200112210-00052","article-title":"Lower dopamine transporter binding potential in striatum during depression","volume":"12","author":"Meyer","year":"2001","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2117","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00213-002-1166-3","article-title":"Bupropion occupancy of the dopamine transporter is low during clinical treatment","volume":"163","author":"Meyer","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2118","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nn1438","article-title":"Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype","volume":"8","author":"Meyer-Lindenberg","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2119","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1471-4159.1987.tb04129.x","article-title":"Allosteric interaction between the site labeled by [3H]imipramine and the serotonin transporter in human platelets","volume":"48","author":"Meyerson","year":"1987","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2120","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/0014-4886(88)90119-7","article-title":"Concentrations of cholecystokinin, substance P, and bombesin in discrete regions of male and female in brain: sex differences and estrogen effects","volume":"100","author":"Micevych","year":"1988","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2121","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1017\/S0033291703007931","article-title":"Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression","volume":"33","author":"Michael","year":"2003","journal-title":"Psychol Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2122","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/sj.npp.1300085","article-title":"Neurotrophic effects of electroconvulsive therapy: a proton magnetic resonance study of the left amygdalar region in patients with treatment-resistant depression","volume":"28","author":"Michael","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2123","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1016\/0006-2952(87)90629-0","article-title":"Inhibition of synaptosomal high-affinity uptake of dopamine and serotonin by estrogen agonists and antagonists","volume":"36","author":"Michel","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2124","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1152\/jn.2002.88.2.817","article-title":"Excitatory mechanisms in the suprachiasmatic nucleus: the role of AMPA\/KA glutamate receptors","volume":"88","author":"Michel","year":"2002","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2125","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1056\/NEJM199610173351602","article-title":"Bone mineral density in women with depression","volume":"16","author":"Michelson","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2126","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1176\/appi.ajp.157.2.239","article-title":"Female sexual dysfunction associated with antidepressant administration. A randomised, placebo-controlled study of pharmacologic intervention","volume":"157","author":"Michelson","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2127","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1073\/pnas.0409515102","article-title":"Inferring network mechanisms: the Drosophila melanogaster protein interaction network","volume":"102","author":"Middendorf","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2128","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1471-4892(01)00116-3","article-title":"Serotonergic targets in depression","volume":"2","author":"Middlemiss","year":"2002","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2129","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s002130051074","article-title":"Idazoxan potentiates rather than antagonizes some of the cognitive effects of clonidine","volume":"145","author":"Middleton","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2130","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2174\/1389557033487674","article-title":"Applied introduction to multivariate methods used in drug discovery","volume":"3","author":"Migliavacca","year":"2003","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2131","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(98)00658-X","article-title":"Effects of nicotine and mecamylamine on rat dorsal raphe neurons","volume":"360","author":"Mihailescu","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2132","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00007691-200208000-00016","article-title":"Relationship between plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine, and its clinical effect in depressed patients","volume":"24","author":"Mihara","year":"2002","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(98)00048-3","article-title":"The induction of pain: an integrative review","volume":"57","author":"Millan","year":"1999","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2134","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(02)00009-6","article-title":"Descending control of pain","volume":"66","author":"Millan","year":"2002","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0301-0082(03)00087-X","article-title":"The neurobiology and control of anxious states","volume":"70","author":"Millan","year":"2003","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2136","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejphar.2004.07.038","article-title":"The role of monoamines in the actions of established and \u201cnovel\u201d antidepressant agents: a critical review","volume":"500","author":"Millan","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2137","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00213-005-2199-1","article-title":"NMDA receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives","volume":"179","author":"Millan","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2138","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2515\/therapie:2005065","article-title":"Serotonin2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies","volume":"60","author":"Millan","year":"2005","journal-title":"Therapies"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2139","first-page":"397","article-title":"Targeting multiple serotonin receptors: mixed 5-HT1A agonists\/5-HT1C\/2 antagonists as therapeutic agents","volume":"5","author":"Millan","year":"1992","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2140","first-page":"121","article-title":"5-HT1A receptors and the tail-flick response: VI. Intrinsic alpha1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm","volume":"269","author":"Millan","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2141","first-page":"1418","article-title":"Antagonist properties of LY 165,163 at pre- and postsynaptic dopamine D2, D3 and D1 receptors: modulation of agonist actions at 5-HT1A receptors in vivo","volume":"273","author":"Millan","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2142","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-2999(97)89962-1","article-title":"5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists","volume":"325","author":"Millan","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2143","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0014-2999(97)01445-3","article-title":"WAY100,635 enhances both the \u201cantidepressant\u201d actions of duloxetine and its influence on dialysate levels of serotonin in frontal cortex","volume":"341","author":"Millan","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2144","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s002130050910","article-title":"5-HT2C receptors are involved in the discriminative stimulus effects of citalopram in rats","volume":"142","author":"Millan","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2145","first-page":"61S","article-title":"Inverse agonists and serotonergic transmission: from recombinant, human serotonin (5-HT)1B receptors to G-protein coupling and function in corticolimbic structures in vivo","volume":"21","author":"Millan","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2146","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-3565(24)35260-7","volume":"292","author":"Millan","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2147","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1460-9568.2000.00982.x","article-title":"Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of \u03b12-adrenergic and serotonin2C receptors: a comparison with citalopram","volume":"12","author":"Millan","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2148","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/026988110001400202","article-title":"Reciprocal autoreceptor and heteroceptor control of serotonergic, dopaminergic and adrenergic transmission in frontal cortex: a review, and relevance to the actions of antidepressant agents","volume":"14","author":"Millan","year":"2000","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2149","first-page":"1206","article-title":"S18616, a highly potent spiroimidazoline agonist at alpha2-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine","volume":"295","author":"Millan","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1098-2396(200002)35:2<79::AID-SYN1>3.0.CO;2-X","volume":"35","author":"Millan","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2151","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0893-133X(01)00244-5","article-title":"Anxiolytic properties of the selective non-peptidergic CRF1 antagonists, CP154,526 and DMP695: a comparison to other classes of anxiolytic agent","volume":"25","author":"Millan","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2152","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0022-3565(24)29416-7","article-title":"S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine","volume":"298","author":"Millan","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2153","first-page":"918","article-title":"The novel, potential antidepressants, S35966 and S35967, act as serotonin and norepinephrine reuptake inhibitors and antagonists at \u03b12-adrenoceptors","volume":"27","author":"Millan","year":"2001","journal-title":"Am Soc Neurosci Abstr"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2154","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0022-3565(24)29415-5","article-title":"S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine","volume":"298","author":"Millan","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2155","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1046\/j.1471-4159.2001.00211.x","article-title":"Selective blockade of NK1 receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in rats","volume":"76","author":"Millan","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2156","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0014-2999(01)01127-X","article-title":"Agonist properties of pindolol at h5-HT1A receptors coupled to mitogen-activated protein kinase","volume":"424","author":"Millan","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2157","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0028-3908(02)00021-7","article-title":"Stereospecific blockade of marble-burying behaviour in mice by selective, non-peptidergic neurokinin1 (NK1) receptor antagonists","volume":"42","author":"Millan","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2158","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1124\/jpet.102.039867","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor: I. A multivariate analysis of the binding profiles of 14 drugs at 21 native cloned human receptor profiles","volume":"303","author":"Millan","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2159","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/jpet.103.051797","article-title":"The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-HT2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways","volume":"306","author":"Millan","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2160","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00213-003-1389-y","article-title":"Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes","volume":"168","author":"Millan","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2161","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1124\/jpet.103.062463","article-title":"S32504, a novel naphtoxazine agonist at dopamine D3\/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole","volume":"309","author":"Millan","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2162","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1124\/jpet.103.062414","article-title":"S32504, a novel naptoxazine agonist at dopamine D3\/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole","volume":"309","author":"Millan","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2163","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1124\/jpet.104.069625","article-title":"The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)-1(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioural analysis","volume":"311","author":"Millan","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2164","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00213-003-1770-x","article-title":"The role of dopamine D3 as compared to D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats","volume":"174","author":"Millan","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2165","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00213-004-1962-z","article-title":"Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT(2C) receptor blockade","volume":"17","author":"Millan","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2166","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1124\/mi.5.5.8","article-title":"Serotonin 5-HT2C receptor agonists: potential for the treatment of obesity","volume":"5","author":"Miller","year":"2005","journal-title":"Mol Interv"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2167","doi-asserted-by":"crossref","first-page":"27351","DOI":"10.1016\/S0021-9258(18)46992-X","article-title":"Adenosine A3 receptors regulate serotonin transport via nitric oxide and cGMP","volume":"269","author":"Miller","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2168","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archpsyc.1996.01830020031005","article-title":"Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression","volume":"53","author":"Miller","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2169","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1023\/A:1004070603792","article-title":"Molecular domestication\u2014more than a sporadic episode in evolution","volume":"107","author":"Miller","year":"1999","journal-title":"Genetica"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2170","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0893-133X(00)00232-3","article-title":"Noradrenergic function and clinical outcome in antidepressant pharmacotherapy","volume":"24","author":"Miller","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2171","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1124\/jpet.102.033852","article-title":"Bupropion inhibits nicotine-evoked [3H] overflow from rat striatal slices preloaded with [3H] dopamine and from rat hippocampal slices preloaded with [3H] norepinephrine","volume":"320","author":"Miller","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2172","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1124\/jpet.302.2.687","article-title":"Reboxetine: functional inhibition of monoamine transporters and nicotinic acetylcholine receptors","volume":"302","author":"Miller","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2173","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0889-1591(03)00057-6","article-title":"Pathways linking depression, adiposity, and inflammatory markers in healthy young adults","volume":"17","author":"Miller","year":"2003","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2174","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1124\/jpet.105.084459","article-title":"Primate trace amine receptor1 modulation by the dopamine transporter","volume":"313","author":"Miller","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2175","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1210\/jc.2004-0894","article-title":"Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk","volume":"90","author":"Miller","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2176","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1124\/mol.64.6.1271","article-title":"Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective","volume":"64","author":"Milligan","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2177","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0165-6147(02)00027-5","article-title":"Principles: extending the utility of [35S]GTP gamma S binding assays","volume":"24","author":"Milligan","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/mol.104.000497.","article-title":"G protein-coupled receptor dimerization: function and ligand pharmacology","volume":"66","author":"Milligan","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2179","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.lfs.2003.09.005","article-title":"GPCR dimerisation","volume":"74","author":"Milligan","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2180","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1523\/JNEUROSCI.1366-03.2004","article-title":"Estrogen-induced m\u03bc-opioid receptor internalisation in the medial preoptic nucleus is mediated via neuropeptide Y-Y1 receptor activation in the arcuate nucleus of female rats","volume":"24","author":"Mills","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2181","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1345\/aph.1A402","article-title":"Neurologic, psychological, and aggressive disturbances with sildenafil","volume":"36","author":"Milman","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2182","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.298.5594.824","article-title":"Network motifs: simple building blocks of complex networks","volume":"298","author":"Milo","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2183","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1126\/science.1089167","article-title":"Superfamilies of evolved and designed networks","volume":"303","author":"Milo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2184","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000080971","article-title":"Depressive symptoms increase the likelihood of cognitive impairment in elderly people with subclinical Alzheimer pathology","volume":"19","author":"Milwain","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2185","first-page":"108","article-title":"Splice variants of G-protein-coupled receptors","volume":"1","author":"Minneman","year":"2001","journal-title":"Mol Interv"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2186","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00001504-199703000-00006","article-title":"The adverse effects of antidepressants","volume":"10","author":"Mir","year":"1997","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2187","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1034\/j.1600-0773.2000.pto870605.x","article-title":"Chronic clorgyline induces selective down-regulation of alpha2-adrenoceptor agonist binding sites in rat brain","volume":"87","author":"Miralles","year":"2000","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2188","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1527-3458.2003.tb00247.x","article-title":"Xanomeline and the antipsychotic potential of muscarinic receptor subtype selective agonists","volume":"9","author":"Mirza","year":"2003","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2189","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00213-005-2146-1","article-title":"Lamotrigine has an anxiolytic-like profile in the rat conditioned emotional response test of anxiety: a potential role for sodium channels?","volume":"180","author":"Mirza","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2190","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.npp.1300024","article-title":"Selective 5-HT1A antagonists WAY100,635 and NAD-299 attenuate the impairment of passive avoidance caused by scopolamine in the rat","volume":"28","author":"Misane","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2191","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0006-3223(97)00510-6","article-title":"Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer's type with disturbed sleep-waking","volume":"45","author":"Mishima","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2192","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1054-3589(08)61019-4","article-title":"Neurotransmitter-like actions of L-Dopa","volume":"32","author":"Misu","year":"1995","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2193","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0165-6147(93)90082-U","article-title":"Is L-dopa an endogenous neurotransmitters?","volume":"14","author":"Misu","year":"1993","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2194","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0301-0082(96)00025-1","article-title":"Neurobiology of L-dopaergic systems","volume":"49","author":"Misu","year":"1996","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2195","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0165-6147(02)02013-8","article-title":"Is Dopa a neurotransmitter?","volume":"23","author":"Misu","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2196","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00008877-199711000-00016","article-title":"Potentiation of the time-dependent, antidepressant-induced changes in the agonistic behaviour of resident rats by the 5-HT1A receptor antagonist, WAY-100635","volume":"8","author":"Mitchell","year":"1997","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2197","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.1523\/JNEUROSCI.20-23-08651.2000","article-title":"GABA spillover from single inhibitory axons suppresses low-frequency excitatory transmission at the cerebellar glomerulus","volume":"20","author":"Mitchell","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2198","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0014-2999(01)01469-8","article-title":"LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B\/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat","volume":"432","author":"Mitchell","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2199","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0028-3908(03)00075-3","article-title":"Effects of single and repeated electroconvulsive shock on the social and agonistic behaviour of resident rats","volume":"44","author":"Mitchell","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2200","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.jcp.0000155821.74832.f9","article-title":"A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder","volume":"25","author":"Mitte","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2201","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/mi.3.1.27","article-title":"Recent advances in the neurobiology of schizophrenia","volume":"3","author":"Miyamoto","year":"2003","journal-title":"Mol Interv"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2202","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0006-8993(00)01998-3","article-title":"Acute and long-term effects of 17 beta-estradiol on G(i\/o) coupled neurotransmitter receptor function in the female rat brain as assessed by agonist-stimulated [35S]GTPgammaS binding","volume":"859","author":"Mize","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2203","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000054633","article-title":"Estrogens act in rat hippocampus and frontal cortex to produce rapid, receptor-mediated decreases in serotonin 5-HT1A receptor function","volume":"73","author":"Mize","year":"2001","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2204","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0091-3057(02)00747-5","article-title":"Dopamine-receptor stimulation in the prefrontal cortex ameliorates stress-induced rotarod impairment","volume":"72","author":"Mizoguchi","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2205","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1002\/hup.620","article-title":"Serotonin and noradrenaline reuptake inhibitors in animal models of pain","volume":"19","author":"Mochizucki","year":"2004","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2206","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neuint.2004.08.008","article-title":"Role of C-terminal region in the functional regulation of rat serotonin transporter (SERT)","volume":"46","author":"Mochizuki","year":"2005","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2207","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/ng0102-13","article-title":"A genomic view of alternative splicing","volume":"30","author":"Modrek","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2208","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ng1159","article-title":"Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of exon creation and\/or loss","volume":"14","author":"Modrek","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2209","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0091-3057(03)00220-X","article-title":"Associative and nonassociative learning after chronic imipramine in rats","volume":"76","author":"Mogensen","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2210","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00213-004-1792-z","article-title":"Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia","volume":"174","author":"Moghaddam","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2211","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0031-6997(24)01502-3","article-title":"The molecular and behavioral pharmacology of the orphanin FQ\/nociceptin peptide and receptor family","volume":"53","author":"Mogil","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2212","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1146\/annurev.neuro.23.1.777","article-title":"Pain genes?: natural variation and transgenic mutants","volume":"23","author":"Mogil","year":"2000","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2213","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0091-3057(86)90004-3","article-title":"Effects or REM sleep deprivation on central alpha1- and beta-adrenoceptors in rat brain","volume":"25","author":"Mogilnicka","year":"1986","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2214","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.300.1.2","article-title":"A new benzodiazepine pharmacology","volume":"300","author":"M\u00f6hler","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2215","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/oxfordjournals.schbul.a007047","article-title":"The concept of population prevention: application to schizophrenia","volume":"29","author":"Mojtabai","year":"2003","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2216","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1389-9457(99)00014-3","article-title":"A randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy","volume":"1","author":"Moldofsky","year":"2000","journal-title":"Sleep Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2217","first-page":"204","article-title":"Ethical, social and legal implications of pharmacogenomics: a critical review","volume":"4","author":"Moldrup","year":"2002","journal-title":"Commun Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2218","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.pnpbp.2004.08.006","article-title":"Synergistic interaction between ketoconazole and several antidepressant drugs with allopregnalonone treatments in ovariectomized Wistar rats forced to swim","volume":"28","author":"Molina-Hernandez","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2219","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.pbb.2004.11.017","article-title":"Antidepressant-like actions of intra-accumbens infusions of allopregnanolone in ovariectomized Wistar rats","volume":"80","author":"Molina-Hernandez","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2220","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00004714-200102000-00011","article-title":"Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group","volume":"21","author":"M\u00f6ller","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2221","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/sj.npp.1300413","article-title":"Genetic and pharmacological evidence of a role of GABAB receptors in the modulation of anxiety- and antidepressant-like behavior","volume":"29","author":"Mombereau","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2222","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejphar.2004.06.036","article-title":"Altered response to benzodiazepine anxiolytics in mice lacking GABAB(1) receptors","volume":"497","author":"Mombereau","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2223","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00001756-200502280-00021","article-title":"Altered anxiety and depression-related behaviour in mice lacking GABAB(2) receptor subunits","volume":"16","author":"Mombereau","year":"2005","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2224","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/sj.npp.1300109","article-title":"5-HT1A\/1B receptor-mediated efects of the selective serotonin reuptake inhibitor, citalopram, on sleep: studies in 5-HT1A and 5-HT1B knockout mice","volume":"28","author":"Monaca","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2225","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.brainres.2004.07.020","article-title":"\u03b12-Adrenoceptor modulation of long-term potentiation elicited in vivo in rat occipital cortex","volume":"1021","author":"Mondaca","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2226","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0166-4328(95)00226-X","article-title":"CGP 36,742, an orally active GABAB reeptor antagonist, facilitates memory in a social recognition test in rats","volume":"77","author":"Mondadori","year":"1996","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2227","series-title":"Chance and Necessity","first-page":"268","author":"Monod","year":"1972"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2228","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.7508638","article-title":"Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex","volume":"263","author":"Montague","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2229","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0065-7743(01)36045-1","article-title":"Phosphodiesterase 4 inhibitors","volume":"36","author":"Montana","year":"2001","journal-title":"Ann Reports Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2230","doi-asserted-by":"crossref","first-page":"10827","DOI":"10.1073\/pnas.0402141101","article-title":"Essential role of brain-derived neurotrophic factor in adult hippocampal function","volume":"101","author":"Monteggia","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2231","first-page":"10","article-title":"Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish working group for the study of psychotropic-related sexual dysfunction","volume":"62","author":"Montejo","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2232","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-0327(90)90043-8","article-title":"GABA, depression and the mechanism of action of antidepressant drugs: a neuroendocrine approach","volume":"20","author":"Monteleone","year":"1990","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2233","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.tins.2004.10.006","article-title":"Discrete synaptic states define a major mechanism of synapse plasticity","volume":"27","author":"Montgomery","year":"2004","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2234","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00004850-199803000-00002","article-title":"Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study","volume":"13","author":"Montgomery","year":"1998","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2235","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0165-0327(01)00313-5","article-title":"Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction","volume":"69","author":"Montgomery","year":"2002","journal-title":"J Affect Dis"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2236","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4088\/JCP.v65n0307","article-title":"Venlafaxine versus placebo in the preventive treatment of recurrent major depression","volume":"65","author":"Montgomery","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2237","doi-asserted-by":"crossref","first-page":"S13.05","DOI":"10.1016\/S0924-977X(04)80040-3","article-title":"Peptide approaches in the treatment of major depression\u2014lack of efficacy of the substance P (neurokinin1 receptor) antagonist aprepitant","volume":"14","author":"Montgomery","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2238","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/01.yic.0000137184.64610.c8","article-title":"Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study","volume":"19","author":"Montgomery","year":"2004","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2239","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejphar.2003.08.039","article-title":"Differential effects of the 5-HT1A receptor agonist flesinoxan given locally or systematically on REM sleep in the rat","volume":"478","author":"Monti","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2240","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbr.2003.08.023","article-title":"Effects of the 5-HT1A receptor ligands flesinoxan and WAY100,635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat","volume":"151","author":"Monti","year":"2004","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2241","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1017\/S1461145704004511","article-title":"A study of the brain structures involved in the acute effects of fluoxetine on REM sleep in the rat","volume":"8","author":"Monti","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2242","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0090-4295(94)80216-5","article-title":"Effect of yohimbine-trazodone on psychogenic impotence: a randomized, double-blind, placebo-controlled study","volume":"44","author":"Montorsi","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2243","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1006\/jtbi.2001.2460","article-title":"Small world patterns in food webs","volume":"214","author":"Montoya","year":"2002","journal-title":"J Theor Biol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2244","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0196-9781(99)00164-3","article-title":"Melanin-concentrating hormone (MCH) modifies memory retention in rats","volume":"20","author":"Monzon","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2245","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0014-2999(98)00642-6","article-title":"GABA receptors and benzodiazepine binding sites modulate hippocampal acetylcholine release in vivo","volume":"359","author":"Moor","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2246","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s002210000388","article-title":"Effect of amitriptyline on the messenger RNA of thyroid hormone-responsive genes in rat cerebral tissue","volume":"132","author":"Mooradian","year":"2000","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2247","first-page":"2783","article-title":"Organization and function of a central nervous system oscillator: the suprachiasmatic nucleus","volume":"42","author":"Moore","year":"1983","journal-title":"Fed Proc"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2248","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/cne.903440306","article-title":"Intergeniculate leaflet: an anatomically and functionally distinct subdivision of the lateral geniculate complex","volume":"344","author":"Moore","year":"1994","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2249","first-page":"204","article-title":"Selective inhibitors of neuronal nitric oxide synthas-is no NOS really good NOS for the nervous system?","volume":"18","author":"Moore","year":"1997","journal-title":"Trend Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-3223(00)00252-3","article-title":"Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?","volume":"48","author":"Moore","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2251","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00441-002-0575-2","article-title":"Suprachiasmatic nucleus organization","volume":"309","author":"Moore","year":"2002","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2252","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1046\/j.1460-9568.2003.02911.x","article-title":"Increased neurogenesis and brain-derived neurotrophic factor in neurokinin-1 receptor gene knockout mice","volume":"18","author":"Morcuende","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2253","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/BF02246963","article-title":"Effects of repeated mild stress and two antidepressant treatments on the behavioural response to 5-HT1C receptor activation in rats","volume":"110","author":"Moreau","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2254","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0924-977X(96)00015-6","article-title":"5-HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats","volume":"6","author":"Moreau","year":"1996","journal-title":"Eur Neuropharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2255","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0893-133X(00)00234-7","article-title":"Chronic effects of triiodothyronine in combination with imipramine on 5-HT transporter, 5-HT(1A) and 5-HT(2A) receptors in adult rat brain","volume":"24","author":"Moreau","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2256","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00213-004-1910-y","article-title":"Benzodiazepine receptor and serotonin2A receptor modulated the aversive-like effects of nitric oxide in the dorsolateral periaqueductal gray of rats","volume":"176","author":"Moreira","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2257","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0022-3565(24)38739-7","article-title":"The biochemical and neurologic basis for the treatment of male erectile dysfunction","volume":"296","author":"Moreland","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2258","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1006\/nimg.2000.0619","article-title":"Effects of fluvoxamine treatment on the in vivo binding of [F-18]FESP in drug na\u00efve depressed patients: a PET study","volume":"12","author":"Moresco","year":"2000","journal-title":"Neuroimage"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2259","first-page":"558","article-title":"Impact of gene polymorphisms on depression and its treatment","volume":"7","author":"Moret","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(00)00581-1","article-title":"The possible role of 5-HT1B\/D receptors in psychiatric disorders and their potential as a target for therapy","volume":"404","author":"Moret","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2261","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neubiorev.2003.11.017","article-title":"Estrogens and non-reproductive behaviors related to activity and fear","volume":"28","author":"Morgan","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2262","doi-asserted-by":"crossref","first-page":"774","DOI":"10.4088\/JCP.v66n0617","article-title":"Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study","volume":"66","author":"Morgan","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2263","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pneurobio.2005.01.001","article-title":"A review of systems and networks of the limbic forebrain\/limbic midbrain","volume":"75","author":"Morgane","year":"2005","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2264","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1017\/S1461145704004080","article-title":"Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders","volume":"7","author":"Morilak","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2265","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/07853899909019259","article-title":"Serotonin and the regulation of mammalian circadian rhythmicity","volume":"31","author":"Morin","year":"1999","journal-title":"Ann Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2266","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35048583","article-title":"High constitutive activity of native H3 receptors regulates histamine neurons in brain","volume":"408","author":"Morisset","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2267","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1046\/j.1471-4159.2003.01758.x","article-title":"Facilitation of alpha-amino-3hydroxy-5-methylisoxazole-4-propionate receptor transmission in the suprachiasmatic nucleus by aniracetam enhances photic responses of the biological clock in rodents","volume":"85","author":"Moriya","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2268","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0028-3908(03)00138-2","article-title":"The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats","volume":"45","author":"Mork","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2269","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1523\/JNEUROSCI.22-02-00389.2002","article-title":"Dopamine uptake through the norepinephrine transporter in brain region with low levels of the dopamine transporter: evidence from knock-out mice lines","volume":"22","author":"Moron","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2270","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1359-6446(04)03163-0","article-title":"From magic bullets to designed multiple ligands","volume":"9","author":"Morphy","year":"2004","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2271","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0028-3908(01)00058-2","article-title":"Tianeptine and its enantiomers: effects on spatial memory in rats with medial septum lesions","volume":"41","author":"Morris","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2272","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejphar.2003.08.066","article-title":"Dynamic regulation of the dopamine transporter","volume":"479","author":"Mortensen","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2273","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1471-4159.2001.00587.x","article-title":"Species-scanning mutagenesis of the serotonin transporter reveals residues essential in selective, high-affinity recognition of antidepressants","volume":"79","author":"Mortensen","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2274","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1600-0773.1993.tb01351.x","article-title":"Potential antidepressive properties of amantadine, memantine and bifemelane","volume":"72","author":"Moryl","year":"1993","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2275","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-2999(99)00202-2","article-title":"5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats","volume":"372","author":"Moser","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2276","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.psychres.2003.10.006","article-title":"Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients","volume":"126","author":"Mosimann","year":"2004","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2277","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0014-2999(89)90687-0","article-title":"GABAB receptors are up-regulated by chronic treatment with lithium or carbamazepine. GABA hypothesis of affective disorders?","volume":"166","author":"Motohashi","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2278","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1021\/jm000221f","article-title":"Electrooxidation potential as a tool in the early screening for new safer clozapine-like analogues","volume":"44","author":"Mouithys-Mickalad","year":"2001","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2279","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF00712985","article-title":"Effects of age and chronic antidepressant treatment on [3H]tryptamine and [3H]dihydroalprenodol binding to rat cortical membranes","volume":"13","author":"Mousseau","year":"1993","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2280","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/368251a0","article-title":"Co-evolution of ligand-receptor pairs","volume":"368","author":"Moyle","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2281","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1073\/pnas.111055298","article-title":"Physical stress and diversity\u2013productivity relationships: the role of positive interactions","volume":"98","author":"Mulder","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2282","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.neuroscience.2004.02.007","article-title":"(\u2212)-Nicotine ameliorates corticosterone's potentiation of NMDA receptor-mediated cornu ammonis 1 toxicity","volume":"125","author":"Mulholland","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2283","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00001504-200405000-00007","article-title":"Mood disorders in early Parkinson's disease","volume":"17","author":"M\u00fcller","year":"2004","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2284","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0893-133X(00)00099-3","article-title":"Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA, in specific areas of rat brain","volume":"23","author":"M\u00fcller","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2285","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/oxfordjournals.schbul.a006856","article-title":"Depressive factors and their relationships with other symptom domains in schizophrenia, schizoaffective disorder, and psychotic depression","volume":"27","author":"M\u00fcller","year":"2001","journal-title":"Schizophrenia Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2286","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0893-133X(99)00041-X","article-title":"Effects of antidepressants on 5-HT7 receptor regulation in the rat hypothalamus","volume":"21","author":"Mullins","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2287","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.tig.2004.06.014","article-title":"Meta-analysis of genetic association studies","volume":"20","author":"Munafo","year":"2004","journal-title":"Trends Gen"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2288","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00004850-200015020-00002","article-title":"Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive\u2013compulsive disorder","volume":"15","author":"Mundo","year":"2000","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2289","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1046\/j.1471-4159.2001.00091.x","article-title":"Effect of subchronic lithium treatment on citalopram-induced increases in extracellular concentrations of serotonin in the medial prefrontal cortex","volume":"76","author":"Muraki","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2290","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0092-8674(04)00259-4","article-title":"A distinct role for norepinephrine in memory retrieval","volume":"117","author":"Murchison","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2291","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.psyneuen.2004.02.006","article-title":"Intravenous administration of the neuropeptide galanin has fast antidepressant efficacy and affects the sleep EEG","volume":"59","author":"Murck","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2292","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/mds.10256","article-title":"Levodopa but not ropinirole induces an internalisation of D1 dopamine receptors in parkinsonian rats","volume":"17","author":"Muriel","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2293","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/S0306-4530(97)00021-8","article-title":"Antiglucocorticoid therapies in major depression: a review","volume":"22","author":"Murphy","year":"1997","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2294","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archpsyc.1984.01790120037006","article-title":"Cognitive therapy and pharmacotherapy, singly and together in the treatment of depression","volume":"41","author":"Murphy","year":"1981","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2295","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF00444705","article-title":"Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-cholorophenylpiperazine given intravenously or orally to healthy volunteers","volume":"98","author":"Murphy","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2296","first-page":"209","article-title":"Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486","volume":"18","author":"Murphy","year":"1993","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2297","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/070674379804300307","article-title":"Neuroendocrine response to inhibitors of steroid biosynthesis in patients with major depression resistant to antidepressant therapy","volume":"43","author":"Murphy","year":"1998","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2298","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1601-1848.2003.00049.x","article-title":"Experimental gene interaction studies with SERT mutant mice as models for human polygenic and epistatic traits and disorders","volume":"2","author":"Murphy","year":"2003","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2299","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1176\/appi.ajp.160.10.1830","article-title":"Pharmacogenetics of antidepressant medication intolerance","volume":"160","author":"Murphy","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2300","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1124\/mi.4.2.8","article-title":"Serotonin transporter genes, genetic disorders, and pharmacogenetics","volume":"4","author":"Murphy","year":"2004","journal-title":"Mol Interv"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2301","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/archpsyc.61.11.1163","article-title":"Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression","volume":"61","author":"Murphy","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2302","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1046\/j.1365-2826.2000.00577.x","article-title":"The effect of leptin on luteinizing hormone release is exerted in the zona incerta and mediated by melanin-concentrating hormone","volume":"12","author":"Murray","year":"2000","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2303","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF00199545","article-title":"The connectivity of the brain: multi-level quantitative analysis","volume":"73","author":"Murre","year":"1995","journal-title":"Biol Cybern"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2304","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0014-2999(00)00317-4","article-title":"Inverse agonism at \u03b12-adrenoceptors in native issue","volume":"398","author":"Murrin","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2305","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF00171039","article-title":"Facilitation of noradrenaline release from rat brain slices by \u03b2-adrenoceptors","volume":"351","author":"Murugaiah","year":"1995","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2306","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/j.1460-9568.2005.03949.x","article-title":"Changes in signalling pathways regulating neuroplasticity induced by neurokinin1 receptor knockout","volume":"21","author":"Musazzi","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2307","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0166-4328(96)00061-7","article-title":"Ventral tegmental area 5-HT receptors: mesolimbic dopamine release and behavioural studies","volume":"73","author":"Mylecharane","year":"1996","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2308","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.yco.0000069080.26384.d8","article-title":"Current review of the comorbidity of affective, anxiety, and substance use disorders","volume":"16","author":"Myrick","year":"2003","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2309","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0015-0282(01)02006-4","article-title":"Phytoestrogens: are they really estrogen mimics?","volume":"77","author":"Naftolin","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2310","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0014-2999(87)90648-0","article-title":"The effect of agonists at the GABA-benzodiazepine receptor complex on the duration of immobility of mice in the forced swimming test","volume":"142","author":"Nagatani","year":"1987","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2311","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.neuron.2004.11.016","article-title":"Bidirectional activity-dependent morphological plasticity in hippocampal neurons","volume":"44","author":"N\u00e4gerl","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2312","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nrd989","article-title":"The further evolution of biotech","volume":"2","author":"Nagle","year":"2003","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2313","first-page":"221","article-title":"The melanin-concentrating hormone: from the peptide to the gene","volume":"8","author":"Nahon","year":"1994","journal-title":"Crit Rev Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2314","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1460-9568.2005.03864.x","article-title":"Pharmacological antagonism of metabotropic glutamate receptor1 regulates long-term potentiation and spatial reference memory in the dentate gyrus of freely moving rats via N-methyl-d-aspartate and metabotropic glutamate receptor-dependent mechanisms","volume":"21","author":"Naie","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2315","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/syn.20054","article-title":"Activation of 5-HT2 receptors enhances the release of acetylcholine in the prefrontal cortex and hippocampus of the rat","volume":"53","author":"Nair","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2316","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0006-8993(96)00413-1","article-title":"Involvement of GABAB receptor systems in action of antidepressants: II. Baclofen attenuates the effect of desipramine whereas muscimol has no effect in learned helplessness paradigm in rats","volume":"728","author":"Nakagawa","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2317","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0006-8993(96)00929-8","article-title":"Involvement of GABAB receptor systems in experimental depression: baclofen but not bicuculline exacerbates helplessness in rats","volume":"741","author":"Nakagawa","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2318","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0006-8993(95)01273-7","article-title":"Involvement of GABA(B) receptor systems in action of antidepressants: baclofen but not bicuculline attenuates the effects of antidepressants on the forced swim test in rats","volume":"709","author":"Nakagawa","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2319","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(99)00567-1","article-title":"The GABAB receptor antagonist CGP36742 improves learned helplessness in rats","volume":"381","author":"Nakagawa","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2320","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s002100000222","article-title":"Serotonergic mechanisms involved in the attentional and vigilance task performance of rats and the palliative action of aniracetam","volume":"361","author":"Nakamura","year":"2000","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2321","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-2999(98)00191-5","article-title":"Characterization of \u03b2-phenylethylamine-induced monoamine release in rat nucleus accumbens: a microdialysis study","volume":"349","author":"Nakamura","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2322","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1213\/01.ANE.0000154303.93909.A3","article-title":"The effects of the tramadol metabolite O-desmethyl tramadol on muscarinic receptor-induced responses in Xenopus oocytes expressing cloned M1 or M3 receptors","volume":"101","author":"Nakamura","year":"2005","journal-title":"Aneth Analg"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2323","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.brainresbull.2004.02.007","article-title":"Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation","volume":"63","author":"Nakayama","year":"2004","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2324","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0014-2999(02)01660-6","article-title":"Repeated imipramine and electroconvulsive shock increase \u03b11A-adrenoceptor mRNA levels in rat prefrontal cortex","volume":"444","author":"Nalepa","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2325","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/syn.20048","article-title":"Identification and characterization of a novel allosteric modulator (SoRI-6238) of a serotonin transporter","volume":"53","author":"Nandi","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2326","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0014-2999(95)00222-7","article-title":"Increased 5-HT2 receptor-mediated behavior 11 days after shock in learned helplessness rats","volume":"281","author":"Nankai","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2327","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0014-2999(96)00254-3","article-title":"Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain","volume":"307","author":"Narita","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2328","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0920-1211(95)00035-9","article-title":"Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve","volume":"22","author":"Naritoku","year":"1995","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2329","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1054\/mehy.2001.1484","article-title":"Inspection time: a neuropsychophysiological test for measuring the functional integrity of the cholinergic system","volume":"57","author":"Nathan","year":"2001","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2330","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00008877-200011000-00011","article-title":"Serotonin, noradrenaline and cognitive function: a preliminary investigation of the acute pharmacodynamic effects of a serotonin versus a serotonin and noradrenaline reuptake inhibitor","volume":"11","author":"Nathan","year":"2000","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2331","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/1099-1077(200008)15:6<397::AID-HUP212>3.0.CO;2-L","article-title":"A review of the role of serotonin receptors in psychiatric disorders","volume":"15","author":"Naughton","year":"2000","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2332","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0304-3940(01)01930-9","article-title":"Melatonin reduces anxiety induced by lipopolysaccharide in the rat","volume":"307","author":"Nava","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2333","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0014-2999(01)01163-3","article-title":"\u03b3-Hydroxybutyric acid and baclofen decrease extracellular acetylcholine levels in the hippocampus via GABAB receptors","volume":"430","author":"Nava","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2334","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1081\/CNV-200027137","article-title":"Role of neurokinin-1 receptor antagonists in chemotherapy-induced emesis: summary of clinical trials","volume":"22","author":"Navari","year":"2004","journal-title":"Cancer Invest"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2335","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1211\/0022357011775235","article-title":"Effect of chronic and acute administration of fluoxetine and its additive effect with morphine on the behavioural response in the formalin test in rats","volume":"53","author":"Nayebi","year":"2001","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2336","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1086\/423901","article-title":"The future of association studies: gene-based analysis and replication","volume":"75","author":"Neale","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2337","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1034\/j.1399-0004.1999.560401.x","article-title":"Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?","volume":"56","author":"Nebert","year":"1999","journal-title":"Clin Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2338","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ejphar.2004.07.031","article-title":"Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead","volume":"500","author":"Nebert","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2339","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00129785-200303060-00002","article-title":"Pharmacogenomics and \u201cindividualized drug therapy\u201d: high expectations, disappointing achievements","volume":"3","author":"Nebert","year":"2003","journal-title":"Am J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2340","first-page":"26","article-title":"Cognitive effects of paroxetine in older depressed patients","volume":"60","author":"Nebes","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2341","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3956(02)00085-7","article-title":"Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomised, double-blind clinical trial with nortriptyline and paroxetine","volume":"37","author":"Nebes","year":"2003","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2342","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0924-977X(03)00015-4","article-title":"Brain neurosteroid changes after paroxetine administration in mice","volume":"13","author":"Nechmad","year":"2003","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2343","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0166-4328(96)00204-5","article-title":"Sleep and EEG power spectrum effects of the 5-HT1A antagonist NAN-190 alone and in combination with citalopram","volume":"75","author":"Neckelmann","year":"1996","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2344","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-4328(03)00215-8","article-title":"Different roles of 5-HT2A and 5-HT2C receptors in regulation of female rat paced mating behaviour","volume":"149","author":"Nedergaard","year":"2004","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2345","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11934-002-0099-z","article-title":"Combination therapy for erectile dysfunction: where we are and what's in the future","volume":"3","author":"Nehra","year":"2002","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2346","first-page":"35","article-title":"Treatment of antidepressant nonresponders: augmentation or switch?","volume":"59","author":"Nelson","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2347","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0006-3223(99)00173-0","article-title":"A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression","volume":"46","author":"Nelson","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2348","first-page":"5","article-title":"Managing treatment-resistant major depression","volume":"64","author":"Nelson","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2349","first-page":"53","article-title":"5-HT5 receptors","volume":"3","author":"Nelson","year":"2004","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2350","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1176\/ajp.154.11.1497","article-title":"DST studies in psychotic depression: a meta-analysis","volume":"154","author":"Nelson","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2351","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archpsyc.1991.01810280019002","article-title":"A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression","volume":"48","author":"Nelson","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2352","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/378383a0","article-title":"Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase","volume":"378","author":"Nelson","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2353","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.biopsych.2003.08.007","article-title":"Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study","volume":"55","author":"Nelson","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2354","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/(SICI)1520-6394(1996)4:4<169::AID-DA3>3.0.CO;2-A","article-title":"Augmentation strategies in patients with refractory depression","volume":"4","author":"Nemeroff","year":"1997","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2355","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0304-3959(90)90021-5","article-title":"Visceral pain: a review of experimental studies","volume":"41","author":"Ness","year":"1990","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2356","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2357","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3959(02)00140-9","article-title":"Metabotropic glutamate receptors\u2014important modulation of nociception and pain behavior","volume":"98","author":"Neugebauer","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2358","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0893-133X(96)00095-4","article-title":"Chronic fluoxetine reduces serotonin transporter mRNA and 5-HT1B mRNA in a sequential manner in the rat dorsal raphe nucleus","volume":"15","author":"Neumaier","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2359","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0891-0618(00)00092-2","article-title":"Localization of 5-HT7 receptors in rat brain by immunocytochemistry, in situ hybridisation, and agonist stimulated cFos expression","volume":"21","author":"Neumaier","year":"2001","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2360","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/archpsyc.55.2.167","article-title":"Effects of tryptophan depletion in drug-free depressed patients who responded to total sleep deprivation","volume":"55","author":"Neumeister","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2361","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/archpsyc.55.6.524","article-title":"Effects of tryptophan depletion verses catecholamine depletion in patients with seasonal affective disorder in remission with light therapy","volume":"55","author":"Neumeister","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2362","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/archpsyc.61.8.765","article-title":"Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls","volume":"61","author":"Neumeister","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2363","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00213-004-1950-3","article-title":"Implications of genetic research on the role of serotonin in depression: emphasis on the serotonin type1A receptor and the serotonin transporter","volume":"174","author":"Neumeister","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2364","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1126\/science.1068326","article-title":"Stability in real food webs: weak links in long loops","volume":"296","author":"Neutel","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2365","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1073\/pnas.101109298","article-title":"Evolution of genome\u2013phenome diversity under environmental stress","volume":"98","author":"Nevo","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2366","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0165-1781(90)90093-K","article-title":"Distinguishing depression and negative symptoms in unmedicated patients with schizophrenia","volume":"31","author":"Newcomer","year":"1990","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2367","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archpsyc.56.6.527","article-title":"Decreased memory performance in healthy humans induced by stress-level cortisol treatment","volume":"56","author":"Newcomer","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2368","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.coph.2003.11.001","article-title":"Effects of nicotinic stimulation on cognitive performance","volume":"4","author":"Newhouse","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2369","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S1461145700001875","article-title":"Pharmacological mechanisms of T3 augmentation of antidepressant action","volume":"3","author":"Newman","year":"2000","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2370","first-page":"93","article-title":"Down-regulation of rat beta-adrenoceptors by clenbuterol or desipramine does not require chronic treatment: [3H] CGP-12177 binding reveals rapid (24 hour) modulation","volume":"41","author":"Newman-Tancredi","year":"1996","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2371","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0014-2999(96)00985-5","article-title":"Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptors","volume":"319","author":"Newman-Tancredi","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2372","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0028-3908(97)00022-1","article-title":"Agonist and inverse agonist efficacy at human recombinant serotonin 5-HT1A receptors as a function of receptor G-protein stoichiometry","volume":"36","author":"Newman-Tancredi","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2373","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0893-133X(97)00169-3","article-title":"Agonist and antagonist actions of (-) pindolol at recombinant, human serotonin1A (5-HT1A) receptors","volume":"18","author":"Newman-Tancredi","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2374","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/PL00005243","article-title":"Actions of \u03b12 adrenoceptor ligands at alpha2A and 5-HT1A receptors; the agonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors","volume":"358","author":"Newman-Tancredi","year":"1998","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2375","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s002100000306","article-title":"Pindolol antagonises G-protein activation at both pre- and postsynaptic serotonin 5-HT1A receptors","volume":"363","author":"Newman-Tancredi","year":"2001","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2376","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0006-8993(01)02927-4","article-title":"Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra","volume":"920","author":"Newman-Tancredi","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2377","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1124\/jpet.102.039875","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor: II. Agonist and antagonist properties at subtypes of dopamine \u201cD2-like receptor' and \u03b11\/\u03b12-adrenoceptor","volume":"308","author":"Newman-Tancredi","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2378","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1124\/mol.62.3.590","article-title":"Antibody capture assay reveals bell-shaped concentration-response isotherms for h5-HT(1A) receptor-mediated Galpha (i3) activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signaling","volume":"62","author":"Newman-Tancredi","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2379","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1124\/jpet.102.039883","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor: III. Agonist and antagonist properties at serotonin \u201c5-HT1\u201d and \u201c5-HT2\u201d receptor subtypes","volume":"303","author":"Newman-Tancredi","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2380","doi-asserted-by":"crossref","first-page":"10883","DOI":"10.1523\/JNEUROSCI.22-24-10883.2002","article-title":"Inhibition of cAMP response element-binding protein of dynorphin in the nucleus accumbens produces an antidepressant-like effect","volume":"24","author":"Newton","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2381","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.pneurobio.2003.12.003","article-title":"Regulation of hippocampal synaptic plasticity by cyclic AMP-dependent protein kinases","volume":"71","author":"Nguyen","year":"2003","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2382","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1073\/pnas.94.5.2036","article-title":"Blockade of 5-HT2C serotonin receptors by fluoxetine (Prozac)","volume":"94","author":"Ni","year":"1997","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2383","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","article-title":"Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments","volume":"15","author":"Nibuya","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2384","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1523\/JNEUROSCI.16-07-02365.1996","article-title":"Chronic antidepressant administration increases the expression of camp response element binding protein (CREB) in rat hippocampus","volume":"16","author":"Nibuya","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2385","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00004714-200304000-00008","article-title":"Clinical and neurobiological effects of tianeptine and paroxetine in major depression","volume":"23","author":"Nickel","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2386","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0022-3565(24)29585-9","article-title":"Antidepressant drug-induced alterations in neuron-localized tumor necrosis factor-\u03b1 mRNA and \u03b12-adrenergic receptor sensitivity","volume":"297","author":"Nickola","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2387","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2004.07.091","article-title":"Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice","volume":"499","author":"Nielsen","year":"2004","journal-title":"Eur J Pharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2388","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0301-0082(02)00011-4","article-title":"Dopamine and the regulation of cognition and attention","volume":"67","author":"Nieoullon","year":"2002","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2389","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1176\/ajp.151.7.1069","article-title":"Trazodone for antidepressant-associated insomnia","volume":"151","author":"Nierenberg","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2390","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4088\/JCP.v60n0403","article-title":"Residual symptoms in depressed patients who respond acutely to fluoxetine","volume":"60","author":"Nierenberg","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2391","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00004714-200302000-00013","article-title":"Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressants","volume":"23","author":"Nierenberg","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2392","first-page":"13","article-title":"Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy","volume":"64","author":"Nierenberg","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2393","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/sj.npp.1300405","article-title":"Placebo-controlled continuation treatment with mirtazapine: acute pattern of response predicts relapse","volume":"29","author":"Nierenberg","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2394","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0022-5347(05)64754-4","article-title":"A causative factor of copulatory disorder in rats following social stress","volume":"168","author":"Niikura","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2395","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1017\/S1461145705005158","article-title":"Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram","volume":"8","author":"Nikisch","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2396","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1359-6446(05)03420-3","article-title":"Biological networks and analysis of experimental data in drug discovery","volume":"10","author":"Nikolsky","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2397","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/sj.npp.1300658","article-title":"Prolonged effects of repeated social defeat stress on mRNA expression and function of \u03bc-opioid receptors in the ventral tegmental area of rats","volume":"30","author":"Nikulina","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2398","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00001504-200405000-00008","article-title":"Psychiatric and cognitive disorders in Parkinson's disease","volume":"17","author":"Nilsson","year":"2004","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2399","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4088\/JCP.v63n0510","article-title":"Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination","volume":"63","author":"Ninan","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2400","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4088\/JCP.v65n0318","article-title":"Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue","volume":"65","author":"Ninan","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2401","doi-asserted-by":"crossref","first-page":"9472","DOI":"10.1074\/jbc.274.14.9472","article-title":"RNA editing of the human serotonin 5-hydroxytryptamine2C receptor silences constitutive activity","volume":"274","author":"Niswender","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2402","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0306-4522(01)00593-0","article-title":"Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group","volume":"111","author":"Nocjar","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2403","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0006-8993(03)03330-4","article-title":"Antisense knockdown of spinal-mGluR1 reduces the sustained phase of formalin-induced nociceptive responses","volume":"987","author":"Noda","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2404","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S1389-9457(04)90003-2","article-title":"What can neuroimaging findings tell us about sleep disorders?","volume":"5","author":"Nofzinger","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2405","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/BF02244315","article-title":"Effects of chronic electroconvulsive shock on interstitial concentrations of dopamine in the nucleus accumbens","volume":"105","author":"Nomikos","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2406","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/2647","article-title":"Leptin-insensitive hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene","volume":"4","author":"Nonogaki","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2407","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2337\/diabetes.52.2.315","article-title":"Hyperactivity and reduced energy cost of physical activity in serotonin 5-HT2C receptor mutant mice","volume":"52","author":"Nonogaki","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2408","doi-asserted-by":"crossref","first-page":"11376","DOI":"10.1073\/pnas.171315998","article-title":"Phenotypic diversity and ecosystem functioning in changing environments: a theoretical framework","volume":"98","author":"Norberg","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2409","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/depr.3050020208","article-title":"Buspirone treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors","volume":"2","author":"Norden","year":"1994","journal-title":"Depression"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2410","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4088\/JCP.v63n0411","article-title":"Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study","volume":"63","author":"Normann","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2411","doi-asserted-by":"crossref","first-page":"7476","DOI":"10.1074\/jbc.M306818200","article-title":"The paired activation of the two components of the muscarinic M3 receptor dimer is required for induction of ERK1\/2 phosphorylation","volume":"279","author":"Novi","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2412","doi-asserted-by":"crossref","first-page":"19768","DOI":"10.1074\/jbc.M411281200","article-title":"Paired activation of the two components within muscarinic M3 receptor dimers is required for recruitment of beta-arrestin-1 to the plasma membrane","volume":"280","author":"Novi","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2413","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/hup.411","article-title":"Tianeptine and fluoxetine in major depression: a 6-week randomised, double-blind study","volume":"17","author":"Novotny","year":"2002","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2414","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0014-2999(97)01589-6","article-title":"Adaptations of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors","volume":"342","author":"Nowak","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2415","first-page":"1143","article-title":"Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study","volume":"55","author":"Nowak","year":"2003","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2416","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00019053-199508020-00007","article-title":"A Markov process analysis comparing the cost-effectiveness of maintenance therapy with citalopram versus standard therapy in major depression","volume":"8","author":"Nuijten","year":"1995","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2417","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4088\/JCP.v60n0902","article-title":"Antidepressant medication change in a clinical treatment setting: a comparison of the effectiveness of selective serotonin reuptake inhibitors","volume":"60","author":"Nurnberg","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2418","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1176\/appi.ajp.158.11.1926","article-title":"Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors","volume":"158","author":"Nurnberg","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2419","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.289.1.56","article-title":"Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial","volume":"289","author":"Nurnberg","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2420","doi-asserted-by":"crossref","first-page":"S433","DOI":"10.1016\/S0924-977X(00)00110-3","article-title":"Treatment of depression and concomitant anxiety","volume":"10","author":"Nutt","year":"2000","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2421","first-page":"35","article-title":"\u03b12-Adrenoceptors and depression","volume":"10","author":"Nutt","year":"1996","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2422","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1017\/S1461145702003048","article-title":"Generalized anxiety disorder: comorbidity, comparative biology and treatment","volume":"5","author":"Nutt","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2423","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0169-5347(00)01948-0","article-title":"Coral reef disturbance and resilience in a human-dominated environment","volume":"15","author":"Nystrom","year":"2000","journal-title":"Trends Ecol Evol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2424","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0014-2999(00)00562-8","article-title":"The dopamine D4 receptor: one decade of research","volume":"405","author":"Oak","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2425","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1124\/mol.64.3.731","article-title":"A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5","volume":"64","author":"O'Brien","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2426","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.biopsych.2004.10.002","article-title":"Priority actions to improve the care of persons with co-occurring subtance abuse and other mental disorders: a call to action","volume":"56","author":"O'Brien","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2427","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/hup.609","article-title":"Cytokines: abnormalities in major depression and implications for pharmacological treatment","volume":"19","author":"O'Brien","year":"2004","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2428","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neubiorev.2004.08.006","article-title":"Does neuropeptide Y (NPY) mediate the effects of psychotropic drugs?","volume":"28","author":"Obuchowicz","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2429","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004714-199802000-00018","article-title":"Adding risperidone to selective serotonin reuptake inhibitor improves chronic depression","volume":"18","author":"O'Connor","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2430","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neuropharm.2004.08.014","article-title":"Effects of long-term biogenic amine transporter blockade on receptor\/G-protein coupling in rat brain","volume":"48","author":"O'Connor","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2431","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1124\/jpet.104.078451","article-title":"Time-dependent changes in receptor\/G-protein coupling in rat brain following chronic monoamine transporter blockade","volume":"313","author":"O'Connor","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2432","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/0269881105051526","article-title":"Trazodone and its active metabolite m-chlorophenylpiperazine as partial agonists at 5-HT1A receptors assessed by [35S]GTP\u03b3S binding","volume":"19","author":"Odagaki","year":"2005","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2433","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0091-3057(97)00038-5","article-title":"Pharmacological characterization of the discriminative stimulus effects of clenbuterol in rats","volume":"58","author":"O'Donnell","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2434","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tips.2004.01.003","article-title":"Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4)","volume":"25","author":"O'Donnell","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2435","first-page":"246","article-title":"Involvement of beta-1 and beta-2 adrenergic receptors in the antidepressant-like effects of centrally administered isoproterenol","volume":"271","author":"O'Donnell","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2436","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0014-827X(00)00050-1","article-title":"Design, synthesis and biological evaluation of new 3-[(4-aryl)piperazin-1-yl]-1-arylpropane derivatives as potential antidepressants with a dual mode of action: serotonin reuptake inhibition and 5-HT1A receptor antagonism","volume":"55","author":"Oficialdegui","year":"2000","journal-title":"Il Farmaco"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2437","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1213\/01.ANE.0000108963.77623.A4","article-title":"The inhibitory effects of tramadol on 5-HT2C receptors expressed in Xenopus oocytes","volume":"98","author":"Ogata","year":"2004","journal-title":"Anesth Analg"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2438","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/sj.mp.4001547","article-title":"Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach","volume":"9","author":"Ogden","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2439","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00004714-199806000-00006","article-title":"Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimes","volume":"18","author":"O'Hanlon","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2440","first-page":"5","article-title":"Specific characteristics of the pain\/depression association in the general population","volume":"65","author":"Ohayon","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2441","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archpsyc.60.1.39","article-title":"Using chronic pain to predict depressive morbidity in the general population","volume":"60","author":"Ohayon","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2442","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.biopsych.2003.09.016","article-title":"Endogenous dopamine release induced by repetitive transcranial magnetic stimulation over the primary motor cortex: an [11C]raclopride positron emission tomography study in anesthetized macaque monkeys","volume":"55","author":"Ohnishi","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2443","series-title":"Evolution by Gene Duplication","first-page":"262","author":"Ohno","year":"1970"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2444","doi-asserted-by":"crossref","first-page":"16134","DOI":"10.1073\/pnas.252626899","article-title":"Near-neutrality in evolution of genes and gene regulation","volume":"99","author":"Ohta","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2445","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.bjp.0702994","article-title":"Functional neuroimaging of cognition impaired by a classical antihistamine, d-chlorpheniramine","volume":"129","author":"Okamura","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2446","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuint.2004.08.002","article-title":"Allosteric modulation of GABAB receptor function in human frontal cortex","volume":"46","author":"Olianas","year":"2005","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2447","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0006-8993(00)02273-3","article-title":"Localization of 5-HT5A receptor-like immunoreactivity in the rat brain","volume":"867","author":"Oliver","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2448","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/00004850-199807006-00003","article-title":"Serotonin, serotonergic receptors, selective serotonin reuptake inhibitors and sexual behaviour","volume":"13","author":"Olivier","year":"1998","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2449","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-0348-8391-7_3","article-title":"Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors","volume":"54","author":"Olivier","year":"2000","journal-title":"Prog Drug Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2450","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0924-977X(99)00065-6","article-title":"5-HT3 receptor antagonists and anxiety; a preclinical and clinical review","volume":"10","author":"Olivier","year":"2000","journal-title":"J Eur Neuropsychopharm"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2451","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0165-0327(02)00090-3","article-title":"Faster response in depressive patients treated with fluoxetine alone than in combination with buspirone","volume":"76","author":"Onder","year":"2003","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2452","doi-asserted-by":"crossref","first-page":"982","DOI":"10.4088\/JCP.v66n0804","article-title":"Association between pain and depression among older adults in Europe: results from the aged in home care (AdHOC) project: a cross-sectional study","volume":"66","author":"Onder","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2453","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/hup.496","article-title":"Animal models of depression: are there any?","volume":"18","author":"O'Neil","year":"2003","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2454","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0091-3057(95)02047-0","article-title":"GR 127935 blocks the locomotor and antidepressant-like effects of RU 24969 and the action of antidepressants in the mouse tail suspension test","volume":"53","author":"O'Neill","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2455","first-page":"181","article-title":"AMPA receptor potentiators for the treatment of CNS disorders","volume":"3","author":"O'Neill","year":"2004","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2456","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/A:1021368007777","article-title":"Current trends in lead discovery: are we looking for the appropriate properties?","volume":"5","author":"Oprea","year":"2002","journal-title":"Mol Divers"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2457","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1021\/ci010366a","article-title":"Is there a difference between leads and drugs? A historical perspective","volume":"41","author":"Oprea","year":"2001","journal-title":"J Chem Inf Comput Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2458","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1017\/S1461145704004468","article-title":"Effect of repeated treatment with olanzapine or olanzapine plus fluoxetine on tyrosine hydroxylase in the rat locus coeruleus","volume":"7","author":"Ordway","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2459","first-page":"379","article-title":"Quantitative autoradiography of central beta adrenoceptor subtypes: comparison of the effects of chronic treatment with desipramine or centrally administered l-isoproterenol","volume":"247","author":"Ordway","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2460","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0006-3223(02)01728-6","article-title":"Elevated agonist binding to \u03b12-adrenoceptors in the locus coeruleus in major depression","volume":"53","author":"Ordway","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2461","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.biopsych.2003.12.020","article-title":"Response to tryptophan depletion in major depression treated with either cognitive therapy or selective serotonin reuptake inhibitor antidepressants","volume":"55","author":"O'Reardon","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2462","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0006-3223(95)00079-8","article-title":"Circadian profiles of cortisol, prolactin, and thyrotropin in seasonal affective disorder","volume":"39","author":"Oren","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2463","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1101\/lm.67303","article-title":"Acquisition, retention, and recall of memory after injection of RS67333, a 5-HT(4) receptor agonist, into the nucleus basalis magnocellularis of the rat","volume":"10","author":"Orsetti","year":"2003","journal-title":"Learn Mem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2464","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/archpsyc.58.1.77","article-title":"Serum thyrotropin concentrations and bioactivity during sleep deprivation in depression","volume":"58","author":"Orth","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2465","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0091-3057(88)90315-2","article-title":"Antihistaminic drugs increase feeding, while histidine suppresses feeding in rats","volume":"31","author":"Orthen-Gambill","year":"1988","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2466","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0031-9384(92)90132-L","article-title":"FMH-induced decrease in central histamine levels produces increased feeding and body weight in rats","volume":"51","author":"Orthen-Gambill","year":"1992","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2467","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/sj.npp.1300267","article-title":"Altered serotonergic neurotransmission but normal hypothalamic\u2013pituitary\u2013adrenocortical axis activity in mice treated chronically with the corticotropin-releasing hormone receptor type 1 antagonist NBI 30775","volume":"28","author":"Oshima","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2468","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4088\/JCP.v60n0410","article-title":"Risperidone augmentation of selective serotonin reuptake inhibitors in major depression","volume":"60","author":"Ostroff","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2469","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00511408","article-title":"Acute and chronic effects of lithium chloride on GABA-ergic function in the rat corpus striatum and frontal cerebral cortex","volume":"332","author":"Otero Losada","year":"1986","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2470","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0306-3623(86)90049-2","article-title":"Time-related response of central serotonergic function to lithium administration","volume":"17","author":"Otero Losada","year":"1986","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2471","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1017\/S1461145704004298","article-title":"Effect of treatment with bupropion on EEG sleep: relationship to antidepressant response","volume":"7","author":"Ott","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2472","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.biopsych.2004.06.003","article-title":"Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: the heart and soul study","volume":"56","author":"Otte","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2473","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.4088\/JCP.v63n1204","article-title":"Comorbidity of obsessive\u2013compulsive disorder and depression: prevalence, symptom severity, and treatment effect","volume":"63","author":"Overbeek","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2474","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2004.06.035","article-title":"Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression","volume":"497","author":"Overstreet","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2475","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00001756-199801260-00014","article-title":"Effect of melatonin receptor ligands on swim test immobility","volume":"9","author":"Overstreet","year":"1998","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2476","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/1025389031000111311","article-title":"Involvement of 5-HT1A receptors in animal tests of anxiety and depression: evidence from genetic models","volume":"6","author":"Overstreet","year":"2003","journal-title":"Stress"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2477","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/sj.bjp.0706188","article-title":"Effects of amantadine and budipine on antidepressant drug-evoked changes in extracellular 5-HT in the frontal cortex of freely moving rats","volume":"145","author":"Owen","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2478","first-page":"1305","article-title":"Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites","volume":"283","author":"Owens","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2479","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1460-9568.2003.02724.x","article-title":"Different alpha(2) adrenoceptor subtypes control noradrenaline release and cell firing in the locus coeruleus of wildtype and monoamine oxidase-A knockout mice","volume":"18","author":"Owesson","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2480","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/syn.10273","article-title":"Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors","volume":"50","author":"Oz","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2481","doi-asserted-by":"crossref","first-page":"43991","DOI":"10.1074\/jbc.M306360200","article-title":"Glycosyl modification facilitates homo- and hetero-oligomerization of the serotonin transporter","volume":"278","author":"Ozaslan","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2482","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejphar.2003.11.047","article-title":"Loss of amitriptyline analgesia in alpha2A-adrenoceptor deficient mice","volume":"485","author":"Ozdogan","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2483","series-title":"Neuropsychopharmacology\u2014The Fifth Generation of Progress","first-page":"1859","article-title":"Basic mechanisms of sleep: new evidence of the neuroanatomy and neuromodulation of the NRME-REM cycle","author":"Pace-Schott","year":"2002"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2484","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.2174\/1381612043383872","article-title":"Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?","volume":"10","author":"Pacher","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2485","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2174\/0929867043455594","article-title":"Trends in the development of new antidepressants. Is there a light at the end of the tunnel?","volume":"11","author":"Pacher","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2486","first-page":"638","article-title":"Repetitive transcranial magnetic stimulation in major depression: relation between efficacy and stimulation intensity","volume":"27","author":"Padberg","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2487","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0094-0143(05)70141-5","article-title":"Oral drug therapy for erectile dysfunction","volume":"28","author":"Padma-Nathan","year":"2001","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2488","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pbb.2003.09.015","article-title":"Antidepressant-like effects of NMDA-receptor antagonist injected into the dorsal hippocampus of rats","volume":"77","author":"Padovan","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2489","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1124\/jpet.102.034280","article-title":"Behavioral and neurochemical effects of 5-(4-[4-(5-cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist","volume":"302","author":"Page","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2490","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s00213-002-1269-x","article-title":"Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action","volume":"165","author":"Page","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2491","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1176\/appi.ajp.158.2.314","article-title":"Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation","volume":"158","author":"Paill\u00e8re-Martinot","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2492","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1126\/science.1069811","article-title":"Trophic control of production in rocky intertidal community","volume":"296","author":"Paine","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2493","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1073\/pnas.0138018100","article-title":"Dopamine controls the firing pattern of dopamine neurons via a network feedback mechanism","volume":"100","author":"Paladini","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2494","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0306-4522(02)00660-7","article-title":"Postsynaptic dorsal column neurons express NK1 receptors following colon inflammation","volume":"116","author":"Palecek","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2495","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0306-4522(02)00228-2","article-title":"Thyroid hormone distribution in the mouse brain: the role of transthyretin","volume":"113","author":"Palha","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2496","first-page":"581","article-title":"On the role of metabotropic glutamate receptors in the mechanisms of actions of antidepressants","volume":"54","author":"Palucha","year":"2002","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2497","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neuropharm.2003.09.006","article-title":"Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats","volume":"46","author":"Palucha","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2498","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/BF02246453","article-title":"Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2C receptor","volume":"126","author":"P\u00e4lvim\u00e4ki","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2499","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.phrs.2004.11.005","article-title":"Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroid plexus after fluoxetine and citalopram treatments","volume":"51","author":"P\u00e4lvim\u00e4ki","year":"2005","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2500","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archpsyc.61.7.714","article-title":"Combined pharmacotherapy and psychological treatment for depression","volume":"61","author":"Pampallona","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2501","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pneurobio.2004.09.003","article-title":"The supramammillary area: its organization, functions and relationship to the hippocampus","volume":"74","author":"Pan","year":"2004","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2502","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0165-3806(00)00145-0","article-title":"Plasticity in serotonin uptake in primary neuronal cultures of serotonin transporter knockout mice","volume":"126","author":"Pan","year":"2001","journal-title":"Dev Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2503","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/syn.20034","article-title":"Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex","volume":"53","author":"Pan","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2504","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0165-0327(00)00328-1","article-title":"Psychopathological dimensions of depression: a factor study of the 17-item Hamilton depression rating scale in unipolar depressed outpatients","volume":"68","author":"Pancheri","year":"2002","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2505","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0022-3565(24)37206-4","article-title":"Inhibition of neuronal Na+ channels by antidepressant drugs","volume":"284","author":"Pancrazio","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2506","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1461145704004936","article-title":"Focus on protein kinase A and protein Kinase C critical components of signal transduction system, in mood disorders and suicide","volume":"8","author":"Pandey","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2507","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0196-9781(01)00438-7","article-title":"Antidepressant-type effect of the NK3 tachykinin receptor agonist aminosenktide in mouse lines differing in endogenous opioid system activity","volume":"22","author":"Panocka","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2508","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4088\/JCP.v65n0212","article-title":"Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder","volume":"65","author":"Papakostas","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2509","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1017\/S1461145704004602","article-title":"Obesity among outpatients with major depressive disorder","volume":"8","author":"Papakostas","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2510","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1034\/j.1600-0447.2002.02342.x","article-title":"Melatonin response to atenolol administration in depression: indication of \u03b2-adrenoceptor dysfunction in a subtype of depression","volume":"106","author":"Paparrigopoulos","year":"2002","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2511","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0165-1781(96)02935-6","article-title":"Modulation of learned helplessness by 5-hydroxtryptamine2A receptor antisense oligodeoxynucleotides","volume":"63","author":"Papolos","year":"1996","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2512","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1074\/jbc.M308177200","article-title":"The 5-hydroxytryptamine(1A) receptor is stably palmitoylated, and acylation is critical for communication of receptor with Gi protein","volume":"279","author":"Papoucheva","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2513","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/sj.npp.1300091","article-title":"Effect of agomelatine in the chronic mild stress model of depression in the rat","volume":"28","author":"Papp","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2514","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00213-001-0924-y","article-title":"The effects of noradrenergic re-uptake inhibition on memory encoding in man","volume":"159","author":"Papps","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2515","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.tins.2004.05.004","article-title":"Presynaptic induction and expression of NMDA-dependent LTP","volume":"27","author":"Pare","year":"2004","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2516","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0361-9230(94)00235-S","article-title":"The G.ABAB antagonist CGP 35348 inhibits the effects of baclofen on sexual behavior and motor coordination","volume":"36","author":"Paredes","year":"1995","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2517","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pneurobio.2004.05.001","article-title":"Has dopamine a physiological role in the control of sexual behavior? A critical review of the evidence","volume":"73","author":"Paredes","year":"2004","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2518","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0006-3223(97)00513-1","article-title":"Relationships between thyroid hormone and antidepressant responses to total sleep deprivation in mood disorder patients","volume":"43","author":"Parekh","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2519","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0006-3223(00)01088-X","article-title":"Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment","volume":"49","author":"Pariante","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2520","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/sj.npp.1300661","article-title":"Chronic reboxetine desensitises terminal but not somatodendritic \u03b12-adrenoceptors controlling noradrenaline release in the rat dorsal hippocampus","volume":"30","author":"Parini","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2521","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1523\/JNEUROSCI.22-11-04399.2002","article-title":"Peroxynitrite inactivates the human dopamine transporter by modification of cystein 342: potential mechanism of neurotoxicity in dopamine neurons","volume":"22","author":"Park","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2522","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1046\/j.1460-9568.1999.00553.x","article-title":"Regional distribution of Y-receptor subtype mRNAs in rat brain","volume":"11","author":"Parker","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2523","doi-asserted-by":"crossref","first-page":"21576","DOI":"10.1074\/jbc.M210973200","article-title":"Agonist-induced phosphorylation of the serotonin 5-HT2C receptor regulates its interaction with multiple PDZ protein 1","volume":"278","author":"Parker","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2524","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neulet.2004.10.025","article-title":"Lithium inhibits internalisation and endosomal processing of both neuropeptide Y (NPY) Y1 and transferring receptors","volume":"374","author":"Parker","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2525","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-2999(01)01307-3","article-title":"NMDA receptors as targets for drug action in neuropathic pain","volume":"429","author":"Parsons","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2526","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0028-3908(99)00019-2","article-title":"Memantine is a clinically well-tolerated NMDA receptor antagonist\u2014a review of preclinical data","volume":"38","author":"Parsons","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2527","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tree.2004.11.012","article-title":"Criticality and disturbance in spatial ecological systems","volume":"20","author":"Pascual","year":"2005","journal-title":"Trends Ecol Evol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2528","first-page":"17","article-title":"The neuronal histaminergic system in cognition","volume":"4","author":"Passani","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2529","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.tips.2004.10.003","article-title":"The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders","volume":"25","author":"Passani","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2530","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.bmcl.2004.03.031","article-title":"Synthesis of 3a,4-dihydro-3H-[1]benzopyrano[4,3-c)isoxazoles, displaying combined 5-HT uptake inhibiting and alpha2-adrenoceptor antagonistic activities. Part 2: further exploration of the cinnamyl moiety","volume":"14","author":"Pastor","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2531","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0022-5193(03)00028-6","article-title":"Evolving protein interaction networks through gene duplication","volume":"222","author":"Pastor-Satorras","year":"2003","journal-title":"J Theor Biol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2532","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2125.1994.tb04255.x","article-title":"EEG profile of litoxetine after single and repeated administration in healthy volunteers","volume":"37","author":"Patat","year":"1994","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2533","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0306-4522(94)90330-1","article-title":"The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus","volume":"62","author":"Patchev","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2534","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1517\/14656566.4.12.2279","article-title":"Aprepitant\u2014a novel NK1-receptor antagonist","volume":"4","author":"Patel","year":"2003","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2535","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/syn.10308","article-title":"The highly selective 5-hydrotryptamine (5-HT)2A receptor antagonist, EMD 281014, significantly increases swimming and decreases immobility in male congenital learned helpless rats in the forced swim test","volume":"52","author":"Patel","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2536","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.biopsych.2003.09.002","article-title":"Robust and tissue-specific expression of TPH2 versus TPH1 in rat raphe and pineal gland","volume":"55","author":"Patel","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2537","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1113\/jphysiol.2003.049015","article-title":"GABAB receptor- and metabotropic glutamate receptor-dependent cooperative long-term potentiation of rat hippocampal GABAA synaptic transmission","volume":"553","author":"Patenaude","year":"2003","journal-title":"J Physiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2538","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0301-0082(99)00045-3","article-title":"Neuronal nicotinic receptors in the human brain","volume":"61","author":"Paterson","year":"2000","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2539","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/070674379003500312","article-title":"Propranolol and depression: evidence from the antihypertensive trials","volume":"35","author":"Patten","year":"1990","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2540","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00002018-199410030-00003","article-title":"Drug-induced depression: incidence, avoidance and management","volume":"10","author":"Patten","year":"1994","journal-title":"Drug Safey"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2541","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1196\/annals.1300.016","article-title":"Glutamate and depression","volume":"1003","author":"Paul","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2542","first-page":"95","article-title":"Adaptation of the NMDA receptor complex following chronic antidepressant treatments","volume":"269","author":"Paul","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2543","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1126\/science.279.5352.860","article-title":"Fishing down marine food webs","volume":"279","author":"Pauly","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2544","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/PL00005271","article-title":"Dimerization of 8-OH-DPAT increases activity at serotonin 5-HT1A receptors","volume":"358","author":"Pauwels","year":"1998","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2545","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0006-8993(99)02188-5","article-title":"Effects of mineralocorticoid and glucocorticoid receptors on long-term potentiation in the CA3 hippocampal field","volume":"851","author":"Pavlides","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2546","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/hipo.450030210","article-title":"Effects of glucocorticoids on hippocampal long-term potentiation","volume":"3","author":"Pavlides","year":"1993","journal-title":"Hippocampus"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2547","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1017\/S0033291700033146","article-title":"Residual symptoms after partial remission: an important outcome in depression","volume":"25","author":"Paykel","year":"1995","journal-title":"Psychol Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2548","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.euroneuro.2005.04.008","article-title":"Size and burden of depressive disorders in Europe","volume":"15","author":"Paykel","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2549","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1017\/S003329170400282X","article-title":"Duration of relapse prevention after cognitive therapy in residual depression: follow-up of controlled trial","volume":"35","author":"Paykel","year":"2005","journal-title":"Psychol Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2550","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0006-3223(02)01676-1","article-title":"Timing is everything: does the robust up-regulation of noradrenergically regulated plasticity genes underlie the rapid antidepressant effects of sleep deprivation?","volume":"52","author":"Payne","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2551","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1046\/j.1471-4159.2002.01046.x","article-title":"Mechanisms of ligand binding and efficacy at the human D2 (short) dopamine receptor","volume":"82","author":"Payne","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2552","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2165\/00023210-199402030-00007","article-title":"Serotonin 5-HT1A agonists. A comparative review","volume":"2","author":"Pecknold","year":"1994","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2553","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00004850-199701000-00009","article-title":"Antagonism of SSRI-induced nausea by mirtazapine","volume":"12","author":"Pedersen","year":"1997","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2554","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1517\/14656566.4.10.1659","article-title":"Towards the pharmacotherapy of eating disorders","volume":"4","author":"Pederson","year":"2003","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2555","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.npep.2004.05.007","article-title":"Importance of NPY Y1 receptor-mediated pathways: assessment using NPY Y1 receptor knockouts","volume":"38","author":"Pedrazzini","year":"2004","journal-title":"Neuropeptide"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2556","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pbb.2004.06.001","article-title":"Rapid eye movement sleep deprivation-induced down-regulation of beta-adrenergic receptors in the rat brainstem and hippocampus","volume":"79","author":"Pedrazzoli","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2557","doi-asserted-by":"crossref","unstructured":"Pehek, E.A., Nocjar, C., Roth, B.L., Byrd, T.A., Mabrouk, O.S. (in press). Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex. Neuropsychopharmacology.","DOI":"10.1038\/sj.npp.1300819"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2558","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0306-4522(03)00504-9","article-title":"Antidepressant drug treatment induces Arc gene expression in the rat brain","volume":"121","author":"Pei","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2559","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejphar.2004.03.002","article-title":"The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortex","volume":"489","author":"Pei","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2560","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neuropharm.2003.09.017","article-title":"Glutamate receptor activation is involved in 5-HT2 agonist-induced Arc gene expression in the rat cortex","volume":"46","author":"Pei","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2561","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0306-4530(91)90034-Q","article-title":"Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain","volume":"16","author":"Peiffer","year":"1991","journal-title":"Psychoneuorendocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2562","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S1388-2457(00)00354-0","article-title":"Working memory dysfunction in major depression: an event-related potential study","volume":"111","author":"Pelosi","year":"2000","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2563","first-page":"1896","article-title":"Effect of sleep and sleep deprivation on serotonergic neurotransmission in the hippocampus: a combined in vivo microdialysis\/EEG study in rats","volume":"17","author":"Penalva","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2564","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1017\/S146114570400450X","article-title":"Effects of fluoxetine on dopamine D2 receptors in the human brain: a positron emission tomography study with [11C]raclopride","volume":"7","author":"Penttil\u00e4","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2565","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/molbev\/msi024","article-title":"An exponential core in the heart of the yeast protein interaction network","volume":"22","author":"Pereira-Leal","year":"2004","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2566","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/prot.10505","article-title":"Detection of functional modules from protein interaction networks","volume":"54","author":"Pereira-Leal","year":"2004","journal-title":"Proteins"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2567","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-0447.2000.tb10944.x","article-title":"Safety and tolerability considerations: tricyclic antidepressants versus selective serotonin reuptake inhibitors","volume":"101","author":"Peretti","year":"2000","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2568","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0091-3057(97)10002-8","article-title":"Activities of monoamine oxidase (MAO) A and B in discrete regions of rat brain after rapid eye movement (REM) sleep deprivation","volume":"58","author":"Perez","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2569","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0960-894X(98)00222-4","article-title":"Dimers of 5-HT1 ligands preferentially bind to 5-HT1B\/1D receptor subtypes","volume":"8","author":"Perez","year":"1998","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2570","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0960-894X(98)00090-0","article-title":"Dimerization of sumatriptan as an efficient way to design a potent, centrally and orally active 5-HT1B agonist","volume":"8","author":"Perez","year":"1998","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3733","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1016\/S0960-894X(98)00619-2","article-title":"Design and synthesis of new potent, silent 5-HT1A antagonists by covalent coupling of aminopropanaol derivatives with selective serotonin reuptake inhibitors","volume":"8","author":"Perez","year":"1998","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2571","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00004714-200102000-00008","article-title":"Augmentation of fluoxetine's antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors","volume":"21","author":"Perez","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2572","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0006-3223(03)00424-4","article-title":"Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment","volume":"54","author":"Perlis","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2573","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.biopsych.2004.09.006","article-title":"Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness","volume":"56","author":"Perlman","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2574","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00004714-199902000-00007","article-title":"Beneficial treatment of age-related sleep disturbances with prolonged intranasal vasopressin","volume":"19","author":"Perras","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2575","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0091-3057(92)90444-K","article-title":"Activity of litoxetine and other serotonin uptake inhibitors in the tail suspension test in mice","volume":"42","author":"Perrault","year":"1992","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2576","first-page":"471","article-title":"Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro","volume":"254","author":"Perrone","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2577","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4088\/JCP.v65n0215","article-title":"Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomised, controlled trial","volume":"65","author":"Perry","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2578","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1461-0248.2002.00339.x","article-title":"Functional diversity (FD), species richness and community composition","volume":"5","author":"Petchey","year":"2002","journal-title":"Ecol Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2579","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0278-5846(01)00250-0","article-title":"A survey of prescribing practices in the treatment of depression","volume":"26","author":"Petersen","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2580","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1213\/01.ANE.0000081061.12235.55","article-title":"The role of NMDA receptors in pain: a review","volume":"97","author":"Petrenko","year":"2003","journal-title":"Anesth Analg"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2581","first-page":"4","article-title":"The evolving definition of treatment resistance","volume":"60","author":"Peuskens","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2582","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nn1463","article-title":"5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression","volume":"8","author":"Pezawas","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2583","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pneurobio.2004.09.004","article-title":"Mesolimbic dopaminergic pathways in fear conditioning","volume":"74","author":"Pezze","year":"2004","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2584","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1006\/nimg.2002.1087","article-title":"Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI","volume":"16","author":"Phan","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2585","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nrn847","article-title":"Complex-trait genetics: emergence of multivariate strategies","volume":"3","author":"Phillips","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2586","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1021\/jm0340602","article-title":"3-(4-[Benzyl (methyl) amino] methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy","volume":"46","author":"Piazzi","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2587","first-page":"103","article-title":"Knock-out mouse models used to study neurobiological systems","volume":"13","author":"Picciotto","year":"1999","journal-title":"Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2588","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1080\/14622299050011931","article-title":"Use of knock-out mice to determine the molecular basis for the actions of nicotine","volume":"1","author":"Picciotto","year":"1999","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2589","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0893-133X(99)00146-3","article-title":"Nicotinic receptors in the brain: links between molecular biology and behavior","volume":"22","author":"Picciotto","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2590","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0163-7258(01)00161-9","article-title":"Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioural phenotypes and possible clinical implications","volume":"92","author":"Picciotto","year":"2001","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2591","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/00001756-200207020-00006","article-title":"Effect of nicotine and nicotinic receptors on anxiety and depression","volume":"13","author":"Picciotto","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2592","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/brain\/awh190","article-title":"Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism","volume":"127","author":"Picconi","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2593","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1615\/CritRevNeurobiol.v11.i2-3.20","article-title":"Dopamine D2 receptors in signal transduction and behavior","volume":"11","author":"Picetti","year":"1997","journal-title":"Crit Rev Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2594","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1523\/JNEUROSCI.19-10-04034.1999","article-title":"5-HT1B receptor-mediated presynaptic inhibition of retinal input to the suprachiasmatic nucleus","volume":"19","author":"Pickard","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2595","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.1523\/JNEUROSCI.16-24-08208.1996","article-title":"5-HT1B receptor agonists inhibit light-induced phase shifts of behavioural circadian rhythms and expression of the immediate early gene c-fos in the suprachiasmatic nucleus","volume":"16","author":"Pickard","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2596","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2005.03.028","article-title":"Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats","volume":"514","author":"Pietraszek","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2597","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/cne.1301","article-title":"Distribution of substance P and neurokinin-1 receptor immunoreactivity in the suprachiasmatic nuclei and intergeniculate leaflet of hamster, mouse, and rat","volume":"438","author":"Piggins","year":"2001","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2598","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0006-3223(93)90272-F","article-title":"A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPP","volume":"33","author":"Pigott","year":"1993","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2599","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0028-3908(02)00082-5","article-title":"Multiple MPEP administration evokes anxiolytic- and antidepressant-like effects in rats","volume":"43","author":"Pilc","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2600","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1358\/dof.2002.027.08.687386","article-title":"A role for glutamate in the treatment of anxiety and depression: focus on group I metabotropic glutamate (mGlu) receptors","volume":"27","author":"Pilc","year":"2002","journal-title":"Drugs Future"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2601","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/1568007023339328","article-title":"The metabotropic glutamate receptors: structure, activation, mechanism and pharmacology","volume":"1","author":"Pin","year":"2002","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2602","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0028-3908(94)00129-G","article-title":"The metabotropic glutamate receptors: structure and functions","volume":"34","author":"Pin","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2603","first-page":"5","article-title":"The societal costs of chronic major depression","volume":"62","author":"Pincus","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2604","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00169324","article-title":"Effect of acute and prolonged tianeptine administration on the 5-HT transporter: electrophysiological, biochemical and radioligand binding studies in the rat brain","volume":"351","author":"Pineyro","year":"1995","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2605","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0006-3223(03)00414-1","article-title":"Thyroid hormones in the rat amygdala as common targets for antidepressant drugs, mood stabilizers, and sleep deprivation","volume":"54","author":"Pinna","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2606","doi-asserted-by":"crossref","first-page":"6222","DOI":"10.1073\/pnas.0401479101","article-title":"Fluoxetine and norfluoxetine stereospecifically facilitate pentobarbital sedation by increasing neurosteroids","volume":"101","author":"Pinna","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2607","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1016\/j.lfs.2003.12.002","article-title":"Neurosteroids and neuroactive drugs in mental disorders","volume":"74","author":"Pisu","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2608","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0006-8993(03)03091-9","article-title":"The 5-HT1A receptor antagonist WAY 100,635 improves rats performance in different models of amnesia evaluated by the object recognition task","volume":"983","author":"Pitsikas","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2609","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1017\/S1092852900019623","article-title":"Pharmacotherapy of seasonal affective disorder","volume":"10","author":"Pjrek","year":"2005","journal-title":"CNS Spectrum"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2610","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0028-3908(03)00066-2","article-title":"Neuroprotective properties of tianeptine: interactions with cytokines","volume":"44","author":"Plaisant","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2611","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1600-0773.1997.tb00396.x","article-title":"An affinity-modulating site on neuronal monoamine transport proteins","volume":"80","author":"Plenge","year":"1997","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2612","doi-asserted-by":"crossref","first-page":"7397","DOI":"10.1523\/JNEUROSCI.21-18-07397.2001","article-title":"Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated camp response element-binding protein expression in nucleus accumbens","volume":"21","author":"Pliakas","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2613","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0143-4179(90)90130-Q","article-title":"NPY-induced inhibition of male copulatory activity is a direct behavioural effect","volume":"16","author":"Poggioli","year":"1990","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2614","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-8993(94)91818-X","article-title":"Nitric oxide inhibits [3H]dopamine uptake","volume":"641","author":"Pogun","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2615","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1161\/01.STR.29.11.2311","article-title":"Frequency and clinical determinants of poststroke depression","volume":"29","author":"Pohjasvaara","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2616","first-page":"33","article-title":"MT melatonin receptor mRNA tissular localization by PCR amplification","volume":"24","author":"Poirel","year":"2003","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2617","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1192\/bjp.175.1.12","article-title":"Venlafaxine and paroxetine in treatment-resistant depression. Double-blind, randomised comparison","volume":"175","author":"Poirier","year":"1999","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2618","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/089198879100400405","article-title":"Sleep problems and institutionalization of the elderly","volume":"4","author":"Pollak","year":"1991","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2619","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0014-2999(93)90179-L","article-title":"5-HT1A and 5-HT1C\/1D receptors produce reciprocal effects on male sexual behavior of rhesus monkeys","volume":"243","author":"Pomerantz","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2620","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0169-328X(94)90223-2","article-title":"Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors","volume":"23","author":"Pompeiano","year":"1994","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2621","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.tips.2004.08.006","article-title":"PKC-interacting proteins: from function to pharmacology","volume":"25","author":"Poole","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2622","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/sj.bjp.0705359","article-title":"Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram","volume":"139","author":"Popik","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2623","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejphar.2005.04.009","article-title":"Nicotine produces antidepressant-like actions: behavioral and neurochemical evidence","volume":"515","author":"Popik","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2624","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1471-4159.2000.0740021.x","article-title":"Second messenger-regulated protein kinases in the brain: their functional role and the action of antidepressant drugs","volume":"74","author":"Popoli","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2625","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0163-7258(00)00108-X","article-title":"Serine\/threonine kinases as molecular targets of antidepressants: implications for pharmacological treatment and pathophysiology of affective disorders","volume":"89","author":"Popoli","year":"2001","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2626","first-page":"1","article-title":"Modulation of synaptic plasticity by stress and antidepressants","volume":"3","author":"Popoli","year":"2002","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2627","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000063681","article-title":"5-HT2A and 5-HT2C serotonin receptors differentially modulate mouse sexual arousal and the hypothalamo\u2013pituitary\u2013testicular response to the presence of a female","volume":"76","author":"Popova","year":"2001","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2628","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1515\/REVNEURO.2000.11.1.53","article-title":"Animal models of depression: utility for transgenic research","volume":"11","author":"Porsolt","year":"2000","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2629","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0301-0082(98)00097-5","article-title":"Serotonin and the sleep\/wake cycle: special emphasis on microdialysis studies","volume":"60","author":"Portas","year":"2000","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2630","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0006-8993(02)02721-X","article-title":"M1 muscarinic receptor signalling in mouse hippocampus and cortex","volume":"944","author":"Porter","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2631","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1192\/bjp.182.3.214","article-title":"Neurocognitive impairment in drug-free patients with major depressive disorder","volume":"182","author":"Porter","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2632","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1021\/jm010158+","article-title":"From models to molecules: opioid receptor dimers, bivalent and selective opioid receptor probes","volume":"44","author":"Portoghese","year":"2001","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2633","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2003.09.083","article-title":"Involvement of prolactin, vasopressin and opioids in post-ictal antinociception induced by electroshock in rats","volume":"1003","author":"Portugal-Santana","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2634","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0006-3223(92)90216-M","article-title":"Endogenous biochemical abnormalities in affective illness: therapeutic versus pathogenic","volume":"32","author":"Post","year":"1992","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2635","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00004850-199100640-00001","article-title":"Lack of beneficial effects of 1-baclofen in affective disorder","volume":"6","author":"Post","year":"1991","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2636","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4088\/JCP.v62n0212","article-title":"Switching versus augmentation: a prospective, naturalistic comparison in depressed, treatment-resistant patients","volume":"62","author":"Posternak","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2637","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4088\/JCP.v66n0605","article-title":"Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: a retrospective study","volume":"66","author":"Posternak","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2638","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4088\/JCP.v66n0201","article-title":"Is there a delay in the antidepressant effect? A meta-analysis","volume":"66","author":"Posternak","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2639","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1046\/j.1471-4159.1999.0731051.x","article-title":"Fluoxetine increases extracellular dopamine in the prefrontal cortex by a mechanism not dependent on serotonin: a comparison with citalopram","volume":"73","author":"Pozzi","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2640","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1096\/fj.01-0754fje","article-title":"The neuropeptide Y Y1 receptor regulates leptin-mediated control of energy homeostasis and reproductive functions","volume":"16","author":"Pralong","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2641","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.biopsych.2004.07.018","article-title":"Tryptophan depletion and serotonin loss in selective serotonin reuptake inhibitor-treated depression: an [18F]MPPF positron emission tomography study","volume":"56","author":"Praschak-Rieder","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2642","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0163-7258(92)90014-Q","article-title":"The neuroanatomical basis of anxiety","volume":"55","author":"Pratt","year":"1992","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2643","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1476-5381.1993.tb13872.x","article-title":"Repeated administration of desipramine and a GABAB receptor antagonist, CGP 36742, discretely up-regulates GABAB receptor binding sites in rat frontal cortex","volume":"110","author":"Pratt","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2644","doi-asserted-by":"crossref","first-page":"9474","DOI":"10.1073\/pnas.181356198","article-title":"Following the trace of elusive amines","volume":"98","author":"Premont","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2645","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.expneurol.2004.06.021","article-title":"Involvement of dopamine D2\/D3 receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells","volume":"190","author":"Presgraves","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2646","first-page":"6","article-title":"Antidepressant drug selection: criteria and options","volume":"55","author":"Preskorn","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2647","first-page":"12","article-title":"Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine","volume":"56","author":"Preskorn","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2648","series-title":"Antidepressants: Past, Present and Future","first-page":"615","year":"2004"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2649","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2869.1996.00238.x","article-title":"Sleep deprivation reduces the citalopram-induced inhibition of serotoninergic neuronal firing in the nucleus raphe dorsalis of the rat","volume":"5","author":"Prevot","year":"1996","journal-title":"J Sleep Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2650","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1126\/science.288.5472.1769","article-title":"Psychological and neural mechanisms of the affective dimension of pain","volume":"288","author":"Price","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2651","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/da.20075","article-title":"A retrospective chart review of the effects of modafinil on depression as monotherapy and as adjunctive therapy","volume":"21","author":"Price","year":"2005","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2652","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00213-002-1114-2","article-title":"Evidence for corticotropin-releasing factor regulation of serotonin in the lateral septum during acute swim stress: adaptation produced by repeated swimming","volume":"162","author":"Price","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2653","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0306-4522(02)00199-9","article-title":"Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat","volume":"113","author":"Prickaerts","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2654","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00213-004-1967-7","article-title":"Dissociable effects of acetylcholinesterase inhibitors and phosphodiesterase type 5 inhibitors on object recognition memory: acquisition versus consolidation","volume":"177","author":"Prickaerts","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2655","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0169-328X(94)00184-G","article-title":"Temporal regulation by estrogen of beta-preprotachykinin mRNA expression in the rat ventromedial nucleus of the hypothalamus","volume":"28","author":"Priest","year":"1995","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2656","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1111\/j.1476-5381.1995.tb16684.x","article-title":"Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area","volume":"116","author":"Prisco","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2657","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1517\/13543784.9.6.1317","article-title":"Novel anti-obesity drugs","volume":"9","author":"Proietto","year":"2000","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2658","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1358\/dnp.2004.17.8.863695","article-title":"The role of neuropeptides in sleep modulation","volume":"17","author":"Prospero-Garcia","year":"2004","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2659","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1176\/ajp.153.8.985","article-title":"Resistance to antidepressant medications and short-term clinical response to ECT","volume":"153","author":"Prudic","year":"1996","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2660","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0028-3908(93)90036-3","article-title":"The effect of repeated combined treatment with nifedipine and antidepressant drugs or electroconvulsive shock on the hippocampal corticosteroid recptors in rats","volume":"32","author":"Przegalinski","year":"1993","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2661","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0091-3057(99)00214-2","article-title":"Tolerance to anxiolytic- and antidepressant-like effects of a partial agonist of glycineB receptors","volume":"64","author":"Przegalinski","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2662","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00004850-199703000-00005","article-title":"Milnacipran, a new serotonin and noradrenaline uptake inhibitor: an overview of its antidepressant activity and clinical tolerability","volume":"12","author":"Puech","year":"1997","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2663","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cercor\/bhh104","article-title":"Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA","volume":"15","author":"Puig","year":"2005","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2664","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(00)00728-7","article-title":"LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine2A receptor antagonist: a comparison with the antidepressant, nefazodone","volume":"407","author":"Pullar","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2665","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-2999(01)01468-6","article-title":"In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B\/1D\/2) receptor antagonist properties","volume":"432","author":"Pullar","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2666","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejphar.2004.04.029","article-title":"The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig","volume":"493","author":"Pullar","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2667","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1073\/pnas.0337683100","article-title":"Short-term administration of omega 3 fatty acids from fish oil results in increased transthyretin transcription in old rat hippocampus","volume":"100","author":"Puskas","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2668","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(02)00300-5","article-title":"Role of palmitoylation\/depalmitoylation reactions in G-protein-coupled receptor function","volume":"97","author":"Qanbar","year":"2003","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2669","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1523\/JNEUROSCI.17-01-00045.1997","article-title":"Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression","volume":"17","author":"Qian","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2670","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s002130050406","article-title":"SSRI treatment decreases prolactin and hyperthermic responses to mCPP","volume":"133","author":"Quested","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2671","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.bjp.0705447","article-title":"Effects of GABA agonists on body temperature regulation in GABAB(1) mice","volume":"140","author":"Qu\u00e9va","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2672","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0896-6273(03)00605-6","article-title":"Regulating the conducting states of a mammalian serotonin transporter","volume":"40","author":"Quick","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2673","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/neu.10109","article-title":"Desensitization of neuronal nicotinic receptors","volume":"53","author":"Quick","year":"2002","journal-title":"J Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2674","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1527-3458.2002.tb00228.x","article-title":"LY404187: a novel positive allosteric modulator of AMPA receptors","volume":"8","author":"Quirk","year":"2002","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2675","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4088\/JCP.v62n0509","article-title":"Does mirtazapine have a more rapid onset than SSRIs?","volume":"62","author":"Quitkin","year":"2001","journal-title":"Int Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2676","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.parkreldis.2003.12.001","article-title":"Quality of life and pain in Parkinson's disease: a controlled cross-sectional study","volume":"10","author":"Quittenbaum","year":"2004","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2677","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0028-3908(99)00264-6","article-title":"Estrogen desensitizes 5-HT1A receptors and reduces levels of Gi2, Gi1 and Gi3 proteins in the hypothalamus","volume":"39","author":"Raap","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2678","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/sj.bjp.0704153","article-title":"Biological significance of agmatine, an endogenous ligand at imidazoline binding sites","volume":"133","author":"Raasch","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2679","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1210\/endo.138.12.5580","article-title":"Regulation of pituitary V1b vasopressin receptor messenger ribonucleic acid by adrenalectomy and glucocorticoid administration","volume":"138","author":"Rabadan-Diehl","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2680","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1176\/appi.ajp.158.12.2080","article-title":"Pindolol augmentation of selective serotonin reuptake inhibitors: PET evidence that the dose used in clinical trials is too low","volume":"158","author":"Rabiner","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2681","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/sj.npp.1300472","article-title":"Preferential 5-HT1A autoreceptor occupancy by pindolol is attenuated in depressed patients: effect of treatment or an endophenotype of depression?","volume":"29","author":"Rabiner","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2682","doi-asserted-by":"crossref","first-page":"13941","DOI":"10.1073\/pnas.95.23.13941","article-title":"Estrogen alters behavior and forebrain c-fos expression in ovariectomized rats subjected to the forced swim test","volume":"95","author":"Rachman","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2683","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0028-3908(91)90145-2","article-title":"Systemic morphine simultaneously decreases extracellular acetylcholine and increases dopamine in the nucleus accumbens of freely moving rats","volume":"30","author":"Rada","year":"1991","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2684","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1124\/jpet.104.082776","article-title":"Acetazolamide, a carbonic anhydrase inhibitor, reverses inflammation-induced thermal hyperalgesia in rats","volume":"313","author":"Radhakrishnan","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2685","first-page":"275","article-title":"Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an \u201catypical\u201d opioid analgesic","volume":"260","author":"Raffa","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2686","first-page":"331","article-title":"Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol","volume":"267","author":"Raffa","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2687","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1073\/pnas.98.4.1958","article-title":"Female preproenkephalin-knockout mice display altered emotional responses","volume":"98","author":"Ragnauth","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2688","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1176\/appi.ajp.160.9.1554","article-title":"When not enough is too much : the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders","volume":"160","author":"Raison","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2689","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4088\/JCP.v66n0106","article-title":"Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction","volume":"66","author":"Raison","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2690","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0301-0082(02)00059-X","article-title":"Coexistence and function of different neurotransmitter transporters in the plasma membrane of CNS neurons","volume":"68","author":"Raiteri","year":"2002","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2691","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1523\/JNEUROSCI.16-01-00065.1996","article-title":"11 beta-hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity","volume":"16","author":"Rajan","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2692","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0006-3223(99)00041-4","article-title":"Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression","volume":"45","author":"Rajkowska","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2693","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0197-0186(01)00103-6","article-title":"The non-competitive AMPA receptor antagonist (GYKI 52466) blocks quisqualate-induced acetylcholine release from the rat hippocampus and striatum: an in vivo microdialysis study","volume":"40","author":"Rakovska","year":"2002","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2694","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/brain\/122.9.1637","article-title":"Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [18F]dopa-PET study","volume":"122","author":"Rakshi","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2695","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0006-8993(86)91154-6","article-title":"Effects of diazepam on circadian phase advances and delays","volume":"372","author":"Ralph","year":"1986","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2696","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1126\/science.285.5428.763","article-title":"Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants","volume":"285","author":"Ramamoorthy","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2697","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1074\/jbc.273.4.2458","article-title":"Phosphorylation and regulation of antidepressant-sensitive serotonin transporters","volume":"273","author":"Ramamoorthy","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2698","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3940(01)01872-9","article-title":"The NMDA receptor channel blockers memantine, MRZ 2\/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and NE-115 cell systems in a non-competitive manner","volume":"306","author":"Rammes","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2699","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00213-003-1698-1","article-title":"Prediction of the response to citalopram and reboxetine in post-stroke depressed patients","volume":"173","author":"Rampello","year":"2004","journal-title":"Psychopharmaocology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2700","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000052329","article-title":"Pharmacology of alpha-adrenoceptors in male sexual function","volume":"36","author":"Rampin","year":"1999","journal-title":"Eur Urol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2701","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0024-3205(03)00122-X","article-title":"Proerectile effects of apomorphine in mice","volume":"72","author":"Rampin","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2702","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1523\/JNEUROSCI.19-10-04102.1999","article-title":"Dopamine fluctuations in the nucleus accumbens during maintenance, extinction, and reinstatement of intravenous d-amphetamine self administration","volume":"19","author":"Ranaldi","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2703","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/hup.456","article-title":"Modafinil affects mood, but not cognitive function, in healthy young volunteers","volume":"18","author":"Randall","year":"2003","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2704","first-page":"25","article-title":"Clinical experience with substance P receptor (NK1) antagonists in depression","volume":"11","author":"Ranga","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2705","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/1099-1166(200102)16:2<175::AID-GPS298>3.0.CO;2-0","article-title":"Depression in older people with mild stroke, carotid stenosis and peripheral vascular disease: a comparison with healthy controls","volume":"16","author":"Rao","year":"2001","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2706","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature01258","article-title":"Control, exploitation and tolerance of intracellular noise","volume":"420","author":"Rao","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2707","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/0149-2918(95)80055-7","article-title":"Drug utilization review of concomitant use of specific serotonin reuptake inhibitors or clomipramine with antianxiety\/sleep medications","volume":"17","author":"Rascati","year":"1995","journal-title":"Clin Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2708","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ana.10513","article-title":"Limitations of current Parkinson's disease therapy","volume":"53","author":"Rascol","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2709","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1210\/en.2004-0052","article-title":"Minireview: diversity and complexity of signaling through peptidergic G protein-coupled receptors","volume":"145","author":"Rashid","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2710","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4088\/JCP.v64n1015","article-title":"Duloxetine in the long-term treatment of major depressive disorder","volume":"64","author":"Raskin","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2711","first-page":"1","article-title":"Study of mirtazapine antidepressant effects in rats","volume":"15","author":"Rauggi","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2712","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1124\/jpet.303.2.664","article-title":"Reboxetine: attenuation of intravenous nicotine self-administration in rats","volume":"303","author":"Rauhut","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2713","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0165-6147(90)90004-R","article-title":"Cholecystokinin and anxiety","volume":"11","author":"Ravard","year":"1990","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2714","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1126\/science.1073374","article-title":"Hierarchical organization of modularity in metabolic networks","volume":"297","author":"Ravasz","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2715","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1365-2265.1995.tb02930.x","article-title":"Extra-adrenal effects of metyrapone include inhibition of the 11-oxoreductase activity of 11 beta-hydrosyxteroid dehydrogenase: a model for 11-HSD I deficiency","volume":"43","author":"Raven","year":"1995","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2716","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0306-4530(95)00057-7","article-title":"The relationship between the effects of metyrapone treatment on depressed mood and urinary steroid profiles","volume":"21","author":"Raven","year":"1996","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2717","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/sj.bjp.0702723","article-title":"The recombinant 5-HT1A receptor: G-protein coupling and signalling pathways","volume":"127","author":"Raymond","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2718","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1073\/pnas.0307294101","article-title":"Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: reversal by tianeptine","volume":"101","author":"Reagan","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2719","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/10606820308243","article-title":"Protein complexes involved in heptahelical receptor-mediated signal transduction","volume":"9","author":"Rebois","year":"2003","journal-title":"Receptors Channels"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2720","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1097\/00001756-199809140-00028","article-title":"Sigma1 receptor mediated anti-depressant-like effects of neurosteroids in the Porsolt forced swim test","volume":"9","author":"Reddy","year":"1998","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2721","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/074873098128999907","article-title":"Entrainment of rat circadian rhythms by the melatonin agonist S20098 requires intact suprachiasmatic nuclei but not the pineal","volume":"13","author":"Redman","year":"1998","journal-title":"J Biol Rhythms"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2722","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF02245938","article-title":"Dose-dependent effects of S20098, a melatonin agonist on direction of reentrainment of rat circadian rhythms","volume":"118","author":"Redman","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2723","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050638","article-title":"Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity","volume":"138","author":"Redrobe","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2724","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0893-133X(01)00403-1","article-title":"The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test","volume":"26","author":"Redrobe","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2725","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/S0024-3205(02)02159-8","article-title":"Neuropeptide (NPY) and depression: from animal studies to the human condition","volume":"71","author":"Redrobe","year":"2002","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2726","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0166-4328(02)00374-1","article-title":"Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice","volume":"141","author":"Redrobe","year":"2003","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2727","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1385\/JMN:22:3:159","article-title":"Characterization of neuropeptide Y, Y(2) receptor knockout mice in two animal models of learning and memory processing","volume":"22","author":"Redrobe","year":"2004","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2728","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0006-8993(98)01129-9","article-title":"Modification of sexual behavior of Long-Evans male rats by drugs acting on the 5-HT1A receptor","volume":"821","author":"Rehman","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2729","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/00023210-200317130-00003","article-title":"Pramipexole in routine clinical practice: a prospective observational trial in Parkinson's disease","volume":"17","author":"Reichmann","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2730","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.mcna.2004.01.010","article-title":"Circadian rhythm sleep disorders","volume":"88","author":"Reid","year":"2004","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2731","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneumeth.2004.09.015","article-title":"Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity","volume":"143","author":"Reith","year":"2005","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2732","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system","volume":"128","author":"Remy","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2733","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s002130100836","article-title":"Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test?","volume":"159","author":"Renard","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2734","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s002130050555","article-title":"Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test","volume":"136","author":"Reneric","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2735","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0893-133X(00)00214-1","article-title":"Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA\/5-HT reuptake inhibition in the rat forced swimming test","volume":"24","author":"R\u00e9n\u00e9ric","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2736","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/jnr.20410","article-title":"Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice","volume":"79","author":"Ren-Patterson","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2737","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1177\/074873049701200606","article-title":"Melatonin receptors: molecular biology of a new family of G protein-coupled receptors","volume":"12","author":"Reppert","year":"1997","journal-title":"J Biol Rhythms"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2738","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0165-6147(96)10005-5","article-title":"Melatonin receptors step into the light: cloning and classification of subtypes","volume":"17","author":"Reppert","year":"1996","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2739","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1471-4892(01)00117-5","article-title":"Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression","volume":"2","author":"Reul","year":"2002","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2740","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1517\/13543784.10.10.1789","article-title":"Antiglucocorticoid drugs in the treatment of depression","volume":"10","author":"Reus","year":"2001","journal-title":"Exp Opin Invest"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2741","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1073\/pnas.0500008102","article-title":"Ecosystem recovery after climatic extremes enhanced by genotypic diversity","volume":"102","author":"Reusch","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2742","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/archpsyc.62.8.868","article-title":"Cost-effectiveness of evidence-based pharmacotherapy or cognitive behavior therapy compared with community referral for major depression in predominantly low-income minority women","volume":"62","author":"Revicki","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2743","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/01.chi.0000135623.12843.60","article-title":"Is the party over? Cannabis and juvenile psychiatric disorder: the past 10 years","volume":"43","author":"Rey","year":"2004","journal-title":"J Am Acad Child Adolesc Psych"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2744","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4088\/JCP.v58n0206f","article-title":"Sertraline-induced anorgasmia treated with intermittent nefazodone","volume":"58","author":"Reynolds","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2745","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1124\/jpet.104.067835","article-title":"Brain-derived tumor necrosis factor-\u03b1 and its involvement in noradrenergic neuron functioning involved in the mechanism of action of an antidepressant","volume":"310","author":"Reynolds","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2746","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1523\/JNEUROSCI.0950-04.2004","article-title":"Acute treatment with the antidepressant fluoxetine internalises 5-HT1A autoreceptors and reduces the in vivo binding of the PET radioligand [18F]MPPF in the nucleus raphe dorsalis of rat","volume":"24","author":"Riad","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2747","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1054\/npep.1999.0021","article-title":"Tachykinin NK3 receptor involvement in anxiety","volume":"33","author":"Ribeiro","year":"1999","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2748","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1054\/npep.2000.0834","article-title":"Neuroanatomical localisation of substance P in the CNS and sensory neurons","volume":"34","author":"Ribeiro-da-Silva","year":"2000","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2749","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1073\/pnas.0500130102","article-title":"Lasting impressions: motifs in protein\u2013protein maps may provide footprints of evolutionary events","volume":"102","author":"Rice","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2750","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1126\/science.1105717","article-title":"Independent origins of middle ear bones in monotremes and therians","volume":"307","author":"Rich","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2751","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1068-607X(00)00049-4","article-title":"Menopause and depression: a review of psychologic function and sex steroid neurobiology during the menopause","volume":"7","author":"Richardson","year":"2000","journal-title":"Prim Care Update Ob Gyns"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2752","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.biopsych.2004.10.010","article-title":"Effect of acute tryptophan depletion on the response to controllable noise stress","volume":"57","author":"Richell","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2753","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/09595230100100642","article-title":"Review of bupropion for smoking cessation","volume":"22","author":"Richmond","year":"2003","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2754","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00004714-199804000-00007","article-title":"Nefazodone in major depression: adjunctive benzodiazepine therapy and tolerability","volume":"18","author":"Rickels","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2755","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1176\/appi.ajp.157.6.968","article-title":"Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder","volume":"157","author":"Rickels","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2756","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1176\/appi.ajp.160.4.749","article-title":"Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study","volume":"160","author":"Rickels","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2757","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-4328(02)00272-3","article-title":"Glutamate receptor function in learning and memory","volume":"140","author":"Riedel","year":"2003","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2758","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/0269881105048887","article-title":"Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment","volume":"19","author":"Riedel","year":"2005","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2759","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.2174\/0929867043364775","article-title":"Clinical applications of MAO-inhibitors","volume":"11","author":"Riederer","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2760","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0301-0511(01)00090-4","article-title":"Sleep and depression\u2014results from psychobiological studies: an overview","volume":"57","author":"Riemann","year":"2001","journal-title":"Biol Psychol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2761","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/0269881103017002008","article-title":"REM sleep effects as a biomarker for the effects of antidepressants in healthy volunteers","volume":"17","author":"Rijnbeek","year":"2003","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2762","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3122\/jabfm.17.3.212","article-title":"Treatment of primary insomnia","volume":"17","author":"Ringdahl","year":"2004","journal-title":"J Am Board Fam Pract"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2763","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1440-1681.2004.04076.x","article-title":"Interactions between delta opioid receptors and alpha-adrenoceptors","volume":"31","author":"Rios","year":"2004","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2764","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0197-0186(03)00173-6","article-title":"Chronic nicotine causes functional upregulation of ionotropic glutamate receptors mediating hippocampal noradrenaline and striatal dopamine release","volume":"44","author":"Risso","year":"2004","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2765","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1192\/bjp.184.2.147","article-title":"Prevalence of DSM-IV psychiatric disorder in the French elderly population","volume":"184","author":"Ritchie","year":"2004","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2766","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1210\/endo.133.2.8344205","article-title":"Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of prolactin secretion via 5-HT1C\/2 receptors","volume":"133","author":"Rittenhouse","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2767","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s002210000407","article-title":"Chemical neuromodulation of frontal-executive functions in humans and other animals","volume":"133","author":"Robbins","year":"2000","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2768","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0306-4522(96)00110-8","article-title":"Nitric oxide and GABAA receptor function in the rat cerebral cortex and cerebellar granule cells","volume":"74","author":"Robello","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2769","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s002130051022","article-title":"Self-administration of cocaine analogs by rats","volume":"144","author":"Roberts","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2770","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/sj.tpj.6500099","article-title":"A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression","volume":"2","author":"Roberts","year":"2002","journal-title":"Pharmacogenetics J"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2771","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.neuropharm.2004.01.010","article-title":"GABAergic modulation of 5-HT7 receptor-mediated effects on 5-HT efflux in the guinea-pig dorsal raphe nucleus","volume":"46","author":"Roberts","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2772","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.bcp.2003.12.030","article-title":"Investigation of the mechanism of agonist and inverse agonist action at D2 dopamine receptors","volume":"67","author":"Roberts","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2773","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1124\/mol.104.004077","article-title":"Mechanisms of agonist action at D2 dopamine receptors","volume":"66","author":"Roberts","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2774","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1523\/JNEUROSCI.09-09-03326.1989","article-title":"Evidence that l-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms","volume":"9","author":"Robertson","year":"1989","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2775","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1111\/j.1460-9568.2005.03990.x","article-title":"Regulation of corticosteroid receptors in the rat brain: the role of serotonin and stress","volume":"21","author":"Robertson","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2776","first-page":"124","article-title":"Monoamine oxidase inhibitors: a new generation","volume":"36","author":"Robinson","year":"2002","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2777","doi-asserted-by":"crossref","first-page":"67S","DOI":"10.1097\/00004714-199006001-00013","article-title":"Clinical effects of the 5-HT1A partial agonists in depression: a composite analysis of buspirone in the treatment of depression","volume":"10","author":"Robinson","year":"1990","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2778","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1124\/jpet.102.044834","article-title":"Fluoxetine increases GABAA receptor activity through a novel modulatory site","volume":"304","author":"Robinson","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2779","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.bmcl.2004.02.088","article-title":"Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism\/SSRI activities. Part 4","volume":"14","author":"Rocco","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2780","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/cercor\/bhg122","article-title":"Acute stress-induced changes in hippocampal\/prefrontal circuits in rats: effects of antidepressants","volume":"14","author":"Rocher","year":"2004","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2781","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1523\/JNEUROSCI.22-12-05219.2002","article-title":"The group I metabotropic glutamate receptor mGluR5 is required for fear memory formation and long-term potentiation in the lateral amygdala","volume":"22","author":"Rodriguez","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2782","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(99)00140-5","article-title":"Yohimbine interacts with the dopaminergic system to reverse sexual satiation: further evidence for a role of sexual motivation in sexual exhaustion","volume":"372","author":"Rodriguez-Manzo","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2783","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0166-4328(94)90019-1","article-title":"Reversal of sexual exhaustion by serotonergic and noradrenergic agents","volume":"62","author":"Rodriguez-Manzo","year":"1994","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2784","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0361-9230(95)02007-E","article-title":"Participation of the central noradrenergic system in the reestablishment of copulatory behavior of sexually exhausted rats by yohimbine, naloxone and 8-OH-DPAT","volume":"38","author":"Rodriguez-Manzo","year":"1995","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2785","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/sj.bjp.0704827","article-title":"Participation of 5-HT(1B) receptors in the inhibitory actions of serotonin on masculine sexual behaviour of mice: pharmacological analysis in 5-HT(1B) receptor knockout mice","volume":"136","author":"Rodriguez-Manzo","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2786","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1527-3458.2003.tb00254.x","article-title":"The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease","volume":"9","author":"Rogawski","year":"2003","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2787","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s002130000485","article-title":"Anxiolytic profile of ropinirole in the rat, mouse and common marmoset","volume":"151","author":"Rogers","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2788","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0028-3908(01)00079-X","article-title":"Effect of repeated treatment with tianeptine and fluoxetine on the central alpha(1)-adrenergic system","volume":"41","author":"Rogoz","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2789","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0028-3908(02)00055-2","article-title":"Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats","volume":"42","author":"Rogoz","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2790","first-page":"381","article-title":"Effect of repeated treatment with mirtazapine on the central dopaminergic D2\/D3 receptors","volume":"54","author":"Rogoz","year":"2002","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2791","first-page":"105","article-title":"Effect of repeated treatment with mirtazapine on the central alpha1-adrenergic receptors","volume":"53","author":"Rogoz","year":"2002","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2792","first-page":"993","article-title":"Effects of combined treatment with imipramine and metyrapone in the forced swimming test in rats. Behavioral and pharmacokinetic studies","volume":"55","author":"Rogoz","year":"2003","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2793","first-page":"849","article-title":"Effect of metyrapone supplementation on imipramine therapy in patients with treatment-resistant unipolar depression","volume":"56","author":"Rogoz","year":"2004","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2794","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0278-5846(02)00307-X","article-title":"Biphasic changes in the Ser-9 phosphorylation of glycogen synthase kinase-3\u03b2 after electroconvulsive shock in the rat brain","volume":"27","author":"Roh","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2795","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.npp.1300659","article-title":"The subjective and cognitive effects of acute phenylalanine and tyrosine depletion in patients recovered from depression","volume":"30","author":"Roiser","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2796","doi-asserted-by":"crossref","first-page":"L175","DOI":"10.1016\/S0024-3205(98)00369-5","article-title":"Tramadol induces antidepressant-type effects in mice","volume":"63","author":"Rojas-Corrales","year":"1998","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2797","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0024-3205(02)02220-8","article-title":"Antidepressant-like effects of tramadol and other central analgesics with activity on monoamine reuptake, in helpless rats","volume":"72","author":"Rojas-Corrales","year":"2002","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2798","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/026988110401800305","article-title":"Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates","volume":"18","author":"Rojas-Corrales","year":"2004","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2799","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejphar.2005.02.006","article-title":"Role of 5-HT1A and 5-HT1B receptors in the antinociceptive effect of tramadol","volume":"511","author":"Rojas-Corrales","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2800","first-page":"S37","article-title":"Comparison of the effects of CP-93,393 and buspirone on 5-HT and NE release: microdialysis studies in the hippocampus of freely-moving rats and guinea pigs","volume":"66","author":"Rollema","year":"1996","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2801","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0006-3223(00)00850-7","article-title":"5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex","volume":"48","author":"Rollema","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2802","series-title":"The Brain and Emotion","first-page":"247","author":"Rolls","year":"1999"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2803","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archpsyc.56.12.1101","article-title":"Attenuation of the euphoric effects of cocaine by the dopamine D1\/D5 antagonist ecopipam (SCH39166)","volume":"56","author":"Romach","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2804","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/med.10037","article-title":"Cholinergic nicotinic receptors: competitive ligands, allosteric modulators and their potential applications","volume":"23","author":"Romanelli","year":"2003","journal-title":"Med Res Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2805","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.npp.1300062","article-title":"Modulation of serotonergic function in rat brain by VN2222, a serotonin reuptake inhibitor and 5-HT1A receptor agonist","volume":"28","author":"Romero","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2806","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1006\/nlme.2002.4080","article-title":"Stress and memory: opposing effects of glucocorticoids on memory consolidation and memory retrieval","volume":"78","author":"Roozendaal","year":"2002","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2807","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0306-4530(96)00028-5","article-title":"Dose-dependent suppression of adrenocortical activity with metyrapone: effects on emotion and memory","volume":"21","author":"Roozendaal","year":"1996","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2808","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1523\/JNEUROSCI.4664-03.2004","article-title":"The basolateral amygdala interacts with the medial prefrontal cortex in regulating glucocorticoid effects on working memory impairment","volume":"24","author":"Roozendaal","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2809","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0361-9230(02)00859-6","article-title":"Effects of single or repeated restraint stress on GluR1 and GluR2 flip and flop mRNA expression in the hippocampal formation","volume":"59","author":"Rosa","year":"2002","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2810","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00004714-199902000-00013","article-title":"Effects of SSRIs on sexual function: a critical review","volume":"19","author":"Rosen","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2811","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0022-2836(02)00994-4","article-title":"Negative autoregulation speeds the response times of transcription networks","volume":"323","author":"Rosenfeld","year":"2002","journal-title":"J Mol Biol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2812","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/archpsyc.1984.01790120076010","article-title":"Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy","volume":"41","author":"Rosenthal","year":"1984","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2813","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0165-0327(98)00226-2","article-title":"Clinical pharmacology of befloxatone: a brief review","volume":"51","author":"Rosenzweig","year":"1998","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2814","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/35015728","article-title":"Pharmacogenetics and the practice of medicine","volume":"405","author":"Roses","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2815","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrd840","article-title":"Genome-based pharmacogenetics and the pharmaceutical industry","volume":"1","author":"Roses","year":"2002","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2816","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.tpj.6500126","article-title":"SNPs\u2014where's the beef?","volume":"2","author":"Roses","year":"2002","journal-title":"Pharmacogen J"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2817","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neulet.2003.12.061","article-title":"S 18986, a positive modulator of AMPA receptors with cognition-enhancing properties, increases Ach release in the hippocampus of young and aged rat","volume":"361","author":"Rosi","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2818","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1021\/jm049112h","article-title":"Rational approach to discover multipotent anti-Alzheimer drugs","volume":"48","author":"Rosini","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2819","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.mehy.2003.12.030","article-title":"Obesity and depression: same disease, different names?","volume":"62","author":"Rosmond","year":"2004","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2821","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00213-003-1683-8","article-title":"Serotonin receptors represent highly favourable molecular targets for cognitive enhancement in schizophrenia and other disorders","volume":"174","author":"Roth","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2822","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrd1346","article-title":"Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia","volume":"3","author":"Roth","year":"2004","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2823","first-page":"303","article-title":"Ramelteon (TAK-375), a selective MT1\/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment","volume":"28","author":"Roth","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2824","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/01.jcp.0000130557.08996.7a","article-title":"A double-blind, randomized study of olanzapine and olanzapine\/fluoxetine combination for major depression with psychotic features","volume":"24","author":"Rothschild","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2825","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.biopsych.2004.05.009","article-title":"Treatment of cocaine dependence and depression","volume":"56","author":"Rounsaville","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2826","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.pain.2004.05.010","article-title":"Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study","volume":"110","author":"Rowbotham","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2827","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0166-4328(03)00116-5","article-title":"Long-term effects of BIBN-99, a selective muscarinic M2 receptor antagonist, on improving spatial memory performance in aged cognitively impaired rats","volume":"145","author":"Rowe","year":"2003","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2828","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1073\/pnas.0405621102","article-title":"Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates","volume":"102","author":"Rowlett","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2829","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1021\/jm0002432","article-title":"Current and novel approaches to the drug treatment of schizophrenia","volume":"44","author":"Rowley","year":"2001","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3734","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/sj.npp.1300805","article-title":"Genetic inactivation of melanin-concentrating hormone receptor subtype 1 (MCHR1) in mice exerts anxiolytic-like behavioral effects","volume":"31","author":"Roy","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2830","doi-asserted-by":"crossref","first-page":"9M","DOI":"10.1016\/S0002-9149(03)00824-5","article-title":"Overview of phosphodiesterase 5 inhibition in erectile dysfunction","volume":"92","author":"Rozen","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2831","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/archpsyc.1992.01820070052008","article-title":"Neuroendocrine aspects of primary endogenous depression: XI. Serum melatonin measures in patients and matched control subjects","volume":"49","author":"Rubin","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2832","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0006-3223(03)00587-0","article-title":"Epidemiology of comorbid coronary artery disease and depression","volume":"54","author":"Rudish","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2833","first-page":"396","article-title":"ECT alters human monoamines in a different manner from that of antidepressant drugs","volume":"24","author":"Rudorfer","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2834","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1016\/S0968-0896(03)00449-8","article-title":"QSAR study of dual cyclooxygenase and 5-lipoxygenase inhibitors 2,6-di-tert-butylphenol derivatives","volume":"11","author":"Ruiz","year":"2003","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2835","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.biopsych.2004.10.029","article-title":"Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study","volume":"57","author":"Rumi","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2836","first-page":"257","article-title":"Elucidating the antidepressant actions of substance P (NK1 receptor) antagonists","volume":"3","author":"Rupniak","year":"2002","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2837","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0165-6147(99)01396-6","article-title":"Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists","volume":"20","author":"Rupniak","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2838","series-title":"Neuropsychopharmacology: The Fifth Generation of Progress","first-page":"169","article-title":"Substance P and related tachykinins","author":"Rupniak","year":"2002"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2839","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00008877-200111000-00011","article-title":"Comparison of the phenotype of NK1A\u2212\/\u2212 mice with pharmacological blockade of the substance P (NK1) receptor in assays for antidepressant and anxiolytic drugs","volume":"12","author":"Rupniak","year":"2001","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2840","first-page":"457","article-title":"P-glycoprotein efflux reduces the brain concentration of the substance P (NK1 receptor) antagonists SR140333 and GR205171: a comparative study using mdrla\u2212\/\u2212 and mdrla+\/+ mice","volume":"14","author":"Rupniak","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2841","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0022-3956(96)00060-X","article-title":"The neuropsychopharmacological potential of neuroactive steroids","volume":"31","author":"Rupprecht","year":"1997","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2842","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0006-3223(97)00521-0","article-title":"Neuroactive steroid concentrations following metyrapone administration in depressed patients and healthy volunteers","volume":"44","author":"Rupprecht","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2843","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/da.20051","article-title":"Escitalopram in clinical practice: results of an open-label trial in a naturalistic setting","volume":"21","author":"Rush","year":"2005","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2844","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4088\/JCP.v57n1006","article-title":"The dexamethasone suppression test in patients with mood disorders","volume":"57","author":"Rush","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2845","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1037\/1064-1297.6.1.32","article-title":"Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans","volume":"6","author":"Rush","year":"1998","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2846","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00008877-200203000-00002","article-title":"Acute behavioural and physiological effects of modafinil in drug abusers","volume":"13","author":"Rush","year":"2002","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2847","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0376-8716(02)00082-0","article-title":"Discriminative-stimulus effects of modafinil in cocaine-trained humans","volume":"67","author":"Rush","year":"2002","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2848","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1111\/j.0953-816X.2004.03426.x","article-title":"Sleep deprivation impairs hippocampus-mediated contextual learning but not amygdala-mediated cued learning in rats","volume":"19","author":"Ruskin","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2849","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1460-9568.1996.tb01294.x","article-title":"The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia","volume":"8","author":"Russ","year":"1996","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2850","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1038\/sj.npp.1300514","article-title":"Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise","volume":"29","author":"Russo-Neustadt","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2851","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbr.2005.04.021","article-title":"The selective PDE5 inhibitor, sildenafil, improves object memory in Swiss mice and increases cGMP levels in hippocampal slices","volume":"164","author":"Rutten","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2852","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0022-3956(99)00014-X","article-title":"The dexamethasone\/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness","volume":"33","author":"Rybakowski","year":"1999","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2853","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000026610","article-title":"Potentiation of antidepressants with lithium or carbamazepine in treatment-resistant depression","volume":"40","author":"Rybakowski","year":"1999","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2854","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0960-894X(01)00727-2","article-title":"First dual NK(1) antagonists-serotonin reuptake inhibitors: synthesis and SAR of a new class of potential antidepressants","volume":"12","author":"Ryckmans","year":"2002","journal-title":"Bioog Med Chem Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2855","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1016\/S0960-894X(02)00563-2","article-title":"Dual NK1 antagonists-serotonin reuptake inhibitors as potential antidepressants: Part 2. SAR and activity of benzyloxyphenethyl piperazine derivatives","volume":"12","author":"Ryckmans","year":"2002","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2856","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1523\/JNEUROSCI.23-01-00349.2003","article-title":"Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioural effects","volume":"23","author":"Saarelainen","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2857","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0165-1781(01)00326-2","article-title":"Psychomotor slowing, neuroendocrine responses, and behavioural changes after oral administration of meta-chlorophenylpiperazine in normal volunteers","volume":"105","author":"Sabbe","year":"2001","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2858","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1176\/jnp.7.1.6","article-title":"Phenylethlyamine modulation of affect: therapeutic and diagnostic implications","volume":"7","author":"Sabelli","year":"1995","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2859","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1176\/jnp.8.2.168","article-title":"Sustained antidepressant effects of PEA replacement","volume":"8","author":"Sabelli","year":"1996","journal-title":"J Neuropsychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2860","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/0269881104047273","article-title":"Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders","volume":"18","author":"Sacco","year":"2004","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2861","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0006-3223(01)01298-7","article-title":"Effects of different frequencies of transcranial magnetic stimulation (TMS) on the forced swim test model of depression in rats","volume":"51","author":"Sachdev","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2862","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/07853899808999393","article-title":"Use of melatonin for sleep and circadian rhythm disorders","volume":"30","author":"Sack","year":"1998","journal-title":"Ann Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2863","first-page":"10","article-title":"The definition and meaning of treatment-resistant depression","volume":"62","author":"Sackeim","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2864","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3317\/jraas.2002.023","article-title":"Vasopeptidase inhibitors","volume":"3","author":"Sagnella","year":"2002","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2865","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1523\/JNEUROSCI.3741-04.2005","article-title":"Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects of neuronal turnover, proliferation, and survival in the adult dentate gyrus","volume":"25","author":"Sairanen","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2866","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/22321","article-title":"Molecular characterization of the melanin-concentrating-hormone receptor","volume":"400","author":"Saito","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2867","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/cne.1191","article-title":"Expression of the melanin-concentrating hormone (MCH) receptor mRNA in the rat brain","volume":"435","author":"Saito","year":"2001","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2868","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1254\/jphs.91.87","article-title":"Roles of substance P and NK1 receptor in the brainstem in the development of emesis","volume":"91","author":"Saito","year":"2003","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2869","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1254\/jphs.FPJ04014X","article-title":"Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioural models in rodents","volume":"95","author":"Saitoh","year":"2004","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2870","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.npep.2004.05.006","article-title":"Interactions between NPY and CRF in the amygdala to regulate emotionality","volume":"38","author":"Sajdyk","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2871","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0006-8993(88)91423-0","article-title":"Blockade of the histamine H1-receptor in the rat ventromedial hypothalamus and feeding elicitation","volume":"441","author":"Sakata","year":"1988","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2872","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00315137","article-title":"Does tolerance develop to the sedative and amnesic effects of antidepressants? A comparison of amitriptyline, trazodone and placebo","volume":"40","author":"Sakulsripong","year":"1991","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2873","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0031-9384(90)90057-B","article-title":"Central effect of yohimbine on sexual behavior in the rat","volume":"47","author":"Sala","year":"1990","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2874","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.euroneuro.2003.12.005","article-title":"Stress and hippocampal abnormalities in psychiatric disorders","volume":"14","author":"Sala","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2875","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archinte.162.1.19","article-title":"The effect of antidepressant treatment on lower back pain: a meta-analysis","volume":"162","author":"Salerno","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2876","doi-asserted-by":"crossref","first-page":"15482","DOI":"10.1074\/jbc.M201539200","article-title":"Oligomerization of G-protein-coupled receptors shown by selective co-immunoprecipitation","volume":"277","author":"Salim","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2877","first-page":"387","article-title":"Antidepressant effect of transdermal nicotine patches in non-smoking patients with major depression","volume":"57","author":"Salin-Pascual","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2878","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.mp.4000543","article-title":"Genetic alteration of the \u03b12-adrenoceptor subtype C in mice effects the development of behavioral despair and stress-induced increases in plasma corticosterone levels","volume":"4","author":"Sallinen","year":"1999","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2879","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ddr.10012","article-title":"Metabotropic glutamate (mGlu) receptor and nociceptive processing","volume":"54","author":"Salt","year":"2002","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2880","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.tips.2004.12.007","article-title":"Why does the rapid delivery of drugs to the brain promote addiction?","volume":"26","author":"Samaha","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2881","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.1523\/JNEUROSCI.1205-04.2004","article-title":"The rate of cocaine administration alters gene regulation and behavioral plasticity: implications for addiction","volume":"24","author":"Samaha","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2882","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0773.1993.tb01537.x","article-title":"Neurochemical mechanism of action of anorectic drugs","volume":"73","author":"Samanin","year":"1993","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2884","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1359-6446(04)03316-1","article-title":"Target-based drug discovery: is something wrong?","volume":"10","author":"Sams-Dodd","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2885","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1074\/jbc.R200032200","article-title":"RNA editing minireview series","volume":"278","author":"Samuel","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2886","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1523\/JNEUROSCI.3754-04.2005","article-title":"A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression","volume":"25","author":"Samuvel","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2887","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1176\/appi.ajp.159.4.663","article-title":"Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors","volume":"159","author":"Sanacora","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2888","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1176\/appi.ajp.160.3.577","article-title":"Increased cortical GABA concentrations in depressed patients receiving ECT","volume":"160","author":"Sanacora","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2889","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1196\/annals.1300.018","article-title":"Clinical studies implementing glutamate neurotransmission in mood disorders","volume":"1003","author":"Sanacora","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2890","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/sj.npp.1300418","article-title":"Addition of the \u03b12-antagonist yohimbine to fluoxetine: effects on rate of antidepressant response","volume":"29","author":"Sanacora","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2891","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archpsyc.61.7.705","article-title":"Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression","volume":"61","author":"Sanacora","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2892","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nature02301","article-title":"Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration","volume":"427","author":"Sanal","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2893","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s002130050181","article-title":"Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?","volume":"129","author":"Sanchez","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2894","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1023\/A:1006986824213","article-title":"Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding","volume":"19","author":"Sanchez","year":"1999","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2895","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/(SICI)1096-9861(19990607)408:3<365::AID-CNE5>3.0.CO;2-N","article-title":"Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in non human primate brain","volume":"408","author":"Sanchez","year":"1999","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2896","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00213-002-1364-z","article-title":"Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities","volume":"167","author":"Sanchez","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2897","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0306-4522(03)00078-2","article-title":"Manipulation of dopamine D1-like receptor activation in the rat medial prefrontal cortex alters stress- and cocaine-induced renstatement of conditioned place preference behavior","volume":"119","author":"Sanchez","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2898","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00213-004-1865-z","article-title":"Escitalopram versus citalopram: the surprising role of the R-enantiomer","volume":"174","author":"Sanchez","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2899","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF00634454","article-title":"Sertraline-induced desensitization of the serotonin 5-HT2 receptor transmembrane signaling system","volume":"99","author":"Sanders-Bush","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2900","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0009-8981(79)90261-4","article-title":"Decreased cerebrospinal fluid concentration of free phenylacetic acid in depressive illness","volume":"93","author":"Sandler","year":"1979","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2901","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.bcp.2003.10.008","article-title":"Relationship between the antinociceptive response to desipramine and changes in GABAB receptor function and subunit expression in the dorsal horn of the rat spinal cord","volume":"67","author":"Sands","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2902","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.bcp.2004.07.027","article-title":"Effect of antidepressants on GABAB receptor function and subunit expression in rat hippocampus","volume":"68","author":"Sands","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2903","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/sj.bjp.0705742","article-title":"Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain","volume":"141","author":"Sanger","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2904","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/cercor\/bhh070","article-title":"Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex","volume":"14","author":"Santana","year":"2004","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2905","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1073\/pnas.98.4.1912","article-title":"Genetic and pharmacological disruption of neurokinin1 receptor function decreases anxiety-related behaviors and increases serotonergic function","volume":"98","author":"Santarelli","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2906","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.1083328","article-title":"Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants","volume":"301","author":"Santarelli","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2907","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00008877-200011000-00005","article-title":"Place aversion induced by blockade of mu or activation of kappa opioid receptors in the dorsal periaqueductal gray matter","volume":"11","author":"Sante","year":"2000","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2908","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1124\/mol.61.5.1222","article-title":"The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system","volume":"61","author":"Santos","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2909","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10253899609001092","article-title":"Stress, glucocorticoids, and damage to the nervous system: the current state of confusion","volume":"1","author":"Sapolski","year":"1996","journal-title":"Stress"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2910","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/archpsyc.57.10.925","article-title":"Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders","volume":"57","author":"Sapolski","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2911","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.biopsych.2004.04.012","article-title":"Is impaired neurogenesis relevant to the affective symptoms of depression?","volume":"56","author":"Sapolski","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2912","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0163-1047(89)91039-X","article-title":"Idazoxan, an \u03b12 antagonist, facilitates memory retrieval in the rat","volume":"51","author":"Sara","year":"1989","journal-title":"Behav Neural Biol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2913","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0278-5846(87)90075-3","article-title":"The regional distribution of p-tyramine and m-tyramine in the rat corpus striatum and the effect of monoamine oxidase inhibition","volume":"11","author":"Sardar","year":"1987","journal-title":"Prog Neuropsychopharmacol Biol Psychiatr"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2914","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.neubiorev.2004.08.008","article-title":"Serotonin1B receptors: from protein to physiological function and behavior","volume":"28","author":"Sari","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2915","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-2999(99)00259-9","article-title":"The tachykinin NK1 receptor in the brain: pharmacology and putative functions","volume":"375","author":"Saria","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2916","first-page":"865","article-title":"In quest of thyroid hormone function in mature mammalian brain","volume":"40","author":"Sarkar","year":"2002","journal-title":"Indian J Exp Biol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2917","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrn1588","article-title":"Choline transporters, cholinergic transmission and cognition","volume":"6","author":"Sarter","year":"2005","journal-title":"Nat Res Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2918","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1074-7427(03)00070-4","article-title":"Attentional functions of cortical cholinergic inputs: what does it mean for learning and memory","volume":"80","author":"Sarter","year":"2003","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2919","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.brainresrev.2004.08.006","article-title":"Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection","volume":"48","author":"Sarter","year":"2005","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2920","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1192\/S0007125000298395","article-title":"Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary health care","volume":"168","author":"Sartorius","year":"1996","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2921","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0006-3223(02)01600-1","article-title":"Choline rise in the rat hippocampus induced by electroconvulsive shock treatment","volume":"53","author":"Sartorius","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2922","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.peptides.2004.04.001","article-title":"Facilitative effect of a novel AVP fragment analog, NC-1900, on memory retention and recall in mice","volume":"25","author":"Sato","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2923","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0163-7258(95)02011-X","article-title":"Molecular pharmacology of the opioid receptors","volume":"68","author":"Satoh","year":"1995","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2924","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.parkreldis.2004.02.002","article-title":"Treatment of depression in Parkinson's disease","volume":"10","author":"Sawabini","year":"2004","journal-title":"Parkinson Related Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2925","doi-asserted-by":"crossref","first-page":"8620","DOI":"10.1523\/JNEUROSCI.20-22-08620.2000","article-title":"Hypothalamic arousal regions are activated during modafinil-induced wakefulness","volume":"20","author":"Scammell","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2926","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1051","article-title":"3-Iodothyronamine is an endogenous and rapid-acting derivation or thyroid hormone","volume":"10","author":"Scanlan","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2927","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2174\/1389557043403251","article-title":"Dual acting antihistaminergic agents","volume":"4","author":"Scannell","year":"2004","journal-title":"Mini-Rev Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2928","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1517\/13543784.14.7.835","article-title":"Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential","volume":"14","author":"Scatena","year":"2005","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2929","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/10253890009001124","article-title":"Corticosterone effects on BDNF expression in the hippocampus. Implications for memory formation","volume":"3","author":"Schaaf","year":"2000","journal-title":"Stress"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2930","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1212\/WNL.59.6_suppl_4.S15","article-title":"Vagus nerve stimulation therapy summary: five years after FDA approval","volume":"59","author":"Schachter","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2931","first-page":"S203","article-title":"Neurotransmitter changes by interferon-alpha and therapeutic implications","volume":"3","author":"Schaefer","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2932","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1124\/mol.64.4.798","article-title":"Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2","volume":"64","author":"Schaffhauser","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2933","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tins.2004.12.005","article-title":"Similarities between actions of estrogen and BDNF in the hippocampus: coincidence or clue?","volume":"28","author":"Scharfman","year":"2005","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2934","first-page":"14","article-title":"Antidepressant effectiveness in severe depression and melancholia","volume":"60","author":"Schatzberg","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2935","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1002\/hup.399","article-title":"Pharmacological principles of antidepressant efficacy","volume":"17","author":"Schatzberg","year":"2002","journal-title":"Human Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2936","first-page":"30","article-title":"Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder","volume":"64","author":"Schatzberg","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2937","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1176\/ajp.149.6.733","article-title":"Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV?","volume":"149","author":"Schatzberg","year":"1992","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2938","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archpsyc.62.5.513","article-title":"Medication (Nefazodone) or psychotherapy (CBASP) is effective when the other is not","volume":"62","author":"Schatzberg","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2939","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/1381612023396483","article-title":"The potential utility of 5-HT1A receptor antagonists in the treatment of cognitive dysfunction associated with Alzheimer's disease","volume":"8","author":"Schechter","year":"2002","journal-title":"Curr Pharma Des"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2940","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1124\/jpet.105.086363","article-title":"Lecozotan (SRA-333): a selective serotonin1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties","volume":"314","author":"Schechter","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2941","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/35098000","article-title":"Catastrophic shifts in ecosystems","volume":"413","author":"Scheffer","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2942","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/S0024-3205(01)01016-5","article-title":"Evaluation of the alpha2C-adrenoceptor as a neuropsychiatric drug target: studies in transgenic mouse models","volume":"68","author":"Scheinin","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2943","first-page":"198","article-title":"Cell-turnover in the gyrus dentatus in mice is enhanced by metyrapone treatment","volume":"34","author":"Schick","year":"2001","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2944","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1176\/appi.ajp.161.5.909","article-title":"Toward a rapidly acting antidepressant: the normetanephrine and extraneuronal monoamine transporter (uptake 2) hypothesis","volume":"161","author":"Schildkraut","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2945","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.npp.1300038","article-title":"Efficacy of repetitive transcranial magnetic stimulation (rTMS) in the treatment of affective disorders","volume":"28","author":"Schlaepfer","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2946","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0092-8674(00)00114-8","article-title":"Cell signalling by receptor tyrosine kinases","volume":"103","author":"Schlessinger","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2947","doi-asserted-by":"crossref","first-page":"12590","DOI":"10.1021\/bi00039a014","article-title":"Heterogeneity of antidepressant binding sites on the recombinant rat serotonin transporter SERT1","volume":"34","author":"Schloss","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2948","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pharmthera.2004.02.001","article-title":"New insights into the mechanisms of antidepressant therapy","volume":"102","author":"Schloss","year":"2004","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2949","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.brainres.2004.03.036","article-title":"The biogenic trace amine tyramine induces a pronounced hydroxyl radical production via a monoamine oxidase dependent mechanism: an in vivo microdialysis study in mouse striatum","volume":"1012","author":"Schmidt","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2950","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)01188-8","article-title":"Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile","volume":"425","author":"Schmidt","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2951","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/026988110101500304","article-title":"Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors","volume":"15","author":"Schmitt","year":"2001","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2952","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/026988110201600303","article-title":"Additional dopamine reuptake inhibition attenuates vigilance decrement induced by serotonergic reuptake inhibition in man","volume":"16","author":"Schmitt","year":"2002","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2953","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/jnr.10521","article-title":"Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient mice","volume":"71","author":"Schmitt","year":"2003","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2954","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archpsyc.62.2.154","article-title":"Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression","volume":"62","author":"Schmidt","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2955","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00019442-200111000-00007","article-title":"Estrogen replacement therapy and antidepressant response to sertraline in older depressed women","volume":"9","author":"Schneider","year":"2001","journal-title":"Am J Geriatr Psychiatr"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2956","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrn1650","article-title":"Normal and pathological oscillatory communication in the brain","volume":"6","author":"Schnitzler","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2957","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1073\/pnas.78.8.5240","article-title":"Differentiation of the open and closed states of the ionic channels of nicotine acetylcholine receptors by tricyclic antidepressants","volume":"78","author":"Schoefield","year":"1981","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2958","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF00432680","article-title":"Differences in presynaptic alpah-blockade, noradrenaline uptake inhibition, and potential antidepressant activity between (+)-and (-)-mianserin","volume":"74","author":"Schoemaker","year":"1981","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2959","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0022-3565(24)29296-X","article-title":"Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system","volume":"299","author":"Schoepp","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2960","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1523\/JNEUROSCI.21-13-04875.2001","article-title":"The \u03b12A-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety","volume":"2","author":"Schramm","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2961","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0014-2999(94)90816-8","article-title":"The potent activity of the 5-HT1A receptor agonists, S14506 and S14671, in the rat forced swim test is blocked by novel 5-HT1A receptor antagonists","volume":"271","author":"Schreiber","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2962","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1385\/JMN:18:1-2:143","article-title":"Venlafaxine and mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects- a possible opioid involvement in severe depression?","volume":"18","author":"Schreiber","year":"2002","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2963","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0278-5846(02)00264-6","article-title":"Endocrinological effects of mirtazapine in healthy volunteers","volume":"26","author":"Sch\u00fcle","year":"2002","journal-title":"Prog NeuroPsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2964","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0896-6273(01)00345-2","article-title":"Epilepsy, hyperalgesia, impaired memory, and loss of pre-and postsynaptic GABAB responses in mice lacking GABAB1","volume":"31","author":"Schuller","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2965","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/PL00007092","article-title":"Central effects of sildenafil (Viagra) on auditory selective attention and verbal recognition memory in humans: a study with event-related brain potentials","volume":"19","author":"Schultheiss","year":"2001","journal-title":"World J Urol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2966","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4088\/JCP.v59n0406","article-title":"Buspirone and imipramine for the treatment of major depression in the elderly","volume":"59","author":"Schweizer","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2967","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-0327(02)00026-5","article-title":"Vasopressin as a target for antidepressant development: an assessment of the available evidence","volume":"72","author":"Scott","year":"2002","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2968","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00001504-200401000-00002","article-title":"Brief psychotherapies for depression: current status","volume":"17","author":"Scott","year":"2004","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2969","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/exnr.2000.7458","article-title":"Neurogenesis in the dentate gyrus of the rat following electroconvulsive shock seizures","volume":"165","author":"Scott","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2970","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1192\/bjp.182.3.221","article-title":"Use of cognitive therapy for relapse prevention in chronic depression: cost effectiveness study","volume":"182","author":"Scott","year":"2003","journal-title":"Br J Psychiatr"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2971","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00213-005-2198-2","article-title":"Chronic coadministration of olanzapine and fluoxetine activates locus coeruleus neurons in rats: implications for bipolar disorder","volume":"181","author":"Seager","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2972","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2004.05.006","article-title":"The principal features and mechanisms of dopamine modulation in the prefrontal cortex","volume":"74","author":"Seamans","year":"2004","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2973","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0165-0173(97)00047-7","article-title":"How to study consciousness scientifically","volume":"26","author":"Searle","year":"1998","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2974","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrd1152","article-title":"Pharmacophylogenomics: genes, evolution and drug targets","volume":"2","author":"Searls","year":"2003","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2975","first-page":"763.9","article-title":"The neuropeptide MCH controls feeding and mood via action on the nucleus accumbens shell","volume":"29","author":"Sears","year":"2004","journal-title":"Am Soc Neuroscience Abstr"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2976","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/sj.bjp.0702893","article-title":"Contrasting EEG profiles elicited by antipsychotic agents in the prefrontal cortex of the conscious rat: antagonism of the effects of clozapine by modafinil","volume":"128","author":"Sebban","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2977","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/sj.bjp.0702894","article-title":"Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission","volume":"128","author":"Sebban","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2978","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jad.2004.07.002","article-title":"A comparative study of milnacipran and paroxetine in outpatients with major depression","volume":"83","author":"Sechter","year":"2004","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2979","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/frne.1996.0143","article-title":"11 \u03b2-hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action?","volume":"18","author":"Seckl","year":"1997","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2980","doi-asserted-by":"crossref","first-page":"10117","DOI":"10.1523\/JNEUROSCI.3581-04.2004","article-title":"M2 muscarinic acetylcholine receptor knock-out mice show deficits in behavioural flexibility, working memory, and hippocampal plasticity","volume":"24","author":"Seeger","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2981","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/hbeh.2001.1688","article-title":"Estradiol induces formation of dendritic spines in hippocampal neurons: functional correlates","volume":"40","author":"Segal","year":"2001","journal-title":"Horm Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2982","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s002100000370","article-title":"Regulatory role of nitric oxide over hippocampal 5-HT release in vivo","volume":"363","author":"Segieth","year":"2001","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2983","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/hup.672","article-title":"Pindolol augmentation of selective serotonin reuptake inhibitors: accounting for the variability of results of placebo-controlled double-blind studies in patients with major depression","volume":"20","author":"Segrave","year":"2005","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2984","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0165-1781(91)90013-F","article-title":"Effects of ritanserin on the behavioural, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects","volume":"38","author":"Seibyl","year":"1991","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2985","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1176\/appi.ajp.158.10.1623","article-title":"Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate","volume":"158","author":"Seidman","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2986","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00210-002-0588-0","article-title":"Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors","volume":"366","author":"Seifert","year":"2002","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2987","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0022-3956(97)00020-4","article-title":"Effect of sleep deprivation on neuroendocrine response to a serotonergic probe in healthy male subjects","volume":"31","author":"Seifritz","year":"1997","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2988","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1159\/000118569","article-title":"Potential antidepressant properties of subchronic GABA transaminase inhibitors in the forced swimming test in mice","volume":"21","author":"Semba","year":"1989","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2989","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neuroimage.2004.01.015","article-title":"Limbic-frontal circuitry in major depression: a path modelling metanalysis","volume":"22","author":"Seminowicz","year":"2004","journal-title":"Neuroimage"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2990","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(98)00856-5","article-title":"Effect of alterations in extracellular norepinephrine on adrenoceptors: a microdialysis study in freely moving rats","volume":"365","author":"Seo","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2991","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1097\/00001756-199912160-00044","article-title":"Serotonin and substance P co-exist in dorsal raphe neurons of the human brain","volume":"10","author":"Sergeyev","year":"1999","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2992","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00213-004-2015-3","article-title":"Neuropeptide expression in rats exposed to chronic mild stress","volume":"178","author":"Sergeyev","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2993","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1124\/jpet.300.3.1122","article-title":"Characterisation of (2S, 4R)-1-[5-chloro-1-[2,4-dimethoxyphenyl) sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist","volume":"300","author":"Serradeil-Le Gal","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2994","first-page":"53","article-title":"An overview of SSRI149415, a selective nonpeptide vasopressin V1b receptor antagonist for the treatment of stress-related disorders","volume":"11","author":"Serradeil-Le Gal","year":"2005","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2995","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1471-4159.2003.01557.x","article-title":"GABAB receptor mRNA in the raphe nuclei: co-expression with serotonin transporter and glutamic acid decarboxylase","volume":"84","author":"Serrats","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2996","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1017\/S1461145703003924","article-title":"An autoradiographic study of the influence of pindolol upon [35S]GTP\u03b3s binding in rat, guinea pig and human brain","volume":"7","author":"Serrats","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2997","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/syn.10287","article-title":"5-HT5B receptor mRNA in the raphe nuclei: coexpression with serotonin transporter","volume":"51","author":"Serrats","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2998","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s00213-004-1822-x","article-title":"From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes","volume":"174","author":"Serretti","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib2999","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/sj.tpj.6500250","article-title":"The pharmacogenomics of selective serotonin reuptake inhibitors","volume":"4","author":"Serretti","year":"2004","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3000","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2350-5-27","article-title":"Neural network analysis in pharmacogenetics of mood disorders","volume":"5","author":"Serretti","year":"2004","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3001","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/0929867043456043","article-title":"New antipsychotics and schizophrenia: a review on efficacy and side effects","volume":"11","author":"Serretti","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3002","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1196\/annals.1300.066","article-title":"Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions","volume":"1003","author":"Sesack","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3003","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0091-3057(01)00715-8","article-title":"Nicotinic-serotonergic interactions in brain and behaviour","volume":"71","author":"Seth","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3004","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1527-3458.2003.tb00244.x","article-title":"The pharmacology of CP154,526, a non-peptide antagonist of the CRH1 receptor: a review","volume":"9","author":"Seymour","year":"2003","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3005","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1192\/bjp.172.6.527","article-title":"Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study","volume":"172","author":"Shah","year":"1998","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3006","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1523\/JNEUROSCI.22-09-03638.2002","article-title":"Overcoming the effects of stress on synaptic plasticity in the intact hippocampus: rapid actions of serotonergic and antidepressant agents","volume":"22","author":"Shakesby","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3007","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4088\/JCP.v62n0312b","article-title":"Treatment of refractory major depression with tramadol monotherapy","volume":"62","author":"Shapira","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3008","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0028-3908(94)90077-9","article-title":"Slow wave sleep in humans: role or 5-HT2A and 5-HT2C receptors","volume":"33","author":"Sharpley","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3009","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF02246410","article-title":"Effects of paroxetine and nefazodone on sleep: a placebo controlled trial","volume":"126","author":"Sharpley","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3010","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.biochem.68.1.821","article-title":"CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals","volume":"68","author":"Shaywitz","year":"1999","journal-title":"Ann Rev Biochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3011","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.brainresrev.2004.04.009","article-title":"Regulation of affect by the lateral septum: implications for neuropsychiatry","volume":"46","author":"Sheehan","year":"2004","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3012","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0091-3057(01)00688-8","article-title":"Role of norepinephrine in the dorsomedial hypothalamic panic response: an in vivo microdialysis study","volume":"71","author":"Shekhar","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3013","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0028-3908(99)00215-4","article-title":"LY354740, a potent group II metabotropic glutamate receptor agonist prevents lactate-induced panic-like response in panic-prone rats","volume":"39","author":"Shekhar","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3014","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0006-3223(01)01263-X","article-title":"Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant teatment: an fMRI study","volume":"50","author":"Sheline","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3015","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1517\/14656566.4.7.1175","article-title":"The combination of olanzapine and fluoxetine in mood disorders","volume":"4","author":"Shelton","year":"2003","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3016","first-page":"29","article-title":"Long-term management of major depressive disorder: are differences among antidepressant treatments meaningful?","volume":"65","author":"Shelton","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3017","first-page":"5","article-title":"The dual-action hypothesis: does pharmacology matter?","volume":"65","author":"Shelton","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3018","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1176\/appi.ajp.158.1.131","article-title":"A novel augmentation strategy for treating resistant major depression","volume":"158","author":"Shelton","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3019","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0304-3940(03)00178-2","article-title":"Electroconvulsive shock increases serotonin transporter in the rat frontal cortex","volume":"341","author":"Shen","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ng881","article-title":"Network motifs in the transcriptional regulation network of Escherichia coli","volume":"31","author":"Shen-Orr","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3021","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1021\/ci990087b","article-title":"Mining and visualizing large anticancer drug discovery database","volume":"40","author":"Shi","year":"2000","journal-title":"J Chem Inf Comput Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3022","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0006-8993(92)91482-T","article-title":"Effect of substance P on circadian rhythms of firing activity and the 2-deoxyglucose uptake in the rat suprachiasmatic nucleus in vitro","volume":"597","author":"Shibata","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3023","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0161-813X(03)00112-8","article-title":"Cloning, after-cloning, knock-out mice, and physiological functions of MAO A and B","volume":"25","author":"Shih","year":"2004","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3024","first-page":"235","article-title":"MAO-A and B gene knock-out mice exhibit distinctly different behavior","volume":"7","author":"Shih","year":"1999","journal-title":"Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejphar.2003.09.044","article-title":"Transporter-mediated actions of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane","volume":"482","author":"Shimazu","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3026","first-page":"1551","article-title":"Chronic antidepressant exposure enhances 5-hydroxytryptamine7 receptor-mediated cyclic adenosine monophosphate accumulation in rat frontocortical astrocytes","volume":"279","author":"Shimizu","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3027","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1124\/jpet.104.074856","article-title":"An antisense oligonucleotide to the NMDA subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance","volume":"312","author":"Shimoyama","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3028","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0006-8993(94)91875-9","article-title":"The medial preoptic area is involved in both sexual arousal and performance in male rats: reevaluation of neuron activity in freely moving animals","volume":"640","author":"Shimura","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3029","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0006-8993(96)00812-8","article-title":"Reduction of substance P after chronic antidepressant treatment in the striatum, substantia nigra and amygdala of the rat","volume":"739","author":"Shirayama","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3030","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1523\/JNEUROSCI.22-08-03251.2002","article-title":"Brain-derived neurotrophic factor produces antidepressant effects in behavioural models of depression","volume":"22","author":"Shirayama","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3031","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1471-4159.2004.02589.x","article-title":"Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin-antagonism produces antidepressant-like effects","volume":"90","author":"Shirayama","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3032","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0893-133X(01)00400-6","article-title":"Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat","volume":"26","author":"Shirazi-Southall","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3033","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-0327(02)00428-7","article-title":"Estrogen-mediated effects on depression and memory formation in females","volume":"74","author":"Shors","year":"2003","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3034","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/bmj.327.7407.158","article-title":"Separation of anxiety and depressive disorders: blind alley in psychopharmacology and classification of disease","volume":"327","author":"Shorter","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3035","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/sj.mp.4001035","article-title":"Nicotinic acetylcholine receptors as targets for antidepressants","volume":"7","author":"Shytle","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3036","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/da.10035","article-title":"Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine","volume":"16","author":"Shytle","year":"2002","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3037","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1124\/mol.52.6.1056","article-title":"Antisense inhibition of 5-hydroxytryptamine2A receptors induces an antidepressant-like effect in mice","volume":"52","author":"Sibille","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3038","first-page":"181","article-title":"Structure and pharmacology of \u03b3-aminobutyric acidA receptor subtypes","volume":"47","author":"Sieghart","year":"1995","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3039","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s002130100791","article-title":"The effects of reboxetine on autonomic and cognitive functions in healthy volunteers","volume":"157","author":"Siepmann","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00213-003-1448-4","article-title":"Effects of sertraline on automatic and cognitive functions in healthy volunteers","volume":"168","author":"Siepmann","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3041","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-2999(97)01235-1","article-title":"Opposite effects of dopamine D2 and D3 receptors on learning and memory in the rat","volume":"336","author":"Sigala","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3042","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0165-6147(97)90675-1","article-title":"The benzodiazepine binding site of GABAA receptors","volume":"18","author":"Sigel","year":"1997","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3043","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.nlm.2004.04.005","article-title":"Effects of pre-or post-training paradoxical sleep deprivation on two animal models of learning and memory in mice","volume":"82","author":"Silva","year":"2004","journal-title":"Neurobiol Learn Memory"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3044","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1527-3458.2001.tb00200.x","article-title":"Fluvoxamine as an adjunctive agent in schizophrenia","volume":"7","author":"Silver","year":"2001","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3045","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.expneurol.2004.03.022","article-title":"Selective blockade of D3 dopamine receptors enhances the antiparkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate","volume":"188","author":"Silverdale","year":"2004","journal-title":"Experimental Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3046","first-page":"19","article-title":"Qualitative review of SNRIs in anxiety","volume":"65","author":"Silverstone","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3047","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00004850-199409000-00005","article-title":"The effects of administration of mCPP on psychological, cognitive, cardiovascular, hormonal and MHPG measurements in human volunteers","volume":"9","author":"Silverstone","year":"1994","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3048","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.tree.2004.09.003","article-title":"Plant coexistance and the niche","volume":"19","author":"Silvertown","year":"2004","journal-title":"Trends Ecol Evol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3049","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0091-3057(02)00849-3","article-title":"Group II mGluR receptor agonists are effective in persistent and neuropathic pain models in rats","volume":"73","author":"Simmons","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3050","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0006-3223(03)00420-7","article-title":"Social and economic burden of mood disorders","volume":"54","author":"Simon","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3051","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM199910283411801","article-title":"An international study of the relation between somatic symptoms and depression","volume":"341","author":"Simon","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3052","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/archpsyc.58.4.395","article-title":"Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians","volume":"58","author":"Simon","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3053","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jpsychires.2003.10.004","article-title":"Extended-release venlafaxine in relapse prevention for patients with major depressive disorder","volume":"38","author":"Simon","year":"2004","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3054","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000065541","article-title":"Penile arteries and erections","volume":"39","author":"Simonsen","year":"2002","journal-title":"J Vasc Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3055","series-title":"Neuropathic Pain: Pathophysiology and Treatment","first-page":"169","article-title":"Antidepressants in the treatment of neuropathic pain","author":"Sindrup","year":"2001"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3056","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/jama.293.5.596","article-title":"Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence","volume":"293","author":"Sink","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3057","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0091-3057(02)00776-1","article-title":"Reinforcing effects of the neurosteroid allopregnanolone in rats","volume":"72","author":"Sinnott","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3058","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0006-8993(86)90957-1","article-title":"Regulation of lordosis behaviour in the female rat by corticotropin-releasing factor, \u03b2-endorphin\/corticotropin and luteinizing hormone-releasing hormone neuronal systems in the medial preoptic area","volume":"375","author":"Sirinathsinghji","year":"1986","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3059","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0006-8993(87)91236-4","article-title":"Inhibitory influence of corticotropin releasing factor on components of sexual behavior in the male rat","volume":"407","author":"Sirinathsinghji","year":"1987","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3060","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1176\/appi.ajp.157.9.1379","article-title":"Depression in schizophrenia: perspectives in the era of \u201catypical\u201d antipsychotic agents","volume":"157","author":"Siris","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3061","first-page":"49","article-title":"Cetral \u03b11-adrenoceptors: their role in the modulation of attention and memory formation","volume":"83","author":"Sirvio","year":"1999","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3062","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1124\/mi.4.1.38","article-title":"Sodium-dependent neurotransmitter transporters: oligomerization as a determinant of transporter function and trafficking","volume":"4","author":"Sitte","year":"2004","journal-title":"Mol Interventions"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3063","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejphar.2003.08.072","article-title":"Oligomer formation by Na+-Cl- coupled neurotransmitter transporters","volume":"479","author":"Sitte","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3064","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1046\/j.1471-4159.1998.71031289.x","article-title":"Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine and dopamine in mammalian cells transfected with the human dopamine transporter","volume":"71","author":"Sitte","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00213-004-1809-7","article-title":"The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors","volume":"175","author":"Siuciak","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3066","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0197-4580(98)00086-4","article-title":"Decreased monoamine metabolites in frontotemporal dementia and Alsheimer's disease","volume":"19","author":"Sjogren","year":"1998","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3067","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0278-5846(01)00333-5","article-title":"Evaluation of the face validity of reserpine administration as an animal model of depression-Parkinson's disease association","volume":"26","author":"Skalisz","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3068","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1742-1241.2003.tb10489.x","article-title":"COX-LOX inhibition: current evidence for an emerging new therapy","volume":"57","author":"Skelly","year":"2003","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3069","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0531-5565(02)00198-5","article-title":"Melatonin rhythmicity: effect of age and Alzheimer's disease","volume":"38","author":"Skene","year":"2003","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3070","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2125.1994.tb04258.x","article-title":"Comparison of the effects of acute fluvoxamine and desipramine administration on melatonin and cortisol production in human","volume":"37","author":"Skene","year":"1994","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3071","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2007-979537","article-title":"Adaptation of NMDA receptors following antidepressant treatment: implications for the pharmacotherapy of depression","volume":"29","author":"Skolnick","year":"1996","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3072","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1006\/phrs.2000.0806","article-title":"Current perspectives on the development of non-biogenic amine-based antidepressants","volume":"43","author":"Skolnick","year":"2001","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3073","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(03)01310-4","article-title":"Antidepressant-like actions of DOV 21,947: a \u201ctriple\u201d reuptake inhibitor","volume":"461","author":"Skolnick","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3074","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1016\/j.lfs.2003.06.007","article-title":"\u201cBroad spectrum\u201d antidepressants: is more better for the treatment of depression?","volume":"73","author":"Skolnick","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3075","first-page":"923","article-title":"Potential antidepressant activity of sigma ligands","volume":"55","author":"Skuza","year":"2003","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3076","first-page":"1149","article-title":"Sigma1 receptor antagonists attenuate antidepressant-like effect induced by co-administration of 1,3 di-o-tolylguanidine (DTG) and memantine in the forced swimming test in rats","volume":"55","author":"Skuza","year":"2003","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3077","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1124\/jpet.104.073536","article-title":"GABAB receptor antagonist-mediated antidepressant-like behavior is serotonin-dependent","volume":"312","author":"Slattery","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3078","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0014-2999(88)90199-9","article-title":"Chronic MAO A and MAO B inhibition decreases the 5-HT1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase","volume":"154","author":"Sleight","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3079","first-page":"99","article-title":"Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment","volume":"47","author":"Sleight","year":"1995","journal-title":"Mol Pharm"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3080","first-page":"321","article-title":"Bupropion is a nicotinic antagonist","volume":"295","author":"Slemmer","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3081","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/089198879600900402","article-title":"Circadian rhythms and psychiatric disorders in the elderly","volume":"9","author":"Sloane","year":"1996","journal-title":"J Geriatr Psychiatr Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3082","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0028-3908(02)00062-X","article-title":"Effect of chronic imipramine or electroconvulsive shock on the expression of mGluR1a and mGluR5a immunoreactivity in rat brain hippocampus","volume":"42","author":"Smialowska","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3094","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1360-0443.2004.00683.x","article-title":"Cannabis use and the risk of later schizophrenia: a review","volume":"99","author":"Smit","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3083","first-page":"826","article-title":"Therapeutic, NMDA receptor antagonists: will reality meet expectation?","volume":"4","author":"Smith","year":"2003","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3084","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s002130050374","article-title":"Evidence that the enhancement of dopamine function by repeated electroconvulsive shock requires concomitant activation of D1-like and D2-like dopamine receptors","volume":"133","author":"Smith","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3085","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(00)01378-1","article-title":"Nitric oxide modulates N-methyl-D-aspartate-evoked serotonin release in the raphe nuclei and frontal cortex of the freely moving rat","volume":"291","author":"Smith","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3086","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF02311181","article-title":"Electroconvulsive shock increases dopamine D1 and D2 receptor mRNA in the nucles accumbens of the rat","volume":"120","author":"Smith","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3087","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0031-9384(95)02128-0","article-title":"Central propranolol and pindolol, but not atenolol not metoprolol, inhibit sexual behavior in male rats","volume":"59","author":"Smith","year":"1996","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3088","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0896-6273(00)80491-2","article-title":"Corticotropin releasing factor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development","volume":"20","author":"Smith","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3089","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0091-3057(98)00230-5","article-title":"The dopamine D3\/D2 receptor agonist 7-OH-DPAT induces cognitive impairment in the marmoset","volume":"63","author":"Smith","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/074873040101600104","article-title":"Serotonergic modulation of retinal input to the mouse suprachiasmatic nucleus mediated by 5-HT1B and 5-HT7 receptors","volume":"16","author":"Smith","year":"2001","journal-title":"J Biol Rhythms"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3091","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0306-4522(02)00257-9","article-title":"Dopamine D2L receptor knockout mice display deficits in positive and negative reinforcing properties of morphine and in avoidance learning","volume":"113","author":"Smith","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3092","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0091-3057(01)00702-X","article-title":"Effect of SB-243213, a selective 5-HT2C receptor antagonist, on the rat sleep profile: a comparison to paroxetine","volume":"71","author":"Smith","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3093","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0165-0327(01)00352-4","article-title":"Is extended clonazepam co-therapy of fluoxetine effective for outpatients with major depression?","volume":"70","author":"Smith","year":"2002","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3095","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1038\/sj.npp.1300552","article-title":"Effects of serotonin transporter promoter polymorphisms on serotonin function","volume":"29","author":"Smith","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3096","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1523\/JNEUROSCI.4079-04.2005","article-title":"Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice","volume":"25","author":"Smith","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3097","unstructured":"Smith, D.G., Davis, R.J., Rorick-Kehn, L., Morin, M., Witkin, J.M., McKinzie, D.L., et al. (in press). Melanin-concentrating hormone-1 receptor modulates neuroendocrine, behavioural, and corticolimbic neurochemical stress responses in mice. Neuropsychopharmacology."},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3098","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.mp.4001488","article-title":"Influence of SERTPR and Stin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review","volume":"9","author":"Smits","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3099","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archpsyc.58.6.529","article-title":"Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial","volume":"58","author":"Soares","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3100","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1096-9861(19961118)375:3<417::AID-CNE6>3.0.CO;2-5","article-title":"Retrograde transport of brain-derived neurotrophic factor (BDNF) following infusion in neo-and limbic cortex in rat: relationship to BDNF mRNA expressing neurons","volume":"375","author":"Sobreviela","year":"1996","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3101","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0166-2236(99)01490-3","article-title":"Postsynaptic protein phosphorylation and LTP","volume":"23","author":"Soderling","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3102","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/301608a0","article-title":"Vasopressin alters female sexual behaviour by acting on the brain independently of alterations in blood pressure","volume":"301","author":"Sodersten","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3103","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1017\/S109285290001960X","article-title":"Update on the biology of seasonal affective disorder","volume":"10","author":"Sohn","year":"2005","journal-title":"CNS Spectrum"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3104","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0006-8993(03)03255-4","article-title":"Inhibitory effects of spinal baclofen on spinal dorsal horn neurones in inflamed and neuropathic rats in vivo","volume":"987","author":"Sokal","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3105","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0006-8993(02)04057-X","article-title":"Effects of spinal administration of muscimol on C-and A-fibre evoked neuronal responses of spinal dorsal horn neurones in control and nerve injured rats","volume":"962","author":"Sokal","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3106","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.psychres.2003.12.006","article-title":"Once-daily high-dose pindolol for SSRI-refractory depression","volume":"125","author":"Sokolski","year":"2004","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3107","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1098\/rspb.2001.1767","article-title":"Complexity and fragility in ecological networks","volume":"268","author":"Sol\u00e9","year":"2001","journal-title":"Proc Biol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3108","first-page":"685","article-title":"Adaptive walks in a gene network model of morphogenesis: insights into the cambrian explosion","volume":"47","author":"Sol\u00e9","year":"2003","journal-title":"Int J Dev Biol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3109","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4088\/JCP.v66n0302","article-title":"Tachyphylaxis in unipolar major depressive disorder","volume":"66","author":"Solomon","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1385\/MN:30:2:117","article-title":"Serotonin in pain and analgesia: actions in the periphery","volume":"30","author":"Sommer","year":"2004","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3111","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1517\/14740338.2.4.367","article-title":"Safety of antidepressants in the elderly","volume":"2","author":"Sommer","year":"2003","journal-title":"Expert Opin Drug Safety"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3112","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2165\/00002512-200421090-00001","article-title":"Future options for combination therapy in the management of erectile dysfunction in older men","volume":"21","author":"Sommer","year":"2004","journal-title":"Drugs Aging"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3113","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1124\/jpet.102.045773","article-title":"Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors","volume":"305","author":"Somochocki","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3114","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1358\/dof.1999.024.07.530723","article-title":"Robalzotan tartrate hydrate","volume":"24","author":"Sorbera","year":"1999","journal-title":"Drugs Future"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1358\/dof.2001.026.03.611242","article-title":"Vilazodone hydrochloride-antidepressant 5-HT1A partial agonist 5-HT reuptake inhibitor","volume":"26","author":"Sorbera","year":"2001","journal-title":"Drugs Future"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3116","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tig.2003.12.004","article-title":"How prevalent is functional alternative splicing in the human genome?","volume":"20","author":"Sorek","year":"2004","journal-title":"Trends Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3117","first-page":"339","article-title":"A double-blind group comparative study using the new anti-depressant Org 3770, placebo and diazepam in patients with expected insomnia and anxiety before elective gynaecological surgery","volume":"71","author":"Sorensen","year":"1995","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3118","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0006-8993(01)02101-1","article-title":"Sleep and waking following microdialysis perfusion of the selective 5-HT1A receptor antagonist m-MPPI into the dorsal raphe nucleus in the freely moving rat","volume":"897","author":"Sorensen","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3119","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/jnr.20200","article-title":"Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation","volume":"77","author":"Sorensen","year":"2004","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3120","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.neuropharm.2004.08.011","article-title":"Novel neuronal targets for the acetylcholinesterase inhibitor donepezil","volume":"47","author":"Sortino","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3121","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1471-4159.2004.02721.x","article-title":"Dopamine transporter-dependent and independent actions of the trace amine, \u03b2-phenylethylamine","volume":"91","author":"Sotnikova","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3122","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1471-4159.2005.03094.x","article-title":"Mild prenatal protein malnutrition increases \u03b12C-adrenoceptor density in the cerebral cortex during postnatal life and impairs neocortical long-term potentiation and visuo-spatial performance in rats","volume":"93","author":"Soto-Moyano","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3123","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jnr.20537","article-title":"Acute morphine admistration increases extracellular DA levels in the rat lateral septum by decreasing the GABAergic inhibitory tone in the ventral tegmental area","volume":"81","author":"Sotomayor","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3735","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0165-0327(99)00014-2","article-title":"Pharmacotherapy response and diagnostic validity in atypical depression","volume":"54","author":"Sotsky","year":"1999","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3124","first-page":"749","article-title":"Allosteric modulation of G protein-coupled receptors","volume":"5","author":"Soudijn","year":"2002","journal-title":"Curr Opin Drug Discovery Dev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3125","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S1359-6446(04)03220-9","article-title":"Allosteric modulation of G protein-coupled receptors: perspectives and recent developments","volume":"9","author":"Soudijn","year":"2004","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3126","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0165-1781(89)90207-2","article-title":"Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality","volume":"28","author":"Souetre","year":"1989","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3127","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1515\/REVNEURO.2002.13.1.59","article-title":"Corticosteroids: sculptors of the hippocampal formation","volume":"13","author":"Sousa","year":"2002","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3128","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1600-0447.1992.tb03232.x","article-title":"Therapeutic sleep deprivation in a depressed patient: prolongation of response with concurrent thyroxine","volume":"86","author":"Southmayd","year":"1992","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3129","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1046\/j.1471-4159.2003.02309.x","article-title":"Transthyretin is involved in depression-like behaviour and exploratory activity","volume":"88","author":"Souza","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3130","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1124\/mol.61.6.1297","article-title":"Discovery of an ectopic activation site on the M1 muscarinic recepotr","volume":"61","author":"Spalding","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3131","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.89.6.2046","article-title":"Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway","volume":"89","author":"Spanagel","year":"1992","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3132","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1080\/000486700284","article-title":"The efficacy of intramuscular tramadol as a rapid-onset antidepressant","volume":"34","author":"Spencer","year":"2000","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3133","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s002130000669","article-title":"Tryptophan depletion in SSRI-recovered depressed outpatients","volume":"155","author":"Spillmann","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3134","first-page":"1267","article-title":"Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents","volume":"295","author":"Spooren","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00213-004-1785-y","article-title":"Pharmacological and genetic evidence indicates that combined inhibition of NR2A and NR2B subunit containing NMDA receptors is required to disrupt prepulse inhibition","volume":"175","author":"Spooren","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3136","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/10401230009147102","article-title":"Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review","volume":"12","author":"Sporn","year":"2000","journal-title":"Annals Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3137","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1006\/nlme.2000.3965","article-title":"A behavioural study of alpha-1b adrenergic receptor knockout mice: increased reaction to novelty and selectively reduced learning capacities","volume":"75","author":"Spreng","year":"2001","journal-title":"Neurobiol Learn Memory"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3138","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/syn.20070","article-title":"Serotonin-induced phase advances of SCN neuronal firing in vitro: a possible role for 5-HT5A receptors?","volume":"54","author":"Sprouse","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3139","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neuropharm.2003.08.007","article-title":"8-OH-DPAT as a 5-HT7 agonist: phase shifts on the circadian biological clock through increases in cAMP production","volume":"46","author":"Sprouse","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3140","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/0748730404273432","article-title":"Circadian rhythm phenotype of 5-HT7, receptor knockout mice: 5-HT and 8-OH-DPAT-induced phase advances of SCN neuronal firing","volume":"20","author":"Sprouse","year":"2005","journal-title":"J Biol Rhythms"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3141","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2165\/00003495-200262110-00005","article-title":"Generalised anxiety disorder","volume":"6","author":"Sramek","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3142","first-page":"319","article-title":"Augmentation of antidepressants by estrogen","volume":"34","author":"Stahl","year":"1998","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3143","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1017\/S1461145704004146","article-title":"Focus on antipsychotic polypharmacy: evidence-based prescribing or prescribing-based evidence?","volume":"7","author":"Stahl","year":"2004","journal-title":"Int J Neupsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3144","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1017\/S1092852900022641","article-title":"Antidepressant treatment of psychotic major depression: potential role of the \u03c3 receptor","volume":"10","author":"Stahl","year":"2005","journal-title":"CNS Spectr"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/0929867043456070","article-title":"A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation","volume":"11","author":"Stahl","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3146","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1017\/S1461145798001059","article-title":"Effectiveness of ipsapirone, a 5-HT1A partial agonist, in major depressive disorder: support for the role of 5-HT1A receptors in the mechanism of action of serotonergic antidepressants","volume":"1","author":"Stahl","year":"1998","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3147","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0006-3223(02)01425-7","article-title":"Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression","volume":"52","author":"Stahl","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3148","first-page":"6","article-title":"Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder","volume":"64","author":"Stahl","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2004.10.022","article-title":"Function of alternative splicing","volume":"344","author":"Stamm","year":"2005","journal-title":"Gene"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3150","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0006-3223(99)00170-5","article-title":"Corticotropin-releasing hormone receptor subtypes and emotion","volume":"46","author":"Steckler","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3151","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0091-3057(97)00290-6","article-title":"D1 agonist dihydrexidine releases acetylcholine and improves cognitive performance in rats","volume":"58","author":"Steele","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3152","first-page":"1038","article-title":"Neuropeptides and human sleep","volume":"20","author":"Steiger","year":"1997","journal-title":"Sleep"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3153","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1523\/JNEUROSCI.1200-04.2004","article-title":"cAMP response element-binding protein, activating transcirption factor-4, and upstream stimulatory factor differentially control hippocampal GABAB R1a and GABAB R1b subunit gene expression through alternative promoters","volume":"24","author":"Steiger","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3154","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-0327(02)00457-3","article-title":"Well-being and life satisfaction in generalized anxiety disorder: comparison to major depressive disorder in a community sample","volume":"79","author":"Stein","year":"2004","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3155","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/archpsyc.58.3.251","article-title":"Social anxiety disorder and the risk of depression. A prospective community study of adolescents and young adults","volume":"58","author":"Stein","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3156","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/da.20043","article-title":"Escitalopram in the treatment of social anxiety disorder: analysis of efficacy for different clinical subgroups and symptom dimensions","volume":"20","author":"Stein","year":"2004","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3157","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00213-004-1957-9","article-title":"Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomised controlled trial","volume":"177","author":"Stein","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3158","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0924-977X(02)00018-4","article-title":"Carbamazepine augmentation in depressive patients non-responding to citalopram: a pharmacokinetic and clinical pilot study","volume":"12","author":"Steinacher","year":"2002","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3159","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0022-3565(24)29250-8","article-title":"Selective blockade of neurokinin-2 receptors produces antidepressant-like effects associated with reduced corticotropin-releasing factor function","volume":"299","author":"Steinberg","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3160","doi-asserted-by":"crossref","first-page":"14439","DOI":"10.1073\/pnas.2435457100","article-title":"Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors","volume":"100","author":"Stell","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3161","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.npp.1300562","article-title":"Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin V(1b) receptor antagonist, SSR149415","volume":"30","author":"Stemmelin","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3162","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/jnr.490240315","article-title":"Effect of repeated electroconvulsive treatment on regional concentration of tachykinins, neurotensin, vasoactive intestinal polypeptide, neuropeptide Y, and galanin in rat brain","volume":"24","author":"Stenfors","year":"1989","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3163","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.0021-8782.2004.00359.x","article-title":"On the role of general system theory for functional neuroimaging","volume":"205","author":"Stephan","year":"2004","journal-title":"J Anat"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3164","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1098\/rstb.2000.0552","article-title":"Computational analysis of functional connectivity between areas of primate cerebral cortex","volume":"29","author":"Stephan","year":"2000","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3165","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0962-8924(01)02239-5","article-title":"Arresting developments in heptahelical receptor signalling and regulation","volume":"12","author":"Stephen","year":"2002","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3166","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1021\/jm020120c","article-title":"Novel dual inhibitors of AchE and MAO derived from hydroxyaminoindan and phenethylamine as potential treatment for Alzheimer's disease","volume":"45","author":"Sterling","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3167","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nature01725","article-title":"The evolution of comets in the oort cloud and kuiper belt","volume":"424","author":"Stern","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3168","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.psyneuen.2004.03.003","article-title":"Uncoupling of social zeitgebers and diurnal cortisol secretion in clinical depression","volume":"29","author":"Stetler","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3169","doi-asserted-by":"crossref","first-page":"10093","DOI":"10.1523\/JNEUROSCI.23-31-10093.2003","article-title":"Neuroprotection by nicotine in mouse primary cortical cultures involves activation of calcineurin and L-type calcium channel inactivation","volume":"23","author":"Stevens","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3170","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0896-6273(01)00275-6","article-title":"Selective targeting of newly synthesized Arc mRNA to active synapses requires NMDA receptor activation","volume":"30","author":"Steward","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3171","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s002130050045","article-title":"Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity","volume":"148","author":"Stewart","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3172","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000048126","article-title":"Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle","volume":"56","author":"Stewart","year":"2001","journal-title":"Horm Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3173","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jad.2005.01.009","article-title":"Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions","volume":"86","author":"Stewart","year":"2005","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3174","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1001\/jama.289.23.3135","article-title":"Cost of lost productive work time among US workers with depression","volume":"289","author":"Stewat","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3175","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pnpbp.2004.11.004","article-title":"On the trail of a cognitive enhancer for the treatment of schizophrenia","volume":"29","author":"Stip","year":"2005","journal-title":"Prog NeuroPsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3176","first-page":"S25","article-title":"Sibutramine: a review of the pharmacology of a novel anti-obesity agent","volume":"21","author":"Stock","year":"1997","journal-title":"Int J Obesity"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3177","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.biopsych.2004.08.022","article-title":"Cellular changes in the postmortem hippocampus in major depression","volume":"56","author":"Stockmeier","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3178","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1196\/annals.1286.007","article-title":"Neurosteroid biosynthesis in the human brain and its clinical implications","volume":"1007","author":"Stofel-Wagner","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3179","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1016\/S0014-2999(99)00800-6","article-title":"Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats","volume":"387","author":"Stogner","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3180","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1176\/ajp.156.12.2017","article-title":"Treatment augmentation with opiates in severe and refractory major depression","volume":"156","author":"Stoll","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3181","first-page":"72","article-title":"Methylphenidate augmentation of serotonin selective reuptake inhibitors: a case series","volume":"57","author":"Stoll","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3182","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/PL00006540","article-title":"On the possibility of constructive neutral evolution","volume":"49","author":"Stoltzfus","year":"1999","journal-title":"J Mol Evol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3183","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/1573400052953565","article-title":"The brain epinephrine-\u03b11-adrenoceptor system in behavioural activation and depression","volume":"1","author":"Stone","year":"2005","journal-title":"Curr Psychiatr Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3184","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/syn.10127","article-title":"Role of brain \u03b11B-adrenoceptors in modafinil-induced behavioural activity","volume":"46","author":"Stone","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3185","first-page":"1387","article-title":"Emerging evidence for a central epinephrine-innervated \u03b11-adrenergic system that regulates behavioural activation and is impaired in depression","volume":"28","author":"Stone","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3186","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0893-133X(00)00243-8","article-title":"Effects of sodium valproate on corticotropin-releasing factor systems in rat brain","volume":"24","author":"Stout","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3187","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.302.3.957","article-title":"Rapid desensitisation of serotonin2C receptor system: effector pathway and agonist dependence","volume":"302","author":"Stout","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3188","doi-asserted-by":"crossref","first-page":"RC157","DOI":"10.1523\/JNEUROSCI.21-15-j0003.2001","article-title":"Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus","volume":"21","author":"Strafella","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3189","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0165-6147(02)01993-4","article-title":"Mechanisms of inverse agonism at G-protein-coupled receptors","volume":"23","author":"Strange","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3190","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/BF00168636","article-title":"Expression of the extraneuronal monoamine transporter (uptake2) in human glioma cells","volume":"353","author":"Streich","year":"1996","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3191","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/35065725","article-title":"Exploring complex networks","volume":"410","author":"Strogatz","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3192","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0006-3223(98)00328-X","article-title":"Concentrations of 3\u03b1-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery","volume":"45","author":"Str\u00f6hle","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3193","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nbt0397-194","article-title":"The coming Kuhnian revolution in biology","volume":"15","author":"Strohman","year":"1997","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3194","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00004850-200303000-00005","article-title":"Amantadine as augmentation therapy in the management of treatment-resistant depression","volume":"18","author":"Stryjer","year":"2003","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3195","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1073\/pnas.0501179102","article-title":"Subnets of scale-free networks are not scale-free: sampling properties of networks","volume":"102","author":"Stumpf","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3196","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archpsyc.1990.01810210065009","article-title":"Direction of weight change in recurrent depression. Consistency across episodes","volume":"47","author":"Stunkard","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3197","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0006-3223(03)00608-5","article-title":"Depression and obesity","volume":"54","author":"Stunkard","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3198","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1176\/ajp.156.5.710","article-title":"Low levels of transthyretin in the CSF of depressed patients","volume":"156","author":"Sullivan","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3199","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/078538902320772106","article-title":"The role of CREB and other transcription factors in the pharmacotherapy and etiology of depression","volume":"34","author":"Sulser","year":"2002","journal-title":"Ann Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3200","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1124\/mol.104.001974","article-title":"Chronic nicotine treatment leads to induction of tyrosine hydroxylase in locus ceruleus neurons: the role of transcriptional activation","volume":"66","author":"Sun","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3201","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1523\/JNEUROSCI.23-05-01697.2003","article-title":"A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity","volume":"23","author":"Sung","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3202","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2174\/1389557043403792","article-title":"COX-2 selective inhibitors, carbonic anhydrase inhibition and anticancer properties of sulfonamides belonging to this class of pharmacological agents","volume":"4","author":"Supuran","year":"2004","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3203","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1046\/j.1471-4159.1998.70062545.x","article-title":"Distinct effects of imipramine on 5-hydroxytryptamine uptake mediated by the recombinant rat serotonin transporter SERT1","volume":"70","author":"Sur","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3204","doi-asserted-by":"crossref","first-page":"13674","DOI":"10.1073\/pnas.1835612100","article-title":"N-desmethylclozapine, an allosteric agonist at muscarinic1 receptor, potentiates NMDA receptor activity","volume":"100","author":"Sur","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3205","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0165-0327(00)00164-6","article-title":"Elevated plasma nitrate levels in depressive states","volume":"63","author":"Suzuki","year":"2001","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3206","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0304-3940(02)01035-2","article-title":"Antipsychotic, antidepressant, anxiolytic, and anticonvulsant drugs induce type II nitric oxide synthase mRNA in rat brain","volume":"333","author":"Suzuki","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3207","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1017\/S1461145703004012","article-title":"Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophrenia","volume":"7","author":"Suzuki","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3208","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0272-7358(99)00026-4","article-title":"The comorbidity of depression and substance use disorders","volume":"20","author":"Svendson","year":"2000","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3209","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1073\/pnas.052712799","article-title":"Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioural effects of fluoxetine (Prozac)","volume":"99","author":"Svenningsson","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3210","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.pnpbp.2003.09.009","article-title":"\u03b1-adrenoceptor modulation hypothesis of antipsychotic atypically","volume":"27","author":"Svensson","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3211","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0074-7696(04)40003-5","article-title":"Neuropeptides in hypothalamic neuronal disorders","volume":"240","author":"Swaab","year":"2004","journal-title":"Int Rev Cytol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3212","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0079-6123(00)26025-1","article-title":"Interaction of prefrontal cortical and hypothalamic systems in the pathogenesis of depression","volume":"126","author":"Swaab","year":"2000","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3213","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0006-8993(00)02905-X","article-title":"Cerebral hemisphere regulation of motivated behavior","volume":"886","author":"Swanson","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3214","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1046\/j.1471-4159.2003.02125.x","article-title":"The mGlu2\/3 receptor agonist, LY354740, blocks immobilization-induced increases in noradrenaline and dopamine release in the rat medial prefrontal cortex","volume":"88","author":"Swanson","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3215","first-page":"15","article-title":"Electroconvulsive therapy-induced cortisol release: changes with depressive state","volume":"1","author":"Swartz","year":"1985","journal-title":"Convuls Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3216","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00702-004-0120-4","article-title":"Glia and volume transmission during physiological and pathological states","volume":"112","author":"Sykova","year":"2005","journal-title":"J Neural Transmission"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3217","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0361-9230(96)00159-1","article-title":"Physiological and pathophysiological roles of nitric oxide in the central nervous system","volume":"41","author":"Szabo","year":"1996","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3218","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0893-133X(01)00284-6","article-title":"Effects of the selective norepinephrine reuptake inhibitor reboxetine on norepinephrine and serotonin transmission in the rat hippocampus","volume":"25","author":"Szabo","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3219","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/bjsm.35.5.342","article-title":"Phenylethylamine, a possible link to the antidepressant effects of exercise?","volume":"35","author":"Szabo","year":"2001","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3220","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/00002826-199720001-00006","article-title":"Pramipexole, a dopamine agonist, in major depression: antidepressant effects and tolerability in an open-label study with multiple doses","volume":"20","author":"Szegedi","year":"1997","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3221","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/sj.tpj.6500289","article-title":"The catechol-O-methyltransferase Val108\/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression","volume":"5","author":"Szegedi","year":"2005","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3222","first-page":"681","article-title":"Interaction of zinc with antidepressants in the forced swimming test in mice","volume":"54","author":"Szewszyk","year":"2002","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3223","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/1520-6394(2000)12:3<170::AID-DA9>3.0.CO;2-M","article-title":"Physiological effects of electroconvulsive therapy and transcranial magnetic stimulation in major depression","volume":"12","author":"Szuba","year":"2000","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3224","first-page":"192","article-title":"Diurnal profile of melatonin concentrations in patients with major depression: relationship to the clinical manifestation and antidepressant treatment","volume":"22","author":"Szymanska","year":"2001","journal-title":"Neuroendocrinol Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3225","doi-asserted-by":"crossref","first-page":"16952","DOI":"10.1073\/pnas.0405387101","article-title":"Ca2+ activity at GABAB receptors constitutively promotes metabotropic glutamate signaling in the absence of GABA","volume":"101","author":"Tabata","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3226","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/gut.2003.036400","article-title":"Corticotropin releasing factor receptor antagonists: potential future therapy in gastroenterology?","volume":"53","author":"Tache","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3227","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.bjp.0705760","article-title":"CRF1 receptor signalling pathways are involved in stress-related alterations of colonic function and viscerosensibility: implications for irritable bowel syndrome","volume":"141","author":"Tache","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3228","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.0306-5251.2001.01183.x","article-title":"Differential cognitive effects of ebastine and (+)-chlorpheniramine in healthy subjects: correlation between cognitive impairment and plasma drug concentration","volume":"53","author":"Tagawa","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3229","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0006-8993(01)02405-2","article-title":"Antagonism of CRF2 receptors produces anxiolytic behavior in animal models of anxiety","volume":"902","author":"Takahashi","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3230","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/S0024-3205(01)01279-6","article-title":"Repeated treatment with imipramine, fluvoxamine and tranylcypromine decreases the number of escape failures by activating dopaminergic systems in a rat learned helplessness test","volume":"69","author":"Takamori","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3231","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s00210-002-0640-0","article-title":"Astroglial dopamine transport is mediated by norepinephrine transporter","volume":"366","author":"Takeda","year":"2002","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3232","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0014-2999(97)10108-X","article-title":"Pharmacological studies on YM992, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT2A receptor antagonistic activity","volume":"329","author":"Takeuchi","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3233","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0024-3205(89)90148-3","article-title":"Statistical analysis of drug-drug and site-site interactions with isobolograms","volume":"45","author":"Tallarida","year":"1989","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3234","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1476-5381.1996.tb15367.x","article-title":"Modulation of sexual behaviour in the rat by a potent and selective \u03b12-adrenoceptor antagonist, delequamine (RS-15385-197)","volume":"118","author":"Tallentire","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3235","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0163-7258(01)00156-5","article-title":"Yohimbine: a clinical review","volume":"91","author":"Tam","year":"2001","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3236","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF02850015","article-title":"Selective serotonin reuptake inhibitor discontinuation syndrome: a review","volume":"19","author":"Tamam","year":"2002","journal-title":"Adv Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3237","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1021\/jm000552s","article-title":"Pharmacological and behavioural analysis of the effects of some bivalent ligand-based monoamine reuptake inhibitors","volume":"44","author":"Tamiz","year":"2001","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3238","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0006-3223(02)01470-1","article-title":"Developing novel treatments for mood disorders: accelerating discovery","volume":"52","author":"Tamminga","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3239","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00001756-199902250-00034","article-title":"Role of serotonergic neurons in L-Dopa-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats","volume":"10","author":"Tanaka","year":"1999","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3240","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1523\/JNEUROSCI.19-14-05792.1999","article-title":"Estrogen stimulates a transient increase in the number of new neurons in the dentate gyrus of the adult female rat","volume":"19","author":"Tanapat","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3241","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1073\/pnas.0308661100","article-title":"Revealing modularity and organization in the yeast molecular network by integrated analysis of highly heterogeneous genomewide data","volume":"101","author":"Tanay","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3242","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02244785","article-title":"Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?","volume":"115","author":"Tanda","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3243","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0014-2999(94)00675-W","article-title":"Modafinil and cortical gamma-aminobutyric acid outflow. Modulation by 5-HT neurotoxins","volume":"273","author":"Tanganelli","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3244","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1172\/JCI200419656","article-title":"The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions","volume":"113","author":"Tanoue","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3245","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1476-5381.1996.tb16049.x","article-title":"Differential regulation of 5-hydroxytryptamine release by GABAA and GABAB receptors in midbrain raphe nuclei and forebrain of rats","volume":"119","author":"Tao","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3246","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.bjp.0703923","article-title":"Potential anxiolytic-and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist","volume":"132","author":"Tatarczynska","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3247","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s002130100798","article-title":"The anxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration","volume":"158","author":"Tatarczynska","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3248","first-page":"707","article-title":"Anxiolytic-and antidepressant-like effects of group III metabotropic glutamate agonists 1S, 3R, 4S-1-aminocyclo-pentane-1 tricarboxylic acid (ACPT-I) in rats","volume":"54","author":"Tatarczynska","year":"2002","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3249","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00008877-200412000-00001","article-title":"Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression","volume":"15","author":"Tatarczynska","year":"2004","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3250","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejphar.2005.04.025","article-title":"Antidepressant-like effect of the selective 5-HT1B receptor agonist CP 94253: a possible mechanism of action","volume":"516","author":"Tatarczynska","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3251","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(97)01393-9","article-title":"Pharmacological profile of antidepressants and related compounds at human monoamine transporters","volume":"340","author":"Tatsumi","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3252","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/da.10115","article-title":"The efficacy of nefazodone augmentation for treatment-resistant depression with anxiety symptoms or anxiety disorders","volume":"18","author":"Taylor","year":"2003","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3253","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cellsig.2004.12.007","article-title":"Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways","volume":"17","author":"Taylor","year":"2005","journal-title":"Cell Signalling"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3254","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/archpsyc.62.7.792","article-title":"Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction","volume":"62","author":"Taylor","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3255","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/374542a0","article-title":"Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors","volume":"374","author":"Tecott","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3256","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0014-2999(95)00110-7","article-title":"The \u03b12-adrenoceptor antagonist, (+)-efaroxan, enhances acetylcholine release in the rat cortex in vivo","volume":"277","author":"Tellez","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3257","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/bmb\/ldh022","article-title":"Management of hepatitis C","volume":"70","author":"Teo","year":"2004","journal-title":"Br Med Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3258","series-title":"Nucleus of the Solitary Tract","first-page":"107","article-title":"Ascending projections of the solitary tract nucleus","author":"Ter Horst","year":"1994"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3259","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1017\/S1092852900019611","article-title":"Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects","volume":"10","author":"Terman","year":"2005","journal-title":"CNS Spectrum"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3260","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.embor.7400052","article-title":"Roles of G-protein-coupled receptor dimerization","volume":"5","author":"Terrillon","year":"2004","journal-title":"EMBO Rep"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3261","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/jpet.102.041616","article-title":"The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development","volume":"306","author":"Terry","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3262","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00213-004-2114-1","article-title":"Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys","volume":"179","author":"Terry","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3263","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0092-8674(00)00109-4","article-title":"Translocation and reversible localization of signaling proteins: a dynamic future of signal transduction","volume":"103","author":"Teruel","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3264","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0306-4522(93)90433-G","article-title":"Effect of rapid eye movement sleep deprivation on rat brain monoamine oxidases","volume":"55","author":"Thakkar","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3265","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0169-328X(02)00383-2","article-title":"Sex differences in the regulation of tyrosine hydroxylase gene transcription by estrogen in the locus coeruleus of TH9-LacZ transgenic mice","volume":"104","author":"Thanky","year":"2002","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3266","first-page":"55","article-title":"Depression, sleep and antidepressants","volume":"59","author":"Thase","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3267","first-page":"46","article-title":"Treatment issues related to sleep and depression","volume":"61","author":"Thase","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3268","first-page":"4","article-title":"Comparing the methods used to compare antidepressants","volume":"36","author":"Thase","year":"2002","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3269","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1017\/S1092852900002236","article-title":"Therapeutic alternatives for difficult-to-treat depression: a narrative review of the state of the evidence","volume":"9","author":"Thase","year":"2004","journal-title":"CNS Spectr"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0327(99)00033-6","article-title":"Is psychotherapy an effective treatment for melancholia and other severe depressive states","volume":"54","author":"Thase","year":"1998","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3271","first-page":"1081","article-title":"Treatment-resistant depression","volume":"92","author":"Thase","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3272","first-page":"23","article-title":"When a first you don't succeed: sequential strategies for antidepressant nonresponders","volume":"58","author":"Thase","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3273","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archpsyc.1997.01830230043006","article-title":"Treatment of major depression with psychotherapy of psychotherapy-pharmacotherapy combinations","volume":"54","author":"Thase","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3274","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1192\/bjp.178.3.234","article-title":"Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors","volume":"178","author":"Thase","year":"2001","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3275","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/da.10055","article-title":"Citalopram treatment of paroxetine intolerant patients","volume":"16","author":"Thase","year":"2002","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3276","doi-asserted-by":"crossref","first-page":"493","DOI":"10.4088\/JCP.v63n0605","article-title":"Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression","volume":"63","author":"Thase","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3277","doi-asserted-by":"crossref","first-page":"974","DOI":"10.4088\/JCP.v66n0803","article-title":"Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials","volume":"66","author":"Thase","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3278","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.jcp.0000155815.44338.95","article-title":"Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine","volume":"25","author":"Thase","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3279","first-page":"1592","article-title":"NS-2330 (Neurosearch)","volume":"2","author":"Thatte","year":"2001","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3280","first-page":"830","article-title":"Bromocriptine as an antidepressant: double-blind comparative study with imipramine in psychogenic and endogenous depression","volume":"30","author":"Theohar","year":"1981","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3281","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1001\/jama.291.21.2581","article-title":"Prevalence, severity, and unmet need for treatment of mental disorders, World Health Organization, World Mental Health Surveys","volume":"291","author":"The WHO World Mental Health Survey Consortium","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3282","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1192\/S0007125000296670","article-title":"Animal behavioural studies in the evaluation of antidepressant drugs","volume":"15","author":"Thiebot","year":"1992","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3283","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2","article-title":"From specific gene regulation to genomic networks: a global analysis of transcriptional regulation in Escherichia coli","volume":"20","author":"Thieffry","year":"1998","journal-title":"BioEssays"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3284","first-page":"81","article-title":"5-HT7 receptors","volume":"3","author":"Thomas","year":"2004","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3285","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrn1346","article-title":"MAPK cascade signalling and synaptic plasticity","volume":"5","author":"Thomas","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3286","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0028-3908(01)00091-0","article-title":"Glutamate release inhibiting properties of the novel mGlu5 receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP): complementary in vitro and in vivo evidence","volume":"41","author":"Thomas","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3287","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.bjp.0705290","article-title":"SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats","volume":"139","author":"Thomas","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3288","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0006-8993(02)03882-9","article-title":"Corticotropin-releasing factor in the dorsal raphe nucleus regulates activity of lateral septal neurons","volume":"960","author":"Thomas","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3289","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0165-0327(02)00349-X","article-title":"Depression and vascular disease: what is the relationship?","volume":"79","author":"Thomas","year":"2004","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3290","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/46457","article-title":"The formation of Uranus and Neptune in the Jupiter-Saturn region of the solar system","volume":"402","author":"Thommes","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3291","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejphar.2005.02.005","article-title":"Estrogen mediated inhibition of dopamine transport in the striatum: regulation by G\u03b1i\/o","volume":"511","author":"Thompson","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3292","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1113\/jphysiol.1992.sp019167","article-title":"Comparison of the actions of baclofen at pre-and postsynaptic receptors in the rat hippocampus in vitro","volume":"451","author":"Thompson","year":"1992","journal-title":"J Physiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3293","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1192\/bjp.152.2.260","article-title":"A comparison of melatonin secretion in depressed patients and normal subjects","volume":"152","author":"Thompson","year":"1988","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3294","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1054\/npep.2002.0897","article-title":"Diverse functions of neuropeptide Y revealed using genetically modified animals","volume":"36","author":"Thorsell","year":"2002","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3295","doi-asserted-by":"crossref","first-page":"12852","DOI":"10.1073\/pnas.220232997","article-title":"Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression","volume":"97","author":"Thorsell","year":"2000","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3296","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1073\/pnas.0409902102","article-title":"Climate change threats to plant diversity in Europe","volume":"102","author":"Thuiller","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3297","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0006-8993(02)02468-X","article-title":"Delta opioid inhibition of light-induced phase advances in hamster circadian activity rhythms","volume":"937","author":"Tierno","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3298","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF02247377","article-title":"Serotonergic modulation of striatal D2 dopamine receptor binding in humans measured with positron emission tomography","volume":"126","author":"Tiihonen","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3299","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1060391","article-title":"Diversity and productivity in a long-term grassland experiment","volume":"294","author":"Tilman","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3300","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/520","article-title":"Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor I","volume":"19","author":"Timpl","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3301","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1517\/13543784.12.11.1803","article-title":"Dopamine agonists in Parkinson's disease","volume":"12","author":"Tintner","year":"2003","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3302","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/0269881105051529","article-title":"Selective effects of clonidine and temazepam on attention and memory","volume":"19","author":"Tiplady","year":"2005","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3303","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s002130050879","article-title":"Antidepressant effects of nicotine in an animal model of depression","volume":"142","author":"Tizabi","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3304","first-page":"275","article-title":"G-protein-coupled receptor phosphorylation and palmitoylation","volume":"259","author":"Tobin","year":"2004","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3305","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.pharmthera.2004.11.011","article-title":"Nitric oxide and penile erectile function","volume":"106","author":"Toda","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3306","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF02802028","article-title":"Regulation of neuronal plasticity in the central nervous system by phosphorylation and dephosphorylation","volume":"17","author":"Tokuda","year":"1998","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3307","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1126\/science.282.5395.1846","article-title":"Consciousness and complexity","volume":"282","author":"Tononi","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3308","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-2999(02)01504-2","article-title":"Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors","volume":"442","author":"Tordera","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3309","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1016\/j.bmc.2004.07.059","article-title":"Novel selective and potent 5-HT reuptake inhibitors with 5-HT1D antagonist activity: chemistry and pharmacological evaluation of a series of thienopyran derivatives","volume":"12","author":"Torrado","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3310","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/sj.npp.1300345","article-title":"The \u03b4-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats","volume":"29","author":"Torregrossa","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3311","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1101\/gr.1455503","article-title":"A genome-wide survey of human pseudogenes","volume":"13","author":"Torrents","year":"2003","journal-title":"Genome Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3312","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1074\/jbc.M201926200","article-title":"Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter","volume":"278","author":"Torres","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3313","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrn1008","article-title":"Plasma membrane monoamine transporters: structure, regulation and function","volume":"4","author":"Torres","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3314","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/jnr.20247","article-title":"5-HT1A, 5-HT2, and GABAB receptors interact to modulate neurotransmitter release probability in layer 2\/3 somatosensory rat cortex as evaluated by the paired pulse protocol","volume":"78","author":"Torres-Escalante","year":"2004","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3315","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1179\/joc.2004.16.Supplement-1.41","article-title":"Strategies for multiple signalling inhibition","volume":"16","author":"Tortora","year":"2004","journal-title":"J Chemother"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3316","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0028-3908(01)00147-2","article-title":"Antidepressant-like responses to the combined sigma and 5-HT1A receptor agonist OPC-14523","volume":"41","author":"Tottori","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3317","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.brainres.2004.01.090","article-title":"The effects of nitric oxide on striatal serotoninergic transmission involve multiple targets: an in vivo microdialysis study in the awake rat","volume":"1008","author":"Trabace","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3318","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00004714-200302000-00011","article-title":"Dual monoamine modulation for improved treatment of major depressive disorder","volume":"23","author":"Tran","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3319","series-title":"Handbook of Experimental Pharmacology","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-3-642-46625-0_6","article-title":"The extraneuronal uptake and metabolism of catecholamines","author":"Trendelenburg","year":"1988"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3320","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/0269881104042622","volume":"18","author":"Trick","year":"2004","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3321","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1046\/j.1471-4159.1997.69052019.x","article-title":"Regulation of serotonin release in the frontal cortex and ventral hippocampus of homozygous mice lacking 5-HT1B receptors: in vivo microdialysis studies","volume":"69","author":"Trillat","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3322","first-page":"459","article-title":"Valproic acid inhibits corticotropin-releasing factor synthesis and release from the rat hypothalamus in vitro: evidence for the involvement of GABAergic neurotransmission","volume":"29","author":"Tringali","year":"2004","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3323","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/10401230309085670","article-title":"Treatment-resistant depression: new therapies on the horizon","volume":"15","author":"Trivedi","year":"2003","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3324","first-page":"296","article-title":"Glutamate co-transmission as an emerging concept in monoamine neuron function","volume":"29","author":"Trudeau","year":"2004","journal-title":"Rev Psychiatr Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3325","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1126\/science.1073885","article-title":"Identification of a potential ejaculation generator in the spinal cord","volume":"297","author":"Truitt","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3326","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1570160033378312","article-title":"Pharmacogenetics of selective serotonin reuptake inhibitor response in major depression","volume":"1","author":"Tsai","year":"2004","journal-title":"Curr Pharmacogenomics"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3327","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ajmg.b.20026","article-title":"Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response","volume":"123B","author":"Tsai","year":"2003","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3328","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1460-9568.2003.02725.x","article-title":"Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors","volume":"18","author":"Tschenett","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3329","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00213-001-0926-9","article-title":"Difference in serotonergic and noradrenergic regulation of human social behaviours","volume":"159","author":"Tse","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3330","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nature03539","article-title":"Origin of the orbital architecture of the giant planets of the solar system","volume":"435","author":"Tsiganis","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3331","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1017\/S0033291701005001","article-title":"Evidence of an early information processing speed deficit in unipolar major depression","volume":"32","author":"Tsourtos","year":"2002","journal-title":"Psychol Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3332","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1192\/bjp.163.3.299","article-title":"Genotypes, phenotypes, and the brain. A search for connections in schizophrenia","volume":"163","author":"Tsuang","year":"1993","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3333","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF02190719","article-title":"Identification of the phenotype in psychiatric genetics","volume":"243","author":"Tsuang","year":"1993","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3334","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1081\/CBI-100107514","article-title":"S20098 affects the free-running rhythms of body temperature and activity and decreases light-induced phase delays of circadian rhythms of the rat","volume":"18","author":"Tuma","year":"2001","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3335","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.euroneuro.2005.02.004","article-title":"Anxiolytic-like action of the antidepressant agomelatine (S 20098) after a social defeat requires the integrity of the SCN","volume":"15","author":"Tuma","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3336","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1023\/A:1023287729363","article-title":"Central GABAergic systems and depressive illness","volume":"28","author":"Tunnicliff","year":"2003","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3337","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0893-133X(00)00220-7","article-title":"Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects","volume":"24","author":"Turcotte","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3338","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00213-002-1250-8","article-title":"Cognitive enhancing effects of modafinil in healthy volunteers","volume":"165","author":"Turner","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3339","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/sj.mp.4001270","article-title":"Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2\/M4 muscarinic receptor knockout mice","volume":"8","author":"Tzavara","year":"2003","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3340","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1124\/jpet.104.079541","article-title":"Heterodimerization with \u03b22-adrenergic receptors promotes surface expression and functional activity of \u03b11D-adrenergic receptors","volume":"313","author":"Uberti","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3341","first-page":"25","article-title":"Genetic polymorphisms of serotonin and dopamine transporters in mental disorders","volume":"50","author":"Ueno","year":"2003","journal-title":"J Med Invest"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3342","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00213-004-1808-8","article-title":"In vitro inhibition of recombinant ligand-gated ion channels by high concentrations of milnacipran","volume":"175","author":"Ueta","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3343","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.febslet.2005.02.001","article-title":"From protein networks to biological systems","volume":"579","author":"Uetz","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3344","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2165\/00023210-199605050-00006","article-title":"Comparative review of dopamine receptor agonists in Parkinson's disease","volume":"5","author":"Uitti","year":"1996","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3345","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejphar.2003.11.023","article-title":"Sibutramine induces potential-dependent exocytotic release but not carrier-mediated release of dopamine and 5-hydroxytryptamine","volume":"484","author":"Ukai","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3346","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(03)12705-5","article-title":"Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis","volume":"361","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3347","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ng1610","article-title":"Nova regulates brain-specific splicing to shape the synapse","volume":"37","author":"Ule","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3348","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.npp.1300005","article-title":"Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia","volume":"28","author":"Umbricht","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3349","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0165-0173(00)00032-1","article-title":"Female gonadal hormones, serotonin, and sexual receptivity","volume":"33","author":"Uphouse","year":"2000","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3350","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.brainres.2004.04.013","article-title":"WAY100,635 and female rat lordosis behavior","volume":"1013","author":"Uphouse","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3351","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0022-3565(24)29502-1","article-title":"The antidepressant-like effect induced by sigma(1)-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test","volume":"298","author":"Urani","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3352","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00213-002-1150-y","article-title":"The antidepressant-like effect induced by the sigma1 receptor agonist igmesine involves modulation of intracellular calcium mobilization","volume":"163","author":"Urani","year":"2002","journal-title":"Psychophamacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3353","first-page":"57","article-title":"Serotonin and sleep","volume":"6","author":"Ursin","year":"2002","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3354","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.neuropharm.2004.10.013","article-title":"Mechanisms of allosteric modulation at GABAB receptors by CGP7930 and GS39783: effects on affinities and efficacies of orthosteric ligands with distinct intrinsic properties","volume":"48","author":"Urwyler","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3355","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/35041572","article-title":"Distinct functions of the two isoforms of dopamine D2 receptors","volume":"408","author":"Usiello","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3356","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1176\/ajp.156.9.1444","article-title":"Association of depressive symptoms during abstinence with the subjective high produced by cocaine","volume":"156","author":"Uslaner","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3357","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1073\/pnas.95.6.3239","article-title":"Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine","volume":"95","author":"Uzunova","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3358","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1523\/JNEUROSCI.17-08-02785.1997","article-title":"5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex","volume":"17","author":"Vaidya","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3359","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(99)00006-3","article-title":"Role of 5-HT2A receptors in the stress-induced down-regulation of brain-derived neurotrophic factor expression in rat hippocampus","volume":"262","author":"Vaidya","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3360","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1176\/appi.ajp.161.4.654","article-title":"Benzodiazepine use among depressed patients treated in mental health settings","volume":"161","author":"Valenstein","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3361","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1046\/j.1471-4159.2003.02238.x","article-title":"Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine","volume":"88","author":"Valentini","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3362","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1471-4159.2005.03030.x","article-title":"Selective serotonin reuptake blockade increases extracellular dopamine in noradrenaline-rich isocortical but not prefrontal areas: dependence on serotonin1A receptors and independence from noradrenergic innervation","volume":"93","author":"Valentini","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3363","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.npep.2004.09.005","article-title":"Peptides that fine-tune the serotonin system","volume":"39","author":"Valentino","year":"2005","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3364","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1749-6632.1993.tb49931.x","article-title":"The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses","volume":"697","author":"Valentino","year":"1993","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3365","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1043-2760(01)00422-2","article-title":"In vivo assessment of the effects of estrogen on human brain","volume":"12","author":"Van Amelsvoort","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3366","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00213-002-1257-1","article-title":"Neurosteroids in depression: a review","volume":"165","author":"Van Broekhoven","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3367","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-0447.2004.00333.x","article-title":"Is depression related to subsequent diabetes mellitus?","volume":"110","author":"Van den Akker","year":"2004","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3368","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00213-004-1853-3","article-title":"A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients","volume":"175","author":"Van den Broek","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3369","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/01.jcp.0000130551.70878.56","article-title":"Effect of antidepressant medication resistance on short-term response to electroconvulsive therapy","volume":"24","author":"Van den Broek","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3370","first-page":"1","article-title":"Allosteric modulation of neurotransmitter transporters at excitatory synapses","volume":"23","author":"Vanderberg","year":"2004","journal-title":"Pharmaceutical Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3371","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-0327(00)00209-3","article-title":"The effects of tryptophan depletion on mood and psychiatric symptoms","volume":"64","author":"Van der Does","year":"2001","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3372","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/sj.mp.4001130","article-title":"Substance P receptor antagonist and clomipramine prevent stress-induced alterations in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume","volume":"7","author":"Van der Hart","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3373","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00213-005-2260-0","article-title":"Chronic psychosocial stress in tree shrews: effect of the substance P (NK1 receptor) antagonist L-760735 and clomipramine on endocrine and behavioral parameters","volume":"181","author":"Van der Hart","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3374","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/cne.20569","article-title":"Estrogen receptor-alpha and-beta immunoreactive neurons in the brainstem and spinal cord of male and female mice: relationships to monoaminergic, cholinergic, and spinal projection systems","volume":"488","author":"Vanderhorst","year":"2005","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3375","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0928-0987(01)00150-6","article-title":"Active efflux of the 5-HT1A receptor agonist flesinoxan via P-glycoprotein at the blood-brain barrier","volume":"14","author":"Van der Sandt","year":"2001","journal-title":"Eur J Pharmaceutical Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3376","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1601-1848.2001.00007.x","article-title":"The fallacy of behavioural phenotyping without standardisation","volume":"1","author":"Van der Staay","year":"2002","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3377","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.euroneuro.2004.01.001","article-title":"Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine in patients with panic disorder and controls","volume":"14","author":"Van der Wee","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3378","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0166-4328(02)00381-9","article-title":"Reduced attention in mice overproducing corticotropin-releasing hormone","volume":"142","author":"Van Gaalen","year":"2003","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3379","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/sj.mp.4001367","article-title":"Genetics of personality: are we making progress?","volume":"8","author":"Van Gestel","year":"2003","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3380","first-page":"S227","article-title":"Onset of action of mirtazapine on anxiety symptoms related to depression","volume":"3","author":"Van Hensbeek","year":"2000","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3381","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0306-4522(02)00548-1","article-title":"Effects of oligonucleotide antisense to dopamine D3 receptor mRNA in a rodent model of behavioural sensitisation to Levodopa","volume":"116","author":"Van Kampen","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3382","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1111\/j.0953-816X.2004.03342.x","article-title":"Induction of neurogenesis in the adult rat subventricular zone and neostriatum following dopamine D3 receptor stimulation","volume":"19","author":"Van Kampen","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3383","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00213-003-1668-7","article-title":"AR-R17779 improves social recognition in rats by activation of nicotinic alpha7 receptors","volume":"172","author":"Van Kampen","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3384","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0924-977X(96)00038-7","article-title":"Cholecystokinin in anxiety","volume":"6","author":"Van Megen","year":"1996","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3385","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/S0024-3205(03)00141-3","article-title":"5-HT2A and 5-HT2C receptors and their atypical regulation properties","volume":"72","author":"Van Oekelen","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3386","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/1029842021000022115","article-title":"Crossroads of corticotropin releasing hormone, corticosteroids and monoamines","volume":"4","author":"Van Praag","year":"2002","journal-title":"Neurotox Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3387","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.pnpbp.2004.05.031","article-title":"Can stress cause depression?","volume":"28","author":"Van Praag","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3388","first-page":"24","article-title":"Melatoninergic and serotonergic receptors: their role in depression and potential therapeutic applications","volume":"25","author":"Van Reeth","year":"2003","journal-title":"Medicographia"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3389","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1097\/00001756-199806010-00043","article-title":"Resynchronisation of a diurnal rodent circadian clock accelerated by a melotonin agonist","volume":"9","author":"Van Reeth","year":"1998","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3390","first-page":"1582","article-title":"Melatonin or a melatonin agonist corrects age-related changes in circadian response to environmental stimulus","volume":"280","author":"Van Reeth","year":"2001","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3391","first-page":"R981","article-title":"Aging alters feedback effects of the activity-rest cycle on the circadian clock","volume":"263","author":"Van Reeth","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3392","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/sj.embor.7400284","article-title":"Reductionism and complexity in molecular biology","volume":"5","author":"Van Regenmortel","year":"2004","journal-title":"EMBO Rep"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3393","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0006-8993(00)03081-X","article-title":"The effect of phosphodiesterase inhibition on cyclic GMP and cyclic AMP accumulation in the hippocampus of the rat","volume":"888","author":"Van Staveren","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3394","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0196-9781(01)00591-5","article-title":"Melanin concentrating hormone increase hippocampal synaptic transmission in the rat","volume":"23","author":"Varas","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3395","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.peptides.2003.09.006","article-title":"Increased susceptivitlity to LTP generation and changes in NMDA-NR1 and-NR2B subunits mRNA expression in rat hippocampus after MCH administration","volume":"24","author":"Varas","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3396","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.molbrainres.2003.09.010","article-title":"Activation of 5-HT2C receptors acutely induces per gene expression in the rat suprachiasmatic nucleus at night","volume":"119","author":"Varcoe","year":"2003","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3397","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/35067550","article-title":"The brainweb: phase synchronization and large-scale integration","volume":"2","author":"Varela","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3398","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.lfs.2004.07.020","article-title":"Agonist-specific regulation of the \u03b4-opioid receptor","volume":"76","author":"Varga","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3399","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0306-3623(97)00328-5","article-title":"Dissimilar effects of lithium and valproic acid on GABA and glutamine concentrations in rat cerebrospinal fluid","volume":"30","author":"Vargas","year":"1998","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3400","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/hbm.20035","article-title":"Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain","volume":"22","author":"Varnas","year":"2004","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3401","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00213-005-2143-4","article-title":"The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles","volume":"179","author":"Varty","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3402","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.103.052423","article-title":"Phosphorylation and regulation of psychostimulant-sensitive neurotransmitter transporters","volume":"310","author":"Vaughan","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3403","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pbb.2004.03.002","article-title":"Antidepressant-like effects of the acute and chronic administration of nicotine in the rat forced swimming test and its interaction with fluoxetine","volume":"78","author":"Vazquez-Palacios","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3404","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0898-6568(02)00151-1","article-title":"G protein-coupled receptor cross-talk: pivotal roles of protein phosphorylation and protein-protein interactions","volume":"15","author":"Vazquez-Prado","year":"2003","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3405","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence to oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3406","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0924-977X(97)00072-2","article-title":"Patterns of c-fos expression induced by fluvoxamine are different after acute vs chronic oral administration","volume":"8","author":"Veening","year":"1998","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3407","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/archpsyc.1994.03950050071008","article-title":"Sympathetic nervous system activity in major depression: basal and desipramine-induced alterations in plasma norepinephrine kinetics","volume":"51","author":"Veith","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3408","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1058040","article-title":"The sequence of the human genome","volume":"291","author":"Venter","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3409","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF02245639","article-title":"Chronic administration of l-sulpiride at non-neuroleptic doses reduces the duration of immobility in experimental models of \u201cdepression-like\u201d behavior","volume":"121","author":"Vergoni","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-4-19","article-title":"A role of melanin-concentrating hormone producing neurons in the central regulation of paradoxical sleep","volume":"4","author":"Verret","year":"2003","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3411","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0014-2999(00)00565-3","article-title":"Antidepressants: past, present and future","volume":"405","author":"Vetulani","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3412","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1523\/JNEUROSCI.5147-03.2004","article-title":"Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation","volume":"24","author":"Vialou","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3413","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pharmthera.2004.06.001","article-title":"Genetic manipulations of GABAA receptor in mice make inhibition exciting","volume":"103","author":"Vicini","year":"2004","journal-title":"Pharmacol Ther."},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3414","first-page":"377","article-title":"Serotonin receptor ligands and the treatment of obesity","volume":"5","author":"Vickers","year":"2004","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3415","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s002130050952","article-title":"Reduced satiating effect of d-fenfluramine in serotonin 5-HT2C receptor mutant mice","volume":"143","author":"Vickers","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3416","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0028-3908(01)00063-6","article-title":"Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors","volume":"41","author":"Vickers","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3417","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00213-002-1378-6","article-title":"Oral administration of the 5-HT2C receptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia","volume":"167","author":"Vickers","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3418","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/00004714-199910000-00005","article-title":"Precision and comparability of adverse event rates of newer antidepressants","volume":"19","author":"Vida","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3419","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1176\/appi.ajp.161.11.1957","article-title":"Hippocampal volume and depression: a meta-analysis of MRI studies","volume":"161","author":"Videbech","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3420","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0165-6147(00)01577-7","article-title":"Is there a gap between preclinical and clinical studies of analgesia?","volume":"21","author":"Villanueva","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3421","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.2174\/1381612043383368","article-title":"New classes of AChE inhibitors with additional pharmacological effects of interest for the treatment of Alzheimer's disease","volume":"10","author":"Villarroya","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3422","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-2999(02)01585-6","article-title":"Differential effects of chronic antidepressant treatments on micro- and delta-opioid receptors in rat brain","volume":"443","author":"Vilpoux","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3423","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1460-9568.1992.tb00176.x","article-title":"Blockade of glutamatergic neurotransmission in the suprachiasmatic nucleus prevents cellular and behavioural responses of the circadian system to light","volume":"4","author":"Vindlacheruvu","year":"1992","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3424","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s002130051101","article-title":"Interactions between social stress and morphine in the periaqueductal gray: effects on affective vocal and reflexive pain responses in rats","volume":"146","author":"Vivian","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3425","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0165-0173(99)00016-8","article-title":"Modulatory role of presynaptic nicotinic receptors in synaptic and non-synaptic chemical communication in the central nervous system","volume":"30","author":"Vizi","year":"1999","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3426","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.neuint.2003.11.016","article-title":"Nonsynaptic communication in the central nervous system","volume":"45","author":"Vizi","year":"2004","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3427","doi-asserted-by":"crossref","first-page":"7888","DOI":"10.1523\/JNEUROSCI.1506-04.2004","article-title":"Uptake and release of norepinephrine by serotonergic terminals in norepinephrine transporter knock-out mice: implications for the action of selective serotonin reuptake inhibitors","volume":"24","author":"Vizi","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3428","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0165-1781(93)90080-Z","article-title":"Profiles of spontaneous 24-hour and stimulated growth hormone secretion in male patients with endogenous depression","volume":"47","author":"Voderholzer","year":"1993","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3429","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/archpsyc.1980.01780160017001","article-title":"Improvement of depression by REM sleep deprivation. New findings and a theory","volume":"37","author":"Vogel","year":"1980","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3430","first-page":"667","article-title":"Histamine-selective H3 receptor ligands and cognitive function: an overview","volume":"7","author":"Vohora","year":"2004","journal-title":"IDrugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3431","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0065-3233(01)55003-2","article-title":"Rational evolutionary design: the theory of in vitro protein evolution","volume":"55","author":"Voigt","year":"2000","journal-title":"Adv Protein Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3432","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0031-9384(00)00405-4","article-title":"Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies","volume":"72","author":"Voikar","year":"2001","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3433","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1124\/mol.64.5.1037","article-title":"Different affinities of inhibitors to the outwardly and inwardly directed substrate binding site of organic cation transporter 2","volume":"64","author":"Volk","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3434","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0166-4328(02)00312-1","article-title":"Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice","volume":"140","author":"Volke","year":"2003","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3435","first-page":"653","article-title":"Augmentation of the NO-cGMP cascade induces anxiogenic-like effect in mice","volume":"54","author":"Volke","year":"2003","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3436","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.biopsych.2004.07.007","article-title":"The reality of comorbidity: depression and drug","volume":"56","author":"Volkow","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3437","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/386827a0","article-title":"Relationship between subjective effects of cocaine and dopamine transporter occupancy","volume":"386","author":"Volkow","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3438","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1176\/ajp.155.10.1325","article-title":"Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate","volume":"155","author":"Volkow","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3439","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/sj.mp.4001507","article-title":"Dopamine in drug abuse and addiction: results from imaging studies and treatment implications","volume":"9","author":"Volkow","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3440","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.biopsych.2004.12.007","article-title":"The slow and long-lasting blockade of dopamine transporters in human brain induced by the new antidepressant drug radafaxine predict poor reinforcing effects","volume":"57","author":"Volkow","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3441","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1196\/annals.1296.035","article-title":"Regulation of vasopressin V1b receptors and stress adaptation","volume":"1018","author":"Volpi","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3442","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00004691-200109000-00002","article-title":"The mechanism of action of vagus nerve stimulation for refractory epilepsy: the current status","volume":"18","author":"Vonck","year":"2001","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3443","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0304-3940(01)02062-6","article-title":"Chronic imipramine treatment partially reverses the long-term changes of hippocampal synaptic plasticity in socially stressed rats","volume":"309","author":"Von Frijtag","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3444","doi-asserted-by":"crossref","first-page":"14533","DOI":"10.1073\/pnas.2136809100","article-title":"Genome evolution reveals biochemical networks and functional modules","volume":"100","author":"Von Mering","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3445","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archpsyc.61.11.1097","article-title":"The burden of major depression avoidable by longer-term treatment strategies","volume":"61","author":"Vos","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3446","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biopsych.2004.04.002","article-title":"Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment","volume":"56","author":"Vythilingam","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3447","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1124\/mol.59.3.532","article-title":"Inverse agonist at the alpha(2A)-adrenergic receptor","volume":"59","author":"Wade","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3448","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1517\/14656566.6.13.2291","article-title":"What can be learned from the experience with the fixed low-dose combination of perindopril\/indapamide in the treatment of hypertension?","volume":"6","author":"Waeber","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3449","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-0327(81)90044-6","article-title":"Bromocriptine and imipramine in endogenous depression, a double-blind controlled trial in out-patients","volume":"3","author":"Waehrens","year":"1981","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3450","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1073\/pnas.91.10.4387","article-title":"Evolution of gene networks by gene duplications: a mathematical model and its implications on genome organization","volume":"91","author":"Wagner","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3451","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/oxfordjournals.molbev.a003913","article-title":"The yeast protein interaction network evolves rapidly and contains few redundant duplicate genes","volume":"18","author":"Wagner","year":"2001","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3452","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1101\/gr.193902","article-title":"Estimating coarse gene network structure from large-scale gene perturbation data","volume":"12","author":"Wagner","year":"2002","journal-title":"Genome Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3453","doi-asserted-by":"crossref","first-page":"1012.1","DOI":"10.1186\/gb-2002-3-5-reviews1012","article-title":"Selection and gene duplication: a view from the genome","volume":"3","author":"Wagner","year":"2002","journal-title":"Genome Biol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3454","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1098\/rspb.2002.2269","article-title":"How the global structure of protein interaction networks evolves","volume":"270","author":"Wagner","year":"2003","journal-title":"Proc R Soc Lond B"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3455","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1098\/rspb.2001.1711","article-title":"The small world inside large metabolic networks","volume":"268","author":"Wagner","year":"2001","journal-title":"Proc R Soc Lond B"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3456","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2165\/00023210-200115030-00006","article-title":"Tianeptine: a review of its use in depressive disorders","volume":"15","author":"Wagstaff","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3457","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1038\/sj.npp.1300135","article-title":"ECT of major depressed patients in relation to biological and clinical variables: a brief overview","volume":"28","author":"Wahlund","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3458","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jnr.10281","article-title":"Atypical neuroleptics stimulate neurogenesis in adult rat brain","volume":"69","author":"Wakade","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3459","doi-asserted-by":"crossref","first-page":"9050","DOI":"10.1073\/pnas.0501112102","article-title":"A heterodimer-selective agonist shows in vivo relevance of G-protein-coupled receptor dimers","volume":"102","author":"Waldhoer","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3460","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0166-4328(97)00183-6","article-title":"Premature ejaculation and serotonergic antidepressant-induced delayed ejaculation: the involvement of serotonergic system","volume":"92","author":"Waldinger","year":"1998","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3461","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00004714-200106000-00007","article-title":"A double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone","volume":"21","author":"Waldinger","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3462","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/01.jcp.0000088904.24613.e4","article-title":"Antidepressants and ejaculation: a double-blind, randomized, fixed-dose study with mirtazapine and paroxetine","volume":"23","author":"Waldinger","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3463","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/j.1476-5381.1994.tb17168.x","article-title":"GABA and glutamate release affected by GABAB receptor antagonists with similar potency: no evidence for pharmacologically different presynaptic receptors","volume":"113","author":"Waldmeier","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3464","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.pbb.2004.03.023","article-title":"Antidepressant effects of ER\u03b2-selective estrogen receptor modulators in the forced swim test","volume":"78","author":"Walf","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3465","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1213\/00000539-200209000-00033","article-title":"Combination spinal analgesic chemotherapy: a systematic review","volume":"95","author":"Walker","year":"2002","journal-title":"Anesth Analg"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3466","doi-asserted-by":"crossref","unstructured":"Walker, E. A., Kohut, S. J., Hass, R. W., Brown, E. K., Prabandham, A., Lefever, T. (in press). Selective and nonselective serotonin antagonists block the aversive stimulus properties of MK212 and m-chlorophenylpiperazine (mCPP) in mice. Neuropharmacology.","DOI":"10.1016\/j.neuropharm.2005.07.015"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3467","series-title":"Textbook of Pain","first-page":"1190","year":"1999"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3468","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.biopsych.2004.04.010","article-title":"Effects of cyclic adenosine monophosphate response element binding protein overexpression in the basolateral amygdala on behavioral models of depression and anxiety","volume":"56","author":"Wallace","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3469","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/pmj.77.904.89","article-title":"Parkinson's disease and anxiety","volume":"77","author":"Walsh","year":"2001","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3470","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF02245629","article-title":"The anxiolytic-like activity of GR159897, a non-peptide NK2 receptor antagonist, in rodent and primate models of anxiety","volume":"121","author":"Walsh","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3471","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1001\/jama.287.14.1840","article-title":"Placebo response in studies of major depression: variable, substantial and growing","volume":"287","author":"Walsh","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3472","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1385\/MN:27:1:99","article-title":"Signaling from camp\/PKA to MAPK and synaptic plasticity","volume":"27","author":"Waltereit","year":"2003","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3473","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1126\/science.1078197","article-title":"Synthesis of serotonin by a second tryptophan hydroxylase isoform","volume":"299","author":"Walther","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3474","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1517\/14656566.1.2.207","article-title":"Advances in use of the 5-HT3 receptor antagonists","volume":"1","author":"Walton","year":"2000","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3475","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/syn.20104","article-title":"Potential antidepressant LY 367265 presynaptically inhibits the release of glutamate in rat cerebral cortex","volume":"55","author":"Wang","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3476","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1046\/j.1471-4159.2000.741290.x","article-title":"Altered G protein-coupling functions of RNA editing isoform and splicing variant serotonin2C receptors","volume":"74","author":"Wang","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3477","doi-asserted-by":"crossref","first-page":"8305","DOI":"10.1523\/JNEUROSCI.20-22-08305.2000","article-title":"Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions","volume":"20","author":"Wang","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3478","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/syn.10200","article-title":"Fluoxetine depresses glutamate exocytosis in the rat cerebrocortical nerve terminals (synaptosomes) via inhibition of P\/Q-type Ca2+ channels","volume":"48","author":"Wang","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3479","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/sj.npp.1300449","article-title":"Effects of antipsychotic drugs on neurogenesis in the forebrain of the adult rat","volume":"29","author":"Wang","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3480","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1471-4159.2004.02921.x","article-title":"Heterodimerization of opioid receptor-like 1 and \u03bc-opioid receptors impairs the potency of \u03bc receptor agonist","volume":"92","author":"Wang","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3481","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archpsyc.62.6.603","article-title":"Failure and delay in initial treatment contact after first onset of mental disorders in the national comorbidity survey replication","volume":"62","author":"Wang","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3482","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1101\/gr.3929705","article-title":"Origin and evolution of new exons in rodents","volume":"15","author":"Wang","year":"2005","journal-title":"Genome Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3483","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/01621459.1963.10500845","article-title":"Hierarchical grouping to optimise an objective function","volume":"58","author":"Ward","year":"1963","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3484","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0031-9384(99)00020-7","article-title":"Fluoxetine-maintained obese humans: effect on food intake and body weight","volume":"66","author":"Ward","year":"1999","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3485","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1126\/science.1109049","article-title":"Bottom-up ecosystem trophic dynamics determine fish production in the Northeast Pacific","volume":"308","author":"Ware","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3486","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S1388-2457(01)00585-5","article-title":"Therapeutic application of repetitive transcranial magnetic stimulation: a review","volume":"112","author":"Wassermann","year":"2001","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3487","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0091-3057(91)90135-O","article-title":"DOI-induced inhibition of copulatory behavior in male rats: reversal by 5-HT2 antagonists","volume":"39","author":"Watson","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3488","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/30918","article-title":"Collective dynamics of \u201csmall-world\u201d networks","volume":"393","author":"Watts","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3489","series-title":"Basic and Clinical Pharmacology","first-page":"460","article-title":"Opioid analgesics and antagonists","author":"Way","year":"1995"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3490","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/074873098129000057","article-title":"Local administration of serotonin agonists blocks light-induced phase advances of the circadian activity rhythm in the hamster","volume":"13","author":"Weber","year":"1998","journal-title":"J Biol Rhythms"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3491","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0920-9964(00)90567-X","article-title":"Decreased glucocorticoid receptor mRNA levels in individuals with depression, bipolar disorder and schizophrenia","volume":"41","author":"Webster","year":"1999","journal-title":"Schizophrenia Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3492","first-page":"7985","article-title":"Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders","volume":"924","author":"Webster","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3493","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.bjp.0703349","article-title":"Endogenous nitric oxide increases hippocampal levels of serotonin and dopamine in vivo","volume":"130","author":"Wegener","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3494","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00213-002-1341-6","article-title":"Increased extracellular serotonin levels in rat hippocampus induced by chronic citalopram is augmented by subchronic lithium: neurochemical and behavioural studies in the rat","volume":"166","author":"Wegener","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3495","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0006-8993(02)03738-1","article-title":"Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity","volume":"959","author":"Wegener","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3496","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0006-8993(00)02806-7","article-title":"A melatonin agonist facilitates circadian resynchronization in old hamsters after abrupt shifts in the light\u2013dark cycle","volume":"880","author":"Weibel","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3497","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/026988110401800311","article-title":"The role of \u03b11- and \u03b12-adrenoceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus","volume":"18","author":"Weikop","year":"2004","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3498","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0169-328X(92)90086-Q","article-title":"Acute lithium treatment enhances neuropeptide Y gene expression in rat hippocampus","volume":"12","author":"Weiner","year":"1992","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3499","series-title":"Clinical Memory Assessment of Older Adults","first-page":"218","article-title":"Automatic and effort demanding cognitive processes in depression","author":"Weingartner","year":"1986"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3500","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s00213-001-0978-x","article-title":"Effect of TV3326, a novel monoamine-oxidase cholinesterase inhibitor, in rat models of anxiety and depression","volume":"160","author":"Weinstock","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3501","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0278-5846(03)00053-8","article-title":"A novel cholinesterase and brain-selective monoamine oxidase inhibitor for the treatment of dementia comorbid with depression and Parkinson's disease","volume":"27","author":"Weinstock","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3502","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2001.tb03556.x","article-title":"Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress and conditioning factors","volume":"937","author":"Weiss","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3503","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/jpet.102.046532","article-title":"Inhibition of P-glycoprotein by newer antidepressants","volume":"305","author":"Weiss","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3504","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1515\/REVNEURO.2000.11.1.59","article-title":"Measurement of anxiety in transgenic mice","volume":"11","author":"Weiss","year":"2000","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3505","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/362423a0","article-title":"The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation","volume":"362","author":"Weisskopf","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3506","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jama.1996.03540040037030","article-title":"Cross-national epidemiology of major depression and bipolar disorder","volume":"276","author":"Weissman","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3507","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.281.18.1707","article-title":"Depressed adolescents grown up","volume":"281","author":"Weissman","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3508","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/archpsyc.56.10.897","article-title":"Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices","volume":"56","author":"Wells","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3509","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1126\/science.284.5411.92","article-title":"Complexity in biological signalling systems","volume":"284","author":"Weng","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3510","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1021\/jm021053p","article-title":"A comparison of physiochemical property profiles of development and marketed oral drugs","volume":"46","author":"Wenlock","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3511","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.biopsych.2003.11.011","article-title":"Electroconvulsive seizures induce proliferation of NG2-expressing glial cells in adult rat amygdala","volume":"55","author":"Wennst\u00f6m","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3512","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1021\/jm030480f","article-title":"Selective optimisation of side activities: another way for drug discovery","volume":"47","author":"Wermuth","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3513","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/bj20030312","article-title":"Mechanisms of cross-talk between G-protein-coupled receptors resulting in enhanced release of intracellular Ca2+","volume":"374","author":"Werry","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3514","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/sj.mp.4001195","article-title":"Vasopressin V1b receptor knockout reduces aggressive behavior in male mice","volume":"7","author":"Wersinger","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3515","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s002130100916","article-title":"Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine","volume":"159","author":"Wesensten","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3516","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.pharmtox.44.101802.121622","article-title":"Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications","volume":"44","author":"Wess","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3517","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(02)02496-2","article-title":"Can antipsychotic drugs be classified by their effects on a particular group of dopamine neurons in the brain?","volume":"455","author":"Westerink","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3518","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0022-3565(24)37396-3","article-title":"The pharmacology of mesocortical dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain","volume":"285","author":"Westerink","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3519","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0163-7258(95)98598-K","article-title":"Central nervous system pharmacology of neuropeptide Y","volume":"65","author":"Wettstein","year":"1995","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3520","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s002130050058","article-title":"Does mirtazapine enhance serotonergic neurotransmission in depressed patients?","volume":"148","author":"Whale","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3521","doi-asserted-by":"crossref","first-page":"13967","DOI":"10.1073\/pnas.240452197","article-title":"The GABAB receptor interacts directly with the related transcription factors CREB2 and ATFx","volume":"97","author":"White","year":"2000","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3522","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1017\/S0033291703007645","article-title":"Antidepressants for the treatment of depression in people with schizophrenia: a systematic review","volume":"33","author":"Whitehead","year":"2003","journal-title":"Psychol Med"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3523","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0028-3908(91)90035-A","article-title":"The effect of the novel antidepressant tianeptine on the concentration of 5-hydroxytryptamine in rat hippocampal dialysates in vivo","volume":"30","author":"Whitton","year":"1991","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3524","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ana.10609","article-title":"Slower progression of Parkinson's disease with ropinirole vs Levodopa: the REAL-PET study","volume":"54","author":"Whone","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3525","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.4088\/JCP.v65n1208","article-title":"Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors","volume":"65","author":"Whyte","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3526","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.1016\/S0924-977X(03)91811-6","article-title":"R-citalopram decreases the association of [3H]-S-citalopram with the human serotonin tranporter by an allosteric mechanism","volume":"13","author":"Wiborg","year":"2003","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3527","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0022-3956(88)90030-1","article-title":"Neuropeptide Y and Peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively","volume":"22","author":"Widerlov","year":"1988","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3528","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.pnpbp.2004.05.042","article-title":"Nefazodone in primary insomnia: an open pilot study","volume":"28","author":"Wiegand","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3529","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0301-0082(00)00056-3","article-title":"Arginine metabolism and the synthesis of nitric oxide in the nervous system","volume":"64","author":"Wiesinger","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.npp.1300290","article-title":"Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin","volume":"29","author":"Wigger","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3531","first-page":"335","article-title":"A double-blind trial of low- and high-dose ranges of gepirone-ER compared with placebo in the treatment of depressed outpatients","volume":"32","author":"Wilcox","year":"1996","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3532","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2165\/00003495-199549030-00007","article-title":"Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression","volume":"49","author":"Wilde","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3533","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0165-0327(02)00069-1","article-title":"The relationship between interpersonal sensitivity, anxiety disorders and major depression","volume":"79","author":"Wilhelm","year":"2004","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3534","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2165\/00002512-200421070-00004","article-title":"Cholinesterase inhibitors used in the treatment of Alzheimer's disease","volume":"21","author":"Wilkinson","year":"2004","journal-title":"Drug Aging"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3535","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1523\/JNEUROSCI.22-07-02843.2002","article-title":"The physiological role of 5-HT2A receptors in working memory","volume":"22","author":"Williams","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3536","doi-asserted-by":"crossref","first-page":"12913","DOI":"10.1073\/pnas.192448799","article-title":"Two degrees of separation in complex food webs","volume":"99","author":"Williams","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3537","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/00129785-200303060-00004","article-title":"Rhetoric and hype: where's the \u201cethics\u201d in pharmacogenomics?","volume":"3","author":"Williams-Jones","year":"2003","journal-title":"Am J Pharmacog"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3538","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainres.2004.11.066","article-title":"Melanin concentrating hormone (MCH): a novel neural pathway for regulation of GnRH neurons","volume":"1041","author":"Williamson-Hughes","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3539","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.neuroscience.2004.10.005","article-title":"Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates","volume":"130","author":"Willie","year":"2005","journal-title":"Neuroscience"},{"issue":"Suppl 3","key":"10.1016\/j.pharmthera.2005.11.006_bib3540","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/00004850-199707003-00002","article-title":"The mesolimbic dopamine system as a target for rapid antidepressant action","volume":"12","author":"Willner","year":"1997","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3541","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00008877-200205000-00001","article-title":"The validity of animal models of predisposition to depression","volume":"13","author":"Willner","year":"2002","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3542","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jad.2004.12.010","article-title":"Dopaminergic mechanism of antidepressant action in depressed patients","volume":"86","author":"Willner","year":"2005","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3543","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/gps.1156","article-title":"A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis","volume":"19","author":"Wilson","year":"2004","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3544","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0361-9230(89)90040-3","article-title":"Direct effects of ovarian hormones on antidepressant binding sites","volume":"22","author":"Wilson","year":"1988","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3545","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0304-3959(00)00440-1","article-title":"Alternative diagnostic criteria for major depressive disorder in patients with chronic pain","volume":"91","author":"Wilson","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3546","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.euroneuro.2003.11.004","article-title":"Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram","volume":"14","author":"Wilson","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3547","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1126\/science.1105322","article-title":"Comparison of fine-scale recombination rates in humans and chimpanzees","volume":"308","author":"Winckler","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3548","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/da.1043","article-title":"Depression, sleep physiology, and antidepressant drugs","volume":"14","author":"Winokur","year":"2001","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3549","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4088\/JCP.v64n1013","article-title":"Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia","volume":"64","author":"Winokur","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3550","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.conb.2004.03.009","article-title":"Neuroendocrine basis of social recognition","volume":"14","author":"Winslow","year":"2004","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3551","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0091-3057(93)90016-M","article-title":"Antagonism of the stimulus effects of yohimbine and 8-hydroxy-2-(di-n-propylamino)tetralin","volume":"44","author":"Winter","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3552","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.pbb.2005.03.022","article-title":"Serotonergic\/glutamatergic interactions: potentiation of phencyclidine-induced stimulus control by citalopram","volume":"81","author":"Winter","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3553","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neulet.2004.09.015","article-title":"D1 but not D2 dopamine receptors or adrenoceptors mediate dopamine-induced potentiation of N-methyl-d-aspartate currents in the rat prefrontal cortex","volume":"372","author":"Wirkner","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3554","first-page":"358","article-title":"Novel antispychotics: comparison of weight gain liabilities","volume":"60","author":"Wirshing","year":"1999","journal-title":"J Clin Psychol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0361-9230(01)00487-7","article-title":"Localization of GABA(B) receptors in midbrain monoamine containing neurons in the rat","volume":"56","author":"Wirtshafter","year":"2001","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3556","series-title":"Psychopharmacology: The Fourth Generation of Progress","first-page":"999","article-title":"Biological rhythms in mood disorders","author":"Wirz-Justice","year":"1995"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3557","first-page":"29","article-title":"Circadian disturbances in depression: therapeutic perspectives","volume":"25","author":"Wirz-Justice","year":"2003","journal-title":"Medicographia"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3558","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0006-3223(99)00125-0","article-title":"Sleep deprivation in depression: what do we know, where do we go?","volume":"46","author":"Wirz-Justice","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3559","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1471-4159.1974.tb12198.x","article-title":"The effect of oestradiol dipropionate and progesterone on monoamine uptake in rat brain","volume":"22","author":"Wirz-Justice","year":"1974","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3560","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S0924270800037522","article-title":"Circadian rhythms and sleep regulation in seasonal affective disorder","volume":"7","author":"Wirz-Justice","year":"1995","journal-title":"Acta Neuropsychiat"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3561","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1126\/science.303.5657.467c","article-title":"Brightening depression","volume":"303","author":"Wirz-Justice","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3562","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0149-7634(89)80021-1","article-title":"Opiate reward: sites and substrates","volume":"13","author":"Wise","year":"1989","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3563","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.ps.40.020189.001203","article-title":"Brain dopamine and reward","volume":"40","author":"Wise","year":"1989","journal-title":"Ann Rev Psychol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3564","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.neuroscience.2005.02.003","article-title":"Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil","volume":"132","author":"Wisor","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3565","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1523\/JNEUROSCI.21-05-01787.2001","article-title":"Dopaminergic role in stimulant-induced wakefulness","volume":"21","author":"Wisor","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3566","first-page":"29","article-title":"Comorbidity in primary care: presentation and consequences","volume":"60","author":"Wittchen","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3567","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.0065-1591.2000.acp29-03.x","article-title":"Why do people with anxiety disorders become depressed? A prospective-longitudinal community study","volume":"102","author":"Wittchen","year":"2000","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3568","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/S0024-3205(03)00098-5","article-title":"Melatonin receptors and their regulation: biochemical and structural mechanisms","volume":"72","author":"Witt-Enderby","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3569","first-page":"878","article-title":"SLV-308. Solvay","volume":"4","author":"Wolf","year":"2003","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3570","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0006-8993(98)00625-8","article-title":"Attenuation of the lordosis-inhibiting effects of 8-OH-DPAT by TFMPP and quipazine","volume":"804","author":"Wolf","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3571","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0006-8993(99)01159-2","article-title":"5-HT2C receptor involvement in female rat lordosis behavior","volume":"825","author":"Wolf","year":"1999","journal-title":"Brain Res"},{"issue":"Suppl 1","key":"10.1016\/j.pharmthera.2005.11.006_bib3572","first-page":"S231","article-title":"Deficit in prepulse inhibition and enhanced sensitivity to amphetamine in mice lacking the trace amine-1 receptor","volume":"29","author":"Wolinsky","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3573","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0006-3223(96)00043-1","article-title":"Dehydroepiandrosterone (DHEA) treatment of depression","volume":"41","author":"Wolkowitz","year":"1997","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3574","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0006-3223(98)00267-4","article-title":"Antiglucocorticoid treatment of depression: double-blind ketoconazole","volume":"45","author":"Wolkowitz","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3575","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1176\/ajp.156.4.646","article-title":"Double-blind treatment of major depression with dehydroepiandrosterone","volume":"156","author":"Wolkowitz","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3576","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0091-3057(92)90190-Q","article-title":"Effects of chronic administration and withdrawal of antidepressant agents on circadian activity rhythms in rats","volume":"53","author":"Wollnick","year":"1992","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3577","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/35072566","article-title":"Research and treatment approaches to depression","volume":"2","author":"Wong","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3578","first-page":"136","article-title":"From monoamines to genomic targets: a paradigm shift for drug discovery in depression","volume":"3","author":"Wong","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3579","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.pnpbp.2003.09.005","article-title":"The dopamine D4 receptors and mechanisms of antipsychotic atypicality","volume":"27","author":"Wong","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3580","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0006-3223(99)00291-7","article-title":"Reboxetine: a pharmacologically-potent, selective, and specific norepinephrine reuptake inhibitor","volume":"47","author":"Wong","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3581","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0166-2236(96)10073-4","article-title":"Presynaptic nicotinic Ach receptors","volume":"20","author":"Wonnacott","year":"1997","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3582","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2174\/1568007033482698","article-title":"Therapeutic potential of 5-HT2C receptor antagonists in the treatment of anxiety disorders","volume":"2","author":"Wood","year":"2003","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3583","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0028-3908(01)00054-5","article-title":"SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety","volume":"41","author":"Wood","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3584","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1073\/pnas.0400208101","article-title":"Stress-induced structural remodelling in hippocampus: prevention by lithium treatment","volume":"101","author":"Wood","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3585","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1527-3458.2002.tb00237.x","article-title":"Nicotinic cholinergic modulation: galantamine as a prototype","volume":"8","author":"Woodruff-Pak","year":"2002","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3586","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.tree.2005.04.005","article-title":"Body size in ecological networks","volume":"20","author":"Woodward","year":"2005","journal-title":"Trends Ecol Evol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3587","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0896-6273(00)80487-0","article-title":"Null mutations lacking substance P: elucidating pain mechanisms by genetic pharmacology","volume":"20","author":"Woolf","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3588","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1006\/hbeh.1998.1466","article-title":"Estrogen-mediated structural and functional synaptic plasticity in the female rat hippocampus","volume":"34","author":"Woolley","year":"1998","journal-title":"Horm Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3589","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0028-3908(01)00056-9","article-title":"A role for 5-HT6 receptors in retention of spatial learning in the Morris water maze","volume":"41","author":"Woolley","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3590","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1568007043482561","article-title":"5-HT6 receptors","volume":"3","author":"Woolley","year":"2004","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3591","series-title":"Mental Health: New Understanding, New Hope","author":"World Health Organization","year":"2001"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3592","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1358\/dot.2003.39.11.799466","article-title":"Treatment of antidepressant-induced sexual dysfunction","volume":"39","author":"Worthington","year":"2003","journal-title":"Drugs Today"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3593","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00004850-200211000-00006","article-title":"Ropinirole for antidepressant-induced sexual dysfunction","volume":"17","author":"Worthington","year":"2002","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3594","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/sj.bjp.0702720","article-title":"Comparison of changes in the extracellular concentration of noradrenaline in rat frontal cortex induced by sibutramine or d-amphetamine: modulation by alpha2-adrenoceptors","volume":"127","author":"Wortley","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3595","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0306-4522(97)00683-0","article-title":"Dissociated central and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress: new insights into the secretory capacities of peptidergic neurons","volume":"85","author":"Wotjak","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3596","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1152\/physrev.00040.2003","article-title":"Molecular and cellular physiology of renal organic cation and anion transport","volume":"84","author":"Wright","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3597","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.410340312","article-title":"Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability","volume":"34","author":"Wright","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3598","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0006-8993(96)00859-1","article-title":"Subpallidal outputs to the nucleus accumbens and the ventral tegmental area: anatomical and electrophysiological studies","volume":"740","author":"Wu","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3599","doi-asserted-by":"crossref","first-page":"32776","DOI":"10.1074\/jbc.273.49.32776","article-title":"Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain","volume":"273","author":"Wu","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3600","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1176\/ajp.156.8.1149","article-title":"Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex","volume":"156","author":"Wu","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3601","first-page":"F449","article-title":"Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney","volume":"279","author":"Wu","year":"2000","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3602","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/S0893-133X(01)00336-0","article-title":"Clinical neurochemical implications of sleep deprivation's effects on the anterior cingulate of depressed responders","volume":"25","author":"Wu","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3603","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1124\/jpet.103.052514","article-title":"Acetylcholinesterase inhibitors activate septohippocamapal GABAergic neurons via muscarinic but not nicotinic receptors","volume":"307","author":"Wu","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3604","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1210\/jc.2003-030833","article-title":"Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: alterations in preclinical and clinical stages","volume":"88","author":"Wu","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3605","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1124\/jpet.104.070417","article-title":"Electrophysiological, pharmacological, and molecular evidence for \u03b17-nicotinic acetylcholine receptors in rat midbrain dopamine neurons","volume":"311","author":"Wu","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3606","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1152\/jn.00180.2004","article-title":"Group I metabotropic glutamate receptor activation produces a direct excitation of identified septohippocampal cholinergic neurons","volume":"92","author":"Wu","year":"2004","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3607","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1471-4159.2004.02526.x","article-title":"AMPA protects cultured neurons against glutamate excitotoxicity through a phsophatidylinositol 3-kinase-dependent activation in extracellular signal-regulated kinase to upregulate BDNF gene expression","volume":"90","author":"Wu","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3608","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng1242","article-title":"Evolutionary conservation of motif constituents in the yeast protein interaction network","volume":"35","author":"Wuchty","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3609","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/S0022-3565(24)35044-X","article-title":"Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release","volume":"290","author":"Xi","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3610","doi-asserted-by":"crossref","first-page":"21901","DOI":"10.1074\/jbc.M301905200","article-title":"A direct interaction of PSD-95 with 5-HT2A serotonin receptors regulates receptor trafficking and signal1 transduction","volume":"278","author":"Xia","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3611","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000026527","article-title":"Cellular and molecular actions of lamotrigine: possible mechanisms of efficacy in bipolar disorder","volume":"38","author":"Xie","year":"1998","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3612","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-5793(99)00918-7","article-title":"Serotonin 5-HT1B and 5-HT1D receptors form homodimers when expressed alone and heterodimers when co-expressed","volume":"456","author":"Xie","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3613","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1101\/gr.1304504","article-title":"The multi-assembly problem: reconstructing multiple transcript isoforms from EST fragment mixtures","volume":"14","author":"Xing","year":"2004","journal-title":"Genome Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3614","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.npp.1300009","article-title":"Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2 and Cu\/Zn-SOD in rat hippocampus","volume":"28","author":"Xu","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3615","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/sj.tpj.6500265","article-title":"Recovery of hippocampal cell proliferation and BDNF levels, both of which are reduced by repeated restraint stress, is accelerated by chronic venlafaxine","volume":"4","author":"Xu","year":"2004","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3616","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1073\/pnas.96.4.1463","article-title":"Biodiversity and ecosystem productivity in a fluctuating environment: the insurance hypothesis","volume":"96","author":"Yachi","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3617","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1176\/appi.ajp.162.4.683","article-title":"Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the multiple outcomes of raloxifene evaluation (MORE) randomized trial","volume":"162","author":"Yaffe","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3618","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0306-4522(02)00367-6","article-title":"\u03b12A and \u03b12C adrenoceptors on spinal neurons controlling penile erection","volume":"114","author":"Ya\u00efci","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3619","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.pbb.2003.12.024","article-title":"Dual effects of nitric oxide in the mouse forced swimming test: possible contribution of nitric oxide mediated serotonin release and potassium channel modulation","volume":"77","author":"Yalcin-Inan","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3620","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0014-2999(01)01240-7","article-title":"Effects of 5-HT2 receptor antagonists on the anti-immobility effects of imipramine in the forced swimming test with mice","volume":"427","author":"Yamada","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3621","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-8993(02)03684-3","article-title":"Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test","volume":"958","author":"Yamada","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3622","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0161-813X(03)00097-4","article-title":"Clinical pharmacology of MAO inhibitors: safety and future","volume":"25","author":"Yamada","year":"2004","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3623","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0028-3908(99)00126-4","article-title":"GABAB receptor-mediated presynaptic inhibition of glutamatergic and GABAergic transmission in the basolateral amygdala","volume":"38","author":"Yamada","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3624","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1440-1819.2003.01099.x","article-title":"Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: a randomized controlled trial","volume":"57","author":"Yamada","year":"2003","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3625","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejphar.2004.09.057","article-title":"Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test","volume":"504","author":"Yamada","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3626","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1163\/1569391041501898","article-title":"Antidepressant research in the era of functional genomics: farewell to the monoamine hypothesis","volume":"18","author":"Yamada","year":"2004","journal-title":"Biogenic Amines"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3627","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1440-1819.1998.00403.x","article-title":"Effects of trazodone hydrochloride and imipramine on polysomnography in healthy subjects","volume":"52","author":"Yamadera","year":"1998","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3628","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1046\/j.1471-4159.1998.71010274.x","article-title":"Regulation of extracellular dopamine by the norepinephrine transporter","volume":"71","author":"Yamamoto","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3629","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/00001756-200105080-00015","article-title":"Fluoxetine reduces l-dopa-derived extracellular DA in the 6-OHDA-lesioned rat striatum","volume":"12","author":"Yamato","year":"2001","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3630","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.pbb.2004.05.003","article-title":"Chronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats","volume":"78","author":"Yamauchi","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3631","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1385\/MN:26:2-3:203","article-title":"Regulation of GABAergic inhibition by serotonin signaling in prefrontal cortex: molecular mechanisms and functional implications","volume":"26","author":"Yan","year":"2002","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3632","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1074\/jbc.R400036200","article-title":"Unraveling the mechanism of protein N-glycosylation","volume":"280","author":"Yan","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3633","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1523\/JNEUROSCI.0406-05.2005","article-title":"Behavioral stress enhances hippocampal CA1 long-term depression through the blockade of the glutamate uptake","volume":"25","author":"Yang","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3634","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.molbrainres.2004.02.010","article-title":"Altered RNA editing of serotonin 5-HT2C receptor induced by interferon: implications for depression associated with cytokine therapy","volume":"124","author":"Yang","year":"2004","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3635","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0928-0987(98)00002-5","article-title":"Simultaneous activation of two different receptor systems by enkephalin\/neurotensin conjugates having spacer chains of various lengths","volume":"7","author":"Yano","year":"1998","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3636","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1176\/appi.ajp.160.2.334","article-title":"Inhibitory effect of hippocampal 5-HT1A receptors on human explicit memory","volume":"160","author":"Yasuno","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3637","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0306-4522(94)00612-9","article-title":"Glucocorticoids, hippocampal corticosteroid receptor gene expression and antidepressant treatment: relationship with partial learning in young and aged rats","volume":"66","author":"Yau","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3638","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1073\/pnas.071562698","article-title":"Lack of tissue glucocorticoid reactivation in 11\u03b2-hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments","volume":"98","author":"Yau","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3639","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1523\/JNEUROSCI.22-04-01436.2002","article-title":"Chronic treatment with the antidepressant amitriptyline prevents impairments in water maze learning in aging rats","volume":"22","author":"Yau","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3640","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.1073\/pnas.0306752101","article-title":"Network motifs in integrated cellular networks of transciption-regulation and protein\u2013protein interaction","volume":"101","author":"Yeger-Lotem","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3641","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s002139900316","article-title":"Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats","volume":"149","author":"Yildiz","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3642","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0091-3057(99)00133-1","article-title":"Anxiolytic-like effects of 7-nitroindazole in the rat plus-maze test","volume":"65","author":"Yildiz","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3643","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-2999(95)00684-2","article-title":"Melatonin analogues as agonist and antagonists in the circadian system and other brain areas","volume":"296","author":"Ying","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3644","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1096\/fj.02-0198fje","article-title":"Involvement of MAP kinase in the regulation of amyloid precursor protein processing by novel cholinesterase inhibitors derived from rasagiline","volume":"16","author":"Yogev-Falach","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3645","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000539-200207000-00029","article-title":"An investigation of monoamine receptors involved in antinociceptive effects of antidepressants","volume":"95","author":"Yokogawa","year":"2002","journal-title":"Anesth Analg"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3646","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.4088\/JCP.v65n1210","article-title":"Clinical characteristics of depressive symptoms in children and adolescents with major depressive disorder","volume":"65","author":"Yorbik","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3647","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0278-5846(98)00015-3","article-title":"Single and repeated electroconvulsive shocks activate dopaminergic and 5-hydroxytryptaminergic neurotransmission in the frontal cortex of rats","volume":"22","author":"Yoshida","year":"1998","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3648","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0278-5846(02)00267-1","article-title":"Monoamine oxidase: a gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder","volume":"26","author":"Yoshida","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3649","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1176\/appi.ajp.161.9.1575","article-title":"Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms","volume":"161","author":"Yoshida","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3650","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bbrc.2004.01.073","article-title":"Increased cell proliferation in the adult mouse hippocampus following chronic administration of group II metabotropic glutamate receptor antagonist, MGS0039","volume":"315","author":"Yoshimizu","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3651","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0197-0186(01)00079-1","article-title":"Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT1A receptors in the rat medial frontal cortex","volume":"40","author":"Yoshino","year":"2002","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3652","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neulet.2004.03.079","article-title":"Perospirone, a novel atypical antipsychotic drug, potentiates fluoxetine induced increases in dopamine levels via multireceptor actions in the rat medial prefrontal cortex","volume":"364","author":"Yoshino","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3653","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tips.2004.11.007","article-title":"Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders","volume":"26","author":"Youdim","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3654","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1749-6632.2001.tb03656.x","article-title":"The anti-Parkinson drug rasagiline and its cholinesterase inhibitor derivatives exert neuroprotection unrelated to MAO inhibition in cell culture and in vivo","volume":"931","author":"Youdim","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3655","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/jnr.20350","article-title":"Rasagiline: neurodegeneration, neuroprotection, and mitochondrial permeability transition","volume":"79","author":"Youdim","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3656","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.mad.2004.08.023","article-title":"Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases","volume":"126","author":"Youdim","year":"2005","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3657","first-page":"291","article-title":"Verbal memory and plasma drug concentration in elderly depressives treated with nortriptyline","volume":"27","author":"Young","year":"1991","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3658","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s002130051057","article-title":"The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers","volume":"145","author":"Young","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3659","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/archpsyc.58.1.55","article-title":"The quality of care for depressive and anxiety disorders in the United States","volume":"58","author":"Young","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3660","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1176\/appi.ajp.159.7.1237","article-title":"Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients","volume":"159","author":"Young","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3661","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/sj.npp.1300471","article-title":"Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder","volume":"29","author":"Young","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3662","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.psyneuen.2004.02.002","article-title":"HPA axis activation in major depression and response to fluoxetine: a pilot study","volume":"29","author":"Young","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3663","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.npp.1300393","article-title":"Nicotine improves sustained attention in mice: evidence for involvement of the alpha7 nicotinic acetylcholine receptor","volume":"29","author":"Young","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3664","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1021\/jm00086a018","article-title":"Novel naphthalenic ligands with high affinity for the melatonin receptor","volume":"35","author":"Yous","year":"1992","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3665","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tig.2004.04.008","article-title":"Genomic analysis of essentiality within protein networks","volume":"20","author":"Yu","year":"2004","journal-title":"Trends Genet"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3666","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nrn1686","article-title":"The cortex as a central pattern generator","volume":"6","author":"Yuste","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3667","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0149-7634(05)80032-6","article-title":"Stressor-induced anhedonia in the mesocorticolimbic system","volume":"15","author":"Zacharko","year":"1991","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3668","first-page":"7","article-title":"Treating depression for remission","volume":"64","author":"Zajecka","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3669","first-page":"11","article-title":"SNRIs in the management of acute major depressive disorder","volume":"65","author":"Zajecka","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3670","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4088\/JCP.v63n0809","article-title":"Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination","volume":"63","author":"Zajecka","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3671","first-page":"111","article-title":"On the nature and pattern of neurocognitive function in major depressive disorder","volume":"11","author":"Zakzanis","year":"1998","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3672","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrd987","article-title":"Knockouts model the 100 best-selling drugs- will they model the next 100?","volume":"2","author":"Zambrowicz","year":"2003","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3673","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00004714-199812000-00004","article-title":"Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: a controlled study","volume":"18","author":"Zanardi","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3674","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4088\/JCP.v61n0107","article-title":"Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study","volume":"61","author":"Zanardi","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3675","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1097\/00001756-200212200-00005","article-title":"Transcranial magnetic stimulation induces increases in extracellular levels of dopamine and glutamate in the nucleus accumbens","volume":"13","author":"Zangen","year":"2002","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3676","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0306-4522(01)00612-1","article-title":"Impaired release of \u03b2-endorphin in response to serotonin in a rat model of depression","volume":"110","author":"Zangen","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3677","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1471-4159.2002.00893.x","article-title":"D3 receptor ligands modulate extracellular dopamine clearance in the nucleus accumbens","volume":"81","author":"Zapata","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3678","first-page":"35","article-title":"Modulators of the glutamatergic system: implications for the development of improved therapeutics in mood disorders","volume":"36","author":"Zarate","year":"2003","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3679","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/0269881103017001709","article-title":"Adrenoceptor mechanisms underlying imipramine-induced memory deficits in rats","volume":"17","author":"Zarrindast","year":"2003","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3680","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.euroneuro.2004.02.002","article-title":"The effect of electroconvulsive shock seizures on behaviour induced by dopaminergic agonists and on immobility in the Porsolt test","volume":"14","author":"Zarrindast","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3681","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0924-977X(03)00068-3","article-title":"GABAergic system and imipramine-induced impairment of memory retention in rats","volume":"14","author":"Zarrindast","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3682","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4088\/JCP.v66n0316","article-title":"The efficacy and safety of the melatonin agonist \u03b2-methyl-6-chloromelatonin in primary insomnia: a randomised, placebo-controlled, crossover clinical trial","volume":"66","author":"Zemlan","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3683","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3928\/0048-5713-19871001-11","article-title":"Melatonin in depression","volume":"17","author":"Zetin","year":"1987","journal-title":"Psychiatr Ann"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3684","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0169-328X(98)00077-1","article-title":"Repeated electroconvulsive shock extends the duration of enhanced gene expression of BDNF in rat brain compared with a single administration","volume":"57","author":"Zetterstrom","year":"1998","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3685","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0169-5347(03)00033-8","article-title":"Evolution by gene duplication: an update","volume":"18","author":"Zhang","year":"2003","journal-title":"Trends Ecol Evol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3686","doi-asserted-by":"crossref","first-page":"10585","DOI":"10.1523\/JNEUROSCI.23-33-10585.2003","article-title":"Glutamate spillover in the striatum depresses dopaminergic transmission by activating group I metabotropic glutamate receptors","volume":"23","author":"Zhang","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3687","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s002130000414","article-title":"Effects of rolipram on scopolamine-induced impairment of working and reference memory in the radial-arm maze tests in rats","volume":"150","author":"Zhang","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3688","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1126\/science.290.5498.1955","article-title":"A primitive enantiornithine bird and the origin of feathers","volume":"290","author":"Zhang","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3689","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0893-133X(00)00119-6","article-title":"Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex","volume":"23","author":"Zhang","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3690","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s002130100889","article-title":"Comparison of the effects of isoproterenol administered into the hippocampus, frontal cortex, or amygdala on behavior of rats maintained by differential reinforcement of low response rats","volume":"159","author":"Zhang","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3691","first-page":"587","article-title":"Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme","volume":"27","author":"Zhang","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3692","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00213-003-1512-0","article-title":"Antagonism of the antidepressant-like effects of clenbuterol by central administration of \u03b2-adrenergic antagonists in rats","volume":"170","author":"Zhang","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3693","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1101\/gr.1429003","article-title":"Millions of years of evolution preserved: a comprehensive catalog of the processed pseudogenes in the human genome","volume":"13","author":"Zhang","year":"2003","journal-title":"Genome Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3694","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.brainres.2004.09.017","article-title":"Substance P promotes sleep in the ventrolateral preoptic area of rats","volume":"1028","author":"Zhang","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3695","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/sj.npp.1300440","article-title":"Inhibition of the phosphodiesterase 4 (PDE4) enzyme reverses memory deficits produced by infusion of the MEK inhibitor U0126 into the CAI subregion of the rat hippocampus","volume":"29","author":"Zhang","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3696","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1097540","article-title":"Tryptophan hydroxylase-2 controls brain serotonin synthesis","volume":"305","author":"Zhang","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3697","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/molbev\/msi034","article-title":"Divergence pattern of duplicate genes in protein\u2013protein interactions follows the power law","volume":"22","author":"Zhang","year":"2004","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3698","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2004.12.014","article-title":"Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression","volume":"45","author":"Zhang","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3699","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1124\/jpet.103.053215","article-title":"Antidepressant-induced increase in high-affinity rolipram binding sites in rat brain: dependence on noradrenergic and serotonergic function","volume":"307","author":"Zhao","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3700","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1358\/dof.2004.029.12.855246","article-title":"Norepinephrine transporter inhibitors and their therapeutic potential","volume":"29","author":"Zhou","year":"2004","journal-title":"Drugs Future"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3701","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.tins.2004.05.006","article-title":"Reversal and consolidation of activity-induced synaptic modifications","volume":"27","author":"Zhou","year":"2004","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3702","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1001\/archpsyc.58.7.655","article-title":"Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression","volume":"58","author":"Zhou","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3703","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0006-8993(01)02747-0","article-title":"Metabotropic glutamate 1\u03b1 receptors on peripheral primary afferent fibers: their role in nociception","volume":"913","author":"Zhou","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3704","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0006-8993(02)02709-9","article-title":"Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative","volume":"942","author":"Zhou","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3705","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1021\/jm040117o","article-title":"Piperidine-based nocaine\/modafinil hybrid ligands as highly potent monoamine transporter inhibitors: efficient drug discovery by rational lead hybridisation","volume":"47","author":"Zhou","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3706","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neuron.2005.02.010","article-title":"Corelease of dopamine and serotonin from striatal dopamine terminals","volume":"46","author":"Zhou","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3707","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1124\/mol.65.6.1462","article-title":"Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation","volume":"65","author":"Zhu","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3708","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2004.09.023","article-title":"Stimulation of serotonin transport by the cyclic GMP phosphodiesterase-5 inhibitor sildenafil","volume":"504","author":"Zhu","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3709","doi-asserted-by":"crossref","first-page":"15649","DOI":"10.1074\/jbc.M410858200","article-title":"p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, PP2A-dependent process","volume":"280","author":"Zhu","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3710","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.molbrainres.2004.10.009","article-title":"Effects of desipramine treatment on tyrosine hydroxylase gene expression in cultured neuroblastoma cells and rat brain tissue","volume":"133","author":"Zhu","year":"2005","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3711","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/cne.20445","article-title":"Organization and regulation of paraventricular nucleus glutamate signalling systems: NMDA receptors","volume":"484","author":"Ziegler","year":"2005","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3712","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1515\/REVNEURO.2004.15.4.253","article-title":"TMS induced plasticity in human cortex","volume":"15","author":"Ziemann","year":"2004","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3713","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.euroneuro.2003.10.002","article-title":"Regional mRNA expression of a second tryptophan hydroxylase isoform in postmortem tissue samples of two human brains","volume":"14","author":"Zill","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3714","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.biopsych.2004.07.015","article-title":"Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims","volume":"56","author":"Zill","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3715","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1176\/appi.ajp.160.3.504","article-title":"Generalized anxiety disorder in patients with major depression: is DSM-IV's hierarchy correct?","volume":"160","author":"Zimmerman","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3716","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0022-3956(03)00018-9","article-title":"Epidemiology, implications and mechanisms underlying drug-induced weight pain in psychiatric patients","volume":"37","author":"Zimmerman","year":"2003","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3717","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1176\/appi.ajp.161.7.1285","article-title":"Which factors influence psychiatrists' selection of antidepressants?","volume":"161","author":"Zimmerman","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3718","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/01.jcp.0000155824.59585.46","article-title":"Is it time to replace the Hamilton depression rating scale as the primary outcome measure in treatment studies of depression?","volume":"25","author":"Zimmerman","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3719","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1176\/ajp.151.8.1153","article-title":"The DSM-IV field trial for mixed anxiety-depression","volume":"151","author":"Zinbarg","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3720","first-page":"189","article-title":"Neurochemical effects of electrically and chemically induced seizures: an in vivo microdialysis study in the rat hippocampus","volume":"7","author":"Zis","year":"1992","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3721","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1176\/ajp.156.11.1736","article-title":"Depressive symptoms in schizophrenia","volume":"156","author":"Zisook","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3722","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ardp.200400996","article-title":"Recent advances in melatonin receptor ligands","volume":"338","author":"Zlotos","year":"2005","journal-title":"Arch Pharm Chem Life Sci"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3723","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0022-3956(00)00016-9","article-title":"Effects of the high-affinity corticotropin-releasing hormone receptor1 antagonist R121919 in major depression: the first 20 patients treated","volume":"34","author":"Zobel","year":"2000","journal-title":"J Psychiatric Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3724","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0304-3940(03)00305-7","article-title":"Effects of antidepressant drugs and GR205171, an neurokinin1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse","volume":"345","author":"Zocchi","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3725","series-title":"Sleep","first-page":"135","article-title":"The neurochemistry of sleep","author":"Zoltoski","year":"1994"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3726","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neuroscience.2004.06.072","article-title":"Chronic antidepressant treatment alters serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons","volume":"129","author":"Zong","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3727","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0006-8993(02)03345-0","article-title":"Urocortin shares the memory modulating effects of corticotropin-releasing factor (CRF): mediation by CRF1 receptors","volume":"952","author":"Zorrilla","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3728","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.b.20073","article-title":"Genome-wide linkage survey for genetic loci that influence the development of depressive disorders in families with recurrent, early-onset, major depression","volume":"123B","author":"Zubenko","year":"2003","journal-title":"Am J Med Gen"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3729","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1126\/science.1060952","article-title":"Regional mu opioid receptor regulation of sensory and affective dimensions of pain","volume":"293","author":"Zubieta","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3730","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/archpsyc.60.11.1145","article-title":"Regulation of human affective responses by anterior cingulate and limbic \u03bc-opioid neurotransmission","volume":"60","author":"Zubieta","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3731","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-2001-15873","article-title":"Lithium augmentation in depressive patients not responding to selective serotonin reuptake inhibitors","volume":"34","author":"Zullino","year":"2001","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pharmthera.2005.11.006_bib3732","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00004714-200104000-00021","article-title":"Lithium augmentation in venlafaxine-refractory depression","volume":"21","author":"Zullino","year":"2001","journal-title":"J Clin Psychopharmacol"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372580500269X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372580500269X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T01:07:50Z","timestamp":1736384870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016372580500269X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":3730,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S016372580500269X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2005.11.006","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}